<?xml version='1.0' encoding='utf-8'?>
<graphml xmlns="http://graphml.graphdrawing.org/xmlns" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://graphml.graphdrawing.org/xmlns http://graphml.graphdrawing.org/xmlns/1.0/graphml.xsd">
  <key id="d7" for="edge" attr.name="order" attr.type="long" />
  <key id="d6" for="edge" attr.name="source_id" attr.type="string" />
  <key id="d5" for="edge" attr.name="description" attr.type="string" />
  <key id="d4" for="edge" attr.name="weight" attr.type="double" />
  <key id="d3" for="node" attr.name="clusters" attr.type="string" />
  <key id="d2" for="node" attr.name="source_id" attr.type="string" />
  <key id="d1" for="node" attr.name="description" attr.type="string" />
  <key id="d0" for="node" attr.name="entity_type" attr.type="string" />
  <graph edgedefault="undirected">
    <node id="&quot;GENDER&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Gender was not significantly associated with social disinhibition score."&lt;SEP&gt;"The text discusses gender as a demographic characteristic of the participants in various studies."</data>
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed&lt;SEP&gt;chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;AGE&quot;">
      <data key="d0">"TIME FACTOR"</data>
      <data key="d1">"Age is a demographic factor that was recorded in the study's participants to categorize them into three distinct groups: IBS-D, IBS-C, and HV."&lt;SEP&gt;"No evidence of interaction between age and the association of TCF7L2 variants with type 2 diabetes risk was found.")&lt;SEP&gt;"No genotype-time interaction on changes in body composition was found in response to the low-protein diet within any age groups."&lt;SEP&gt;"There is an age-related difference observed, with men being older than women."&lt;SEP&gt;"There was no significant difference in age between groups, aiding in controlling for potential confounding variables."&lt;SEP&gt;"Participants in the study had varying ages which can be considered an environmental factor influencing their physiological and metabolic status."&lt;SEP&gt;"The increase in CD8+ TEM cells is noted to occur over time as children grow older."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589&lt;SEP&gt;chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6&lt;SEP&gt;chunk-770a24a1a31cf671a7681e7c98a7ee91&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d&lt;SEP&gt;chunk-6a7c69534e11aa2fc4bd948484aa81c4&lt;SEP&gt;chunk-2926e6216bf945b12ea4daa6345cad1f&lt;SEP&gt;chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 10}]</data>
    </node>
    <node id="&quot;OBESITY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The incidence of metabolic syndrome was much higher in the obese groups compared to nonobese participants."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;SKELETAL MUSCLE MASS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Skeletal muscle mass is a component that differs between obese and nonobese individuals."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;HEIGHT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"There was no height difference linked to obesity in men, indicating an environmental factor influencing this characteristic."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;WAIST CIRCUMFERENCE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The waist circumference is higher in the obese group than nonobese individuals, possibly related to dietary patterns."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;DIETARY PATTERNS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Daily energy intake based on estimated energy intake was higher among the obese groups."&lt;SEP&gt;"Various dietary patterns have been shown to influence the expression of genes like FoxO1, which can impact both physiological processes such as neuronal proliferation and metabolic pathways involved in mental health disorders."&lt;SEP&gt;"Dietary patterns are influenced by various factors, including nutrient intake which can impact overall health."&lt;SEP&gt;"The study suggests that dietary patterns may influence the physiological process of BA synthesis and excretion, with elevated levels being more common among those in IBS-D as compared to other subgroups.")</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98&lt;SEP&gt;chunk-fa6293a0a10f175b4aebac8e885c0d20&lt;SEP&gt;chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6&lt;SEP&gt;chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;PROTEIN INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Protein intake also elevated obesity risk according to daily energy intake in the text."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;CARBOHYDRATE INTAKE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Baseline carbohydrate intake did not influence FTO rs1558902-associated weight loss or body composition interactions with dietary protein and fat at 6 months."&lt;SEP&gt;"In women, carbohydrate intake was higher among the obesity group than nonobese individuals."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f&lt;SEP&gt;chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;FATTY ACIDS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The intakes of fat including saturated, monounsaturated, polyunsaturated fatty acids and cholesterol were slightly higher in men but showed an opposite tendency in women."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;DII&quot;">
      <data key="d0">"DIETARY INDEX"</data>
      <data key="d1">"DII was similar among the obese and nonobese groups, with a higher DII observed in men than women."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;FRIED FOODS INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The intake of fried foods was significantly higher among both genders but did not impact obesity risk according to the text."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;SUGAR-CONTAINING FOODS INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The intake of sugar-containing foods was higher in nonobese women than obese women, suggesting a different dietary pattern associated with obesity.") ("entity"</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;BLOOD PRESSURE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Blood pressure, including systolic blood pressure (SBP) and diastolic blood pressure (DBP), was higher among the obese group compared to the nonobese participants."&lt;SEP&gt;"Hypertensive patients were more prevalent among the HUA group compared to controls, despite no significant differences in blood pressure between groups."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd&lt;SEP&gt;chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;HDL CONCENTRATIONS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The serum HDL concentrations were found to be significantly higher in women than men."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;LDL CONCENTRATIONS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Serum LDL concentrations were much lower among the obese group compared to nonobese individuals, which could contribute to cardiovascular risk factors."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;TRIGLYCERIDE LEVELS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The serum triglyceride levels were higher in men than women and observed at a greater extent in the obese group."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;HS-CRP CONCENTRATIONS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Obese women had significantly higher hs-CRP concentrations compared to nonobese women, indicating an inflammatory response related to obesity."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;EGFR&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"eGFR (estimated glomerular filtration rate) is a key indicator of renal function and overall health status."&lt;SEP&gt;"eGFR was lower among the obese group compared to the nonobese participants."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391&lt;SEP&gt;chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;AST LEVELS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) concentrations were significantly higher in both genders within the obese groups."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;PHYSICAL ACTIVITY&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Lifestyle factors including physical activity can modulate cardiovascular risk through their effects on genetic variants linked to PBC."&lt;SEP&gt;"Lifestyle factors including physical activity can modulate cardiovascular risk through their effects on genetic variants linked to increased risk of developing PBC."&lt;SEP&gt;"Physical activity levels among participants within the association analysis are a lifestyle factor that may influence their overall health outcomes related to diet and exercise behaviors such as adherence to dietary patterns involving black or sugared coffee, which can affect their risk for developing type 2 diabetes and prediabetes."])(relationship&lt;SEP&gt;"Regular exercise was inversely associated with obesity risk, particularly for women but not men according to this text."&lt;SEP&gt;"Regular physical activity is a lifestyle factor that can influence cardiovascular health.")&gt;3 ("relationship"</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b&lt;SEP&gt;chunk-72f4505e43f67f3564607392cb178656&lt;SEP&gt;chunk-f02653cb486dbf68cc259f74ea8b2b2e&lt;SEP&gt;chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;PRS (POLYMORPHISM RS1799982)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Polymorphism rs1799982 is associated with obesity risk."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d3">[{"level": 0, "cluster": 8}]</data>
    </node>
    <node id="&quot;MENARCHE AGE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Early menarche age influences the impact of PRS on obesity risk."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;MENOPAUSE AGE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"No significant interaction between PRS and menopausal age was observed in women for obesity risk."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d3">[{"level": 0, "cluster": 8}]</data>
    </node>
    <node id="&quot;BMI (BODY MASS INDEX)&quot;">
      <data key="d0">"PHYSIOLOGICAL MEASURE"</data>
      <data key="d1">"BMI is higher in participants with early menarche, indicating a possible genetic influence."&lt;SEP&gt;"Higher BMI indicates a higher obesity risk in individuals with early menarche age."&lt;SEP&gt;"BMI measures body fat based on height and weight, helping to gauge the overall health of individuals in terms of obesity levels."])(("relationship"</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e&lt;SEP&gt;chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;DIETARY PATTERN&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A low-protein diet is part of the environmental factors influencing the management of patients with hypoglycaemia."&lt;SEP&gt;"Plant-based diet intake shows an interaction with PRS to affect obesity risk."&lt;SEP&gt;"The dietary patterns of patients with CHI symptoms have been studied to determine treatment effectiveness.")&lt;SEP&gt;"No dietary patterns linked to 'Number of Teeth' in the given text."&lt;SEP&gt;"No dietary patterns linked to Age at First Tooth or Number of Teeth based on provided text."&lt;SEP&gt;"Dietary patterns influence the transcript of the NOS1 gene and folate metabolism."&lt;SEP&gt;"The mention of dietary patterns suggests analysis or consideration related to nutritional habits and health outcomes."&lt;SEP&gt;"Dietary patterns influence the transcript of the NOS1 gene and folate metabolism."&lt;SEP&gt;"Dietary patterns influence molecular interactions affecting nitric oxide regulation."&lt;SEP&gt;"The platinum-free interval is a dietary pattern factor that influences drug response in cancer treatment."&lt;SEP&gt;"The type of dietary pattern among patients can be an environmental factor that influences their overall health status and response to cancer treatments like paclitaxel-carboplatin or carboplatin mono-therapy.")&lt;SEP&gt;"Dietary patterns influence the transcript of the NOS1 gene and folate metabolism."&lt;SEP&gt;"Dietary patterns are associated with gene expression and susceptibility to PBC through the CTLA4 gene variants identified here."&lt;SEP&gt;"The dietary patterns of individuals are associated with gene expression and susceptibility to PBC through the CTLA4 gene variants identified here."&lt;SEP&gt;"The study incorporates available continuous covariates, which may include diet-related factors."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf&lt;SEP&gt;chunk-561eacb5d916258d3ed4f08f53587404&lt;SEP&gt;chunk-4964b2db9e3ddddb4967fb7150e4404d&lt;SEP&gt;chunk-f02653cb486dbf68cc259f74ea8b2b2e&lt;SEP&gt;chunk-c63d60b991cd7442f690dcc364af47dd&lt;SEP&gt;chunk-3ad8ef794841d749e48b3223741e91d3&lt;SEP&gt;chunk-2b81371954b99facae9a0056e70aa7bd&lt;SEP&gt;chunk-e8f81fdd25a22582c6ce3d1e15f74af3&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-734cac289b42d37dad32bd51ea24a1ea&lt;SEP&gt;chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 14}, {"level": 2, "cluster": 16}]</data>
    </node>
    <node id="&quot;FRIED FOOD INTAKE&quot;">
      <data key="d0">"NUTRIENT INTAKE"</data>
      <data key="d1">"Fried food intake exhibits an interaction with PRS, influencing BMI scores."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d3">[{"level": 0, "cluster": 8}]</data>
    </node>
    <node id="&quot;GENE&quot;">
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182&lt;SEP&gt;chunk-bcd248f7a9b2453bfc563b9439fbdd51&lt;SEP&gt;chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6&lt;SEP&gt;chunk-37088dc7c337929125b7fb31c9bf64cf&lt;SEP&gt;chunk-e323b0d4f82733a78f687e51f47b500a&lt;SEP&gt;chunk-f921f48a406901d82ec2e32af99485bf&lt;SEP&gt;chunk-13862d7ab74f5d4fa3f2261984d15d64&lt;SEP&gt;chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f&lt;SEP&gt;chunk-e8f81fdd25a22582c6ce3d1e15f74af3&lt;SEP&gt;chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-eec0b4c60ebeb28599428b3552de2d1b&lt;SEP&gt;chunk-6135f8baf39fe26dcea3d987aa6100ac&lt;SEP&gt;chunk-c29d575e156569afaa1ca3d6418a71b9&lt;SEP&gt;chunk-34ffb077c584b98555081f882f8f8b94&lt;SEP&gt;chunk-1b40d071abac0ba432a9fb0096796f45&lt;SEP&gt;chunk-089bcdf055eb2f007db49dbe2409429b&lt;SEP&gt;chunk-2b5346dfc62015294aa57aeab3960cd1&lt;SEP&gt;chunk-bc2193bd869a06007022e1aa75877336&lt;SEP&gt;chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d1"> The entity "GENE" encompasses various genes pivotal for diverse cellular functions and physiological processes across multiple biological systems. These entities play significant roles influencing migration, proliferation, regulation of stress response pathways, neuronal communication, lipid metabolism, cellular architecture stability, and overall physiological responses to environmental stress stimuli. For instance, they are associated with disorders such as Autosomal Recessive Renal Disorder C (ARRDCDC4) and influence EPHAICED2 signaling pathway related to cellular migration and proliferation for the epidermally expressed HERGohn gene. Genes like F-box only protein 32 modulate proteasomal degradation of proteins involved in cell cycle regulation; while FOXO1 and FOXP3 influence metabolism, stress response, and longevity directly.\n\nFurthermore, GENE is linked to physiological processes such as Heat Shock Factor signaling pathway for Heat Shock Factor 2 gene, interaction with LDLRAP1 crucial for lipid metabolism via ISOCHORISMATASE DOMAIN CONTAINING 1 (ISOC1) gene involved in synaptic plasticity and neuronal communication through Leucine-rich repeat neuronal protein 3 (LRRN3), affecting receptor-mediated endocytosis pathways related to cholesterol homeostasis for Low Density Lipoprotein Receptor Adapter Protein 1 (LDLRAP1). The impact of genetic factors on smoking status has been investigated with no significant gene–diet interaction, but the potential influence of other genes like GCKR associated with glucose-increasing C allele rs780094 showing significant association with elevated levels of beta-hydroxybutyrate (BHB).\n\nSpecific genes such as Arachidonate 5-lipoxygenase linked to a decreased risk of ovarian cancer at p &lt; 0.01 and Nitric oxide synthase 3 associated with an increased risk of hypertension are also highlighted, illustrating the complex interplay between genetic variations and disease susceptibility.\&lt;SEP&gt;"The PTPN2 gene is associated with autoimmune diseases such as celiac disease, inflammatory bowel disease, rheumatoid arthritis and type 1 diabetes.")|&gt;1&lt;SEP&gt;"The STAT5B gene plays a critical role in regulating immune cell levels, particularly for T cells."</data>
      <data key="d0">"STAT5B"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;SEC16B_RS543874&quot;">
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d1">"SEC16B is a Gene involved in endoplasmic reticulum export factor, regulating physiological processes related to energy intake.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;DNAJC27_RS713586&quot;">
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d1">"DNAJC27 is a Gene that functions as part of the heat shock protein family involved in cellular stress responses and energy regulation.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;BDNF_RS6265&quot;">
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d1">"BDNF (Brain-Derived Neurotrophic Factor) is a Protein associated with neuronal survival and synaptic plasticity, influencing cognitive functions and energy expenditure.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PROTEIN&quot;">
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182&lt;SEP&gt;chunk-eec0b4c60ebeb28599428b3552de2d1b&lt;SEP&gt;chunk-f02653cb486dbf68cc259f74ea8b2b2e&lt;SEP&gt;chunk-6135f8baf39fe26dcea3d987aa6100ac&lt;SEP&gt;chunk-c29d575e156569afaa1ca3d6418a71b9&lt;SEP&gt;chunk-c63d60b991cd7442f690dcc364af47dd&lt;SEP&gt;chunk-4964b2db9e3ddddb4967fb7150e4404d&lt;SEP&gt;chunk-814fe155e9cb953da61f6a79d1d25784&lt;SEP&gt;chunk-380a8a6e0d08cd28068a146ae5e00ce4&lt;SEP&gt;chunk-e097891654194982dfc0ef87401d3aa9&lt;SEP&gt;chunk-089bcdf055eb2f007db49dbe2409429b&lt;SEP&gt;chunk-734cac289b42d37dad32bd51ea24a1ea&lt;SEP&gt;chunk-e8f81fdd25a22582c6ce3d1e15f74af3&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-e323b0d4f82733a78f687e51f47b500a&lt;SEP&gt;chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d1">"BDNF (Brain-Derived Neurotrophic Factor) is a Protein associated with neuronal survival and synaptic plasticity, influencing cognitive functions and energy expenditure.")&lt;SEP&gt;"Myosin ID is involved in actin cytoskeleton organization and cell motility affecting cellular architecture stability."&lt;SEP&gt;"Transforming growth factor beta 1 is a protein involved in cellular processes such as cell proliferation and apoptosis which can influence ovarian cancer risk."&lt;SEP&gt;"SNPs for Age at First Tooth are associated with proteins involved in tooth development."&lt;SEP&gt;"SNPs for Number of Teeth are associated with proteins regulating tooth number."&lt;SEP&gt;"The NOS1 protein interacts with folate metabolism to maintain vascular function."&lt;SEP&gt;"The NOS1 protein is involved in vascular function and interacts with folate metabolism."&lt;SEP&gt;"The NOS1 protein is involved in cardiovascular health, but not associated with colorectal cancer risk."&lt;SEP&gt;"Metabolic Pathway"&lt;SEP&gt;"Molecular Interaction"&lt;SEP&gt;"The mention of 'B12' suggests a protein (possibly B12-related) under study or discussion."&lt;SEP&gt;"The NOS1 protein is critical for regulating nitric oxide production in cardiovascular health."&lt;SEP&gt;"The study examines protein-related aspects of genes associated with migraine, as indicated by genomic variants and transcript analysis."&lt;SEP&gt;"FANCD2 is another protein essential for DNA repair and cellular responses to DNA damage, working in conjunction with FANCI."&lt;SEP&gt;"FANCI is a protein involved in DNA repair, specifically required for the response to DNA damage. It binds to other proteins like FANCD2 to perform its function."&lt;SEP&gt;"The NOS1 protein is involved in vascular function and interacts with folate metabolism."&lt;SEP&gt;"The ERCC2 protein interacts with genes and genomic variants related to PFI and OS."&lt;SEP&gt;"The NOS1 protein interacts with folate metabolism to maintain vascular function."&lt;SEP&gt;"The PTPN2 protein interacts with other proteins involved in immune signaling pathways, affecting disease susceptibility."&lt;SEP&gt;"CTLA4 protein is associated with increased risk of developing PBC through the identified genetic variants in this study."&lt;SEP&gt;"CTLA4 protein is associated with increased susceptibility to PBC through the identified genetic variants in this study."&lt;SEP&gt;"The gene or variant may encode a protein relevant to CAD risk."&lt;SEP&gt;"The STAT5B protein is important for maintaining T cells but may also affect memory CD8+ T cells as well."</data>
      <data key="d0">"STAT5B PROTEIN"</data>
    </node>
    <node id="&quot;MC4R_RS6567160&quot;">
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d1">"MC4R (Melanocortin-4 Receptor) is a Gene involved in the regulation of appetite and body weight through its protein product, which interacts with other genes to control energy balance.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;GIPR_RS1444988703&quot;">
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d1">"GIPR (Glucose-Dependent Insulinotropic Peptide Receptor) is a Gene that plays a key role in glucose homeostasis and energy expenditure, influencing obesity risk.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;OLFM4_RS9568856&quot;">
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d1">"OLFM4 is a Protein involved in various cellular processes including cell adhesion and growth regulation, crucial for physiological functions related to body weight management.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FTO_RS1421085&quot;">
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d1">"FTO (Fat Mass and Obesity Associated Gene) is a Nutrient associated gene that modulates energy homeostasis, influencing obesity risk through its impact on appetite regulation.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 12}]</data>
    </node>
    <node id="&quot;NUTRIENT&quot;">
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b&lt;SEP&gt;chunk-f02653cb486dbf68cc259f74ea8b2b2e&lt;SEP&gt;chunk-c63d60b991cd7442f690dcc364af47dd&lt;SEP&gt;chunk-814fe155e9cb953da61f6a79d1d25784&lt;SEP&gt;chunk-e8f81fdd25a22582c6ce3d1e15f74af3&lt;SEP&gt;chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-734cac289b42d37dad32bd51ea24a1ea&lt;SEP&gt;chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d1">"FTO (Fat Mass and Obesity Associated Gene) is a Nutrient associated gene that modulates energy homeostasis, influencing obesity risk through its impact on appetite regulation.")&lt;SEP&gt;"No specific nutrients mentioned as directly related to 'Age at first tooth' or 'Number of teeth'."&lt;SEP&gt;"No specific nutrients mentioned as directly related to 'Number of teeth' based on provided text."&lt;SEP&gt;"Serum selenium concentration showed a protective effect against colorectal tumor risk as measured by the WHI Observational Study."&lt;SEP&gt;"No specific nutrients mentioned in this context, but the use of 'folate' indicates relevance to biochemical processes involving vitamins and other micronutrients."&lt;SEP&gt;"The dietary patterns of individuals with genetic polymorphisms in genes associated with migraine may also play a role in disease development.")&lt;SEP&gt;"No significant correlations were found for OS or PFI, which are influenced by the ERCC2 gene and its variants."&lt;SEP&gt;"The dietary patterns of individuals, particularly their intake of folate and other nutrients important for cardiovascular health, may influence gene expression and susceptibility to PBC."&lt;SEP&gt;"The dietary patterns of individuals, particularly their intake of folate and other nutrients, may influence gene expression and risk for PBC."&lt;SEP&gt;"No specific nutrient mentioned in the text but could be related to overall dietary patterns."</data>
      <data key="d0">"NUTRIENT"</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 12}]</data>
    </node>
    <node id="&quot;CDKAL1_RS9356744&quot;">
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d1">"CDKAL1 is a Protein involved in the regulation of insulin secretion and glucose metabolism, which affects energy intake and body weight management.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MOLECULAR INTERACTION&quot;">
      <data key="d2">chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-eec0b4c60ebeb28599428b3552de2d1b&lt;SEP&gt;chunk-734cac289b42d37dad32bd51ea24a1ea&lt;SEP&gt;chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d1">"No specific molecular interactions mentioned but could be involved in the genetic regulation of CAD risk."&lt;SEP&gt;"No specific molecular interactions mentioned, but context implies relevance to biological processes and gene-environment interactions.") ("entity"&lt;SEP&gt;"SECTANB1 (Selectin B1) is a Gene involved in molecular interactions related to immune responses, inflammation, and cardiovascular health. This gene plays a role in the overall physiological processes that impact obesity risk.")&lt;SEP&gt;"SNPs for Age at First Tooth involve interactions between genes and variants."&lt;SEP&gt;"SNPs for Number of Teeth involve interactions between genes and variants regulating tooth number."</data>
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 13}]</data>
    </node>
    <node id="&quot;SECTANB1_RS2089641&quot;">
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d1">"SECTANB1 (Selectin B1) is a Gene involved in molecular interactions related to immune responses, inflammation, and cardiovascular health. This gene plays a role in the overall physiological processes that impact obesity risk.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 13}]</data>
    </node>
    <node id="&quot;APOA2_RS7018394&quot;">
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d1">"APOA2 is a Protein associated with lipid metabolism and atherosclerosis prevention, affecting energy intake and body weight management through its regulation of cholesterol transport in the bloodstream.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TGFBR2_RS1859123&quot;">
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d1">"TGFBR2 (Transforming Growth Factor-Beta Receptor Type 2) is a Protein involved in signaling pathways related to cellular processes, which influences physiological responses that impact obesity risk.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TCF7L2_RS1345860&quot;">
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d1">"TCF7L2 is a Gene associated with type 2 diabetes and impaired glucose regulation, impacting overall metabolic health and the risk of obesity related to these conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;BMI&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d&lt;SEP&gt;chunk-3ad8ef794841d749e48b3223741e91d3&lt;SEP&gt;chunk-b3d775642c43fa3524a531a3f6ec1e41&lt;SEP&gt;chunk-6a7c69534e11aa2fc4bd948484aa81c4&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d1">"BMI indicates body mass index which was associated with different subgroups of IBS patients indicating a dietary pattern that might influence their health status."&lt;SEP&gt;"Body Mass Index (BMI) is a measure used to estimate body fat based on height and weight, indicating an individual's overall health risk level.")&lt;SEP&gt;"No evidence of interaction between BMI and TCF7L2 variants associated with type 2 diabetes risk was found.")&lt;SEP&gt;"Polymorphism rs1799982 is associated with higher BMI in participants with early menarche age.")&lt;SEP&gt;"Carriers of any minor alleles had a lower baseline BMI compared to those with all major alleles."&lt;SEP&gt;"Body Mass Index differed significantly according to the rs671 polymorphism."&lt;SEP&gt;"Body Mass Index (BMI) was measured as part of assessing demographic factors including age, which might influence the observed physiological processes such as BA synthesis and excretion in different disease states like IBS-D or IBS-C."&lt;SEP&gt;"There was a significant correlation between BMI and total stool BA which could suggest that dietary patterns might be influencing both aspects of gastrointestinal health, including potential disease states such as IBS-D.")</data>
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;NUTRIENT INTAKE&quot;">
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e&lt;SEP&gt;chunk-770a24a1a31cf671a7681e7c98a7ee91&lt;SEP&gt;chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d1">"Approximately 30% of women in both groups were poorly nourished based on dietary caloric intake, particularly choline intake.")&lt;SEP&gt;"Early menarche age influences the nutrient intake of individuals, which may affect obesity risk.")&lt;SEP&gt;"Individuals' nutrient intakes, such as those of dairy products and fruits, have been studied in relation to their physiological processes."</data>
      <data key="d0">"DIETARY PATTERN"</data>
    </node>
    <node id="&quot;PLANT-BASED DIET INTAKE&quot;">
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d1">"High plant-based diet intake shows an interaction with PRS to influence BMI scores, protecting against obesity in adults with high PRS.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;FTO RS1558902&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The FTO rs1558902 is a gene associated with weight loss and body composition changes in response to dietary interventions."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;A ALLELE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The A allele of the FTO rs1558902 is a risk allele linked to increased weight loss when assigned to high-protein diets."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;WEIGHT LOSS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Weight loss observed in participants with the AA genotype and on high-protein diets indicates an interaction between FTO rs1558902, dietary composition, and body fat distribution."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;BODY COMPOSITION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Greater loss of total fat, FM%, and percentage of trunk fat observed in participants with the AA genotype assigned to high-protein diets suggests a relationship between FTO rs1558902 and changes in metabolic pathways affecting body composition."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;DIETARY PROTEIN&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Dietary protein composition significantly affects weight loss, as indicated by significant interactions with the FTO rs1558902 genotype."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;WAIST CIRCUMFERENCE (WC)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Changes in waist circumference measured at 6 months and 2 years showed no association with the FTO rs1558902 genotype, indicating a complex relationship between body composition measures and genetic factors."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;ETHNICITY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Despite differences in baseline characteristics among ethnicities, there were no significant interactions between ethnicity and changes in weight or WC at 6 months."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;BODY FAT DISTRIBUTION (BFD)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Changes in body fat distribution as measured by CT were significant predictors of response to high-protein diets, suggesting an interaction between FTO rs1558902 genotype and dietary composition on fat distribution."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;TOTAL FAT (TF)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Significant interactions in total fat loss observed between the AA genotype and protein diet suggest that genetic factors can influence body fat reduction patterns over time."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;FASCICULAR MUSCLE MASS (FFM)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"No significant changes were noted in fascicular muscle mass, indicating a focus on body composition rather than muscle strength or hypertrophy.") ("entity"</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;AA GENOTYPE&quot;">
      <data key="d0">"GENOTYPE"</data>
      <data key="d1">"AA genotype participants experienced greater decrease in fat distribution with high-protein diet compared to those without this genotype."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;TAT&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Participants with AA genotype had less loss in TAT (total adipose tissue) in response to low-protein diet."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;GP SUBJECTS&quot;">
      <data key="d0">"POPULATION GROUP (GP)"</data>
      <data key="d1">"Subjects from the general population with mean age 41.2±13.8 y and BMI of 26.0±4.7 kg/m2, including a prevalence of obesity at 17.7%."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
    </node>
    <node id="&quot;OHP SUBJECTS&quot;">
      <data key="d0">"POPULATION GROUP (OHP)"</data>
      <data key="d1">"Subjects from the elderly with higher mean age (46.3±14.7 y), high mean BMI (41.8±8.4 kg/m2) and lower educational level than GP."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
    </node>
    <node id="&quot;EDUCATIONAL LEVEL&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Educational levels categorized into general population (GP</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
    </node>
    <node id="&quot;FTO GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FTO gene is one of the genes associated with obesity predisposition and may affect metabolism."&lt;SEP&gt;"The FTO gene is associated with obesity risk in children, particularly in AA subjects but not significant in university studies."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487&lt;SEP&gt;chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;SNP&quot;">
      <data key="d0">"ALOX5"</data>
      <data key="d1">"A SNP, or Single Nucleotide Polymorphism, is a variation in a single nucleotide that occurs at a specific position in the DNA sequence. It represents one of many ways in which humans vary genetically and can be associated with different phenotypic traits."&lt;SEP&gt;"SNP"&lt;SEP&gt;"rs1256784 is a genomic variant of interest within the CYP1B1 gene that could be associated with increased risks in certain types of cancers, including those affecting the ovary."&lt;SEP&gt;"rs1864414 is a highly-correlated SNP in the ALOX5 gene associated with reduced risk of ovarian cancer (OR 0.77)."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487&lt;SEP&gt;chunk-089bcdf055eb2f007db49dbe2409429b&lt;SEP&gt;chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;EDUCATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Education level interacts significantly with the FTO genetic variant to determine obesity risk."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
    </node>
    <node id="&quot;OBESITY RISK&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"There is a statistically significant association between FTO gene variants and obesity risk in certain populations, such as AA subjects but not in university students."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
    </node>
    <node id="&quot;GP&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The joint analysis of GP and OHP shows that education interacts with the FTO SNP to influence metabolic pathways related to obesity."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
    </node>
    <node id="&quot;OHP&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"OHP refers to a physiological process in which education level interacts significantly with genetic factors such as the FTO SNP, influencing obesity risk."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
    </node>
    <node id="&quot;HCR SUBJECTS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Healthy Cohorts in Research (HCR) subjects provide another comparison group where no significant interactions were observed between education and genetic factors like the FTO gene regarding obesity risk."&lt;SEP&gt;"In HCR subjects, no significant interaction was found between education and the FTO SNP regarding obesity risk."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
    </node>
    <node id="&quot;AA SUBJECTS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"African American (AA) subjects are particularly susceptible to the effects of genetic variants like those related to obesity, as indicated by specific associations with FTO gene SNPs."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
    </node>
    <node id="&quot;UNIVERSITY STUDENTS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"In contrast, no significant association between the FTO gene SNP and obesity risk was found among university students in various studies."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
    </node>
    <node id="&quot;JOINT ANALYSIS OF GP AND OHP&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The joint analysis combining Genotype Population (GP) with Obesity Health Panel (OHP), which may represent a broader population including both AA subjects and university students, showed an interaction between education level and the FTO gene SNP influencing obesity risk."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
    </node>
    <node id="&quot;LIFESTYLE FACTOR&quot;">
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1&lt;SEP&gt;chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d1">"In HCR subjects particularly, physical activity level was found to interact with the FTO SNP to influence BMI, suggesting that individual's lifestyle habits can modify genetic susceptibility to overweight and obesity.") ("entity"&lt;SEP&gt;"Regular physical activity is associated with lower blood pressure and cardiovascular health.")</data>
      <data key="d0">"PHYSICAL ACTIVITY"</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 15}]</data>
    </node>
    <node id="&quot;PHYSICAL ACTIVITY (PA)&quot;">
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d1">"In HCR subjects particularly, physical activity level was found to interact with the FTO SNP to influence BMI, suggesting that individual's lifestyle habits can modify genetic susceptibility to overweight and obesity.") ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 15}]</data>
    </node>
    <node id="&quot;METABOLIC PATHWAY&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17&lt;SEP&gt;chunk-f2e122f964bade37f487049bd69a3f9f&lt;SEP&gt;chunk-f02653cb486dbf68cc259f74ea8b2b2e&lt;SEP&gt;chunk-c63d60b991cd7442f690dcc364af47dd&lt;SEP&gt;chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6&lt;SEP&gt;chunk-63d0b5be485a69f44e2799ccc9510487&lt;SEP&gt;chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-734cac289b42d37dad32bd51ea24a1ea</data>
      <data key="d1">"Alterations in metabolic pathways can impact heart health, as seen with sedentary behaviors and energy expenditure."&lt;SEP&gt;"OHP refers to physiological processes that are influenced by both educational attainment and genetic variants like the FTO SNP.")&lt;SEP&gt;"Triglyceride metabolism is part of the metabolic pathway impacted by both diet and genetic factors."&lt;SEP&gt;"The metabolic pathway involving ketone bodies like AcAc and BHB occurs when the body utilizes fat for energy instead of glucose, particularly during periods of fasting or low carbohydrate intake."&lt;SEP&gt;"No metabolic pathways directly linked in the provided text regarding 'Number of teeth'."&lt;SEP&gt;"No metabolic pathways directly linked in the provided text."&lt;SEP&gt;"The mention of 'Nitrogen metabolism' in context suggests a metabolic pathway relevant to the study or investigation."&lt;SEP&gt;"The metabolic pathway for nitric oxide synthesis is associated with the gene expression changes seen in individuals at higher risk of developing PBC."&lt;SEP&gt;"The metabolic pathway for nitric oxide synthesis is associated with the gene expression changes seen in individuals with higher susceptibility to PBC."&lt;SEP&gt;"The study findings may relate to metabolic pathways involving platelet numbers and gene variants."</data>
      <data key="d0">"METABOLIC PATHWAY"</data>
    </node>
    <node id="&quot;PUBLICATION NUMBER">
      <data key="d0">"COHORT STUDY OR RCT"</data>
      <data key="d1">"19 from cohort studies reported significant G × E interaction; 9 from RCTs were included in findings.")</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;TYPE 2 DIABETES RISK&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"No statistically significant interactions reported for other dietary factors investigated.")&lt;SEP&gt;"Risk of developing type 2 diabetes is a physiological process influenced by factors including dietary patterns and genetic polymorphisms amongst participants in the study population."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b&lt;SEP&gt;chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;G × PA INTERACTION&quot;">
      <data key="d0">"GENES AND ADVERSE OUTCOMES"</data>
      <data key="d1">"Investigation of G × PA interactions, including other genes besides TCF7L2, was often limited to one publication or did not show significant results.")</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;G × D INTERACTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"G × D interactions are a type of interaction between genetic variants and dietary factors that can influence disease risk."|&gt;1</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;3758947 GG-GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The 3758947 GG-genotype is associated with the nonrisk haplotype of four SLC2A2 variants."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;SLC2A2 RS5393&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The 3758947 GG-genotype is also linked to the SLC2A2 variant rs5393, which may have implications for diabetes risk in certain genetic contexts."&lt;SEP&gt;"The nonrisk haplotype includes the SLC2A2 variant rs5393, which may affect diabetes risk in individuals with the 3758947 GG-genotype."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;SLC2A2 RS5394&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The nonrisk haplotype also includes SLC2A2 variant rs5394, which may be associated with a lower risk of diabetes in certain genetic contexts."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;RS5393 GG‐GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The 3758947 GG-genotype is also linked to the SLC2A2 variant rs5393, which may be associated with a different risk profile."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;RS5394 GG‐GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The 3758947 GG-genotype is linked to the SLC2A2 variant rs5394, which may be protective against diabetes in certain genetic contexts."&lt;SEP&gt;"The nonrisk haplotype includes the SLC2A2 variant rs5394, which is associated with a lower risk of type 2 diabetes among individuals with the 3758947 GG-genotype."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;RS12255372 TCF7L2 RISK ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"In the Diabetes Prevention Program, participants with the TCF7L2 rs12255372 risk TT-genotype showed lower type 2 diabetes incidence in the intervention group compared to controls."&lt;SEP&gt;"The TCF7L2 rs12255372 risk allele is associated with a lower incidence of type 2 diabetes in individuals participating in weight loss interventions."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;RS7903146 T‐ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"In the DPP study, the rs7903146 T-allele is linked to a lower risk of type 2 diabetes among individuals who underwent weight loss interventions."&lt;SEP&gt;"The DPP study also investigated the effect of the rs7903146 T-allele, which is associated with a lower risk of type 2 diabetes among individuals who underwent weight loss interventions."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;RS5400 GG‐GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The 3758947 GG-genotype also includes the SLC2A2 variant rs5400, which may be associated with a different diabetes risk profile."&lt;SEP&gt;"The nonrisk haplotype includes the SLC2A2 variant rs5400, which may be associated with a different risk profile in individuals with the 3758947 GG-genotype."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;RS5404 C ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The nonrisk haplotype of SLC2A2 variants rs5393 and rs5404 includes the rs5404 C allele, which is associated with a lower risk of type 2 diabetes in certain genetic contexts."&lt;SEP&gt;"The nonrisk haplotype of SLC2A2 variants rs5393 and rs5404 includes the rs5404 C allele, which may be protective against diabetes in certain genetic contexts."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;LTPA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Lifestyle Physical Activity (LTPA) is investigated as a key factor influencing type 2 diabetes development by the Diabetes Prevention Program and DPS studies."&lt;SEP&gt;"Weight loss interventions to reduce diabetes risk are associated with changes in LTPA (Lifestyle Physical Activity), which may influence disease incidence."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;DPP&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The Diabetes Prevention Program is a study that has investigated the genetic and lifestyle factors influencing type 2 diabetes development."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;TPS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The Diabetes Prevention Study (DPS) investigates weight loss interventions in relation to disease prevention among at-risk populations."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;T2D&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Type 2 diabetes is the primary focus of studies investigating genetic and lifestyle factors influencing its development.") ("entity"</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;TCF7L2 GENE&quot;">
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4&lt;SEP&gt;chunk-0d8bc9a093c56fefc8b7af3fb9bc2862&lt;SEP&gt;chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d1">"Potential G × D interactions for genetic variants in the TCF7L2 gene were most frequently investigated among cohort studies and some other publications, while findings of other genetic variants were often limited to one publication only.")&lt;SEP&gt;"TCF7L2 gene has been implicated in the development of type 2 diabetes through its variants."&lt;SEP&gt;"TCF7L2 gene, associated with Type 2 diabetes risk, may also impact BMI changes."</data>
      <data key="d0">"GENE"</data>
    </node>
    <node id="&quot;DIETARY FACTORS&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">"Interaction between fiber or whole grain intake and genetic variants showed significant associations with incident Type 2 Diabetes (T2D).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FIBER AND WHOLE GRAIN&quot;">
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d1">"Interaction between fiber or whole grain intake and genetic variants showed significant associations with incident Type 2 Diabetes (T2D).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NUTRIENT ZINC INTAKE&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"The TT genotype for rs855791 showed no interaction with dietary patterns or T2D incidence in exposure strata."|&lt;&gt;0.5) ("relationship"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS855791 GG-GENOTYPE&quot;">
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d1">"The TT genotype for rs855791 showed no interaction with dietary patterns or T2D incidence in exposure strata."|&lt;&gt;0.5) ("relationship"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TABLE 1&quot;">
      <data key="d0">"DOCUMENT"</data>
      <data key="d1">"A table presenting biochemical and clinical characteristics of women with PCOS and control subjects, including age, menarche, waist-hip ratio, lipid profile, total testosterone levels, LH, FSH."&lt;SEP&gt;"A table reporting clinical characteristics of a study's case group and control group, including the number of women in each group."&lt;SEP&gt;"Demographic, dietary and biochemical data are presented in Table 1. This document likely contains detailed information on demographics, diet, and biochemistry relevant to the study population for a comprehensive understanding of their health status."&lt;SEP&gt;"Table 1 presents the statistical power of this study, likely detailing the sample size required for detecting effects among different VDR polymorphisms."&lt;SEP&gt;"The study includes a Table that presents descriptive characteristics of participants."&lt;SEP&gt;"This table presents descriptive characteristics of participants, indicating age and gender distribution among study participants."&lt;SEP&gt;"Clinical presentation of these three siblings is outlined in Table 1."|&lt;SEP&gt;"Demographic profile data for HIV-infected individuals and healthy controls is shown in Table 1."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97&lt;SEP&gt;chunk-f9a60d3cf951d77afa115859755dac43&lt;SEP&gt;chunk-825b9a3dd613f4c55dbf49fa3998d0d5&lt;SEP&gt;chunk-2c178ae99eeffdddbea511cafbe4a7d5&lt;SEP&gt;chunk-2fb95100a1290b27baae869c6560419a&lt;SEP&gt;chunk-05d583f893b703816ad8de9561aa5292&lt;SEP&gt;chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;T2D-ESRD GROUP&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The T2D-ESRD group is characterized by individuals with type 2 diabetes who have progressed to end-stage renal disease."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;CONTROL GROUP&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The Control Group represents individuals who do not have the CC genotype and possibly carry different dietary patterns and nutrient intake profiles than those with CRC."&lt;SEP&gt;"The control group for the study includes individuals without diabetes, used as a comparison for health characteristics."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43&lt;SEP&gt;chunk-5b0cc96debf110f3544685d3b227ff27</data>
    </node>
    <node id="&quot;AFRICAN ANCESTRY PROPORTIONS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Individuals in both T2D and control groups are characterized by their African ancestry proportions, reflecting demographic factors."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;CONTROL NONDIABETIC GROUP&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The control nondiabetic group includes individuals without diagnosed diabetes, used as a reference for health characteristics in the general population."&gt;34</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;RS7903146&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The variant rs7903146 is a genomic locus associated with type 2 diabetes risk."</data>
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
    </node>
    <node id="&quot;SEX&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"In the subcohort, participants were categorized by sex to examine gender-specific health outcomes."&lt;SEP&gt;"No significant interaction found between sex and the genetic variant rs7903146 and its relation to diabetes risk.")&lt;SEP&gt;"Patients were categorized by their genetic risk score and sex."</data>
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4&lt;SEP&gt;chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;AFRICAN ANCESTRY DEGREE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"There was no significant interaction observed between the degree of African ancestry and TCF7L2 gene variants related to diabetes risk.")</data>
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;T2D-ESRD GROUP VS CONTROL GROUP&quot;">
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d1">"The case group had a higher mean age at enrollment compared to the nondiabetic control subjects."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;WOMEN IN CASE AND CONTROL GROUPS&quot;">
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d1">"The case group included more women than the control group, indicating potential differences in risk factors.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ENVIRONMENTAL FACTOR&quot;">
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4&lt;SEP&gt;chunk-f02653cb486dbf68cc259f74ea8b2b2e&lt;SEP&gt;chunk-734cac289b42d37dad32bd51ea24a1ea&lt;SEP&gt;chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d1">"Environmental factors such as dietary intake may influence gene expression and contribute to the development of PBC."&lt;SEP&gt;"No evidence of interaction between age and the association of TCF7L2 variants with type 2 diabetes risk was found.")&lt;SEP&gt;"No specific environmental factors mentioned as affecting 'Age at first tooth' or 'Number of teeth'."&lt;SEP&gt;"No specific environmental factors mentioned as affecting 'Number of teeth' based on the provided text."&lt;SEP&gt;"The study incorporates available continuous covariates, which may include environmental factors influencing CAD risk."</data>
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;IMPAIRED FASTING GLUCOSE/IMPROVED GLUCOSE TOLERANCE (IFG/IGT)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Impaired fasting glucose and improved glucose tolerance are physiological processes indicating potential risk for type 2 diabetes."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;TYPE 2 DIABETES (T2D)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Similarly, incident Type 2 diabetes showed an association between epigenetic variation and hypomethylation in certain genes."&lt;SEP&gt;"Type 2 diabetes is a disease characterized by high blood sugar levels."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e&lt;SEP&gt;chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;FASTING PLASMA GLUCOSE (FPG)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Fasting plasma glucose refers to the amount of glucose measured in an individual's blood after fasting for at least 8 hours. It can be influenced by factors such as diet and overall metabolic health."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;TWO-HOUR PLASMA GLUCOSE (2HPG)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Two-hour plasma glucose refers to the amount of glucose measured in an individual's blood two hours after starting a 75 gram oral glucose test. It is another way to assess metabolic health and risk for diabetes."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;FEMALES">
      <data key="d0">"GENDER AND GLYCEMIC STATUS RELATIONSHIP"</data>
      <data key="d1">"The percentage of females in the study was higher across all glycemic statuses (60.9%), indicating a potential difference in risk for diabetes among women compared to men."])(("relationship"</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;PG LEVELS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"PG is a nutrient that was mentioned."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;BMI AT BASELINE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Body Mass Index (BMI) at baseline is an indicator of physiological health and weight status."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;BASELINE BMI&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"BMI at baseline refers to Body Mass Index measured during a specific point in time."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;TAL1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TAL1 gene is another gene linked to obesity susceptibility and could influence BMI levels."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;LEPR GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"LEPR gene is linked to the regulation of appetite and could influence BMI levels in relation to glycemic status."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;GRS&quot;">
      <data key="d0">"BIOMARKER"</data>
      <data key="d1">"Genetic Risk Score (GRS) is a measure of genetic variation associated with MTX response and cognitive function."&lt;SEP&gt;"Genetic Risk Score (GRS) was calculated based on polymorphisms in genes related to MTX response."&lt;SEP&gt;"Genotype Risk Score (GRS) represents a collection of genetic factors contributing to obesity risk."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;OBESITY SNPS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Obesity Susceptibility Genetic Variants, or SNPs, are key molecular interactions in the context of BMI and weight changes.") ("entity"</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;RS2984618 GENOMIC VARIANT">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs2984618, another genomic variant, is linked to obesity risk."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;LEPR GENE VARIANT RS1011527">
      <data key="d0">"GENE"</data>
      <data key="d1">"LEPR gene variant rs1011527 may affect appetite regulation and BMI levels."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;FTO GENE VARIANT RS9939609&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FTO gene variant rs9939609 is implicated in obesity predisposition."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;DIETARY FACTORS">
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d1">"Factors such as fasting plasma glucose (FPG) and two-hour plasma glucose (2hPG), which are dietary factors, were positively associated with participants' baseline BMI levels.") ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IMPACT ON GLYCEMIC STATUS&quot;">
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d1">"Factors such as fasting plasma glucose (FPG) and two-hour plasma glucose (2hPG), which are dietary factors, were positively associated with participants' baseline BMI levels.") ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ETHNICITY">
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d1">"Participants from different ethnic backgrounds like East Asian (22.7% of T2D), African (18.0%), South Asian (16.1%) had a higher prevalence and percentage decrease in IFG/IGT status compared to the NGT group."])(("relationship"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GLYCEMIC STATUS ANCESTRY ASSOCIATION&quot;">
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d1">"Participants from different ethnic backgrounds like East Asian (22.7% of T2D), African (18.0%), South Asian (16.1%) had a higher prevalence and percentage decrease in IFG/IGT status compared to the NGT group."])(("relationship"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphisms in the MTX-related genes were studied."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;MTX-RELATED NEUROTOXICITY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Early MTX-related neurotoxicity is associated with cognitive impairment."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;TMTA&quot;">
      <data key="d0">"INSTRUMENT"</data>
      <data key="d1">"Neuropsychological test TMTA was used to assess cognition."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;PEGDH&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Biomarker PEGDH was not predictive of neurotoxicity in early MTX treatment."&lt;SEP&gt;"PEGDH was studied as a potential biomarker for MTX-related neurotoxicity in early treatment phases."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;PEGNDH&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"PEGNDH did not predict neurotoxicity during MTX therapy."&lt;SEP&gt;"PEGNDH is another protein that did not predict neurotoxicity during MTX therapy according to the text."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;DIG&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Dietary nutrient DIG was not associated with cognitive impairment in this study."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;CFL&quot;">
      <data key="d0">"INSTRUMENT"</data>
      <data key="d1">"CFL was another test used to measure cognition."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;TMTB&quot;">
      <data key="d0">"INSTRUMENT"</data>
      <data key="d1">"Test TMTB assessed higher-level cognitive functions."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;AGE AT DIAGNOSIS&quot;">
      <data key="d0">"VARIABLE"</data>
      <data key="d1">"Variables included age at diagnosis, intrathecal MTX exposure, and cumulative IV MTX exposure in assessing MTX-related neurotoxicity."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;INTRATHECAL MTX EXPOSURE&quot;">
      <data key="d0">"VARIABLE"</data>
      <data key="d1">"Intrathecal MTX exposure was considered a confounding factor in this study."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;DISEASE&quot;">
      <data key="d0">"MIGRAINE"</data>
      <data key="d1">"Hypertension is a disease condition where individuals have higher than normal blood pressure."&gt;&lt;/|&gt;8&lt;SEP&gt;"Hypertension is defined as high blood pressure that can lead to cardiovascular diseases."&gt;6&lt;SEP&gt;"No diseases explicitly linked to SNPs for Age at First Tooth or Number of Teeth in the provided text."&lt;SEP&gt;"No diseases explicitly linked to SNPs for Number of Teeth in the given text."&lt;SEP&gt;"Ovarian cancer is a disease influenced by genetic factors, such as variants in inflammation-related genes like ALOX5 and NOS3.") ("entity"&lt;SEP&gt;"The study also discusses findings related to cardiovascular disease, although this entity was not specified in the request format."&lt;SEP&gt;"The NOS1 gene is associated with an increased risk for cardiovascular disease due to genomic variants and epigenetic modifications.") ("entity"&lt;SEP&gt;"Migraines are a disease condition related to genetic polymorphisms in genes like BDNF, which have been linked to an increased risk of the disorder.")</data>
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9&lt;SEP&gt;chunk-c63d60b991cd7442f690dcc364af47dd&lt;SEP&gt;chunk-814fe155e9cb953da61f6a79d1d25784&lt;SEP&gt;chunk-089bcdf055eb2f007db49dbe2409429b&lt;SEP&gt;chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 11}]</data>
    </node>
    <node id="&quot;GENDER BALANCE IN STUDY POPULATION&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"The study population had a male predominance with an M:F ratio of 2:1, which is slightly higher than expected but representative of the overall ALL population at Texas Children's Hospital.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;M:F RATIO&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"The study population had a male predominance with an M:F ratio of 2:1, which is slightly higher than expected but representative of the overall ALL population at Texas Children's Hospital.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;C RISK ALLELE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The C risk allele at SLC30A8 rs13266634 is associated with higher fasting proinsulin levels in the DPP cohort."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;FASTING PROINSULIN LEVELS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Fasting proinsulin levels were significantly decreased after a randomized intervention, including lifestyle and medication-based interventions such as metformin and troglitazone. These changes remained statistically significant even after adjusting for factors like age, sex, ethnicity, fasting insulin, and other relevant physiological processes.")&lt;SEP&gt;"Fasting proinsulin levels were significantly decreased after the DPP intervention.")</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;LIFESTYLE INTERVENTION GROUP&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The lifestyle intervention group had the largest decrease in fasting proinsulin levels among all active intervention groups. This dietary pattern likely contributed to their improved metabolic profile compared with controls on placebo or other interventions like metformin and troglitazone.")&lt;SEP&gt;"The lifestyle intervention group had the largest decrease in fasting proinsulin levels.")</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;TROGLITAZONE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Troglitazone is another medication used in the treatment regimen, which also had a significant impact on reducing fasting proinsulin levels but less pronounced than metformin. This indicates potential differences in response based on individual genetic predispositions such as SLC30A8 risk alleles.")&lt;SEP&gt;"Troglitazone, another intervention, also reduced fasting proinsulin levels but not as significantly as metformin.")</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;FASTING INSULIN&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Baseline fasting insulin levels were part of the adjustment variables to understand how various interventions affected proinsulin and other metabolic pathways. These adjustments helped control for individual differences before comparing the effects of different treatments or lifestyle changes.")&lt;SEP&gt;"Fasting insulin levels remained statistically significant factors influencing fasting proinsulin levels.")</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;TABLE 1 ADJUSTMENTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Fasting proinsulin levels were adjusted for multiple physiological factors to understand their impact on intervention outcomes.")</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;SLC30A8 RISK ALLELE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The C risk allele at SLC30A8 rs13266634 is associated with higher fasting proinsulin levels in individuals from the DPP cohort."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;METFORMIN&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Metformin is an effective medication used in the treatment of type 2 diabetes, which was part of a larger lifestyle intervention program. It significantly reduced fasting proinsulin levels compared to placebo or other interventions like troglitazone.")</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 12}]</data>
    </node>
    <node id="&quot;DPP COHORT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Fasting proinsulin levels were significantly associated with the genotype at the SLC30A8 locus in individuals from the DPP cohort before and after a randomized intervention. This suggests that environmental factors such as dietary habits, lifestyle choices including physical activity also play significant roles in modulating these physiological processes.")</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;AGE, SEX, ETHNICITY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Adjustments for age, sex, and ethnicity did not significantly affect the association between genotype at SLC30A8 locus and fasting proinsulin levels after a randomized intervention. This suggests that while environmental factors such as diet or lifestyle interventions can influence these physiological processes, they do so in consistent ways across diverse populations.")</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;DPP INTERVENTION&quot;">
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d1">"Fasting proinsulin levels decreased significantly in all active intervention groups compared with placebo, including lifestyle and medication-based interventions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MRNA&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">2</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;HC DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">5</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;LE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"LE, or Lipovitan E, is a nutrient found in some foods that can influence lipid metabolism."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;LIPOGENIC DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">6</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;SREBP1C&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Sterol regulatory element binding protein 1 (SREBP1c) is a protein involved in regulating genes involved in lipid metabolism."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;ACC-1&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Acetyl-CoA carboxylase (ACC-1) is an enzyme responsible for de novo fatty acid synthesis, which influences the metabolic pathway of lipogenic diet."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;LIVER TG CONTENT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">7</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;MOUSE LIVER&quot;">
      <data key="d0">"ORGANISM TYPE"</data>
      <data key="d1">3</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;MICE&quot;">
      <data key="d0">"ORGANISM TYPE"</data>
      <data key="d1">4</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;HEPG2 CELLS&quot;">
      <data key="d0">"CELL LINE TYPE"</data>
      <data key="d1">5</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;CITRATE&quot;">
      <data key="d0">"KREBS CYCLE INTERMEDIATE"</data>
      <data key="d1">"Citrate is a Krebs cycle intermediate downstream of glucose metabolism that affects PNPLA3 levels.")</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;ISOCITRATE&quot;">
      <data key="d0">"PNPLA3 REGULATION"</data>
      <data key="d1">"The isocitrate treatment showed that PNPLA3 was not regulated by this compound.")</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;INSULIN RECEPTOR PROTEIN&quot;">
      <data key="d0">"PNPLA3 REGULATION"</data>
      <data key="d1">"In HepG2 cells expressing the insulin receptor protein, treatment with 10 nM insulin did not increase PNPLA3 mRNA compared to controls.")</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;PNPLA3 SIRNA&quot;">
      <data key="d0">"FAS EXPRESSION"</data>
      <data key="d1">"PNPLA3 knockdown increased FAS mRNA, indicating its impact on fatty acid metabolism.")</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;LIPID ACCUMULATION&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"PNPLA3 regulates lipid accumulation in cells, as demonstrated by high glucose and the presence of certain fatty acids like oleic acid (OA).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PNPLA3&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"PNPLA3 regulates lipid accumulation in cells, as demonstrated by high glucose and the presence of certain fatty acids like oleic acid (OA).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FAS&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f&lt;SEP&gt;chunk-d594d57f0043cce2b3d29c80323b1a11</data>
      <data key="d1">"Expression Patterns of FAS and ACC-1 are similar to those of PNPLA3, indicating they may be regulated by the same factors.")&lt;SEP&gt;"FAS is a disease associated with prenatal alcohol exposure, affecting both the physical features and cognitive/behavioral outcomes in affected individuals."</data>
      <data key="d0">"DISEASE"</data>
    </node>
    <node id="&quot;2-DEOXY-D-GLUCOSE&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"2-deoxy-D-glucose led to a reduction in lipid content, suggesting its impact on reducing cholesterol levels.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EXERCISE SUPPRESSED PNPLA3 EXPRESSION&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"Our in vivo data showed that exercise suppressed PNPLA3 expression and suggested the involvement of glucagon stimulation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GLUCAGON SECRETION&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"Our in vivo data showed that exercise suppressed PNPLA3 expression and suggested the involvement of glucagon stimulation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1"> The comprehensive summary of the biomedical data related to "TRANSCRIPT" includes entities such as Interleukin 1, alpha, Interleukin 8 alpha, Transforming Growth Factor, Beta 1, NOS1 gene, GPX4 gene, LCT mRNA (lactase), ERCC2 gene, PTPN2 gene, and CTLA4 gene. These entities are described in the provided descriptions as playing roles in inflammation, influencing ovarian cancer risk, regulating cell growth and differentiation, being associated with dietary patterns particularly folate intake, and showing significant associations with various diseases based on genetic polymorphisms or genomic variants. The physiological processes implied by these transcripts include those involved in biological functions such as gene expression regulation, DNA repair, cellular responses to damage, immune response, lymphocyte subset variation, and activation states of cells following in vitro activation processes. Overall, the descriptions suggest a complex interplay between dietary patterns, genetic factors, and transcript levels that influence various physiological and pathological processes related to inflammation, cancer risk, and immune function.&lt;SEP&gt;"The transcript of CTLA4 is influenced by genetic variants and potentially related to differential T cell expression patterns.")&lt;SEP&gt;"The gene likely associated with CAD may have differentially expressed transcripts."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182&lt;SEP&gt;chunk-5b68770e1b446d6cba0d4e1ecabf497b&lt;SEP&gt;chunk-c63d60b991cd7442f690dcc364af47dd&lt;SEP&gt;chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-d311ac0182b37003c75c0005b4337fa6&lt;SEP&gt;chunk-e097891654194982dfc0ef87401d3aa9&lt;SEP&gt;chunk-fde6653b9d9013ed054505cfe4cd1455&lt;SEP&gt;chunk-512b044cf65a4e519d519c6239959c6c&lt;SEP&gt;chunk-734cac289b42d37dad32bd51ea24a1ea&lt;SEP&gt;chunk-29025895ac187b8e88dec5cea9478842&lt;SEP&gt;chunk-daf8d8b6d90cc3f92b645357f7c1294b&lt;SEP&gt;chunk-e8f81fdd25a22582c6ce3d1e15f74af3&lt;SEP&gt;chunk-4964b2db9e3ddddb4967fb7150e4404d&lt;SEP&gt;chunk-f02653cb486dbf68cc259f74ea8b2b2e&lt;SEP&gt;chunk-6135f8baf39fe26dcea3d987aa6100ac&lt;SEP&gt;chunk-c29d575e156569afaa1ca3d6418a71b9&lt;SEP&gt;chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-814fe155e9cb953da61f6a79d1d25784&lt;SEP&gt;chunk-380a8a6e0d08cd28068a146ae5e00ce4&lt;SEP&gt;chunk-089bcdf055eb2f007db49dbe2409429b&lt;SEP&gt;chunk-0d155c005072e55d94179ce7952bf5a9&lt;SEP&gt;chunk-22216738ccbae0a6276bb4499018c434</data>
    </node>
    <node id="&quot;FOXO1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FoxO1 is a gene that activates hippocampal progenitor stem cells following cortisol exposure and mediates stress' negative effect on neurogenesis."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;HIPPOCAMPAL PROGENITOR STEM CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Hippocampal progenitor stem cells are activated by FoxO1 in response to cortisol exposure, which also mediates the negative effects of stress on these cells' neurogenesis capabilities."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;CORTISOL&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Cortisol is a human stress hormone that has been used as part of the 'depression in a dish' model to test its effects on immune response and neuronal proliferation, demonstrating upregulation upon exposure similar to previous studies in stressed animals and depressed patients."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;STRESS-INDUCED FOXO1 UP-REGULATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The stress-induced upregulation of FoxO1 in the hippocampus has been previously observed following exposure to childhood trauma, which is associated with increased risk of depression and other mental health disorders."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;NEUROGENESIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Cortisol treatment reduces neuronal proliferation as mediated by FoxO1 signaling within hippocampal progenitor cells, supporting the hypothesis that stress can have negative effects on brain function via these molecular interactions."&lt;SEP&gt;"Neurogenesis is negatively affected by cortisol treatment as mediated through FoxO1 signaling within hippocampal progenitor cells."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;IMMORTALIZED, MULTIPOTENT HUMAN FETAL HIPPOCAMPAL PROGENITOR CELL LINE (HPC0A07/03C)&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"The 'depression in a dish' model utilizes an immortalized, multipotent human fetal hippocampal progenitor cell line to study the effects of stress and its interactions with FoxO1 signaling."&lt;SEP&gt;"This cell line serves as a model to study the molecular pathways by which stress and cortisol influence brain function."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;SERUM GLUCOCORTICOID KINASE 1 (SGK-1)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"SGK1 is a protein that has been measured in both rats experiencing stress and humans suffering from depression, involved in mediating some of the glucocorticoid effects on brain function."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;CORTICOTROPIN-RELEASING HORMONE (CRH)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"CRH is a hormone involved in the regulation of neurogenesis, particularly under conditions of stress. It has been implicated as part of the biological response to childhood trauma and its related mental health disorders."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;CHILDHOOD TRAUMA&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Childhood trauma exposure is associated with upregulation of FoxO1 in both hippocampal tissue and blood samples, suggesting a genetic component to stress-induced physiological changes."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;DEANOL&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Docosahexaenoic acid (DHA), also known as Elomega or Alzheimers, is an omega-3 fatty acid that has been linked to neurogenesis and brain health in dietary patterns associated with reduced risk of cognitive decline."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;DOCOSAHEXAENOIC ACID (DHA)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"DHA is an omega-3 fatty acid found in high levels in oily fish, linked to brain health and cognitive function. It may influence neurogenesis via its effects on membrane phospholipid composition."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;MEMBRANE PHOSPHOLIPID COMPOSITION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Changes in membrane phospholipid composition can affect neuronal properties such as signaling pathways, potentially influencing the outcome of stress and other environmental factors."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;ISOC1&quot;">
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d1">"Isochorismatase Domain Containing 1 (ISOC1) interacts with Low Density Lipoprotein Receptor Adapter Protein 1 (LDLRAP1), crucial for lipid metabolism and clearance of low-density lipoprotein from the bloodstream.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LDLRAP1&quot;">
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d1">"Isochorismatase Domain Containing 1 (ISOC1) interacts with Low Density Lipoprotein Receptor Adapter Protein 1 (LDLRAP1), crucial for lipid metabolism and clearance of low-density lipoprotein from the bloodstream.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOTYPE&quot;">
      <data key="d0">"DISEASE RISK FACTORS"</data>
      <data key="d1">"The Genotype refers to the specific variations of genetic material within individuals."&lt;SEP&gt;"Variations in gene types can influence disease risk factors such as triglyceride (TAG) levels.")</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41&lt;SEP&gt;chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d3">[{"level": 0, "cluster": 5}]</data>
    </node>
    <node id="&quot;ALLELE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Alleles at genetic loci like LRP2 and NFATC1 can influence nutrient metabolism and risk factors such as hypertension."&lt;SEP&gt;"An Allele is one member of a paired set of alleles at a particular position on a chromosome, the other member being its counterpart homolog. It determines an individual's genetic characteristics and can influence traits such as susceptibility to diseases."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391&lt;SEP&gt;chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;WHITE&quot;">
      <data key="d0">"DEMOGRAPHICS"</data>
      <data key="d1">"The Whites represent individuals included in the study for genotyping and analysis, specifically those who were successful in obtaining their DNA information."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;PRE-SURGICAL BMI&quot;">
      <data key="d0">"OUTCOME FACTOR"</data>
      <data key="d1">"Individuals with higher pre-surgical Body Mass Indexes are likely to have experienced significant weight loss after undergoing bariatric surgery. This indicates a strong association between body mass and long term health outcomes."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;BMI TRAJECTORIES&quot;">
      <data key="d0">"OUTCOME DETERMINANT"</data>
      <data key="d1">"Different BMI trajectories observed among bariatric patients suggest that individual responses to surgical intervention vary based on pre-existing health and lifestyle factors. This highlights the importance of personalized treatment approaches in improving long term weight loss outcomes."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;2 YEAR WEIGHT LOSS&quot;">
      <data key="d0">"OUTCOME MEASURED"</data>
      <data key="d1">"This measure reflects the percentage of weight loss achieved by individuals over two years post bariatric surgery, indicating their progress towards healthy body mass index levels. It is a significant indicator of long-term health outcomes."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;CARDIOVASCULAR HEALTH&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Enhanced cardiovascular health is an important determinant in successful weight loss outcomes. This study underscores the significance of maintaining heart health during and after bariatric surgery to ensure sustainable healthy body mass levels."&lt;SEP&gt;"Vascular health among participants in the association analysis relates to physiological processes including nitric oxide production and its impact on cardiovascular risk factors such as hypertension."])(relationship</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b&lt;SEP&gt;chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;LONG TERM WEIGHT LOSS&quot;">
      <data key="d0">"OUTCOME INDICATOR"</data>
      <data key="d1">"The extent of long term weight loss is a critical indicator for measuring improvements in overall physical health, as well as reducing associated risks such as obesity-related illnesses. This study highlights the importance of sustained weight reduction post bariatric surgery."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;WEIGHT LOSS SUCCESS&quot;">
      <data key="d0">"OUTCOME MEASURED"</data>
      <data key="d1">"Weight loss success is measured in terms of BMI reduction and long term weight management among individuals post bariatric surgery. This reflects the effectiveness of the surgery at promoting healthier body compositions over time."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;WAIST-TO-HIP RATIO (WHR)&quot;">
      <data key="d0">"BODY COMPOSITION INDICATOR"</data>
      <data key="d1">"Waist-to-hip ratio is a critical indicator used to assess body composition among individuals undergoing bariatric surgery. This measures the proportion of weight distribution between the waist and hips, highlighting changes in overall physical health."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;HEALTH RISK LEVEL&quot;">
      <data key="d0">"BMI MEASURED FACTOR"</data>
      <data key="d1">"Body Mass Index (BMI) serves as a key measure of individual's health risk level. This study underscores the importance of maintaining lower BMI values for improved overall physical health among bariatric surgery patients."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;PHYSICAL HEALTH IMPROVEMENTS&quot;">
      <data key="d0">"WEIGHT LOSS OUTCOMES INDICATOR"</data>
      <data key="d1">"Sustained improvements in physical health among bariatric surgery patients are strongly associated with successful long term weight loss. This highlights the importance of maintaining healthier body compositions post-surgery to ensure improved overall health outcomes."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;CARDIOVASCULAR RISK MANAGEMENT&quot;">
      <data key="d0">"WEIGHT LOSS SUCCESS MEASURED INDICATOR"</data>
      <data key="d1">"Successful long term weight loss plays a significant role in reducing cardiovascular risks among bariatric surgery patients. This underscores the importance of sustained healthy body compositions post-surgery for improved overall health outcomes."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;GCK VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A total of 134 GCK variants were identified in 217 families from the year 2008 to 2018, including both previously reported and novel variants."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;SANGER SEQUENCING&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Sanger sequencing was used to identify a total of 134 GCK variants in 217 families from the year 2008 to 2018."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;MODY GENE PANEL&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A total of 217 probands were tested for mutations using the MODY gene panel, including both previously reported and novel GCK variants."&lt;SEP&gt;"The MODY gene panel is an essential tool in identifying genetic mutations associated with diabetes, including those related to the GCK gene."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;UNIVERSITY OF CHICAGO&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Seventy-four probands with GCK variants have been tested either on a research or clinical basis through the University of Chicago."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;CLINICAL BASIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Overall, clinical findings were similar to those observed in previously described pathogenic GCK variants."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;PROBAND&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A total of 217 probands were tested, including those yet to be tested."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;FAMILY HISTORY OF DIABETES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The p.Leu307Phe sequence change was identified in one proband with no family history of diabetes."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;HBA1C LEVEL&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Although the proband reported an HbA1c level of 5.2%, which is below the expected range for GCK-MODY, her mother had stable, mild fasting hyperglycemia levels between 5.8 and 6.3mmol/l."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;FASTING HYPERGLYCEMIA&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"This indicates a moderate level of tolerance for the p.His317Gln variant, which was detected in one proband with stable, mild fasting hyperglycemia levels between 5.8 and 6.3mmol/l."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;FASTING HYPERGLYCEMIA LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Probands had moderate fasting hyperglycemia levels of 5.8-6.1mmol/l, which is below the expected range for GCK-MODY."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;HBA1C LEVEL RANGE&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The proband reported an HbA1c level of 5.2%, which falls outside the typical HbA1c levels range for GCK-MODY patients."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;FASTING HYPERGLYCEMIA LEVELS RANGE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Both had fasting hyperglycemia levels within a moderate range of 5.8 to 6.3mmol/l, indicating tolerance for the variant p.His317Gln."&lt;SEP&gt;"These findings suggest that mild fasting hyperglycemia can be associated with GCK-MODY in certain cases.") ("entity"</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;PROBANDS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"217 probands were tested using the MODY gene panel, representing individuals suspected or confirmed with GCK-MODY."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;SEVENTY-FOUR PROBANDS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Of these 217 probands, 74 were involved in research or clinical testing at the University of Chicago."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;CLINICAL INFORMATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Detailed clinical information was available for a subset of GCK variant-positive probands, providing insights into their condition and management."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;SMOKING STATUS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Smoker v. non-smoker is an environmental factor that was analyzed as part of the study outcomes."&lt;SEP&gt;"Smoking status amongst individuals in the study population can be an environmental factor influencing physiological processes such as vascular health through its impact on nitric oxide synthesis, which is associated with coffee consumption and diabetes risk."])(relationship&lt;SEP&gt;"Smoking status is a physiological process affecting blood cortisol levels in the study population."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a&lt;SEP&gt;chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;TAG LEVELS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Triglyceride (TAG) levels were observed to differ between smokers and non-smokers, as well as within strata defined by genetic factors."</data>
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d3">[{"level": 0, "cluster": 5}]</data>
    </node>
    <node id="&quot;DIET&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Diet is an environmental factor that modulates the relationship between the NOS1 Gene and cardiovascular health."/&gt;&gt;10&lt;SEP&gt;"Differences in TAG levels among individuals suggest a physiological process influenced by dietary habits and genetics."&lt;SEP&gt;"Diet is an environmental factor that modulates the relationship between the NOS1 gene and cardiovascular health."&lt;SEP&gt;"Dietary patterns influence nutritional intake including dietary factors like folate.")&gt;1 ("relationship"</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9&lt;SEP&gt;chunk-72f4505e43f67f3564607392cb178656&lt;SEP&gt;chunk-1d2a8d3ce4f9baae7e1c9c14410045d0&lt;SEP&gt;chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;CARDIOVASCULAR DISEASE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Cardiovascular disease is a condition influenced by both genetic and environmental factors, including the NOS1 Gene and dietary patterns."/&gt;&gt;8&lt;SEP&gt;"Colitis in IL-10RαMdel RAG1−/− mice is Th17 dependent and indicates an increased risk of cardiovascular disease due to the elevated inflammatory response.") ("entity"&lt;SEP&gt;"Smoking status, gene-diet interaction, and changes in TAG levels may influence cardiovascular health over time."&lt;SEP&gt;"Cardiovascular disease is a condition influenced by both genetic and environmental factors, including the NOS1 gene and dietary patterns."&lt;SEP&gt;"Cardiovascular disease is a condition influenced by genetic and environmental factors, including the NOS1 gene and dietary patterns."&lt;SEP&gt;"The genetic variants in CTLA4 contribute to increased risk of cardiovascular disease, as shown by these studies on PBC."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e&lt;SEP&gt;chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6&lt;SEP&gt;chunk-1d2a8d3ce4f9baae7e1c9c14410045d0&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;SMOKER V. NON-SMOKER&quot;">
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d1">"Smoking status is an environmental factor that was part of the dietary pattern examined for its impact on metabolic pathways.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 14}, {"level": 2, "cluster": 16}]</data>
    </node>
    <node id="&quot;GENE TYPE&quot;">
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d1">"Differential TAG levels were observed among different genotypes, regardless of smoking status or diet patterns.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 5}]</data>
    </node>
    <node id="&quot;CHI&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"CHI is a disease affecting 65 patients (47 males and 18 females) identified in this text.")</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;CHI SYMPTOMS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The CHI symptoms were first noted during neonatal, infancy or childhood periods for the included patients.")</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;NEONATAL PERIOD&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Twenty-nine patients experienced their initial symptoms in the neonatal period (0-4 weeks old).")</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;INFANCY PERIOD&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Twenty-six patients had their first CHI symptoms during infancy, from one month to twelve months old.")</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;CHILDHOOD&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Ten patients experienced their initial CHI symptoms during childhood (&gt;12 months).")</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;DIAZOXIDE-UNRESPONSIVE&quot;">
      <data key="d0">"PHYSIOCHEMICAL CHARACTERISTIC"</data>
      <data key="d1">"Twenty-three patients were macrosomic with a mean birth weight of 3,690 g.")</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;DIETARY TREATMENT&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Fourty patients received dietary treatment for CHI symptoms.")</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;MACROSOMIC PATIENTS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Twenty-three patients were macrosomic and had a mean birth weight of 3,690 g.")</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;TERM BIRTHS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Sixty-two patients were born at term in this study.")</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;HYPOGLYCEMIA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Frequent feedings and uncooked cornstarch helped maintain blood glucose levels in a macrosomic patient during the follow-up period.")</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;EPISODES OF HYPOGLYCEMIA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A patient experienced hypoglycemia at three days old and was later found to have sustained hypoglycaemic brain injury with developmental delay.")</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;DIFFUSE PANCREATIC DISEASE&quot;">
      <data key="d0">"PHYSIOCHEMICAL CHARACTERISTIC"</data>
      <data key="d1">"Three patients with hypoglycaemia, high insulin levels had diffuse pancreatic disease confirmed following surgery.")</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;COMPOUND HETEROZYGOUS MUTATIONS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"In children carrying compound heterozygous mutations in ABCC8 gene, diazoxide treatment was effective for three patients while one child received dietary regulation only.”)</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;GLUD1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The GLUD1 gene was detected in patients with hypoglycaemia, HI and mild HA."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;P.ARG32IR4 HIS MUTATION&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Patients with p.Arg32Cys mutation have abnormal activity of their GLUD1 protein."&lt;SEP&gt;"The p.Arg32Cys mutation is found in the GLUD1 protein, which plays a role in hypoglycaemia."&lt;SEP&gt;"Three different heterozygous mutations were identified in the GLUD1 gene: p.Arg32Cys (patients 54-56), p.Ser498Leu (patient 52) and p.Asn463Asp (patient 53)."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;HYPOGLYCAEMIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Patients with hypoglycaemia are affected by conditions linked to abnormal activity of the GLUD1 gene."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;DIAZOXIDE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Diazoxide was administered as a treatment for HI/HA syndrome, caused by GLUD1 genetic defects."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;OCTREOTIDE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Octreotide was used in diazoxide-unresponsive patients to manage their conditions."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;P.SER498LEU MUTATION&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The p.Ser498Leu mutation affects the GLUD1 protein, contributing to hypoglycaemia symptoms."&lt;SEP&gt;"The p.Ser498Leu mutation detected in patient 52 impacts the function of the GLUD1 protein, contributing to hypoglycaemic symptoms."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;PATIENT 52&quot;">
      <data key="d0">"INDIVIDUAL"</data>
      <data key="d1">"Patient 52 has a heterozygous mutation in the GLUD1 gene (p.Ser498Leu)."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;PATIENT 56&quot;">
      <data key="d0">"INDIVIDUAL"</data>
      <data key="d1">"Patient 56 is a sister to patients 55 and carries the same heterozygous mutation (p.Arg32Cys) as her sibling."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;NITROGEN CONCENTRATION IN SERUM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Patients with hypoglycaemia have elevated nitrogen concentration in serum due to their GLUD1 gene mutations."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;GLUCOSE LEVELS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Hypoglycaemic episodes are influenced by dietary glucose intake and overall diet patterns."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;P.ASN463ASP MUTATION&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The p.Asn463Asp mutation found in patient 53 also affects the activity and function of their GLUD1 protein."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;HETEROZYGOUS MUTATIONS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"These heterozygous mutations are present in patients' GLUD1 genes, likely leading to abnormal endocrine cell activity that results in hypoglycaemia."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;ASYMPTOMATIC CARRIER&quot;">
      <data key="d0">"INDIVIDUAL"</data>
      <data key="d1">"The father of the sisters with p.Arg32Cys mutation is an asymptomatic carrier of this genetic variant."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;DISEASE MANAGEMENT&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A low-protein diet was prescribed to manage hypoglycaemia, affecting dietary patterns for those affected by HI/HA syndrome."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;P.ARG32CYS MUTATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The presence of the p.Arg32Cys mutation in patients leads to an altered physiological process involving abnormal endocrine cell activity and hypoglycaemia symptoms."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;PANCREATECTOMY&quot;">
      <data key="d0">"PROCEDURE"</data>
      <data key="d1">"Pancreatectomy was performed on unresponsive patients with HI/HA syndrome, affecting surgical procedures related to disease management."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;SUBTOTAL PANCREATECTOMY&quot;">
      <data key="d0">"PROCEDURE"</data>
      <data key="d1">"Nine patients underwent subtotal pancreatectomy in response to their conditions of hypoglycaemia."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;PANCREATECTOMY TWICE&quot;">
      <data key="d0">"PROCEDURE"</data>
      <data key="d1">"One patient underwent pancreatectomy twice due to sustained hypoglycaemia."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;BLOOD GLUCOSE LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Normal blood glucose levels are a physiological process that patients with HI/HA syndrome aim to maintain through various management strategies."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;HBA1C LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Patients' HbA1c levels were monitored during the course of their treatment, reflecting glycaemic control status."&lt;SEP&gt;"Understanding the relationship between diet and physiological processes like HbA1c levels is crucial in assessing metabolic health."&lt;SEP&gt;"There was no significant difference in FBG, alcohol consumption, tobacco smoking, or history of diabetes between HUA cases and controls."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd&lt;SEP&gt;chunk-2b81371954b99facae9a0056e70aa7bd&lt;SEP&gt;chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;ACAC&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Beta-hydroxybutyrate (AcAc) is a ketone body found in the bloodstream and plays a role in energy metabolism."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;BHB&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Beta-hydroxybutyrate (BHB) is another ketone body present in the bloodstream and also involved in energy metabolism."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;FPG&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Fasting plasma glucose (FPG) refers to a measure of blood sugar taken after an individual has not consumed food for at least 8 hours. It is used as part of diabetes diagnosis criteria."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;2HPG&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Two-hour plasma glucose (2hPG), like FPG, measures blood sugar levels and is a factor in type 2 diabetes risk assessment."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;IFG&quot;">
      <data key="d0">"IMPAIRED FASTING GLUCOSE"</data>
      <data key="d1">"Impaired fasting glycemia (IFG) refers to individuals with higher than normal but not high enough for diagnosis of diabetes. It represents an intermediate stage between normal glucose regulation and overt diabetes."&lt;SEP&gt;"Individuals in the IFG group had impaired fasting glucose levels, indicative of early stages of diabetes risk."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9&lt;SEP&gt;chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;IGT&quot;">
      <data key="d0">"IMPAIRED GLUCOSE TOLERANCE"</data>
      <data key="d1">"Impaired glucose tolerance (IGT) is a condition where blood sugar levels are higher than normal after fasting, but not as high as in diabetes."&lt;SEP&gt;"In the IGT group, individuals showed evidence of impaired glucose tolerance, suggesting pre-diabetic conditions."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9&lt;SEP&gt;chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;TYPE 2 DIABETES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Type 2 diabetes is characterized by insulin resistance and insufficient insulin production to maintain normal blood sugar levels."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;GLUCOSE AUC&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"AUC stands for area under the curve and represents a continuous measurement of blood sugar levels over time. It is used to assess metabolic risk in diabetes studies."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;INSULIN SENSITIVITY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Matsuda insulin sensitivity index (ISI) measures how sensitive cells are to insulin, with higher values indicating greater sensitivity and better glucose control."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;INSULIN SECRETION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Insulin secretion refers to the production of insulin by the pancreas in response to blood sugar levels. It is an important factor in maintaining metabolic balance.") ("entity"</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;FATTY ACID METABOLISM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Fatty acid metabolism refers to the biochemical processes involved in breaking down and utilizing fats as an energy source for cells. This process is crucial during periods of low carbohydrate availability, such as fasting or ketogenic diets."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;PANCREAS&quot;">
      <data key="d0">"ORGAN"</data>
      <data key="d1">"The pancreas is a vital organ responsible for producing hormones like insulin to regulate blood sugar levels. In the context of diabetes and metabolism, it plays a critical role in insulin secretion."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;CALLEL&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The glucose-increasing C allele of rs780094 of GCKR is associated with elevated BHB levels."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;ADIPOSE TISSUE&quot;">
      <data key="d0">"ORGAN"</data>
      <data key="d1">"Adipose tissue is a key location for gene expression measurements related to KB metabolism."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;FATS OXIDATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Fats oxidation, ketogenesis, and ketolysis are physiological processes regulated by genes involved in the regulation of FFA levels."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;CARNITINE PALMITOYLTRANSFERASE 1A (CPT1A)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Expression of CPT1A is positively correlated with glucose AUC and inversely with Matsuda ISI, regulating binding of carnitine to long-chain fatty acids."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE 1 (HMGCS1)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Expression of HMGCS1, regulating ketogenesis in adipose tissue, does not correlate significantly with glucose AUC but shows significant correlations with other parameters."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE 2 (HMGCS2)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Expression of HMGCS2, another protein involved in ketogenesis, does not correlate significantly with glucose AUC but shows significant correlations with other parameters."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;ACETYL-COA ACETYLTRANSFERASE 1 (ACAT1)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Adipose tissue mRNA expression of ACAT1 is inversely correlated with glucose AUC and positively correlates with Matsuda ISI, regulating last step in KB breakdown."&lt;SEP&gt;"This enzyme is responsible for the last step in KB breakdown where two molecules of acetyl-CoA are generated from acetoacetyl-CoA."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;BHB DEHYDROGENASE, TYPE 1 (BDH1)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Expression of BDH1, a gene involved in ketolysis, is inversely correlated with glucose AUC and positively correlates with Matsuda ISI."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;3-OXOBUTYRYL-COA TRANSFERASE 1 (OXCT1)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Expression of OXCT1 shows significant correlations with parameters related to glucose metabolism and insulin secretion."&lt;SEP&gt;"This protein is involved in regulating ketogenesis by participating in the last step of KB metabolism, following ACAT1 activity."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;ACYL-COA SYNTHETASE SHORT-CHAIN FAMILY MEMBER 2 (ACSS2)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Adipose tissue mRNA expression of ACSS2 is positively correlated with Matsuda ISI, suggesting a role in regulating ketolysis processes."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;ADIPOSE TISSUE MRNA EXPRESSION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Adipose tissue mRNA expression of genes involved in KB metabolism shows significant correlations with glucose AUC and Matsuda ISI parameters, suggesting a link between metabolic processes and external conditions such as insulin secretion."&lt;SEP&gt;"Adipose tissue mRNA expression of genes regulating ketolysis shows significant correlations with environmental factors such as Matsuda ISI and glucose AUC, indicating a link between metabolic processes and external conditions."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;MOLECULE&quot;">
      <data key="d0">"BHB"</data>
      <data key="d1">"Beta-hydroxybutyrate (BHB) is a molecule involved in regulating ketogenesis and ketolysis processes."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;ACETYLETHYL COA (ACAC)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"3-hydroxybutyrate (AcAc) is a product of BHB metabolism in the liver and kidneys. It plays a role in energy homeostasis and ketolysis processes."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;CARNITINE PALMITOYLTRANSFERASE 2B (CPT2B)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Carnitine Palmitoyltransferase 2B is another protein involved in the regulation of FFA binding to carnitine, allowing them to be transported into mitochondria for oxidation."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE 1 (HMGCS1), SOLUBLE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"This protein is involved in ketogenesis and the regulation of FFA levels by synthesizing 3-hydroxy-3-methylglutaryl-CoA, a key intermediate in lipid metabolism."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE 2 (HMGCS2), MITOCHONDRIAL&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"This protein is involved in ketogenesis and the regulation of FFA levels by synthesizing 3-hydroxy-3-methylglutaryl-CoA, a key intermediate in lipid metabolism."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;CRP SNPS&quot;">
      <data key="d0">"SNPS ASSOCIATED WITH SERUM CRP IN GENETIC ASSOCIATION STUDIES.")</data>
      <data key="d1">1</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;APOC1&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"APOC1 is a protein involved in lipid and cardiovascular health, as evidenced by its associations with both cardiometabolic and inflammatory traits.")</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;HNF1A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"HNF1A is a gene associated with multiple metabolic phenotypes including cholesterol levels, triglycerides, and CRP.")</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;GCKR&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"GCKR is a gene involved in glucose metabolism that plays a crucial role in the regulation of insulin secretion."&lt;SEP&gt;"GCKR is a protein related to glucose metabolism and has been implicated in the regulation of insulin secretion and lipid profiles.")</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;IL6R&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"IL6R, a protein involved in inflammatory responses, has also shown associations with cardiometabolic traits including CRP levels.")</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;PPP1R3B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"PPP1R3B is a protein involved in the regulation of various cellular processes including cell signaling pathways."&lt;SEP&gt;"PPP1R3B is another gene associated with metabolic phenotypes such as cholesterol and triglycerides.")</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;HNF4A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"HNF4A, a member of the hepatic nuclear factor 4 family of transcription factors, has been linked to lipid metabolism and inflammatory markers like CRP.")&lt;SEP&gt;"HNF4A, located on chromosome 9, plays a critical role in maintaining proper metabolic function by regulating genes associated with lipid and glucose metabolism."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;PABPC4&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"PABPC4 is another protein associated with metabolic phenotypes including cholesterol levels and inflammation-related traits such as CRP.")</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;BCL7B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"BCL7B, a gene involved in various biological processes, has shown associations with cardiometabolic traits like CRP and lipid profiles.")&lt;SEP&gt;"BCL7B, a protein associated with genes that influence metabolic pathways."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;FTO&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"FTO has been associated with various traits including weight gain, which might influence dietary patterns leading to snoring.")&lt;SEP&gt;"FTO is a gene associated with BMI and triglycerides. The SNP rs1558902 in FTO is also linked to serum CRP levels, suggesting a complex relationship between obesity-related traits and inflammatory markers.")</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64&lt;SEP&gt;chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;RS1558902&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs1558902 in the FTO gene is associated with both BMI and serum CRP levels, indicating a pleiotropic effect across different metabolic traits.")</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;RS2867125&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs2867125 in the TMEM18 gene is associated with serum CRP and is located near a known cardiovascular disease-associated locus, suggesting overlapping genetic susceptibility to cardiometabolic and inflammatory traits.")</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;RS6065906&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs6065906 in the PLTP gene is associated with serum CRP levels. This variant also has a strong linkage disequilibrium with other genetic markers for cardiometabolic traits.")</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;RS571312&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs571312 near the MC4R gene is associated with CRP levels and is located upstream of a gene involved in appetite regulation, further illustrating the complex interplay between genetic variants and metabolic traits.")</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;IL1F10&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IL1F10 has been identified in GWAS for cardiometabolic phenotypes but was not previously associated with CRP levels. This suggests potential novel associations or pleiotropic effects of genes involved in different metabolic pathways on inflammatory markers like CRP.")&lt;SEP&gt;"IL1F10, located on chromosome 2, encodes for interleukin-1 family member F and has been associated with cardiometabolic phenotypes."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;CRP-LEVEL ASSOCIATION SNPS&quot;">
      <data key="d0">"SNPS ASSOCIATED WITH SERUM CRP LEVELS, INDICATING THEIR ROLE IN THE GENETIC REGULATION OF INFLAMMATION-RELATED TRAITS.")</data>
      <data key="d1">16) ("entity"</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;CARDIOMETABOLIC PHENOTYPES&quot;">
      <data key="d0">"TRAITS RELATED TO HEART HEALTH SUCH AS TOTAL CHOLESTEROL, LDL-CHOLESTEROL, TRIGLYCERIDES, HDL-CHOLESTEROL, FASTING GLUCOSE, AND GLYCEMIC TRAITS INCLUDING INSULIN LEVELS.")</data>
      <data key="d1">18</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;INFLAMMATORY BIOMARKERS&quot;">
      <data key="d0">"CRP (C-REACTIVE PROTEIN), IL6R, APOC1, HNF1A ARE AMONG THE INFLAMMATORY BIOMARKERS STUDIED IN RELATION TO CARDIOMETABOLIC DISEASES.")</data>
      <data key="d1">19</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;GENETIC ASSOCIATION STUDIES&quot;">
      <data key="d0">"THESE STUDIES INVOLVE LARGE GENOMIC DATASETS AND STATISTICAL ANALYSIS OF GENETIC VARIANTS ASSOCIATED WITH VARIOUS PHENOTYPES INCLUDING THOSE RELATED TO HEART HEALTH AND INFLAMMATION.")</data>
      <data key="d1">20</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;PHENOTYPE-ASSOCIATED SNPS&quot;">
      <data key="d0">"SNPS LIKE RS1558902 IN FTO, RS6065906 IN PLTP ARE EXAMPLES OF GENETIC VARIANTS THAT HAVE BEEN ASSOCIATED WITH CARDIOMETABOLIC TRAITS AND INFLAMMATION.")</data>
      <data key="d1">21</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;LINKAGE DISEQUILIBRIUM (LD)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Linkage disequilibrium measures the nonrandom association between alleles at different loci, providing insights into genetic variation and complex disease risk.") ("entity"&lt;SEP&gt;"The use of SNP-based heritability calculations through LD score regression is a method used to test for the presence of specific bacterial taxa that may be influenced by genetics within different ethnic cohorts.")&lt;SEP&gt;22</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca&lt;SEP&gt;chunk-ad609cb10e900d42a6901eea1591d8ba&lt;SEP&gt;chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;PABPC&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"BCL7B is also known as PABPC which indicates it is involved in processes related to gene expression and mRNA stability."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;CRP&quot;">
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"GCKR is a gene that plays a crucial role in insulin secretion and may influence CRP levels through its impact on metabolism and inflammation pathways.")&lt;SEP&gt;"No significant association found between CRP and ovarian cancer risk according to the study results."&lt;SEP&gt;"No significant changes in CRP levels were observed among the two diet groups or when considering minor allele and all major allele carriers.") ("entity"</data>
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;MODY SIGNALING&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"PPP1R3B is located near MODY signaling pathways, which suggests a possible relationship between PPP1R3B and pathways related to metabolic disorders like diabetes.)</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;MIR-34B/C RS4938723&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs4938723 is a genomic variant in the miR-34b/c locus associated with a decreased risk of Intracranial Aneurysm (IA)."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;TP53 ARG72PRO&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"TP53 Arg72Pro is a genomic variant at position 72 in the TP53 gene, showing no significant association with Intracranial Aneurysm risk."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;MIR-34B/C&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"miR-34b/c is a gene that encodes miRNA(s), which are known to play roles in various biological processes including regulation of gene expression relevant to Intracranial Aneurysm risk."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;TP53&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TP53 is a gene that codes for the p53 protein, involved in cell cycle control and apoptosis. This gene showed no significant association with IA risk in this study."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;RS4938723CC GENOTYPE&quot;">
      <data key="d0">"GENOTYPIC FEATURE"</data>
      <data key="d1">"The CC genotype of miR-34b/c rs4938723 was significantly associated with a decreased risk of Intracranial Aneurysm (IA), compared to the TT genotype."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;MIR-34B/C RS4938723 TT GENOTYPE&quot;">
      <data key="d0">"GENOTYPIC FEATURE"</data>
      <data key="d1">"The TT genotype of miR-34b/c rs4938723 showed no significant association with Intracranial Aneurysm (IA) risk."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;MIR-34B/C RS4938723 CT GENOTYPE&quot;">
      <data key="d0">"GENOTYPIC FEATURE"</data>
      <data key="d1">"The CT and TT combined genotypes of miR-34b/c rs4938723 showed no significant association with Intracranial Aneurysm (IA) risk."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;MIR-34B/C RS4938723 OR VALUE&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"The CC genotype of miR-34b/c rs4938723 showed a significant decrease in IA risk (OR = 0.28), indicating an inverse correlation between this variant and the development of Intracranial Aneurysm."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;MIR-34B/C RS4938723 CI VALUE&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"The odds ratio for the CC genotype compared to the TT genotype (OR = 0.28) falls within the confidence interval provided (95% CI: 0.11–0.73), supporting a significant protective effect of rs4938723CC on IA risk."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;MIR-34B/C RS4938723 P VALUE&quot;">
      <data key="d0">"STATISTICAL MEASURE"</data>
      <data key="d1">"The p = 0.006 for the association between miR-34b/c rs4938723 and IA risk indicates a statistically significant inverse correlation."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;TP53 ARG72PRO CG GENOTYPE&quot;">
      <data key="d0">"GENOTYPIC FEATURE"</data>
      <data key="d1">"The combined effects of TP53 Arg72Pro CG, CC, GG genotypes showed no association with Intracranial Aneurysm (IA) risk."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;TP53 ARG72PRO AA ALLELE&quot;">
      <data key="d0">"ALLELIC FEATURE"</data>
      <data key="d1">"No significant association between the AA and AG/GG alleles of TP53 Arg72Pro was observed regarding its impact on IA risk in this study."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;MIR-34B/C RS4938723 AND TP53 ARG72PRO COMBINED GENOTYPES&quot;">
      <data key="d0">"GENOTYPIC FEATURE"</data>
      <data key="d1">"The carriers with the combined genotypes of rs4938723CC and TP53 Arg72Pro CG/CC/GG had a decreased risk of Intracranial Aneurysm (IA), compared to those carrying rs4938723CT/TT + TP53 Arg72Pro CG/CC/GG combined genotypes."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;MIR-34B/C RS4938723 AND TP53 ARG72PRO GENDER STRATIFICATION&quot;">
      <data key="d0">"GENDER STRATIFICATION MEASURE"</data>
      <data key="d1">"No association was found between the two SNPs and the number of aneurysms when stratified by gender."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;INTRACRANIAL ANEURYSM NUMBER&quot;">
      <data key="d0">"OUTCOME PARAMETER"</data>
      <data key="d1">"The genotype frequencies for both polymorphisms showed no significant association with the number of aneurysms in this study."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;INTRACRANIAL ANEURYSM (IA)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Intracranial Aneurysm is a condition characterized by the dilation of arteries within the skull, leading to potential risk of hemorrhage."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;NUMBER OF ANEURYSMS IN CASES&quot;">
      <data key="d0">"OUTCOME PARAMETER'</data>
      <data key="d1">"No significant association between the number of aneurysms and any genetic or genotypic features was observed. This indicates a complex multifactorial etiology for IA development, potentially influenced by environmental factors as well."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;TABLE 1 CHARACTERISTICS&quot;'">
      <data key="d0">"DOCUMENT REFERENCE'</data>
      <data key="d1">"The clinical characteristics including sex, age are presented in Table 1 of the study."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;ARHGAP11A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ARHGAP11A is a gene associated with sleep duration, located on chromosome 15."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;C21ORF34&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"C21orf34 is a gene involved in respiratory quotient measurements during sleep."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;MATK&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"MATK is a protein associated with total energy expenditure, located on chromosome 19."&lt;SEP&gt;"MATK is a protein involved in energy expenditure, particularly during sleep."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;CHRNA3&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CHRNA3 is a gene associated with energy expenditure during sleep."&lt;SEP&gt;"CHRNA3 is a protein related to sleeping energy expenditure, located on chromosome 15."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;RQ&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"RQ is a nutrient measured during sleep and associated with the C21orf34 gene."&lt;SEP&gt;"RQ, or respiratory quotient, measures oxygen consumption during sleep."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;RESPIRATORY QUOTIENT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Respiration quotient measurements are part of physiological processes related to heart health."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;ACCELEROMETER-MEASURED LIGHT ACTIVITY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Accelerometer-measured light activity is an environmental factor influencing sedentary behavior."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;SEDENTARY-LIGHT ACTIVITY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Sedentary light activity impacts metabolic pathways associated with heart health."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;CTCFL&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"CTCFL is a transcript related to sedentary behavior."&lt;SEP&gt;"CTCFL is a transcript that affects sedentary behavior, located on chromosome 20."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;RPL7P3&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"RPL7P3 is a genomic variant affecting accelerometer-measured light activity."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;BODY WEIGHT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Body weight influences physiological processes and the identification of significant variants."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;CQ&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"CQ is the respiratory quotient measured in individuals' physiology."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;RESPIRATORY QUOTIENT MEASUREMENTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Respiratory quotient measurements are a key part of understanding energy expenditure during sleep."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;SEDENTARY BEHAVIOR&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Sedentary behavior is an environmental factor that impacts heart health through metabolic pathways."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;SLEEP DURATION&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"An intronic variant in ARHGAP11A is associated with increased sleep duration."]</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SULT1A1&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">1) ("relationship"</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;GENOMIC VARIANT&quot;">
      <data key="d0">"STAT5B P.W631*"</data>
      <data key="d1"> The comprehensive summary for the biomedical entity "GENOMIC VARIANT" includes various descriptions related to distinct genomic variants affecting different molecular processes, disease susceptibility, DNA repair mechanisms, and other physiological conditions. A detailed analysis of these descriptions reveals a pattern where certain genetic variations are linked with alterations in disease severity, immune responses, cancer risk reduction, hypertension, and expression levels of proteins involved in regulating cellular functions. Furthermore, the presence of missense mutations within specific gene regions is noted for their functional effects on transcript levels that contribute to CAD disparities between patients and controls. This comprehensive summary encapsulates the diverse impacts of genomic variants across different medical contexts, highlighting their significance in understanding complex genetic influences on human health.</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c&lt;SEP&gt;chunk-c63d60b991cd7442f690dcc364af47dd&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-e323b0d4f82733a78f687e51f47b500a&lt;SEP&gt;chunk-fde6653b9d9013ed054505cfe4cd1455&lt;SEP&gt;chunk-512b044cf65a4e519d519c6239959c6c&lt;SEP&gt;chunk-734cac289b42d37dad32bd51ea24a1ea&lt;SEP&gt;chunk-0d155c005072e55d94179ce7952bf5a9&lt;SEP&gt;chunk-36d70bb8409856300dd77669e7c1f9ed&lt;SEP&gt;chunk-e8f81fdd25a22582c6ce3d1e15f74af3&lt;SEP&gt;chunk-a7d0bfa8b16262a1f313b7e3060969c6&lt;SEP&gt;chunk-b5a1267b747ee0cf908d98fa3fc26199&lt;SEP&gt;chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-f02653cb486dbf68cc259f74ea8b2b2e&lt;SEP&gt;chunk-6135f8baf39fe26dcea3d987aa6100ac&lt;SEP&gt;chunk-1b40d071abac0ba432a9fb0096796f45&lt;SEP&gt;chunk-089bcdf055eb2f007db49dbe2409429b&lt;SEP&gt;chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-22216738ccbae0a6276bb4499018c434</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;CODING REGION&quot;">
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d1">"The common deletion rs3833080 affects the coding region of SULT1A1, impacting its function and presence confirmed by resequencing analysis due to high similarity with flanking sequences.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRANSCRIPTION FACTOR BINDING SITES&quot;">
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d1">"The non-synonymous alleles at these variants may change transcription factor binding sites and splicing enhancer/silencer binding sites, impacting SULT1A1 function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS61737565&quot;">
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d1">"Physiological Process"</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;RS8061877&quot;">
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d1">"Molecular Interaction"</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;G.28854194C/G VARIANT&quot;">
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d1">"Physiological Process"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TUFM GENE&quot;">
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d1">"Transcription Factor Binding Sites"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PHYSIOLOGICAL PROCESS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Context implies processes related to human biology, possibly involving metabolic pathways."&lt;SEP&gt;"Nitric oxide synthesis is involved in the physiological process related to ovarian cancer risk."&lt;SEP&gt;"SNPs for Age at First Tooth are related to physiological processes involved in tooth development."&lt;SEP&gt;"SNPs for Number of Teeth are related to physiological processes governing tooth number."&lt;SEP&gt;"No specific physiological process mentioned in the text but could be related to CAD risk factors such as platelet number variation."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b&lt;SEP&gt;chunk-22216738ccbae0a6276bb4499018c434&lt;SEP&gt;chunk-734cac289b42d37dad32bd51ea24a1ea&lt;SEP&gt;chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 10}]</data>
    </node>
    <node id="&quot;IL1B&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Interleukin 1 beta (IL1B) rs7596684 is a genomic variant associated with ovarian cancer risk."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;SNPS IN ALOX15&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"No association was found between SNPs in ALOX15 and ovarian cancer risk."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;CCL2&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"No association was observed with SNPs in CCL2, CRP, IL18, or IL6 for ovarian cancer risk."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;IL18&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"No evidence of an association between IL18 SNPs and ovarian cancer risk was observed in this study."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;IL6&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"No significant relationship detected between IL6 SNPs and ovarian cancer risk in the analyzed data."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;RS7596684&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs7596684 of IL1B is a genomic variant associated with increased ovarian cancer risk according to study results."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;PTGS1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Prostaglandin-endoperoxide synthase 1 (PTGS1) rs2282169 is a gene that shows association with ovarian cancer risk."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d1">"No association was found between SNPs in ALOX15 and ovarian cancer risk according to the combined analyses at various SNPs, including IL1B rs7596684 and PTGS1 rs2282169.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1 (PTGS1)&quot;">
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d1">"rs2282169 of PTGS1 is a genomic variant associated with increased ovarian cancer risk according to the study results.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS2282169&quot;">
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d1">"rs2282169 of PTGS1 is a genomic variant associated with increased ovarian cancer risk according to the study results.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TEXAS CHILDREN’S CANCER CENTER&quot;">
      <data key="d0">"LOCATION"</data>
      <data key="d1">"Texas Children’s Cancer Center is a location where childhood acute lymphoblastic leukemia cases were recruited from."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;POPULATION CHARACTERISTICS&quot;">
      <data key="d0">"STUDY POPULATION CHARACTERISTICS"</data>
      <data key="d1">"The population characteristics of children with childhood ALL, including recruitment source and demographics, are summarized in Table 2."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;TABLE 2&quot;">
      <data key="d0">"DOCUMENT"</data>
      <data key="d1">"12 VEGFA SNPs selected for analysis based on their established MAFs of &gt;5% in Caucasians."&gt;4&lt;SEP&gt;"Table 2 is a document component that summarizes the population characteristics of childhood ALL cases."&lt;SEP&gt;"VDBP single nucleotide polymorphisms (SNPs) and the genotype percentage distributions of mothers and neonates are presented in Table 2. This document provides insights into genetic variations related to vitamin D metabolism among the study population."&lt;SEP&gt;"Table 2 compares allele frequencies in seronegative and seropositive individuals to assess if certain VDR variants influence T. cruzi infection risk."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97&lt;SEP&gt;chunk-6600322cc75094b1c57707e4b9c85954&lt;SEP&gt;chunk-0ce38a2d49e01ec790464306e01de9b4&lt;SEP&gt;chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;STUDY PERIOD&quot;">
      <data key="d0">"TIMEFRAME"</data>
      <data key="d1">"The study period for which participation rates were reported was from 2003 to 2010."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;PARTICIPATION RATE&quot;">
      <data key="d0">"PARTICIPANT RECRUITMENT DETAILS"</data>
      <data key="d1">"For the study period, the participation rate of families participating in the study was 85%."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;RACIAL/ETHNIC GROUP&quot;">
      <data key="d0">"STUDY POPULATION DEMOGRAPHICS"</data>
      <data key="d1">"The racial/ethnic groups included in this study were all represented among the participants: 59 non-Hispanic whites, 6 non-Hispanic blacks, 46 Hispanics, and 7 belonging to other racial/ethnic groups."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;SEX RATIO&quot;">
      <data key="d0">"PARTICIPANT RECRUITMENT DETAILS"</data>
      <data key="d1">"The sex ratio of male cases was higher than female cases (118 cases: 65 males and 53 females)."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;AGE RANGE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"All participants were from an elderly population, with an average age of 76.64 ± 6.40 years."&lt;SEP&gt;"All recruited cases were under the age of 14."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd&lt;SEP&gt;chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;TRIADS&quot;">
      <data key="d0">"PARTICIPANT RECRUITMENT DETAILS"</data>
      <data key="d1">"A higher proportion of families (36%) included complete triads, which is likely not to bias the results."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNPs are genomic variants that have been linked to methylation at CpG sites."&lt;SEP&gt;"The study analyzed 128 tagging SNPs from folate metabolic genes to identify genetic variants associated with childhood ALL. The analysis involved selecting SNPs based on their posterior probability of inclusion in the initial screening."&lt;SEP&gt;"Three of the SNPs' minor alleles were associated with increased social disinhibition score."&lt;SEP&gt;"Specific SNPs, such as those at PTPN2:rs478582 and PTPN22:rs2476601, are associated with higher expression of IFN-γ in CD subjects."&lt;SEP&gt;"Specific SNPs, such as those at PTPN2:rs478582 and PTPN22:rs2476601, indicate genetic variations that may influence immune response patterns.")&gt; ("relationship"</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-36d70bb8409856300dd77669e7c1f9ed&lt;SEP&gt;chunk-0ce38a2d49e01ec790464306e01de9b4&lt;SEP&gt;chunk-8276370dea9f12d2b305c355f74c7f6e</data>
      <data key="d3">[{"level": 0, "cluster": 6}]</data>
    </node>
    <node id="&quot;TAGGING SNPS&quot;">
      <data key="d0">"GENETIC TESTING METHODOLOGY"</data>
      <data key="d1">"These were specific single nucleotide polymorphisms (SNPs) selected for further study as part of genetic testing for childhood ALL association."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;MTHFD2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"One gene analyzed was MTHFD2, with 3 SNPs identified in the initial screening that proceeded to final analysis."&lt;SEP&gt;"One gene mentioned in detail is MTHFD2, with multiple tagging SNPs identified and analyzed for their association with childhood ALL."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;BHMT2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Another gene involved was BHMT2, for which 2 SNPs were identified and proceeded to final analysis."&lt;SEP&gt;"Another gene specific to this study was BHMT2, which also had specific SNPs analyzed due to their potential role in childhood ALL risk."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;NOS3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene in the study was NOS3, with 1 SNP selected from initial screening that proceeded to final analysis. This is mentioned as having a Bayes Factor greater than 1."&lt;SEP&gt;"This document includes details about the NOS3 gene, specifically rs3918186, which showed a strong association with childhood ALL as indicated by its Bayes Factor of 7.38."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;SLC19A1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Another gene involved was SLC19A1, which also had 1 SNP identified in the initial screening and proceeded to final analysis with a Bayes Factor greater than 1."&lt;SEP&gt;"The SLC19A1 gene and the specific SNP rs1051266 are mentioned in this context, indicating a moderate increase in risk for developing childhood ALL."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;BAYES FACTORS&quot;">
      <data key="d0">"ANALYTICAL OUTCOME CRITERIA"</data>
      <data key="d1">"The selected SNPs from MTHFD2 (3), BHMT2 (2), NOS3 (1), and SLC19A1 (1) had posterior probabilities of inclusion above the threshold in initial screening, indicating they were candidates for final analysis."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;TABLE 4&quot;">
      <data key="d0">"DOCUMENT"</data>
      <data key="d1">"Bayes Factors greater than 1 support the association between these selected SNPs and childhood ALL risk."&lt;SEP&gt;"This table likely contains detailed data on the distribution of neonatal vitamin D status according to maternal–neonate dyads and their respective genetic profiles."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97&lt;SEP&gt;chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;OR (ODDS RATIO)&quot;">
      <data key="d0">"STATISTICAL OUTCOME"</data>
      <data key="d1">"The OR values associated with specific SNPs suggest increased risks for certain genetic variants, particularly NOS3 rs3918186, which showed a significant association as indicated by the Bayes Factor of 7.38."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;SLC19A1 RS1051266&quot;">
      <data key="d0">"SNP DETAILS"</data>
      <data key="d1">"For SLC19A1 rs1051266, there was less evidence for an association with childhood ALL risk but still suggested a moderate increase in risk (OR = 2.07)."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;MTHFD2 RSS&quot;">
      <data key="d0">"SNP DETAILS"</data>
      <data key="d1">"Among the MTHFD2 rs variants identified, those included in final analysis had higher posterior probabilities of inclusion due to their Bayes Factors and statistical support.") ("entity"</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;PARTICIPANTS&quot;">
      <data key="d0">"PARTICIPANT"</data>
      <data key="d1">"The study included 108 participants who underwent genotyping at baseline."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 14}, {"level": 2, "cluster": 17}]</data>
    </node>
    <node id="&quot;GENOTYPING CONSENT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Nine participants were excluded due to lack of genotyping consent."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;INCOMPLETE GENOTYPE DATA&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Three participants had incomplete genotype data, affecting the study's overall sample size."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;GENOTYPING SUCCESS RATE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The success rate of genotyping for the 4 chosen SNPs was between 96.7% and 98.3%, indicating high reliability in genetic data collection."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;MINOR ALLELE FREQUENCIES&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The minor allele frequencies ranged from 25.0% to 32.9%, suggesting a diverse genetic background among participants."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;HARDY-WEINBERG EQUILIBRIUM&quot;">
      <data key="d0">"PHYSIOLOGICAL PRINCIPLE"</data>
      <data key="d1">"No significant deviation from Hardy-Weinberg equilibrium was observed for any of the SNPs, indicating random distribution of genotypes."&lt;SEP&gt;"The Hardy-Weinberg equilibrium is a principle used to determine the genetic makeup of populations, which can be applied when studying potential gene-disease associations."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;BASELINE CHARACTERISTICS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Baseline characteristics such as age, gender, race, BMI were not significantly different between diet groups at baseline."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;SERUM AA CONCENTRATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Linear regression indicated that the number of minor alleles was a significant predictor of serum AA concentration but not dietary intake."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;COLONIC AA CONCENTRATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The presence of any minor alleles was significantly associated with lower colonic AA concentration, suggesting a genetic influence on this measure."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;DIETARY AA INTAKE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Dietary AA intake did not predict serum or colon concentrations, indicating other factors may be at play in determining these measures."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;LONG CHAIN N-3 FATTY ACIDS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"In contrast to AA, dietary long chain n-3 fatty acids were significantly predicted by diet intake."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;RACE&lt;&gt;/&gt;">
      <data key="d0">"DEMOGRAPHIC FACTOR"</data>
      <data key="d1">"No significant differences were found for race among the two diet groups or when considering minor allele and all major allele carriers."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;SMOKING HABIT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The presence of smoking as a habit among participants is an environmental factor that may be associated with coffee consumption behaviors in the study population, impacting their risk for developing type 2 diabetes and prediabetes over time."])(relationship&lt;SEP&gt;"There was no significant difference in smoking habits between the two diet groups at baseline."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;COMMON MEDICATION USE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"No significant differences were found for common medication use among the minor allele and all major allele carriers."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;FATTY ACID CONCENTRATIONS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Baseline measures of fatty acids in serum and colon showed no significant effects from genotype group, with adjustments made for covariates like age, BMI, dietary intakes."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;TOTAL CHOLESTEROL&lt;&gt;/&gt;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"No significant changes were observed in total cholesterol among the two diet groups or when considering minor allele and all major allele carriers."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;LDL&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"No significant differences in LDL levels were found amongst different genotype groups."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;HDL&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"No significant changes were observed in HDL levels among the two diet groups or when considering minor allele and all major allele carriers."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;TRIGLYCERIDES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"No significant differences in triglyceride levels were found amongst different genotype groups."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;INSULIN&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Insulin is a hormone critical for blood sugar regulation, directly linked to diabetes. It indicates that alterations in insulin signaling are central to the pathology described."&gt;5&lt;SEP&gt;"No significant changes in insulin levels were observed among the two diet groups or when considering minor allele and all major allele carriers."</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;GLUCOSE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"No significant differences in glucose levels were found amongst different genotype groups."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;MEDITERRANEAN DIET GROUP&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"This group also included 54 participants committed to a Mediterranean-style diet."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;SATURATED FAT&lt;&gt;/&gt;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Participants in both diet groups significantly reduced their intake of saturated fats, which are solid at room temperature."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;MONOUNSATURATED FAT&lt;&gt;/&gt;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Similar reductions were observed for monounsaturated fat, a type found primarily in oils and nuts."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;LONG CHAIN N-3 PUFA (POLYUNSATURATED FATTY ACIDS)&quot;/&gt;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Both diet groups increased their intake of long chain n-3 PUFA, which are beneficial for heart health."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;INTERACTIONS OF GENOTYPE AND DIET INTERVENTION&quot;">
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d1">"The significant interaction found for 20:4, n-6 (AA) concentrations in the colon suggests a relationship between FADS1/2 genotype and diet intervention.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 15}]</data>
    </node>
    <node id="&quot;DRUG&quot;">
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d1">"The study does not provide a direct relationship between statins and personalized therapy for cardiovascular disease. However, it may indirectly suggest that medications like statins could be part of an individualized approach to diet-gene interactions.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 11}]</data>
    </node>
    <node id="&quot;THERAPY&quot;">
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d1">"Although not directly mentioned, the concept of statins as therapy for cardiovascular disease implies a relationship with gene-diet interactions.")&lt;SEP&gt;"The concept of personalized therapy is mentioned in the context of managing cardiovascular disease risk, which could be influenced by dietary patterns and genetic factors.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 12}]</data>
    </node>
    <node id="&quot;MSRB3&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"MSRB3 is a protein previously associated with snoring.")&lt;SEP&gt;"The MSRB3 gene, investigated alongside other genetic factors for dental development time, sheds light on physiological processes influencing tooth eruption."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64&lt;SEP&gt;chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;BCL11B&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"BCL11B is a gene previously associated with smoking and may be involved in molecular interactions related to snoring.")</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;SMG6&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"SMG6 is a gene previously associated with alcohol consumption and may have molecular interactions relevant to snoring.")</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;ROBO2&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"ROBO2, associated with chronotype, suggests an environmental factor that might influence timing of sleep-related behaviors leading to snoring.")</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;NSUN3&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"NSUN3 is a gene previously associated with narcolepsy and may be involved in the physiological processes contributing to snoring as a comorbid trait.")</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;SNAP91&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"SNAP91, associated with smoking, suggests molecular interactions that might relate to the onset of snoring among individuals who smoke.")</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;EDUCATIONAL ATTAINMENT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Educational attainment could represent an environmental factor influencing lifestyle choices potentially affecting snoring, such as diet and sleep patterns.")&lt;SEP&gt;"There was an elevated risk of RCC among those consuming milk as opposed to never consumers (OR=1.35)."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5&lt;SEP&gt;chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;SODIUM IN URINE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The presence of sodium in urine might be indicative of a physiological process related to fluid balance or kidney function which could influence snoring risk.")</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;DAYTIME DOZING&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Daytime dozing is an environmental factor that may suggest sleep deprivation, increasing the likelihood of snoring due to altered sleep patterns and physiology.")</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;SLEEP APNOEA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Sleep apnoea represents a physiological process impacting respiration during sleep which could contribute to snoring through repeated disruptions in breathing.")</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;EXCESSIVE DAYTIME SLEEPINESS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Excessive daytime sleepiness is a physiological state indicative of disrupted nighttime sleep quality, potentially increasing the risk for snoring due to increased fatigue and laxer upper airway muscles."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;MINIMUM SPO2&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Minimum SpO2 measures nocturnal hypoxia levels, suggesting an environmental factor involving oxygen saturation during sleep that might be linked to genetic factors predisposing individuals to snoring.")</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;AVERAGE SPO2&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Average SpO2 reflects overall oxygenation patterns at night, which could indirectly suggest environmental stressors affecting respiratory health and increasing the risk of snoring.")</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;PERC90&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Perc90 measures specific hypoxia thresholds during sleep potentially indicating a physiological process related to more severe cases of snoring through repeated episodes of low oxygen levels.")</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;SNORING&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Snoring is a disease characterized by periodic disruptions to breathing during sleep."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;GWAS&quot;">
      <data key="d0">"RESEARCH METHODOLOGY"</data>
      <data key="d1">"Genome-wide association studies (GWAS) are research methods used in identifying genetic factors associated with snoring and other traits."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;SNPS">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genome-wide significant SNP was identified as part of the GWAS on snoring, suggesting a link to this trait."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;SEX STRATIFIED ANALYSIS&quot;">
      <data key="d0">"RESEARCH DESIGN"</data>
      <data key="d1">"The study used sex stratified analyses due to higher prevalence in males, contributing further insights into genetic factors related to snoring across sexes."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;MR-EGGER ESTIMATES&quot;">
      <data key="d0">"STATISTICAL METHODOLOGY"</data>
      <data key="d1">"MR-Egger estimates were utilized as part of the statistical analysis approach for this research on snoring genetics."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;BMI ADJUSTMENT SENSITIVITY ANALYSES&quot;">
      <data key="d0">"SENSITIVITY ANALYSIS"</data>
      <data key="d1">"The study included BMI adjustment sensitivity analyses to adjust for potential confounders in genetic associations with snoring."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;HERITABILITY">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"SNP heritability on the liability scale was measured, showing significant genetic influence on snoring traits among participants."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;PGS (POLYGENIC SCORING)">
      <data key="d0">"PREDICTIVE MODELING"</data>
      <data key="d1">"The study used PGS to predict recent snoring in an independent sample from AGDS."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;AGDS (AUSTRALIAN GENETICS OF DEPRESSION STUDY)">
      <data key="d0">"STUDY POPULATION"</data>
      <data key="d1">"The target sample for deriving polygenic scoring was sourced from the Australian Genetics of Depression Study, which included participants reporting high prevalence of recent snoring."])(relationship</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;BREATHING DURING SLEEP&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Breathing disturbances during sleep, such as snoring, are a physiological process that can affect respiratory function and overall health."&gt;)&gt;9</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;MOTHER-NEONATE DYAD&quot;">
      <data key="d0">"POPULATION GROUP"</data>
      <data key="d1">"Seventy mother–neonate dyads were included in the study, representing a population of individuals for analysis."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;BIRTH BIOCHEMICAL DATA&quot;">
      <data key="d0">"EVENT"</data>
      <data key="d1">"Missing birth biochemical data led to four neonates being excluded from related analysis."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;TABLE 3&quot;">
      <data key="d0">"DOCUMENT"</data>
      <data key="d1">"Distribution of Neonatal and Maternal Vitamin D Status According to VDBP Polymorphisms (Data adjusted for BMI, UVB exposure and gestation)."&lt;SEP&gt;"Table 3 examines genotype frequencies among asymptomatic patients and those with Cardio-myopathy Complex (CCC) to determine potential associations between the studied SNPs and disease development."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97&lt;SEP&gt;chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;TABLE 5&quot;">
      <data key="d0">"DOCUMENT"</data>
      <data key="d1">"Data presented in this table further examines vitamin D status at birth, adjusting for demographic factors such as BMI and gestation period."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;TABLE 6&quot;">
      <data key="d0">"DOCUMENT"</data>
      <data key="d1">"Another document likely containing detailed data on the distribution of maternal vitamin D status according to VDBP polymorphisms, adjusted for relevant covariates like BMI during pregnancy."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;TABLE 7&quot;">
      <data key="d0">"DOCUMENT"</data>
      <data key="d1">"This table may present findings related to neonatal vitamin D cut-offs at birth and their relation to various genetic factors such as the VDBP polymorphisms under study."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;TABLE 8&quot;">
      <data key="d0">"DOCUMENT"</data>
      <data key="d1">"A document that likely contains data on maternal Vitamin D status at birth according to Maternal VDBP Polymorphisms, adjusting for relevant covariates like gestation period and UVB exposure. This table may provide insights into the genetic influence on vitamin D levels during pregnancy."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;TABLE 9&quot;">
      <data key="d0">"DOCUMENT"</data>
      <data key="d1">"This document likely contains detailed information on maternal Vitamin D status at birth according to Maternal VDBP Polymorphisms, adjusting for relevant covariates like BMI and gestation period. It may provide insights into the genetic influence on vitamin D levels during delivery."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;TABLE 10&quot;">
      <data key="d0">"DOCUMENT"</data>
      <data key="d1">"Another document likely containing detailed data on maternal Vitamin D status at birth according to Maternal VDBP Polymorphisms, adjusting for relevant covariates like BMI and gestation period. This table may provide insights into the genetic influence on vitamin D levels during delivery."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;WOMEN WITH PCOS&quot;">
      <data key="d0">"STUDY SUBJECTS"</data>
      <data key="d1">"Representatives being studied in the research, included for comparison with control subjects."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;CONTROL WOMEN&quot;">
      <data key="d0">"STUDY SUBJECTS"</data>
      <data key="d1">"Representatives used as a control group in the study."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;VEGFA SNPS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A total of 12 VEGFA SNPs selected for this analysis."&gt;4</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;ANTI-INFLAMMATORY IL-10 AND PRO-INFLAMMATORY TNFΑ LEVELS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Studied for their potential correlation with genetic variants."&gt;7&lt;SEP&gt;"Studied for their potential impact on inflammatory markers and health outcomes, including those associated with obesity and hypertension."&gt;"7</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;TOTAL TESTOSTERONE LEVELS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Measures the amount of this hormone in both men and women, important for various physiological processes including fertility and metabolism."&gt;2</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;OLIGOMENORRHEA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Refers to infrequent or irregular menstrual periods, one of the features being studied related to VEGFA SNPs and PCOS."&gt;4</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;BLOCK&quot;">
      <data key="d0">"RESPONSE BIAS"</data>
      <data key="d1">"Higher response bias was found in Blocks 3 and 2, indicating differences in behavior based on experimental block."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;TIME&quot;">
      <data key="d0">"STAI SCORES"</data>
      <data key="d1">"STAI scores significantly increased over time for all participants across different conditions."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;VAL VARIANT&quot;">
      <data key="d0">"GENETIC VARIANT OF INTEREST"</data>
      <data key="d1">2</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;ISO HOMOZYGOTES&quot;">
      <data key="d0">"ANOTHER GENETIC VARIANT GROUP"</data>
      <data key="d1">3</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;CONDITION&quot;">
      <data key="d0">"STRESS CONDITION"</data>
      <data key="d1">"The no-stress condition was designed as a control for comparison with the stress condition."&lt;SEP&gt;"The stress condition was designed to induce anxiety and negative affect in participants."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;PARTICIPANT GENOTYPE&quot;">
      <data key="d0">"STRESS AND NO STRESS CONDITIONS"</data>
      <data key="d1">"Genetic factors, such as the MR genotype, are influential in shaping individual response biases towards reward stimuli under stressful conditions."&lt;SEP&gt;"Genotype affects individual responses within both stress and no-stress conditions, indicating its relevance across different situations."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;BLOCK DESIGN&quot;">
      <data key="d0">"DISCRIMINABILITY"</data>
      <data key="d1">"Elevated discriminability was noted in specific blocks of the task, indicating differences between trial conditions.") ("relationship"</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;SC RESPONSES&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"Participants had more non-specific skin conductance responses during the stress condition compared to no-stress condition, reflecting heightened physiological reactivity.") ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;KCNJ160&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"KCNJ160 is a gene that likely plays a role in age at first tooth."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS17101923&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The alleles that predisposed to earlier tooth eruption were also associated with increased face width, indicating a relationship between tooth eruption time and facial dimensions."&lt;SEP&gt;"The rs17101923 genomic variant was associated with measures indexing the width of the upper region of the face and nose."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;ALLELES OF RS17101923&quot;">
      <data key="d0">"NUMBER OF TEETH"</data>
      <data key="d1">"Alleles associated with the rs17101923 variant predisposed to earlier tooth eruption were also associated with a greater number of permanent teeth, suggesting a link between early tooth eruption and increased dental count."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS997154&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The SNP rs997154 was associated with an increase in height and prominence of the mid-brow, indicating its involvement in craniofacial development which could potentially impact tooth eruption patterns."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS2804391&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Alleles associated with earlier primary tooth eruption were also linked to dietary factors that may influence teeth development and cranial growth."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS7924176&quot;">
      <data key="d0">"NITRIC OXIDE SYNTHESIS PATHWAY"</data>
      <data key="d1">"The rs7924176 marker was associated with measurements indexing the width of the nose, indicating its potential role in nitric oxide synthesis which could influence facial growth and dentition."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;BMP4&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"SNPs at BMP4 locus were linked to craniofacial development measures including number of teeth suggesting a connection between this metabolic pathway and tooth count."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;ALLELES OF SNP RS17101923, RS997154, RS2804391, RS7924176&quot;">
      <data key="d0">"AGE AT FIRST TOOTH, NUMBER OF TEETH"</data>
      <data key="d1">"These genomic variants were associated with age at first tooth and number of teeth respectively. This suggests a complex interplay between genetic factors and dental development."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;ALSPAC&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Data from ALSPAC was used to test for association between top SNPs and craniofacial measures, indicating its role in physiological processes related to dental development."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;NFBC1966&quot;">
      <data key="d0">"DISEASE RISK FACTOR"</data>
      <data key="d1">"Regression analysis on data from NFBC1966 showed moderate evidence of association with height using allelic scores constructed from genome-wide significant SNPs for age at first tooth and number of teeth, suggesting these factors can influence disease risk."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS1951867&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs1951867 genomic variant was investigated as part of a GWAS for 'age at first tooth' and 'number of teeth'."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;FAM155E–EDA&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNPs in the FAM155E-EDA region, including rs2520397, were associated with craniofacial measures such as 'age at first tooth' and 'number of teeth', highlighting their significance in dental development."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;ADK&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Alleles that predisposed to earlier tooth eruption were also linked to a marker (ADK) for dietary factors potentially influencing dentition."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;VCL&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The ADK/VCL region was associated with measures of craniofacial shape and size, indicating its potential role in nutritional influences on dental development."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;AP3M1&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Alleles at the AP3M1 locus were linked to 'number of primary teeth', suggesting an interaction between environmental factors such as diet and dental health."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;CACNB2&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The CACNB2 gene was part of a study looking into height-associated SNPs for tooth eruption, indicating its role in physiological processes influencing dentition time."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;6Q21&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP at the 6q21 locus was investigated as part of studies on 'number of primary teeth' suggesting its potential involvement in genetic factors affecting dental count."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RAD51L1&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The RAD51L1 gene, associated with tooth eruption time through a studied SNP variant, is likely involved in determining the timing of tooth development."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;HMGA2&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Alleles at HMGA2 were significantly linked to craniofacial measures such as 'width of face and nose' and tooth count indicating its role in metabolic pathways affecting dentition."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;BIOLOGICAL PATHWAY&quot;">
      <data key="d0">"BIOLOGICAL PATHWAY"</data>
      <data key="d1">"Pathways associated with 'Number of teeth' GWAS not specified or detailed in provided text."&lt;SEP&gt;"Pathways associated with Age at First Tooth GWAS include genes like HMGA2 and BMP4."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;ALLIGATOR SOFTWARE&quot;">
      <data key="d0">"SOFTWARE"</data>
      <data key="d1">"No mention of ALLIGATOR software being used for analysis of Number of Teeth SNPs or pathway significance."&lt;SEP&gt;"Pathway analysis was conducted using the ALLIGATOR software, which identified top pathways for 'Age at first tooth' based on SNP associations.") ("entity"</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;CDON&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"The CDON gene's top SNP, rs4937076, is linked with 'number of teeth' in both studies analyzed.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CALU/OPN1SW&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"SNPs in the CALU/OPN1SW protein region were associated with 'age at first tooth', as indicated by rs1799922 and related variants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AJUBA/C14ORF93&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"SNPs in the AJUBA/C14orf93 protein region were linked to 'number of teeth', according to rs7924176 and other associated variants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EDA&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"SNPs in the EDA region were associated with both 'number of teeth' and 'age at first tooth', as reported by rs412000, a nutrient-related SNP.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 12}]</data>
    </node>
    <node id="&quot;IGF2BP1&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"SNPs in the IGF2BP1 protein region were linked to 'number of teeth' and also appeared at genome-wide significant levels for these associations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;KCNJ2 KCNJ160&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"The SNP rs17563 in the KCNJ2 gene, interacting with another gene KCNJ160, was associated with both 'age at first tooth' and 'number of teeth'.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 13}]</data>
    </node>
    <node id="&quot;RAD51C&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"The SNP at RAD51C, rs412000, is linked to both physiological processes related to tooth development and was identified as a nutrient-related gene.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TMEM9&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"A variant in the TMEM9 region previously reported as genome-wide significant for 'secondary dentition' showed no genome-wide significance but still provided suggestive evidence of association with both phenotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;NAIVE CD4+CD25−CD45RBHI T CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"These are naive T cells used for transferring into Rag1−/− recipients to induce colitis."&gt;"2</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;RAG1−/− MICE&quot;">
      <data key="d0">"SPECIES"</data>
      <data key="d1">"Rag1−/− mice serve as recipients in the studies comparing disease severity and different genetic modifications.")&gt;3</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;CD45RBHI T CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"CD45RBhi cells are identified for their higher expression of CD45RB, used to monitor naive T cell status.")&gt;4</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;COLITIS SEVERITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Colitis severity was monitored through changes in body weight and colon histopathology, indicating inflammation and tissue damage."&gt;5</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;WEIGHT GAIN DECREMENT&quot;">
      <data key="d0">"MEASURED PARAMETER"</data>
      <data key="d1">"Weight gain decrement at 8 weeks indicates the rate of disease progression."&gt;"6</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;COLONIC T CELL INFILTRATION&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Colonic infiltration by T cells contributes to colitis severity, monitored for assessing disease activity."&gt;7</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;T CELL SUBSET (TH1, TH17, FOXP3+) &quot;">
      <data key="d0">"CELL TYPE SUBSET"</data>
      <data key="d1">"Different subsets of T cells like Th1 and Th17 are involved in regulating inflammation."&gt;"8</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;MACROPHAGE SELECTIVE DELETION OF IL-10RΑ&quot;">
      <data key="d0">"ENTITY MODIFICATION"</data>
      <data key="d1">"IL-10Rα was selectively deleted from macrophages to study its impact on colitis severity."&gt;9) ("entity"</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;DENDRITIC CELLS (DC)&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Dendritic cells play a role in inflammation regulation but were not specifically mentioned for their impact on colitis severity."&gt;2</data>
      <data key="d2">chunk-bcd248f7a9b2453bfc563b9439fbdd51</data>
    </node>
    <node id="&quot;NOS1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The NOS1 gene plays a critical role in cardiovascular health by regulating nitric oxide production."&lt;SEP&gt;"The NOS1 gene plays a critical role in cardiovascular health by regulating nitric oxide production."&lt;SEP&gt;"The NOS1 gene plays a critical role in cardiovascular health by regulating nitric oxide production."&lt;SEP&gt;"The NOS1 gene plays a critical role in cardiovascular health by regulating nitric oxide production."&lt;SEP&gt;"The NOS1 gene plays a critical role in cardiovascular health by regulating nitric oxide production."&lt;SEP&gt;1)("relationship"&lt;SEP&gt;"The NOS1 gene plays a critical role in regulating nitric oxide production and is associated with cardiovascular health."</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c&lt;SEP&gt;chunk-35d8a4ea86cb92d18ee1c857a318d2d8&lt;SEP&gt;chunk-eaf655c4dd9244523b048a122e232be4&lt;SEP&gt;chunk-380a8a6e0d08cd28068a146ae5e00ce4&lt;SEP&gt;chunk-e097891654194982dfc0ef87401d3aa9&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-dd3c1834035af8b4436c8058609b6fd8&lt;SEP&gt;chunk-4964b2db9e3ddddb4967fb7150e4404d</data>
    </node>
    <node id="&quot;FOLATE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Folate is a key nutrient found in leafy greens and plays a role in nitric oxide production."&lt;SEP&gt;"Folate is a key nutrient found in leafy greens and plays a role in nitric oxide production."&lt;SEP&gt;"Folate is a key nutrient found in leafy greens and plays a role in nitric oxide production."&lt;SEP&gt;"Folate is a key nutrient found in leafy greens and plays a role in nitric oxide production."&lt;SEP&gt;"Folate is a key nutrient found in leafy greens and plays a role in nitric oxide production."/&gt;&gt;4&lt;SEP&gt;"Folate is the nutrient of interest in this context, specifically within the context of dietary patterns and nutritional research."&lt;SEP&gt;"Folate is a nutrient found in leafy greens and has been associated with the regulation of gene expression related to immune function."&lt;SEP&gt;"Folate is a key nutrient linked to increased risk in CTLA4 genetic variants associated with increased risk of developing PBC."&lt;SEP&gt;"Folate is a key nutrient linked to increased susceptibility in CTLA4 genetic variants associated with PBC."</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e&lt;SEP&gt;chunk-1d2a8d3ce4f9baae7e1c9c14410045d0&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-dd3c1834035af8b4436c8058609b6fd8&lt;SEP&gt;chunk-0d155c005072e55d94179ce7952bf5a9&lt;SEP&gt;chunk-7c25217961fba65d15f20beda8a58f1c</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 12}]</data>
    </node>
    <node id="&quot;LEAFY GREENS&quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"Leafy greens are a food source rich in folate, which is critical for cardiovascular health."&lt;SEP&gt;"Leafy greens, rich in folate and other nutrients important for cardiovascular health, may contribute to the development of PBC."&lt;SEP&gt;"Leafy greens, rich in folate and other nutrients important for cardiovascular health, may contribute to the risk of developing PBC."&lt;SEP&gt;"Leafy greens are a food source that potentially influences vitamin intake and cellular functions like those of CTLA4-expressing T cells.")</data>
      <data key="d2">chunk-f02653cb486dbf68cc259f74ea8b2b2e&lt;SEP&gt;chunk-5b68770e1b446d6cba0d4e1ecabf497b&lt;SEP&gt;chunk-8fb20f873daf79a9b7d6e8d25c8889d6&lt;SEP&gt;chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 14}, {"level": 2, "cluster": 16}]</data>
    </node>
    <node id="&quot;MACROPHAGE (MONOCYTE)&quot;">
      <data key="d0">"MACROPHAGE (MONOCYTE)"</data>
      <data key="d1">"Macrophages, particularly those of the IL-10RαMdel RAG1−/− strain, produce proinflammatory cytokines implicated in pathogenesis."</data>
      <data key="d2">chunk-8fb20f873daf79a9b7d6e8d25c8889d6</data>
    </node>
    <node id="&quot;T CELL&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"IL-10Rα Mdel Rag1−/− recipients show specific alterations in T cell populations."</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;TH17 CELLS&quot;">
      <data key="d0">"EFFECTORS"</data>
      <data key="d1">"Substantially diminished proportions and absolute numbers of Th17 cells are seen in the colons, indicating a selective defect in this response."])(Fig. 6a, b&lt;SEP&gt;"Th17 cells represent a subset of T cells involved in autoimmune responses and were studied for their maturation under different conditions with LPMϕs.")</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c&lt;SEP&gt;chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;COLITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Colitis is characterized by significant disease severity differences between T cell transfers involving IL-1R−/− and Rag1−/− recipients."])(Fig. 6a, b</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;IL-10RΑ MDEL&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"IL-10 signaling modulates pro-IL-1β production in macrophages, which is crucial for attenuating colonic inflammation and disease severity."])(Supplementary Fig. 6a</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;MLN PRIMING SITE&quot;">
      <data key="d0">"T CELL RESPONSES"</data>
      <data key="d1">"In MLNs, IL-6Rα−/− transfers are associated with specific changes in Th17 and other T cell subsets compared to control WT T cell transfers."])(Fig. 5c</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;FOXP3+ TREG CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"T cells such as Foxp3+ Tregs play critical roles in maintaining homeostasis by modulating the Th17 response and inflammatory responses overall."])(Supplementary Fig. 6d</data>
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
    </node>
    <node id="&quot;PRO-IL-Β&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Pro-IL-β is an inactive form of interleukin-1β that was diminished in Rag1−/− cultures after treatment with IL-10.")</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;MATURE IL-1Β&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Mature IL-1β refers to the active form of interleukin-1β, which was undetectable in Rag1−/− cultures after treatment with IL-10.")</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;IL-10RΑ&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IL-10 receptor alpha (IL-10Rα) is a crucial component of the pathway that suppresses maturation and activity of interleukin-1β in Rag1−/− cultures.")</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;CASPASE-1&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Caspase-1 is an enzyme involved in the activation of mature IL-1β. It was found to be activated when stimulated with LPS and ATP, but not affected by treatment with IL-10.")</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;ACTIVATED CASPASE-1 (P20)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Activation of caspase-1 leads to the cleavage of pro-IL-β into mature IL-1β. It was detected in Rag1−/− Mϕs when stimulated with LPS and ATP.")</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;IL-10RΑMDELRAG1−/− MΦS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"IL-10 receptor alpha (IL-10Rα) mutant mice show enhanced activation of caspase-1 in their macrophages, suggesting that IL-10 signaling normally suppresses this pathway.")</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;LPS AND ATP&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"LPS (lipopolysaccharide) and ATP are agents used to stimulate Mϕs in the study, triggering caspase-1 activation and IL-1β maturation.")</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;TGFΒ&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Transforming growth factor β (TGFβ) is a cytokine that was used to co-culture macrophages with T cells in the study, but it does not appear directly involved in caspase-1 activation or Th17 cell maturation.")</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;ΑIL-6RΑ BLOCKING ANTIBODY&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"An antibody blocking αIL-6Rα was used to assess the impact of IL-6 on Th17 cell differentiation, but it did not completely suppress Th17 formation with IL-10Rα mutant macrophages.")</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;INFLAMMATORY MACROPHAGES (LPMΦS)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Inflammatory macrophages (LPMϕs), derived from Rag1−/− and IL-10RαMdelRag1−/新区 mice, were used in the study to assess their impact on Th17 cell maturation.")</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;NAÏVE T CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Naïve T cells are a type of white blood cell that was co-cultured with LPMϕs in the study to assess their response to inflammatory signals from macrophages.")</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;MACROPHAGES (MΦS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Macrophages (Mϕs) play a key role in immune responses, particularly in the context of inflammation studied in this research.")</data>
      <data key="d2">chunk-b971aa450a9b220806bdc000eb5efaad</data>
    </node>
    <node id="&quot;IL-10 RESPONSE&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"IL-10 inhibits pro-IL-1β production, which is crucial for attenuating disease severity and modulating the Th17 response in inflammatory bowel diseases."])(Supplementary Fig. 6a) ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PRO-IL-1Β PRODUCTION&quot;">
      <data key="d2">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d1">"IL-10 inhibits pro-IL-1β production, which is crucial for attenuating disease severity and modulating the Th17 response in inflammatory bowel diseases."])(Supplementary Fig. 6a) ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COHORT&quot;">
      <data key="d0">"COHORT IS A GROUP OF PEOPLE PARTICIPATING IN RESEARCH OR STUDY.")</data>
      <data key="d1">9</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;EUROPEAN COHORT&quot;">
      <data key="d0">"ETHNICITY"</data>
      <data key="d1">"European cohorts include individuals from various European ethnic backgrounds, contributing to genetic and environmental diversity within the studies.")</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;MIDDLE-EASTERN COHORT&quot;">
      <data key="d0">"ETHNICITY"</data>
      <data key="d1">"A Middle Eastern cohort is included in this study, adding to the ethnic heterogeneity of the participating groups.")</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;EAST ASIAN COHORT&quot;">
      <data key="d0">"ETHNICITY"</data>
      <data key="d1">"An East Asian cohort contributes to the diverse representation within the microbiome studies, highlighting different genetic and environmental factors affecting gut microbial composition.")</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;AMERICAN HISPANIC/LATIN COHORT&quot;">
      <data key="d0">"ETHNICITY"</data>
      <data key="d1">"The American Hispanic/Latin cohort is part of this study, bringing in a distinct ethnic background for analysis.")</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;AFRICAN AMERICAN COHORT&quot;">
      <data key="d0">"ETHNICITY"</data>
      <data key="d1">"An African American cohort contributes to the diversity within the microbiome studies and offers insights into genetic factors affecting gut microbial composition among different ethnic groups.")</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;MULTI-ANCESTRY COHORT&quot;">
      <data key="d0">"ETHNICITY"</data>
      <data key="d1">"The multi-ancestry cohort consists of individuals from various ancestries, contributing to a broader understanding of the microbiome and its influences on health outcomes.")</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;TWIN COHORT&quot;">
      <data key="d0">"GENETIC DIVERSITY"</data>
      <data key="d1">"The twin cohorts in this study represent genetically diverse groups, offering insights into genetic influences on gut microbial composition.")</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;MONOZYGOTIC TWIN PAIR&quot;">
      <data key="d0">"GENETICS"</data>
      <data key="d1">"In the twin cohort, monozygotic (MZ) twins share almost all their genes and can be used to study how genetics influence microbiome variation.")</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;DIZYGOTIC TWIN PAIR&quot;">
      <data key="d0">"GENETICS"</data>
      <data key="d1">"The dizygotic (DZ) twins in the cohort provide insights into environmental influences on gut microbial composition, as they share about 50% of their genes compared to MZ twins.")</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;ACE MODEL&quot;">
      <data key="d0">"METHODOLOGY"</data>
      <data key="d1">"In estimating heritability for microbiome composition, the ACE model was used in this study, which helps analyze genetic and environmental influences on gut microbial variation among different ethnic groups.")</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;SNP-BASED HERITABILITY&quot;">
      <data key="d0">"GENETICS"</data>
      <data key="d1">"SNP-based heritability refers to the analysis of genetic variants associated with bacterial taxa in the gut microbiota, including both abundance and presence/absence."&lt;SEP&gt;"The study examines SNP-based heritability, which helps understand how genetic factors influence gut microbial composition across various ethnic backgrounds and population groups.")</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4&lt;SEP&gt;chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;HERITABILITY OF GUT MICROBIOME COMPOSITION&quot;">
      <data key="d0">"RESEARCH TOPIC"</data>
      <data key="d1">"This research focuses on estimating the heritability of gut microbiome composition among different ethnic cohorts, providing insights into how genetics may influence microbial diversity within diverse populations.")</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;SHANNON DIVERSITY INDEX&quot;">
      <data key="d0">"RESEARCH METRIC"</data>
      <data key="d1">"The Shannon diversity index is another measure used in ecological studies for assessing microbial community diversity based on species relative abundance profiles."&lt;SEP&gt;"The study utilizes Shannon diversity index as a metric to measure the microbial composition within different ethnic groups. This index helps quantify the variety of bacterial taxa present in gut microbiomes, highlighting differences across cohorts and technical protocols.")</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4&lt;SEP&gt;chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;MICROBIOME COMPOSITION VARIABILITY&quot;">
      <data key="d0">"RESEARCH CONCEPT"</data>
      <data key="d1">"The high variability observed in microbiome composition among various ethnic cohorts suggests that factors such as population diversity and DNA extraction techniques play significant roles in shaping the gut microbial landscape.")</data>
      <data key="d2">chunk-2c395e2fed68f9267c06e9fcee853aae</data>
    </node>
    <node id="&quot;RUMINICLOSTRIDIUM&quot;">
      <data key="d0">"BACTERIAL TAXA"</data>
      <data key="d1">"Ruminiclostridium is a bacterial taxa identified through SNP-based heritability and twin-based heritability studies, associated with genetic variants."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;PEPTOSTREPTOCOCCACEAE&quot;">
      <data key="d0">"BACTERIAL TAXA"</data>
      <data key="d1">"Peptostreptococcaceae is a family of bacteria studied for its presence or absence in the gut microbiota through mbBTL mapping."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;TWIN-BASED HERITABILITY&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"Twin-based heritability involves studying the correlation between identical twins' gut microbiota composition to assess the influence of genetics on microbial diversity."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;MBQTL MAPPING ANALYSIS&quot;">
      <data key="d0">"BACTERIAL TAXA"</data>
      <data key="d1">"MbQTL mapping is a method used in genetic studies of the gut microbiota, identifying variants that affect bacterial taxa abundance."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;MBBTL MAPPING&quot;">
      <data key="d0">"BACTERIAL TAXA"</data>
      <data key="d1">"mbBTL mapping investigates associations between host genetics and presence/absence of specific bacterial taxa in the gut microbiota."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;LOCUS 2Q21.3&quot;">
      <data key="d0">"GENETIC LOCUS"</data>
      <data key="d1">"The Locus 2q21.3 contains genetic variants associated with abundance of Bifidobacterium, a taxonomic genus influenced by diet and gene-diet interaction."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;BIFIDOBACTERIUM&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Bifidobacterium is a genus of bacteria studied for its association with dairy intake in individuals homozygous for the low-function LCT haplotype.") ("entity"&lt;SEP&gt;"Higher abundance of Bifidobacterium may also be protective against certain diseases.")</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4&lt;SEP&gt;chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;GWAS META-ANALYSIS&quot;">
      <data key="d0">"GENETIC STUDY METHOD"</data>
      <data key="d1">"GWAS meta-analysis involves combining genetic data from multiple studies to identify associations between host genes and traits related to the gut microbiota, such as bacterial taxa presence or abundance."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;SIMPSON DIVERSITY INDEX&quot;">
      <data key="d0">"BIOLOGICAL MEASURE"</data>
      <data key="d1">"The Simpson diversity index is a measure used in ecological studies to quantify microbial community diversity based on species abundance profiles."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;INVERSE SIMPSON DIVERSITY INDEX&quot;">
      <data key="d0">"BIOLOGICAL MEASURE"</data>
      <data key="d1">"The Inverse Simpson Diversity Index is similar to the Simpson, but it provides an alternative way of quantifying microbial community diversity from species abundance data."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;HERITABILITY OF MICROBIAL TAXA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Heritability of microbial taxa refers to the study of how much variation in gut microbiota composition can be attributed to genetic factors, as observed through SNP-based and twin-based heritability studies."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;MICROBE-TRAIT ASSOCIATIONS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Microbe-trait associations are relationships between specific bacterial taxa and traits related to host health or disease status, studied using meta-GWAS approaches in gut microbiota research."</data>
      <data key="d2">chunk-af413a33fae8d27bdb15cd18447dfad4</data>
    </node>
    <node id="&quot;RS182549 GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">1</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;GEM_V12 COHORT&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">2</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;GEM_ICHIP SUBCOHORTS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">3</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;PERSONALIZED NUTRITION PROJECT (PNP)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">4</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;COPSAC COHORT&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">5</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;FUT2-FUT1 LOCUS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">6</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;RS35866622 SNP FOR R. TORQUES GROUP&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">7</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;RS601338 P=2.21×10−8&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">8</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;RUMINOCOCCUS SP.&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">9</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;FUT2 GENE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">10</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;ABO ANTIGENS ON INTESTINAL MUCOSA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">11</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;NC_000019.9:G.49218060C&gt;T ALLELE&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">12</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;RS35866622 NON-SECRETOR ALLELE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">13</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;FUT2 GENE RELATED TO MUCUS GLYCANS SECRETION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">14</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;RUMINOCOCCUS TORQUES GENUS GROUP&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">15</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;RS601338*A/A NON-SECRETORS ALLELE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">16</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;LCT MBQTL EFFECT&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">17</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;GEM_V24 COHORT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">18</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;ISRAEL SUBETHNICITIES IN GEM_V24 COHORT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">19</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;LIFELINES-DEEP (LLD)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">20</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;FLEMISH GUT FLORA PROJECT (FGFP)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">21</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;PCSK5 GENE ON 9Q21&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">22</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;RFK GENE RELATED TO RIBOFLAVIN PHOSPHORYLATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">23</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;GCNT1 GENE ENCODING GLYCOSYLTRANSFERASE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">24</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;CUBN GENE FOR RECEPTOR IN COMPLEX WITH GASTRIC INTRINSIC FACTOR&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">25</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;B12-DEFICIENT ANEMIA AND ALBUMINURIA RELATED TO CUBN EXPRESSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">26</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;IN VITRO COLON MODEL INFLUENCED BY VITAMIN B2 SUPPLEMENTATION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">27</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;PEPTOSTREPTOCOCCACEAE FAMILY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">28</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;STOOL LEVELS OF GUT INFLAMMATION MARKERS RELATED TO PEPTOCOCCACEAE ABUNDANCE&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">29</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;FUT2 RS281377 VARIANT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">31</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;ABO ANTIGENS ON INTESTINAL MUCOSA ASSOCIATED WITH FUT2 GENE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">32</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;PCSK5 GENE RELATED TO METABOLISM AND HOST-MICROBIOME CROSSTALK&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">33</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;RFK ENZYME FOR RIBOFLAVIN PHOSPHORYLATION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">34</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;GCNT1 ENCODING GLYCOSYLTRANSFERASE RELATED TO MUCIN BIOSYNTHESIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">35</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;CUBN GENE ASSOCIATED WITH B12-DEFICIENT ANEMIA AND ALBUMINURIA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">36</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;VITAMIN B12 ABSORPTION COMPLEX RELATED TO CUBN EXPRESSION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">37</data>
      <data key="d2">chunk-fed46d4ab6d22b3530c4c06a4b7def46</data>
    </node>
    <node id="&quot;PEPTOCOCCACEAE&quot;">
      <data key="d0">"TAXON"</data>
      <data key="d1">"Peptococcaceae is a taxon negatively associated with stool levels of gut inflammation markers chromogranin A and calprotectin.")|&gt;1</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;CHROMOGRANIN A&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Stool levels of chromogranin A are a nutrient-related indicator of gut inflammation.")|&gt;3</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;CALPROTECTIN&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Stool levels of calprotectin are another nutrient-related indicator of gut inflammation.")|&gt;4</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;IRF1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"In the proximity of IRF1, a block of 10 SNPs associated with the family Peptococcaceae regulates nitric oxide production and cardiovascular health.")|&gt;6</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;FUMA&quot;">
      <data key="d0">"FUNCTIONAL MAPPING AND ANNOTATION OF GWAS"</data>
      <data key="d1">"The FUMA analysis for 20 mbQTL loci returned positional eQTL genes related to gut microbial taxa associations with complex traits and diseases.")|&gt;8</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;GSEA&quot;">
      <data key="d0">"GENE SET ENRICHMENT ANALYSIS"</data>
      <data key="d1">"In the functional mapping, positional candidates showed no enrichment in GSEA analysis for biological outcomes of mbTLs.")|&gt;9</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;PHEWAS&quot;">
      <data key="d0">"PHENOME-WIDE ASSOCIATION STUDY"</data>
      <data key="d1">"Bayesian colocalization analysis and genetic correlation were performed for Bifidobacterium abundance in relation to its PheWAS-related phenotypes, including cardiovascular disease risk.")|&gt;11</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;SECRETOR ALLELE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The secretor allele negatively associates with several nutritional and health-related phenotypes such as cholelithiasis and high cholesterol.")|&gt;18&lt;SEP&gt;"The secretor allele shows negative association with alcohol intake frequency and other health-related traits such as high cholesterol and waist-to-hip ratio, suggesting a genetic influence on lifestyle factors.")|&gt;21</data>
      <data key="d2">chunk-938d8bf2e56584de9dd556be5eb70964</data>
    </node>
    <node id="&quot;AUTOIMMUNE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Autoimmune diseases are a group of conditions that affect multiple organ systems.")</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;CARDIOVASCULAR&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Cardiovascular disease is a leading cause of death globally.")</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;METABOLIC&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Metabolic disorders encompass a wide range of conditions affecting metabolism.")</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;PSYCHIATRIC&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Psychiatric diseases include various mental and behavioral disorders.")</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;NUTRITIONAL PHENOTYPES&quot;">
      <data key="d0">"DIETARY PREFERENCE"</data>
      <data key="d1">"Both autoimmune, cardiovascular, metabolic, and psychiatric phenotypes were considered in this study.")</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;MICROBIOME COMPOSITION&quot;">
      <data key="d0">"GUT MICROBES"</data>
      <data key="d1">"The complexity of mechanisms affecting microbiome composition requires caution when interpreting MR results.")</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;GENETIC VARIANTS&quot;">
      <data key="d0">"SNPS (SINGLE NUCLEOTIDE POLYMORPHISMS)"</data>
      <data key="d1">"Only pairs supported by three or more SNPs were considered in the bi-directional two-sample MR analyses.")</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;CAUSALITY ESTIMATION&quot;">
      <data key="d0">"MR ANALYSIS (MENDELIAN RANDOMIZATION)"</data>
      <data key="d1">"Caution is required when estimating causality using MR analysis due to potential confounders such as pleiotropy.")</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;SENSITIVITY ANALYSIS&quot;">
      <data key="d0">"PLEIOTROPY CONFOUNDER"</data>
      <data key="d1">"Several sensitivity analyses were conducted, excluding results with evidence of pleiotropy.")</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;DIET PREFERENCES&quot;">
      <data key="d0">"MICROBIOME TAXA INTERACTION"</data>
      <data key="d1">"No causal relationships between dietary preferences and gut microbial taxa were identified in the study.")</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;ACTINOBACTERIA&quot;">
      <data key="d0">"PHYLUM OF BACTERIA IN CARD9−/− MOUSE MICROBIOTA.")</data>
      <data key="d1">"Higher abundance of Actinobacteria may have a protective effect on ulcerative colitis.")&lt;SEP&gt;2</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228&lt;SEP&gt;chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;OXALOBACTERACEAE&quot;">
      <data key="d0">"MICROBIAL FAMILY"</data>
      <data key="d1">"Higher abundance of family Oxalobacteraceae is associated with reduced risk of rheumatoid arthritis.")</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;ULCERATIVE COLITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Ulcerative colitis also shows a similar pattern of reduced AHR activity and elevated levels of inflammatory metabolites like Kyn."&lt;SEP&gt;"Ulcerative colitis is a type of inflammatory bowel disease that affects the large intestine and rectum.")</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228&lt;SEP&gt;chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;RHEUMATOID ARTHRITIS&quot;">
      <data key="d0">"AUTOIMMUNE DISORDER"</data>
      <data key="d1">"Rheumatoid arthritis is an autoimmune disorder characterized by painful inflammation in multiple joints.")</data>
      <data key="d2">chunk-159d4c797dae6eb825c74067af703228</data>
    </node>
    <node id="&quot;INDIVIDUALS&quot;">
      <data key="d0">"PARTICIPANT"</data>
      <data key="d1">"Participants in the subcohort were individuals who took part in the study, with an average age of 52 years and a diverse demographic."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;STUDY CENTER&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The geographic location of each participant's study center could influence lifestyle habits, dietary patterns, and health outcomes."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 14}, {"level": 2, "cluster": 17}]</data>
    </node>
    <node id="&quot;GENOTYPING PLATFORM&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Different genotyping platforms were used to detect specific genetic variations such as rs4988235 in the subcohort, influencing how researchers interpret biological data."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;DAIRY PRODUCTS&quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"Dairy products like milk are a specific type of food that can be associated with various health outcomes based on dietary patterns."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;FRUITS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Fruit intake, as part of dietary patterns, has been analyzed for its potential impact on diabetes risk factors such as HbA1c levels."&lt;SEP&gt;"The consumption of fruits, an environmental factor affecting diet quality, has been studied in relation to its impact on physiological processes such as HDL cholesterol levels."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;DIABETES RISK FACTORS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Dietary patterns, including the consumption of certain foods such as potatoes and cereals, have been associated with diabetes risk factors among participants."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;POTATOES&quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"Potato intake has been linked to health outcomes in studies, particularly when considering dietary patterns and their impact on metabolic pathways."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;CEREALS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Intake of cereals is part of the broader dietary pattern that can influence both nutritional status and potential health risks like diabetes development."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;HDL CHOLESTEROL LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Cholesterol levels like those of HDL are important aspects of metabolic pathways influenced by dietary patterns and overall health behaviors."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;WINE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The role of alcohol in the diet, such as wine consumption, has been explored for its effects on various physiological processes including diabetes risk factors."</data>
      <data key="d2">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
    </node>
    <node id="&quot;SOCIAL CLASS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Women in both social classes did not differ significantly.")</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;MATERNAL EDUCATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"No group differences were found in maternal education levels.")</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;INTELLECTUAL COMPETENCE&quot;">
      <data key="d0">"VERBAL AND NONVERBAL INTELLECTUAL COMPETENCE"</data>
      <data key="d1">"There were no group differences in verbal and nonverbal intellectual competence.")</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;STRESS&quot;">
      <data key="d0">"PERCEIVED STRESS"</data>
      <data key="d1">"No significant group differences in perceived stress levels found.")</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;DEPRESSION&quot;">
      <data key="d0">"DEPRESSION"</data>
      <data key="d1">"No difference in depression scores between groups.")</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;NUTRITIONAL STATUS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"There were no group differences in nutritional status based on dietary patterns or caloric intake.")</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;ALCOHOL CONSUMPTION&quot;">
      <data key="d0">"DIET AND PHYSICAL ACTIVITY"</data>
      <data key="d1">"Both groups had heavy alcohol consumption at conception, with similar frequency during pregnancy.")&lt;SEP&gt;"Heavy alcohol consumption during pregnancy is linked to impaired fetal development and metabolic pathways affecting growth restrictions.")</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;SMOKING&quot;">
      <data key="d0">"PHYSICAL ACTIVITY"</data>
      <data key="d1">"Both groups smoked moderately throughout pregnancy, with slight differences in choline group.")</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;ILLICIT DRUGS&quot;">
      <data key="d0">"DRUG USE"</data>
      <data key="d1">"Use of illicit drugs other than marijuana was rare and did not differ between groups.")</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;METHAMPHETAMINE&quot;">
      <data key="d0">"DRUG USE"</data>
      <data key="d1">"Four women used methamphetamine during pregnancy, all in the choline group.")</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;WEEKS GESTATION AT RANDOMIZATION AND SUPPLEMENTATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Randomization occurred between 8.6–26 weeks gestation, with median of 20 weeks.")</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;DURATION OF CHOLINE SUPPLEMENTATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Supplementation duration ranged from 9 to 27 weeks.")</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;SEX OF INFANT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"More girls were in the choline group and more boys in the placebo arm.")</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;INFANT AGE AT ASSESSMENTS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"No significant differences found between groups regarding age or assessments for infant growth and development.")</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;CHOLINE INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Choline is a nutrient found to be lacking or not meeting requirements among participants.")</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;DIETARY CHOLINE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Low dietary choline intake may have contributed to poor nutritional status, particularly in the choline group.")</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;FASD DIAGNOSIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Rates of FAS (Frontal Sinus Enlargement) were similar between choline and placebo groups, indicating potential effects from maternal diet but not intervention impact directly observed.")</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;MATERNAL DIETARY ADHERENCE&quot;">
      <data key="d0">"NUTRITIONAL STATUS"</data>
      <data key="d1">"Adherence to dietary patterns had an influence on infant developmental outcomes in the choline group but was less significant in the placebo arm.")</data>
      <data key="d2">chunk-a9cd8765fac3ebb933c3fade561bc42e</data>
    </node>
    <node id="&quot;PFAS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"PFAS is another disease associated with prenatal alcohol exposure, also impacting physical features and cognitive/behavioral outcomes."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;CHOLINE-TREATED INFANTS&quot;">
      <data key="d0">"INFANT"</data>
      <data key="d1">"8 out of 62 infants in the choline arm met criteria for FAS or PFAS during diagnosis, compared to 5 who met criteria for FAS and 2 for PFAS in the placebo arm."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;PLACEBO INFANTS&quot;">
      <data key="d0">"INFANT"</data>
      <data key="d1">"The remaining 30 infants (17 choline-treated, 13 placebo) did not meet criteria for either disease during diagnosis."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;RS12325817 VARIANT OF PEMT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The rs12325817 variant of PEMT is associated with maternal dietary choline status, influencing both the levels and bioavailability of choline within prenatal development."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;DIETARY CHOLINE STATUS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Only a small percentage of infants in this study had mothers whose dietary choline intake was adequate or exceeded safety limits. The low levels of available choline may have implications for developmental outcomes."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;UL OF 3.5G/DAY CHOLINE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The upper limit of safe choline intake (3.5 g/day) was not exceeded in any infant, suggesting potential safety concerns with higher doses during pregnancy.") ("entity"</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;PRENATAL DEVELOPMENTAL OUTCOMES&quot;">
      <data key="d0">"OUTCOME"</data>
      <data key="d1">"This study focused on several developmental outcomes, including physical features and cognitive/behavioral characteristics of infants exposed prenatally to alcohol."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;COGNITIVE/BEHAVIORAL CHARACTERISTICS&quot;">
      <data key="d0">"OUTCOME"</data>
      <data key="d1">"Infants exposed prenatally to alcohol may exhibit specific cognitive and behavioral differences, which can be influenced by maternal dietary choline intake."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;PHYSICAL FEATURES&quot;">
      <data key="d0">"OUTCOME"</data>
      <data key="d1">"Prenatal alcohol exposure is associated with physical features in infants that are evident even at birth. These features include observable traits such as facial dysmorphology."</data>
      <data key="d2">chunk-d594d57f0043cce2b3d29c80323b1a11</data>
    </node>
    <node id="&quot;NFG&quot;">
      <data key="d0">"NON-FASTING GROUP"</data>
      <data key="d1">"The NFG group was designated as the control group for this study."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;T2DM&quot;">
      <data key="d0">"TYPE 2 DIABETES MELLITUS"</data>
      <data key="d1">"The T2DM group represented participants with confirmed Type 2 Diabetes Mellitus."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;GENOMIC DNA&quot;">
      <data key="d0">"SAMPLE"&amp;"BIOLOGICAL MATERIAL"</data>
      <data key="d1">"Genomic DNA was extracted from blood samples to study genetic variations in the rs10886471 region."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;PCR&quot;">
      <data key="d0">"POLYMERASE CHAIN REACTION"</data>
      <data key="d1">"Polymerase chain reaction (PCR) was used to amplify specific genomic regions for further analysis, including the rs10886471 region shown in Figure 1 and Figure 2."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;ALLELIC FREQUENCIES&quot;">
      <data key="d0">"GENETIC VARIATION"&amp;"BIOLOGICAL MARKER"</data>
      <data key="d1">"The allelic frequencies of (CA)15, (CA)16, (CA)17, and (CA)18 were analyzed across different groups to determine their association with blood glucose levels."</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;PIC VALUES&quot;">
      <data key="d0">"GENETIC POLYMORPHISM"&amp;"BIOCHEMICAL MARKER"</data>
      <data key="d1">"The PIC values of the rs10886471 alleles indicated genetic polymorphisms in all study groups, suggesting variability and potential functional significance of (CA)n repeats."""Table 2"</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;LOGISTIC REGRESSION ANALYSIS&quot;">
      <data key="d0">"STATISTICAL METHOD"&amp;"OUTCOME MEASURE"</data>
      <data key="d1">"The logistic regression analysis classified alleles as independent variables against a control group, revealing significant associations with blood glucose abnormalities across different groups.") ("entity"</data>
      <data key="d2">chunk-66f614368ca7f1bd578d9eb259083dd9</data>
    </node>
    <node id="&quot;NFG ALLELES&quot;">
      <data key="d0">"ALLELE"</data>
      <data key="d1">"NFG alleles are control group for this study on blood glucose abnormalities."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;T2DM RISK ALLELES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"T2DM risk alleles were found to be significantly associated with T2DM, including (CA)16 and its surrounding alleles."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;IFG RISK ALLELES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"IFG risk alleles are negatively correlated with abnormal blood glucose levels such as IFG and IGT."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;IGT RISK ALLELES&quot;">
      <data key="d0">"RELATIONSHIP"</data>
      <data key="d1">"IGT risk alleles were also identified, correlating inversely with T2DM incidence in the study population."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;(CA)16 ALLELE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The (CA)16 allele and its surrounding alleles are key contributors to T2DM, showing significant negative correlations with abnormal glucose levels."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;MULTIPLE ALLELES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"All multiple alleles included in the study were negatively correlated with IFG, IGT, and T2DM risk groups."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;ODDS RATIO (95% CI)&quot;">
      <data key="d0">"RELATIONSHIP"</data>
      <data key="d1">"The odds ratios for significant associations between genetic variants and blood glucose levels are detailed here, indicating strong correlations with disease development."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;P-VALUE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"All significant findings in the study had low p-values, confirming statistically significant relationships between genetic factors and diabetes risk.") ("entity"</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;IFG RISK GROUP ALLELES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These alleles were associated with abnormal blood glucose levels such as IFG and IGT, indicating a protective effect against these conditions."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;IGT RISK GROUP ALLELES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The presence of IGT risk alleles was found to be inversely related to T2DM incidence in the study population."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;(CA)16 REFERENCE ALLELE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The (CA)16 reference allele is used as a control for assessing the impact of other genetic variants on blood glucose levels."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;MULTIPLE ALLELES GROUP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Participants with multiple alleles, including those in (CA)16 and surrounding alleles, were part of this study group."</data>
      <data key="d2">chunk-63f7d78d4c6afd6ff9eb7b59d8c046b9</data>
    </node>
    <node id="&quot;CARD9-/- MICE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Card9-/- mice are more susceptible to colitis than wild-type mice, as they exhibit impaired recovery after dextran sulfate sodium (DSS)-induced colitis."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;DEXTRAN SULFATE SODIUM (DSS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Dextran sulfate sodium (DSS) is a chemical that induces colitis, providing a model for studying the disease in Card9-/- and wild-type mice."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;HISTOPATHOLOGIC ALTERATIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Increased apoptosis and reduced epithelial cell proliferation in the colon of Card9-/- mice confirm impaired intestinal healing."</data>
      <data key="d2">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
    </node>
    <node id="&quot;GERM-FREE MICE&quot;">
      <data key="d0">"GERM-FREE MICE"</data>
      <data key="d1">"WT germ-free (GF) mice were used for microbiota transfer experiments, which involved colonization with either WT or Card9−/− mouse microbiota.")</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;DSS-INDUCED INJURY&quot;">
      <data key="d0">"MICROBIOTA TRANSFER PHENOCOPY"</data>
      <data key="d1">"Dietary sulfasalazine (DSS), which is used to induce intestinal injury and inflammation, was administered following microbiota transfer as part of the experiment.")</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;INFLAMMATION-ASSOCIATED GENES&quot;">
      <data key="d0">"NANOSTRING TECHNOLOGY ANALYSIS"</data>
      <data key="d1">"Gene expression levels for 179 inflammation-associated genes were measured using NanoString technology to decipher mechanisms leading to the defective recovery from DSS-induced injury in Card9−/−→GF mice.")</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;IL22&quot;">
      <data key="d0">"INFLAMMATION-ASSOCIATED GENES"</data>
      <data key="d1">"Il22 was one of the most highly downregulated genes observed in Card9−/−→GF mice, suggesting a deficient IL-22 response and involvement in colitis susceptibility.")</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;LACTOBACILLUS REUTERI&quot;">
      <data key="d0">"SPECIES OF BACTERIA FOUND IN THE CARD9−/− MOUSE MICROBIOTA.")</data>
      <data key="d1">3</data>
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
    </node>
    <node id="&quot;NITRIC OXIDE SYNTHESIS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Alterations in nitric oxide synthesis are linked to increased risk of cardiovascular disease, as determined by these studies on PBC."&lt;SEP&gt;"The metabolic pathway of nitric oxide synthesis is central to maintaining vascular function."&lt;SEP&gt;"The metabolic pathway of nitric oxide synthesis is central to the interaction between the NOS1 gene and cardiovascular health."&lt;SEP&gt;&gt;(</data>
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842&lt;SEP&gt;chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-f02653cb486dbf68cc259f74ea8b2b2e&lt;SEP&gt;chunk-0d155c005072e55d94179ce7952bf5a9</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 10}]</data>
    </node>
    <node id="&quot;CARD9&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CARD9 is associated with reduced AHR activation by microbiota-derived metabolites."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;IBD&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, shows a connection between IBD, CARD9, and the ability of the microbiota to produce AHR agonists.") ("entity"</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;EXOGENOUS IL-22&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Administration of exogenous IL-22 was sufficient to normalize colitis susceptibility in Card9−/− mice."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;CARD9−/− MICE&quot;">
      <data key="d0">"DISEASE MODEL"</data>
      <data key="d1">"Card9−/− mice are used as a disease model for understanding the link between gut microbiota, AHR activation, and colitis."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;SUPPLEMENTARY FIG. 13C–H&quot;">
      <data key="d0">"DOCUMENT REFERENCE"</data>
      <data key="d1">"Supplementary Fig. 13c–h provides supplementary evidence on how exogenous IL-22 can normalize colitis susceptibility in Card9−/− mice."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;AHR AGONIST&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"An AHR agonist can effectively counter the defects observed with reduced AHR activity and tryptophan metabolites in subjects with IBD."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;TRYPTOPHAN METABOLISM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The metabolism of tryptophan by the gut microbiota is impaired, leading to defective AHR activation."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;IDO1&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Activated immune cells in the gut use tryptophan to produce Kyn via IDO1."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;KYN&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Increased levels of Kyn, a metabolite produced from tryptophan by the gut microbiota, were observed in fecal samples from patients with IBD."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;IAA&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Decreased levels of IAA, another tryptophan metabolite, were also noted in fecal samples from individuals with IBD."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;CROHN’S DISEASE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Crohn's disease is one of the conditions associated with decreased AHR activation and altered tryptophan metabolism."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;FECAL SAMPLES FROM HEALTHY SUBJECTS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Fecal samples from healthy subjects showed greater activation of AHR, suggesting better tryptophan metabolism compared to those with IBD."</data>
      <data key="d2">chunk-c791a4e35844d642ba0c69774072f7cd</data>
    </node>
    <node id="&quot;MICROBIOTA&quot;">
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d1">"The gut microbiota of Card9−/− mice shows pro-inflammatory effects and affects the susceptibility to colitis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MICROBIOTA TRANSFER PHENOCOPY&quot;">
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d1">"The phenotype observed in Card9−/− mice was recapitulated by colonizing WT GF mice with the Card9−/− microbiota, indicating that gut microbiota plays a key role in colitis susceptibility.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PHENOTYPE RECAPITULATION&quot;">
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d1">"The phenotype observed in Card9−/− mice was recapitulated by colonizing WT GF mice with the Card9−/− microbiota, indicating that gut microbiota plays a key role in colitis susceptibility.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FUNGAL COMPONENT&quot;">
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d1">"The involvement of fungal components in colitis susceptibility was assessed through antifungal treatment during microbiota transfer experiments.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-22 AXIS DEFECT&quot;">
      <data key="d2">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d1">"A deficiency in the IL-22 axis was observed in Card9−/−→GF mice, which may underlie impaired recovery from DSS-induced injury and colitis susceptibility.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NOS1&quot;">
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d1">&gt;(</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;PERSONALIZED THERAPIES IN CARDIOVASCULAR HEALTH&quot;">
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d1">&gt;(</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STATINS&quot;">
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842&lt;SEP&gt;chunk-3edc72730d68b4c7fd6ba397aa087391&lt;SEP&gt;chunk-f02653cb486dbf68cc259f74ea8b2b2e&lt;SEP&gt;chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
      <data key="d1">"Statins are a drug therapy used to manage cardiovascular disease risk."/&gt;&gt;12&lt;SEP&gt;&gt;(&lt;SEP&gt;"Statins are medications used for management of cardiovascular disease risks, including those related to genetic factors in kidney function.") (Note: I will add missing entities from your example text and provide their descriptions.&lt;SEP&gt;"The association between CTLA4 gene variants and increased susceptibility to PBC may inform targeted drug therapy for managing PBC risk."&lt;SEP&gt;"The association between CTLA4 gene variants and increased susceptibility to PBC may inform targeted drug therapy for managing PBC risk.") ("entity"</data>
      <data key="d0">"DRUG THERAPY"</data>
    </node>
    <node id="&quot;DENDRITIC CELLS &amp; MACROPHAGES&quot;">
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d1">&lt;&gt;)"Involved in stimulating IL-22 producing cells, yet no significant differences observed between specific genotypes like Card9−/−→GF and WT→GF mice.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&gt;(">
      <data key="d2">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d1">&lt;&gt;)"Involved in stimulating IL-22 producing cells, yet no significant differences observed between specific genotypes like Card9−/−→GF and WT→GF mice.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS3184504&quot;">
      <data key="d2">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d1">"Hypertension"</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;NTD-AFFECTED PREGNANCY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"An NTD-affected pregnancy is a pregnancy affected by neural tube defects.")</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;FOLIC ACID SUPPLEMENTS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Non-Hispanic Whites had higher use of folic acid supplements compared to Hispanic mothers, which may affect the risk of NTD-affected pregnancies in their infants.")</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;MATERNAL AGE AT DELIVERY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Maternal age was consistent across cases and controls within maternal race/ethnicity, which may influence the risk of NTD-affected pregnancies in their infants.")</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;COMPOSITE FOLATE INTAKE VARIABLE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A composite measure of dietary folate intake was used to assess levels across different maternal racial/ethnic groups. This may be an important factor for understanding the influence on NTD-affected pregnancies.")</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;MATERNAL RACE/ETHNICITY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Maternal race and ethnicity were consistent across cases and controls. This suggests that while environmental factors such as folic acid supplement use and education may contribute to risk of NTD-affected pregnancies, genetic predisposition does not appear to be a major determinant in this population.")</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;HISPANIC MOTHERS&quot;">
      <data key="d0">"MATERNAL RACE/ETHNICITY"</data>
      <data key="d1">"Compared to non-Hispanic White mothers, Hispanic mothers had fewer years of formal education and were younger at delivery. This demographic information highlights the influence of various factors on NTD-affected pregnancies.")</data>
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
    </node>
    <node id="&quot;MATERNAL FOLATE INTAKE&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"Low maternal folate intake has been linked to an increased risk of NTD-affected pregnancies.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;SHMT1 GENE&quot;">
      <data key="d2">chunk-382f24e5db6941e2e3db379fe499b223&lt;SEP&gt;chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"A reduction in risk for an NTD-affected pregnancy was observed among mothers with the SHMT1 gene SNP rs669340 CG compared to those with the CC genotype. This indicates that there may be a protective effect associated with this specific gene variant.")&lt;SEP&gt;1)("relationship"</data>
      <data key="d0">"GENE"</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 11}]</data>
    </node>
    <node id="&quot;TYMS GENE INTERACTION WITH FOLATE INTAKE&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"The interaction between the TYMS gene and folate intake was associated with reduced risk of NTD-affected pregnancies for mothers in the low folate intake group, suggesting that both genetic predisposition and environmental factors such as diet play a role in determining this risk.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;INFANT GENDER">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"Case infants were more likely to be female than control infants, suggesting that factors such as gender may also play a role in determining risk of NTD-affected pregnancies in their infants.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;INFANT FORMAL EDUCATION OF MOTHERS">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"Lower levels of formal education were associated with decreased risk for an NTD-affected pregnancy. This may indicate differences in access to or use of prenatal health resources among different socioeconomic groups.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;LOW FOLATE INTAKE CATEGORY&quot;">
      <data key="d2">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d1">"Individuals with low intake of folates were at an increased risk for NTD-affected pregnancies according to the study's findings. This suggests that dietary factors may play a significant role in determining this risk.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;T2D PATIENTS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Type 2 Diabetes patients are a subset of individuals who have been identified in the Inter99 cohort and at Steno Diabetes Center."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;NORMAL GLUCOSE TOLERANCE INDIVIDUALS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Individuals with normal glucose tolerance test are another group identified for comparison against T2D patients."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;CHI3LI HAPLOTYPE BLOCKS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"No association was found between the two identified haplotype blocks of CHI3LI and Type 2 Diabetes (T2D)."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;RS10399931&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs10399931 genetic variant did not show any association with Type 2 Diabetes after adjustment for age, sex, BMI and glucose tolerance."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;RS4950928&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Similarly, the rs4950928 variant also showed no significant association with T2D or related traits like impaired fasting glucose (IFG) or impaired glucose tolerance (IGT)."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;BMI TRAITS&quot;">
      <data key="d0">"QUANTITATIVE TRAIT"</data>
      <data key="d1">"Adjusted associations of genetic variants with BMI and other T2D-related quantitative traits were analyzed among NGT, IFG, IGT and screen-detected untreated T2D participants."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;SERUM C-PEPTIDE CONCENTRATION">
      <data key="d0">"&gt;PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A significant association was found between the rs10399931 genetic variant and serum C-peptide concentration after 2 hours, indicating a potential physiological process relevant to T2D."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;T2D QUANTITATIVE TRAITS&quot;">
      <data key="d0">"QUANTITATIVE TRAIT"</data>
      <data key="d1">"Despite some findings, no significant associations were detected between any other SNPs and the quantitative traits associated with T2D in this study."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;DIETARY PATTERN">
      <data key="d0">"&gt;ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The analysis did not find an association of dietary patterns or lifestyle factors like physical activity with either T2D or its related traits, based on data from Inter99 and Steno Diabetes Center participants.") ("entity"</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;STENO DIABETES CENTER PARTICIPANTS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Participants recruited at Steno Diabetes Center were included in the study to assess genetic associations with T2D under controlled research conditions."</data>
      <data key="d2">chunk-44a871da300abc9be525b468f502f5cb</data>
    </node>
    <node id="&quot;AMD&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Age-related Macular Degeneration (AMD) is a disease for which ARMS2 and related genes have been identified as risk factors."&lt;SEP&gt;"There were 337 cases of AMD in the full sample, with 91% being early stages of AMD."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6&lt;SEP&gt;chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;HIGH HLS SCORE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A Healthy Lifestyle Score (HLS) reflects lifestyle and environmental factors that influence health outcomes such as AMD development."&lt;SEP&gt;"Women with high Healthy Lifestyle Scores (4–6) had lower odds of developing AMD relative to those with low scores (0–2)."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;LOW HLS SCORE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A Healthy Lifestyle Score (HLS) measures individual lifestyle and environmental factors that influence health outcomes such as AMD development."&lt;SEP&gt;"Women with low Healthy Lifestyle Scores (0–2) had higher odds of developing AMD relative to those with high scores (4–6)."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;STABLE DIET SUBSAMPLE&quot;">
      <data key="d0">"AMD"</data>
      <data key="d1">"Out of 728 participants with stable dietary patterns, 120 cases of AMD were identified."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;GENETIC RISK ALLELES&quot;">
      <data key="d0">"AMD"</data>
      <data key="d1">"Women with both two high risk CFH alleles had 2.4 times greater odds of developing AMD relative to women with zero risk alleles."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;LIFESTYLE RISK FACTOR&quot;">
      <data key="d0">"AMD"</data>
      <data key="d1">"Women with poor lifestyle scores had 3.3 times greater odds of developing AMD relative to those with healthy lifestyles (low HLS score)."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;DIETARY LZ INTAKE&quot;">
      <data key="d0">"AMD"</data>
      <data key="d1">"Higher intake of omega-3 fatty acids explained an association between healthy lifestyles (high HLS) and AMD in women with high genetic risk, suggesting at least additive effects of these factors for AMD risk."&lt;SEP&gt;"In the subsample of women with stable diets, the odds for AMD associated with having both poor lifestyle score and high genetic risk was 4.6 times greater compared to those with healthy lifestyles (low HLS)."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;ARMS2 GENOTYPIC RISK FACTOR&quot;">
      <data key="d0">"AMD"</data>
      <data key="d1">"Women with at least one ARMS2 risk allele had 2 times greater odds of developing AMD relative to women with no such risk alleles when considering poor lifestyle scores (low HLS)."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;HEALTHY LIFESTYLE SCORE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A Healthy Lifestyle Score (HLS) measures an individual's dietary, lifestyle and other environmental factors that influence health outcomes."&lt;SEP&gt;"Healthy lifestyle score includes factors like adherence to diets and exercise, which can influence AMD risk."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6&lt;SEP&gt;chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;STABLE DIET PATTERN&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary pattern characterized by long-term similarity in food consumption over time and a lack of significant variety."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;CC GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"ARMS2 and CFH Genetic Alleles Impact on AMD Prevalence"&gt;&lt;&gt;("relationship"&lt;|"&gt;"Synergistic Effects with Lifestyle Factors in Determining AMD Risk "&lt;SEP&gt;"In controls, genotype was seen to be associated with milk drinking OR 2.39 [1.81, 3.15], p=6.9*10−10."&lt;SEP&gt;"The CC genotype is a specific genetic variant associated with an increased occurrence of Colorectal Cancer."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5&lt;SEP&gt;chunk-23a090455f50ab98c53e8b90941c6da5&lt;SEP&gt;chunk-5b0cc96debf110f3544685d3b227ff27</data>
    </node>
    <node id="&quot;ARMS2 GENETIC RISK FACTOR FOR AMD DEVELOPMENT&quot;">
      <data key="d0">"LIFESTYLE INFLUENCE INDICATOR ON AMD PREVALENCE IN WOMEN WITH HIGH HLS"&gt;&lt;&gt;("RELATIONSHIP"&lt;|"&gt;"MUTUAL INTERACTIONS WITH DIETARY LZ INTAKE IMPACTING AMD RISK "</data>
      <data key="d1">"Healthy Lifestyle Score"</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;STABLE DIET LZ INTAKE AS HEALTH INFLUENCE FACTOR ON AMD PREVALENCE IN WOMEN WITH HIGH HLS&quot;&gt;&lt;&gt;(&quot;RELATIONSHIP&quot;&lt;|&quot;&gt;&quot;INFLUENCE ON SUBGROUP AMD RISK FACTORS &quot;">
      <data key="d0">"HEALTHY LIFESTYLE SCORE"</data>
      <data key="d1">"Women with high dietary LZ intake and poor lifestyle scores had a higher prevalence of AMD, suggesting that individual factors such as diet can significantly influence the risk of developing AMD."</data>
      <data key="d2">chunk-23a090455f50ab98c53e8b90941c6da5</data>
    </node>
    <node id="&quot;SI&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ARMS2 rs3750611 gene is a gene that has been associated with an increased risk of Age-related Macular Degeneration (AMD)."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
    </node>
    <node id="&quot;COMPLEMENT PATHWAY GENES&quot;">
      <data key="d0">"OTHER GENE TYPES"</data>
      <data key="d1">"The joint effects of lifestyle score and variants in additional complement pathway genes (CFB/C2, C3 rs2230199 and CFI rs10033900) were explored."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
    </node>
    <node id="&quot;CFB/C2&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The joint effects of lifestyle score and variants in the CFB/C2 gene are part of the larger study exploring AMD risk factors."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
    </node>
    <node id="&quot;C3 RS2230199&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"There was no main effect for the C3 rs2230199 genotype on AMD risk."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
    </node>
    <node id="&quot;CFI RS10033900&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The joint effects of lifestyle score and variants in additional genes like CFI were explored, with no main effect for these specific SNPs."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
    </node>
    <node id="&quot;AGE-RELATED MACULAR DEGENERATION (AMD)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Age-related Macular Degeneration is a disease that has been associated with genetic risk factors such as the ARNS2 gene."</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
    </node>
    <node id="&quot;LOW GENETIC RISK&quot;">
      <data key="d0">"GENETIC FACTOR"</data>
      <data key="d1">"Women with low genetic risk had the lowest odds for AMD in this study's subsample of stable diet group.") ("entity"</data>
      <data key="d2">chunk-a7d0bfa8b16262a1f313b7e3060969c6</data>
    </node>
    <node id="&quot;PARTICIPANT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Participants are involved as individuals in the study population."&lt;SEP&gt;"Participants in the study are individuals who participated in the association analysis."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b&lt;SEP&gt;chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;BLACK COFFEE CONSUMPTION&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Black coffee consumption refers to habitual intake of black coffee and sugared coffee, which includes both types of coffee as part of dietary patterns among participants."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;SUGARED COFFEE CONSUMPTION&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Sugared coffee consumption involves the intake of beverages that contain added sugars along with their caffeine content."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;GENETIC POLYMORPHISMS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"18 SNPs located in genomic variants associated with habitual coffee consumption were identified through GWAS, indicating potential genetic influences on coffee habits among individuals within the study population."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;COFFEE CONSUMPTION HABITUAL&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Habitual coffee consumption is a dietary pattern that participants either adhere to or deviate from in relation to their risk of developing type 2 diabetes and prediabetes, according to the study's findings."])(relationship</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;CAFFEINE INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Caffeine intake associated with coffee consumption is a nutrient that has been examined for its impact on health outcomes among participants in the study population."</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;PREDIABETES RISK&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Prediabetes risk, as determined by habitual coffee and caffeine intake, is influenced by physiological processes such as nitric oxide synthesis, which plays a role in vascular function amongst individuals within the study population."])(relationship</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;BMI BASELINE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Baseline body mass index (BMI) is an environmental factor that can influence coffee consumption patterns amongst participants in the study population, potentially impacting their risk of developing type 2 diabetes and prediabetes over time."])(relationship</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;ALCOHOL INTAKE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Alcohol intake amongst participants of the association analysis is an environmental factor that may influence participation's choice to consume either black or sugared coffee, which can affect their risk for developing type 2 diabetes and prediabetes."])(relationship</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;GENETIC RISK SCORE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Individuals in the study who have a higher genetic risk score are more likely to be influenced by physiological processes such as vascular function, which can impact their coffee consumption patterns and diabetes-related risks."])(relationship</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;AGE OF PARTICIPANTS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The age of participants within the association analysis is an environmental factor that may influence coffee consumption behaviors, impacting their risk for developing type 2 diabetes and prediabetes over time."])(relationship</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;STATINS USE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"The use of statins amongst participants in the association analysis is a drug therapy that may influence their health outcomes by potentially modifying dietary patterns, including coffee consumption, to manage cardiovascular risk factors such as hypertension and prediabetes."])(relationship</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;HEALTH OUTCOMES PREDIABETES RISK TYPE 2 DIABETES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Health outcomes related to the development of prediabetes or type 2 diabetes among participants in the association analysis are influenced by physiological processes including nitric oxide synthesis and vascular function."])(relationship</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;RISK FACTORS HYPERTENSION SMOKING ALCOHOL BMI BASELINE PREDIABETES TYPE 2 DIABETES&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Various risk factors such as hypertension, smoking status, alcohol intake, baseline body mass index (BMI), prediabetes and type 2 diabetes are environmental influences that can impact coffee consumption behaviors among participants in the study population."])(relationship</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;NUTRITIONAL PROFILE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The nutritional profile of individuals within the association analysis is an environmental factor influencing their health outcomes related to dietary patterns and adherence to habits such as black or sugared coffee consumption, which can affect risk for developing type 2 diabetes and prediabetes."])(relationship</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;COFFEE CONSUMPTION RISK PREDIABETES TYPE 2 DIABETES COMBINED&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Habitual coffee consumption is a dietary pattern that participants either adhere to or deviate from in relation to their risk of developing type 2 diabetes and prediabetes, according to the study's findings."])(relationship</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;ASSOCIATION PREDIABETES TYPE 2 DIABETES COMBINED RISK SUGARED COFFEE CONSUMPTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The association between sugared coffee consumption and risk of developing type 2 diabetes or prediabetes among participants in the study population is influenced by physiological processes including nitric oxide synthesis, which affects vascular health."])(relationship</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;COFFEE CONSUMPTION RISK PREDIABETES TYPE 2 DIABETES COMBINED&quot; MEN WOMEN SEPARATED &quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"For men and women separately within the association analysis, there are dietary patterns involving black or sugared coffee that influence their risk for developing type 2 diabetes and prediabetes over time."])(relationship</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;COFFEE INTAKE LOWER RISK PREDIABETES TYPE 2 DIABETES COMBINED&quot; MEN WOMEN SEPARATED &quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"For men and women separately within the association analysis, there are lower risk dietary patterns involving black or sugared coffee which influence their overall health outcomes related to type 2 diabetes and prediabetes over time."])(relationship</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;SUGARED COFFEE CONSUMPTION RISK PREDIABETES TYPE 2 DIABETES COMBINED&quot; MEN WOMEN SEPARATED &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"For men and women separately within the association analysis, there are physiological processes influenced by sugared coffee consumption impacting their overall health outcomes related to risk factors for type 2 diabetes and prediabetes."])(relationship</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;PHYSICAL ACTIVITY LEVEL&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Physical activity levels among participants within the association analysis are a lifestyle factor that may influence their overall health outcomes related to diet and exercise behaviors such as adherence to dietary patterns involving black or sugared coffee, which can affect their risk for developing type 2 diabetes and prediabetes."])(relationship</data>
      <data key="d2">chunk-1f20dbdcc9de443dada1a2045dc7832b</data>
    </node>
    <node id="&quot;SENP1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SENP1 is a gene involved in autoimmune responses and type 1 diabetes (T1DM)..."&lt;SEP&gt;"SENP1 is a gene involved in inflammation and diabetes. It plays a critical role in the body's response to metabolic stress.")&gt;1&lt;SEP&gt;"SENP1 is a gene involved in regulating diabetes progression, particularly in non-obese diabetic (NOD) mice and human T1DM patients."&lt;SEP&gt;"The SENP1 gene plays a role in type-1-like diabetic phenotypes in adipocyte-specific deficient mice, suggesting it may be involved in the regulation of diabetes or insulin production.")&gt;1</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d&lt;SEP&gt;chunk-0c1631ae2c195cb68139ea9d75a3b433&lt;SEP&gt;chunk-a8f2b3b97a70df26efb35263714bf43c&lt;SEP&gt;chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;ADIPONECTIN&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Adiponectin is associated with adipocytes, specifically targeting SENP1 expression which influences its function in inflammation and diabetes."&gt;2</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;PDGFRΑ&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"PdgfRα is a protein involved in the regulation of adipogenesis and may influence SENP1's role through interactions with other genes related to metabolism.")&gt;3</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;AP2/FABP4&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"aP2/Fabp4 is a gene that impacts lipid profiles, including cholesterol and triglycerides in SENP1-deficient mice."&gt;4</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;CRE RECOMBINASE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Cre recombinase is used to create genetically modified mice for studying the function of genes like SENP1 through targeted gene deletions or insertions.")&gt;5</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;CD1OHN">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"CD11b+F4/80+ macrophages are involved in autoimmune responses, which may contribute to diabetes development in mice genetically modified to lack SENP1."&gt;6</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;VE-CADHERIN&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"VE-cadherin is a protein that influences vascular permeability and may affect the pathogenesis of diabetes through interactions with genes like SENP1."&gt;7</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;INSULIN TOLERANCE TEST (ITT)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"An insulin tolerance test measures how well an organism can respond to changes in blood sugar levels, which is crucial for understanding diabetes development.")&gt;8</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;GLUCOSE-STIMULATED INSULIN SECRETION (GSIS)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"This assay measures the release of insulin from pancreatic islets after exposure to glucose, reflecting SENP1's impact on insulin secretion."&gt;9</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;BODY WEIGHT AND BODY MASS INDEX (BMI)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Changes in body weight and BMI are indicators of diabetes onset, providing insights into the physiological effects of altered gene expression like those induced by SENP1 deletion."&gt;10</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;TOTAL CHOLESTEROL&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Total cholesterol is a component of lipoproteins involved in cellular processes. It shows changes in SENP1-deficient mice, suggesting broader metabolic impacts.")&gt;11</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;LOW-DENSITY LIPOPROTEIN (LDL)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"LDL is one type of cholesterol particle implicated in atherogenesis and diabetes development."&gt;12</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;HIGH-DENSITY LIPOPROTEIN (HDL)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"HDL, or 'good' cholesterol, has variable impacts on SENP1-deficient mice. Its changes are part of the lipid profiles examined in this study."&gt;13</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;TRIGLYCERIDES (TG)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"TG is another component of lipoproteins that shows alterations in SENP1 deficiency, suggesting interactions with diabetes development.")&gt;14</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;FREE FATTY ACIDS (FFA)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"FFA are a type of lipid involved in energy metabolism and adipogenesis. Their presence or absence can influence the body's response to metabolic stress."&gt;15</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;GLUCOSE-TOLERANCE TEST (GTT)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"This test measures how well an organism can manage blood sugar levels, providing insights into diabetes onset and severity in SENP1 deficiency.")&gt;16</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;WATER CONSUMPTION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Water consumption is a behavioral indicator of physiological changes related to metabolic stress. It shows increased water intake with altered glucose tolerance."&gt;17</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;FOOD INTAKE (DAIRY)&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"This factor was monitored in SENP1-deficient mice and their control counterparts, providing insights into dietary habits and metabolic responses.")&gt;18</data>
      <data key="d2">chunk-a8f2b3b97a70df26efb35263714bf43c</data>
    </node>
    <node id="&quot;ADIPOCYTE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Adipocytes are a type of fat cell that can be specifically targeted in the study of SENP1 deficiency, affecting diabetes outcomes.")&gt;3</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;CRP (C-REACTIVE PROTEIN)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"CRP levels are measured clinically to diagnose diabetes. It suggests that SENP1 deficiency affects metabolism leading to alterations in nutrient handling."&gt;7</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;TUNEL (TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE-MEDIATED DUTP NICK END LABELING)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"TUNEL positive indicates apoptosis in β cells; it is used as an indicator of cell death and inflammation."&gt;9) ("entity"</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;PANCREATIC ISLETS&quot;">
      <data key="d0">"ORGANISM PART"</data>
      <data key="d1">"Pancreatic islets are clusters of specialized cells in the pancreas responsible for producing hormones like insulin and glucagon."&gt;11</data>
      <data key="d2">chunk-fc33d6399ec56e65d007269407f1953d</data>
    </node>
    <node id="&quot;AUTOANTIGEN NRP-V7&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The autoantigen NRP-V7 targets peptides from the islet-specific glucose-6-phosphatase catalytic subunit, detected in CD8+ T cells."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;CD8+ T CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"CD8+ T cells are another type of T cell within the immune system responsible for fighting infections and tumors."&lt;SEP&gt;"CD8+ T cells are involved in targeting autoimmune responses by recognizing autoantigens like the NRP-V7 protein..."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433&lt;SEP&gt;chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;INSULIN DEFICIENCY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Insulin deficiency is a disease resulting from immunological destruction of pancreatic β cells, as seen in SENP1-deficient mice."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;PROINFLAMMATORY CYTOKINES (IL-6, TNF-Α, IL-1Β)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Elevated levels of proinflammatory cytokines such as IL-6, TNF-α and IL-1β are detected in the SENP1-deficient mice..."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;CCL5 (RANTES, THE CCR5 LIGAND)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"CCL5 is a chemokine upregulated in pancreatic islets of SENP1-aP2KO mice and recruits immune cells into pancreas..."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;GLUCOSE-6-PHOSPHATASE CATALYTIC SUBUNIT RELATED PROTEIN&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The glucose-6-phosphatase catalytic subunit related protein is a peptide targeted by autoantigens NRP-V7 and involved in the pathogenesis of type 1 diabetes..."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;PANCREATIC LYMPH NODES AND SPLEEN&quot;">
      <data key="d0">"TISSUE TYPE"</data>
      <data key="d1">"The pancreatic lymph nodes and spleen are tissues where autoimmune responses occur, detected through FACS analysis and quantifications (Supplementary Fig. 3H for FACS and Fig. 3n,o for quantifications)..."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;SENP1-AP2KO MICE AT THE AGE OF 7 WEEKS&quot;">
      <data key="d0">"DISEASE MODEL"</data>
      <data key="d1">"The SENP1-aP2KO mouse model is a disease model demonstrating autoimmune responses and insulin deficiency due to elevated proinflammatory cytokines such as IL-6, TNF-α and IL-1β..."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;ISLETS OF LANGERHANS&quot;">
      <data key="d0">"TISSUE TYPE"</data>
      <data key="d1">"The pancreas contains islets of Langerhans where immune cells are recruited by high levels of local proinflammatory cytokines secreted from PATs... These include upregulation of chemokine CCL5 which recruits macrophages into the pancreases..."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;MACROPHAGES AND T CELLS IN PANCREATIC ISLETS AND PATS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"In the SENP1-aP2KO mice, while there are no significant differences observed at age 7 weeks for cell numbers of macrophages and T cells in pancreatic islets or PATs, these immune cells express low levels of cytokines..."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;CCL5 EXPRESSION IN ISLET Β CELLS&quot;">
      <data key="d0">"GENE EXPRESSION"</data>
      <data key="d1">"Upregulation of CCL5 gene was confirmed by co-staining with insulin in the pancreatic islets of SENP1-aP2KO mice at age 7 weeks... This upregulation suggests a specific effect of PAT-derived cytokines on adjacent islets..."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;ISLET Β CELLS AND ISLET ADIPOCYTES&quot;">
      <data key="d0">"CELL TYPE INTERACTION"</data>
      <data key="d1">"In the context of high local concentrations of proinflammatory cytokines in SENP1-aP2KO mice, peri-pancreatic adipocytes are identified as primary contributors to cytokine production... This is consistent with human protein expression database..."</data>
      <data key="d2">chunk-0c1631ae2c195cb68139ea9d75a3b433</data>
    </node>
    <node id="&quot;ADIPOSE TISSUE DEPOTS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Adipose tissue depots are functional diversity in body fat distribution, modulating disease processes in depot-specific ways."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;PPARΓ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"PPARγ is a protein involved in adipogenesis and repressing inflammatory responses."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;NF-ΚB PATHWAY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The NF-κB pathway activates genes for inflammation and immune regulation, influencing proinflammatory cytokines like those regulated by SENP1."</data>
      <data key="d2">chunk-eaf655c4dd9244523b048a122e232be4</data>
    </node>
    <node id="&quot;SUMO1&quot;">
      <data key="d0">&gt;"SUMO MODIFICATION IS A POST-TRANSLATIONAL MODIFICATION OF PROTEINS, INCLUDING NEMO AND P65/RELA. IT PLAYS A CRITICAL ROLE IN THE REGULATION OF NF-ΚB SIGNALLING PATHWAYS IN CELLS."</data>
      <data key="d1">3</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;ADIPOCYTES&quot;">
      <data key="d0">&gt;"ADIPOCYTES ARE SPECIALIZED CELLS RESPONSIBLE FOR STORING ENERGY IN THE FORM OF LIPIDS AND SECRETING HORMONES LIKE LEPTIN AND ADIPONECTIN. THEY PLAY A KEY ROLE IN INFLAMMATION, PARTICULARLY THROUGH THEIR ACTIVATION OF NF-ΚB PATHWAYS DUE TO NEMO SUMOYLATION."</data>
      <data key="d1">"Adipocytes of SENP1-aP2KO mice are specifically targeted as they show more severe hyperglycaemia and islet disruption compared to NOD mice, suggesting a role in diabetes progression."&lt;SEP&gt;5</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce&lt;SEP&gt;chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;TNF-Α&quot;">
      <data key="d0">&gt;"CYTOKINES"</data>
      <data key="d1">"TNF-α is another pro-inflammatory cytokine that can be affected by the state of NEMO SUMoylation. Its expression was not found to differ between control and SENP1 knockdown adipocytes."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;IL-1 Β&quot;">
      <data key="d0">)"CYTOKINES"</data>
      <data key="d1">"IL-1 β is a pro-inflammatory cytokine involved in inducing fever, leading to inflammatory responses in the body. Its expression was also not found to differ between control and SENP1 knockdown adipocytes."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;ETOPOSIDE VP16&quot;">
      <data key="d0">)"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Etoposide VP16 is a DNA damaging agent that can induce stress responses in cells, which leads to enhanced NEMO SUMoylation via the activation of IKK and NF-κB pathways."</data>
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
    </node>
    <node id="&quot;NOD MICE&quot;">
      <data key="d0">"DISEASE ENTITY"</data>
      <data key="d1">"Non-obese diabetic (NOD) mice are used as a model for type 1 diabetes and show a late onset of the disease at around 14 weeks of age."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;HUMAN T1DM PATIENTS&quot;">
      <data key="d0">"DISEASE ENTITY"</data>
      <data key="d1">"The study also correlates findings with human T1DM patients, indicating similar inflammatory markers in SENP1-aP2KO mice and human serum suggesting a potential relevance to diabetes progression."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;VENOUS BLOOD&quot;">
      <data key="d0">"SAMPLE TYPE"</data>
      <data key="d1">"Venous blood samples were collected from both healthy and diabetic subjects, providing insight into inflammatory biomarkers indicative of type 1 diabetes."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;PROINFLAMMATORY CYTOKINES&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Levels of proinflammatory cytokines are significantly increased in T1DM patients compared to normal cohorts, suggesting a role in disease progression."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;IFN-Γ&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IFN-γ is a gene associated with the regulation of immune responses, including expression in relation to PTPN2/22 protein and MAPbacteremia presence.")&lt;SEP&gt;"Increased plasma IFN-γ levels observed in NOD mice suggest an association with autoimmune responses leading to islet inflammation and diabetes."&lt;SEP&gt;"The expression of IFN-γ is higher in CD subjects compared to the control group."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021&lt;SEP&gt;chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;CCL5 (C-C MOTIF CHEMOKINE 5)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"No CCL5 expression was detected in the islets of JSH-23 treated group, indicating reduced immune cell infiltration and potential amelioration of disease progression."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;NF-ΚB INHIBITOR II JSH-23&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"NF-κB inhibitors such as NF-κB inhibitor II JSH-23 were administered to SENP1-aP2KO mice and showed reduced inflammatory markers and amelioration of diabetes phenotype."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;BODY WEIGHT, BLOOD GLUCOSE, LIPID PROFILE&quot;">
      <data key="d0">"SAMPLE ENTITY"</data>
      <data key="d1">"NF-κB inhibitors had no effects on body weight or lipid profile in control mice but showed improved glucose levels and reduced inflammation upon administration to SENP1 deficient mice indicating a targeted effect against disease progression."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;PATS (PANCREATIC ADIPOCYTES)&quot;">
      <data key="d0">"TARGET ENTITY"</data>
      <data key="d1">"PATs from SENP1-aP2KO mice exhibited smaller cell sizes with increased numbers under high-fat diet conditions, suggesting enhanced adipogenesis in the presence of SENP1 deficiency."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;ADIPOSE DEPOTS&quot;">
      <data key="d0">"ENVIRONMENT FACTOR"</data>
      <data key="d1">"HFD increased fat weight in all adipose depots, including epididymal fat and PATs."&lt;SEP&gt;"Under high-fat diet (HFD) conditions, both control and SENP1 deficient mice showed augmented fat accumulation across various depots including epididymal fat and pancreatic adipocytes."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987&lt;SEP&gt;chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;ISLET DISRUPTIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The study reports that serum from SENP1-aP2KO mice and human T1DM patients induces β-cell death and islet disruptions, supporting a role in diabetes progression through this pathway.") ("entity"</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;ISLET INFLAMMATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The involvement of SENP1 in islet inflammation suggests a critical role in the autoimmune response leading to T1DM."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;Β-CELL APOPTOSIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Isolated pancreatic islets exposed to serum from SENP1 deficient mice show increased rates of β-cell apoptosis, indicative of disease progression."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;ADIPOGENESIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"High-fat diet (HFD) conditions were shown to augment adipogenic processes in both control and SENP1 deficient mice PATs suggesting a role in metabolic disorders such as T2DM."</data>
      <data key="d2">chunk-8382a49b61215482f9fc75e3a86cb987</data>
    </node>
    <node id="&quot;PATS&quot;">
      <data key="d0">"ORGANELLE"</data>
      <data key="d1">"PATs from SENP1-aP2KO exhibit smaller cell sizes with more cell numbers under HFD compared to Ctrl mice."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;CYTOKINES&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"PATs from SENP1-aP2KO expressed high levels of IL-6, TNF-α, and IL-1β at 7 weeks under normal chow."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;HYPERGLYCAEMIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"HFD significantly augmented cytokine production, leading to accelerated hyperglycaemia in SENP1-aP2KO mice."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;INSULIN LEVELS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Basal and glucose-stimulated insulin levels were significantly reduced in SENP1-aP2KO mice under HFD compared to Ctrl mice."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;INSULIN RESISTANCE&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"HFD significantly induced insulin resistance in Ctrl mice and more severe phenotype observed in SENP1-aP2KO mice."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;SENP1 KO MICE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"HFD affected both T1DM and T2DM phenotypes in SENP1-aP2KO mice, impacting insulin levels and resistance."&lt;SEP&gt;"HFD caused further reduction of insulin levels in SENP1-aP2KO mice and accelerated hyperglycaemia with onset at 8 weeks, impacting both T1DM and T2DM phenotypes."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;HFD (HIGH-FAT DIET)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"HFD increased fat weight and led to alterations in PATs, impacting both T1DM and T2DM phenotypes."</data>
      <data key="d2">chunk-174831b97ed170039b374ba254d4f506</data>
    </node>
    <node id="&quot;NF-ΚB P65/RELA&quot;">
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">"NF-κB p65/RelA activation is regulated by NEMO SUMOylation."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 13}]</data>
    </node>
    <node id="&quot;NEMO&quot;">
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">"Enhanced NEMO SUMoylation enhances NF-κB signalling pathway activation in adipocytes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NF-ΚB SIGNALLING PATHWAY&quot;">
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">"Enhanced NEMO SUMoylation enhances NF-κB signalling pathway activation in adipocytes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INCREASED IKBKAPPA PHOSPHORYLATION AND NEMO SUMOYLATION ENHANCE NF-ΚB P65/RELA ACTIVATION IN ADIPOCYTES.&quot;">
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">6) ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NF-ΚB P65/RELA ACTIVATION&quot;">
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">6) ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-6&quot;">
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">"IL-6 is an inflammatory cytokine produced by macrophages and other immune cells, which was found to be significantly higher in SENP1 knockdown adipocytes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&gt;&quot;CYTOKINES&quot;">
      <data key="d2">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d1">"IL-6 is an inflammatory cytokine produced by macrophages and other immune cells, which was found to be significantly higher in SENP1 knockdown adipocytes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CDX-2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Cdx-2 is a gene that may be associated with ovarian cancer risk."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;TAQI&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variant"</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;POOLED OR&quot;">
      <data key="d0">"STATISTIC"</data>
      <data key="d1">"Pooled odds ratio (OR) represents an overall estimate of association between risk factors and disease in population studies."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;I2&quot;">
      <data key="d0">"STATISTIC"</data>
      <data key="d1">"I2 is a measure used to assess heterogeneity in meta-analyses, indicating the percentage of variation across studies due to true differences rather than chance."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;NULL ASSOCIATION&quot;">
      <data key="d0">"RELATIONSHIP DESCRIPTION"</data>
      <data key="d1">"The null association refers to the absence of any significant relationship between the variant and risk of ovarian cancer according to various statistical tests conducted for this analysis."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;POPULATION VARIATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Population variation, such as ethnicity or geographical location, may influence genetic associations with disease outcomes."</data>
      <data key="d2">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
    </node>
    <node id="&quot;RS731236&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs731236 is a genomic variant that shows high linkage disequilibrium with rs1544410 and rs7975232."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;RS7975232&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs7975232 shows low linkage disequilibrium with other SNPs in the study population."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;RS1544410&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs1544410 shows high linkage disequilibrium with rs731236 and is part of a group with rs731236, rs7975232 in the study population."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;RS2228570&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs2228570 shows low linkage disequilibrium with other SNPs in our study population and is associated with reduced susceptibility to T. cruzi infection according to genetic analyses."</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;ASYMPTOMATIC PATIENTS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Asymptomatic patients show reduced frequency of the rs2228570 variant, suggesting a protective effect against Cardio-myopathy Complex (CCC) development.") ("entity"</data>
      <data key="d2">chunk-6600322cc75094b1c57707e4b9c85954</data>
    </node>
    <node id="&quot;IL-1A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IL-1A is a gene associated with hereditary neuralgous polyneuropathy (HNP)."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;TNF-A&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"TNF-A rs361525 is a genomic variant linked to an increased risk of hereditary neuralgous polyneuropathy in healthy controls."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;VDR&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"VDR TaqI (rs731236) is a genomic variant associated with hereditary neuralgous polyneuropathy, but no significant association was found between this variant and the risk of degenerative disc disease."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;IL-1A -889C&gt;T&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"IL-1A rs1800587 is a genomic variant that has a higher frequency in HNP patients compared to controls, specifically the TT genotype was more common in HNP cases."</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;HNP&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Hereditary neuralgous polyneuropathy (HNP) involves specific genetic variations in genes such as IL-1A, TNF-A, and VDR that influence disease susceptibility."&lt;SEP&gt;"Hereditary neuralgous polyneuropathy (HNP) is associated with specific alleles and genotypes of IL-1A, TNF-A, and VDR polymorphisms.") ("entity"</data>
      <data key="d2">chunk-ba82b7eb40cf9eea561d839b20584f91</data>
    </node>
    <node id="&quot;FOLATE METABOLISM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Folate metabolism is a physiological process that interacts with the NOS1 Protein to maintain vascular function."/&gt;&gt;6&lt;SEP&gt;"Folate metabolism is a physiological process that interacts with the NOS1 protein to maintain vascular function."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9&lt;SEP&gt;chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
    </node>
    <node id="&quot;PERSONALIZED THERAPY&quot;">
      <data key="d2">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
      <data key="d1">"Personalized therapies based on genetic and nutritional profiles are being explored to manage cardiovascular health."/&gt;&gt;13) ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 12}]</data>
    </node>
    <node id="&quot;MTHFR C677T&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant affecting methylene tetrahydrofolate reductase, associated with cardiovascular disease.")</data>
      <data key="d2">chunk-b025a32e74a29cbbd5a0ce3d051f3fdb</data>
    </node>
    <node id="&quot;5-METHYLTHF&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"5-MethylTHF (5-formyltetrahydrofolic acid&lt;SEP&gt;"5-MethylTHF is a form of folate found in serum and plays a role in nitric oxide production."</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;CDC MBA&quot;">
      <data key="d0">"METHOD"</data>
      <data key="d1">"CDC MBA (Mass Spectrometry</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;FOLIC ACID CASEI MEDIUM&quot;">
      <data key="d0">"CRITICAL REAGENT"</data>
      <data key="d1">"The culture medium (Folic Acid Casei Medium</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;SERUM FOLATE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Serum folate refers to the measurement of the naturally occurring form of folate (including 5-methylTHF</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;IH-CAL&quot;">
      <data key="d0">"METHOD NAME"</data>
      <data key="d1">"IH-CAL (Immuno-High Performance Liquid Chromatography</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;CDC-MO &amp; CDC-CAL&quot;">
      <data key="d0">"METHOD NAME"</data>
      <data key="d1">"CDC-MO (Mass Spectrometry Organic Modulator) and CDC-CAL (Mass Spectrometry Organic Calibrator&lt;SEP&gt;"The round-robin kit provided by CDC includes microorganisms and calibrators (CDC-MO &amp; CDC-CAL) that are used for harmonization purposes across different laboratories, suggesting an impact of environmental factors on laboratory results."</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8&lt;SEP&gt;chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;IH-MO &amp; IH-CAL&quot;">
      <data key="d0">"METHOD NAME"</data>
      <data key="d1">"IH-MO (Immuno Modulator) and IH-CAL (Immuno Calibrator</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;POLYNOMIAL REGRESSION (THIRD-ORDER)&quot;">
      <data key="d0">"METHOD NAME"</data>
      <data key="d1">"Polynomial regression (third-order</data>
      <data key="d2">chunk-dd3c1834035af8b4436c8058609b6fd8</data>
    </node>
    <node id="&quot;CDC MBA TARGET VALUE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The CDC Master Biochemical Assay (MBA) target value represents the expected concentration for folate, possibly indicating a nutrient standard or reference point."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;S-FOL&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"S-FOL represents a specific metabolic pathway or test result related to folic acid levels."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;WB-FOL&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"WB-FOL also refers to another instance of folic acid testing within the metabolic pathway relevant to nutritional studies."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;IH REAGENTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The use of IH reagents is associated with a specific physiological process in laboratory measurements, likely related to test methodology and instrument calibration."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;CDC REAGENTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Using CDC reagents involves another physiological process involved in analytical testing protocols."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;LABORATORY #6&quot;">
      <data key="d0">"RELATIONSHIP"</data>
      <data key="d1">"Laboratory #6 showed a lack of agreement between day 1 and day 2 measurements for WB-FOL, indicating variability or potential error in the test results."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;LABORATORY #8&quot;">
      <data key="d0">"RELATIONSHIP"</data>
      <data key="d1">"Laboratory #8 exhibited inconsistent results between different analysis days (day 1 vs day 2) for WB-FOL, suggesting discrepancies that need further investigation."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;GROUP 2 LABORATORIES&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Group 2 laboratories refer to a subset of participants in the study who use folic acid calibrators, indicating their focus on precision and calibration within nutritional studies."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;FOLIC ACID CALIBRATOR&quot;">
      <data key="d0">"RELATIONSHIP"</data>
      <data key="d1">"Folic acid calibrators are used by group 2 laboratories to ensure precise measurements related to nutrient levels such as those of folate in dietary patterns."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;LABORATORY #9&quot;">
      <data key="d0">"RELATIONSHIP"</data>
      <data key="d1">"Laboratory #9 showed a wide limit of agreement in the folic acid measurements compared to the CDC target value, indicating possible issues with analytical methods or instruments used for testing."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;CDC ROUND-ROBIN KIT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The CDC round-robin kit likely refers to a standardized testing procedure involving multiple laboratories, emphasizing environmental factors that can affect the accuracy of test results."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;CDC ROUND-ROBIN KIT - CDC-MO&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The abbreviation 'CDC-MO' likely stands for microorganism utilized in the round-robin kit provided by CDC, suggesting another direct environmental factor impacting the study's analytical processes."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;CDC ROUND-ROBIN KIT - CDC-CAL&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The abbreviation 'CDC-CAL' likely stands for calibrator utilized in the round-robin kit provided by CDC, indicating another environmental factor influencing precision and calibration of laboratory measurements."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;LABORATORY #6 RESULTS&quot;">
      <data key="d0">"RELATIONSHIP"</data>
      <data key="d1">"The inconsistent results observed between day 1 and day 2 for WB-FOL at Laboratory #6 suggest a relationship that warrants further investigation, potentially indicating variability or analytical errors within the testing process."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;LABORATORY #9 RESULTS&quot;">
      <data key="d0">"RELATIONSHIP"</data>
      <data key="d1">"Inconsistent results across different analysis days (day 1 vs day 2) for WB-FOL at Laboratory #9 suggest a significant relationship that requires further clarification, possibly pointing to methodological issues or instrument calibration problems."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;MEAN DIFFERENCE CALCULATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The mean difference calculation between different laboratories and their results for folate measurements indicates the interaction of physiological processes related to analytical testing methodologies."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;LIMITS OF AGREEMENT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The limits of agreement observed across multiple laboratories suggest a complex interplay between various physiological processes affecting the consistency of test outcomes, particularly in folate measurements."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;FOLIC ACID CONCENTRATIONS">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"This refers to specific concentrations of folic acid being tested or measured across different matrices and laboratory conditions, indicative of nutrient-specific analytical interest within the study."</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;INSTRUMENT CALIBRATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The use of 'IH reagents' in one group of laboratories suggests another physiological process directly influencing analytical outcomes through instrument calibration and precision within testing methodologies.</data>
      <data key="d2">chunk-7c25217961fba65d15f20beda8a58f1c</data>
    </node>
    <node id="&quot;RS1695 POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs1695 polymorphism shows no deviation from Hardy-Weinberg equilibrium in both case and control groups, indicating its relevance to breast cancer risk."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;RS1138272 POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs1138272 polymorphism shows no deviation from Hardy-Weinberg equilibrium in both case and control groups, indicating its relevance to breast cancer risk."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;GSTP1 FUNCTION&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Ile105Val SNP does not influence the aggregation tendency of GSTP1 protein but reduces amyloid propensity according to WALTZ algorithm.") ("entity"</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;BREAST CANCER RISK&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Risk of breast cancer is associated with certain genotypes and alleles identified in rs1695 polymorphism and rs1138272 polymorphism respectively."</data>
      <data key="d2">chunk-ab5011584b0230efbf80a98b2a693a0e</data>
    </node>
    <node id="&quot;P.R778L&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variant p.R778L is found in association with three haplogroups A, B and C.")</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP A&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Haplogroup A was overwhelmingly common on WD chromosomes (97/100)." )</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;WD CHROMOSOMES&quot;">
      <data key="d0">"PROTEIN INTERACTION"</data>
      <data key="d1">"Variant p.P992L presented a complex haplotype spectrum including six haplogroups (D, E, F, G, H, I)." )&lt;SEP&gt;"Variant p.R778L is found in association with three haplogroups A, B and C.")</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;P.P992L&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variant p.P992L presented a complex haplotype spectrum including six haplogroups (D, E, F, G, H, I)." )</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;HAPLOGROUP E&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Haplogroup E was more common on WD chromosomes (21/29)." ))</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;P.T935M&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"There was only one kind of haplogroup on WD chromosomes for variant p.T935M." ))</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 14}, {"level": 2, "cluster": 16}]</data>
    </node>
    <node id="&quot;HAPLOGROUP J&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Variant p.T935M presented a uniform state with only one kind of haplogroup on WD chromosomes, haplogroup J." )</data>
      <data key="d2">chunk-fa2d834930246b534181c3d6d2c049e1</data>
    </node>
    <node id="&quot;CYP2C9&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CYP2C9 is a gene involved in the metabolism of warfarin, critical for managing blood clotting."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;RS1799853&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in CYP2C9 has been linked to variations in its function and increased risk of hypertension."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;RS1057910&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another genomic variant in CYP2C9, rs1057910, is associated with an increased risk of cardiovascular disease."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;RS28371686&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A third genomic variant, rs28371686, has also been linked to a higher warfarin dose requirement."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;RS7900194&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another CYP2C9 genomic variant, rs7900194, is associated with reduced activity of the enzyme."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;RS28371685&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Yet another genetic variant in CYP2C9, rs28371685, also found at low frequency and linked to variations in warfarin dosing."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;DVT/PE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Warfarin is prescribed primarily for the prevention and treatment of venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE)."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;CYP2C9*5&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"CYP2C9*5 represents yet another genomic variation within the CYP2C9 gene, affecting drug metabolism."</data>
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
    </node>
    <node id="&quot;NOVEL AA ALGORITHM&quot;">
      <data key="d0">"ALGORITHM"</data>
      <data key="d1">"The novel AA algorithm significantly outperforms the IWPC algorithms in correctly detecting high-dose patients.")</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;IWPC PHARMACOGENOMICS ALGORITHM&quot;">
      <data key="d0">"ALGORITHM"</data>
      <data key="d1">"The IWPC pharmacogenomics algorithm incorrectly assigned a higher percentage of high-dose patients compared to the novel AA algorithm.")</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;CLINICAL ALGORITHMS&quot;">
      <data key="d0">"ALGORITHMS"</data>
      <data key="d1">"Both clinical algorithms correctly assigned lower percentages of high-dose patients, indicating less precision in their predictions.")</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;NNG&quot;">
      <data key="d0">"OUTCOME MEASURE"</data>
      <data key="d1">"The NNG was used to estimate the number of patients that would need to be genotyped to prevent one predicted dose from being outside of the 20% therapeutic dose range.")</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;MEAN PERCENT WAA&quot;">
      <data key="d0">"ADMIXTURE MEASUREMENT"</data>
      <data key="d1">"We examined how well our novel AA algorithm performs given the broad range of WAA among AAs. Mean percent WAA was not significantly different between algorithms, indicating that population-specific variables were considered and accounted for.")</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;PREDICTED DOSES&quot;">
      <data key="d0">"DRUGS"</data>
      <data key="d1">"Predicted doses derived from our novel AA algorithm were closer to observed doses for more patients, suggesting better precision in predicting drug dosages.")</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;HIGH-DOSE PATIENTS&quot;">
      <data key="d0">"PATIENT GROUP"</data>
      <data key="d1">"The novel AA algorithm correctly detected the greatest percentage of high-dose patients compared to other algorithms.")</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;OBSERVED DOSES&quot;">
      <data key="d0">"DRUGS"</data>
      <data key="d1">"Predicted doses were closer to observed doses for more patients, indicating higher precision in our novel AA algorithm. Precision was also demonstrated by consistently lower MAE (mean absolute error).")</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;NNG (NUMBER NEEDED TO HARM)&quot;">
      <data key="d0">"OUTCOME MEASURE"</data>
      <data key="d1">"The NNG was used to estimate how many patients would need to be genotyped to prevent one predicted dose from being outside of the 20% therapeutic range.")</data>
      <data key="d2">chunk-b2730f3087aee6d9cff6e4939b229323</data>
    </node>
    <node id="&quot;CYP2C9*11&quot;">
      <data key="d2">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d1">"rs1057910 is a CYP2C9 genomic variant associated with increased risk of cardiovascular disease.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;65.6 YEARS&quot;">
      <data key="d0">"PHYSIOLOGICAL FACTOR"</data>
      <data key="d1">"This is an age-related physiological factor mentioned for the study population."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;8.5 YEARS&quot;">
      <data key="d0">"MEASUREMENT"</data>
      <data key="d1">"The document includes a measurement of 8.5 as the standard deviation (sd) in participants' ages."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;25(OH)D&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"This is mentioned as an important nutrient measured for participants."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;1,25(OH)2D&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Another vitamin D metabolite also mentioned in the document."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;93.3% MALE&quot;">
      <data key="d0">"PHYSIOLOGICAL FACTOR"</data>
      <data key="d1">"This is a gender-related physiological factor indicated for participants."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;68.1% WHITE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The demographic composition of the study population is presented, highlighting that 68.1% are Caucasian."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;519 RECURRENT ADENOMAS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"This number represents a disease outcome in participants during follow-up."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;28.6% MALE RECURRENT ADENOMAS&quot;">
      <data key="d0">"PHYSIOLOGICAL FACTOR"</data>
      <data key="d1">"A subset of the study population consists of more males, with 28.6% having recurrent adenomas."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;ADVANCED ADENOMAS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Another disease outcome mentioned as advanced adenomas is also a part of this document."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;CYP24A1 SNPS">
      <data key="d0">"VITAMIN D METABOLISM"</data>
      <data key="d1">"This refers to specific genetic markers related to vitamin D metabolism in participants."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;CYP27B1/CYP24A1 GENOTYPING">
      <data key="d0">"GENETIC TESTING FOR VITAMIN D METABOLISM"</data>
      <data key="d1">"The document discusses the process of genotyping, specifically targeting genes like CYP27B1 and CYP24A1."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;VILLOUS ADENOMAS">
      <data key="d0">"ADVANCED ADENOMA SUBTYPE"</data>
      <data key="d1">"This term indicates a specific type of advanced colorectal adenoma mentioned in the context of disease characteristics."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;VITAMIN D DEFICIENT INDIVIDUALS">
      <data key="d0">"BASELINE VITAMIN D LEVELS"</data>
      <data key="d1">"The document refers to participants with lower vitamin D levels, indicating that they were deficient at baseline measurements."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;HOMOZYGOUS FOR MINOR ALLELE WITHIN ADEQUATE 25(OH)D RANGES">
      <data key="d0">"COMPLEX INTERACTION OF SNPS AND VITAMIN D METABOLISM"</data>
      <data key="d1">"This entity represents an interaction between individuals who are both homozygous for a specific minor allele at one or more vitamin D metabolizing gene loci, combined with having adequate levels of 25(OH)D. This suggests a potential biological pathway that may be involved in the risk for colorectal adenoma recurrence."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;VITAMIN D SUFFICIENT INDIVIDUALS">
      <data key="d0">"BASELINE VITAMIN D LEVELS"</data>
      <data key="d1">"The document also refers to participants who were not vitamin D deficient but had levels considered adequate or high, indicating another segment of the study population with different disease outcomes."</data>
      <data key="d2">chunk-2fb95100a1290b27baae869c6560419a</data>
    </node>
    <node id="&quot;CYP24A1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CYP24A1 is a gene associated with melatonin metabolism and vitamin D catabolism."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The c.1186C &gt; T variant in the CYP24A1 gene affects vitamin D catabolism."&lt;SEP&gt;"The c.428_430delAAG variant in the CYP24A1 gene affects melatonin metabolism."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;SAMPLE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Samples were used as positive and wild-type controls, indicating their relevance to melatonin and vitamin D metabolism."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;PRIMER&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Primers are designed ad hoc for HRMA, highlighting the molecular interaction in genotyping process."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;HRMA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"HRMA is a method used to analyze DNA variants, representing a physiological process involved in genetic testing."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;MUTATION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Mutations in the CYP24A1 gene alter metabolic pathway related to melatonin and vitamin D catabolism."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;CONCORDANCE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Genotype assignment by dHRMA was concordant with results of single plex HRMA and Sanger sequencing, indicating strong molecular relationship between methods."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;DNA SEQUENCING&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"DNA sequencing confirmed all genotypes obtained from duplex HRMA, demonstrating the molecular interaction involved in genotyping process."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;MUTANT SITE&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Different CYP24A1 genotypes exhibit specific melting behavior, affecting metabolic pathway related to melatonin and vitamin D catabolism.") ("entity"</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;TM VALUES&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Tm values obtained from HRMA help in distinguishing different CYP24A1 genotypes, which represent an impact on metabolic pathway related to melatonin and vitamin D catabolism."</data>
      <data key="d2">chunk-1327975b50e4a0aac1792cb595041ee5</data>
    </node>
    <node id="&quot;DENVER DEVELOPMENTAL SCREENING TEST II&quot;">
      <data key="d0">"DIAGNOSTIC TOOL"</data>
      <data key="d1">"The Denver Developmental Screening Test II assessed the patient’s developmental skill levels at 20 months of age, including gross motor, fine motor, language, and personal-social skills."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;MRI (MAGNETIC RESONANCE IMAGING)&quot;">
      <data key="d0">"IMAGING TECHNOLOGY"</data>
      <data key="d1">"A brain MRI at 20 months of age revealed atrophy and delayed myelination indicative of developmental delay."&gt;&lt;SEP&gt;"At 20 months of age, a brain MRI showed atrophy and delayed myelination in the patient."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;MEDIAN NERVE COMPOUND MOTOR ACTION POTENTIALS&quot;">
      <data key="d0">"NEUROPHYSIOLOGY STUDY"</data>
      <data key="d1">"The patient’s median nerve compound motor action potentials were within normal values for their age group."&gt;</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;MEDIAN NERVE CONDUCTION VELOCITY&quot;">
      <data key="d0">"NEUROPHYSIOLOGY STUDY"</data>
      <data key="d1">"The patient’s median nerve conduction velocity was slightly below the normal range for 1–2 year old infants."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;MEDIAN NERVE SENSORY ACTION POTENTIAL&quot;">
      <data key="d0">"NEUROPHYSIOLOGY STUDY"</data>
      <data key="d1">"The patient’s median nerve sensory action potential was within normal values for their age group."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;SERUM COPPER LEVEL&quot;">
      <data key="d0">"BIOCHEMICAL MARKER"</data>
      <data key="d1">"The patient had a normal serum copper level, indicating no evidence of copper overload typically seen in Menkes disease."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;URINE B2-MICROGLOBULIN&quot;">
      <data key="d0">"BIOCHEMICAL MARKER"</data>
      <data key="d1">"Normal levels of urine b2-microglobulin were detected, suggesting absence of renal tubular injury due to copper overload and ruling out Menkes disease."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;PLASMA CATECHOLAMINE RATIOS&quot;">
      <data key="d0">"BIOCHEMICAL MARKER"</data>
      <data key="d1">"Plasma catecholamine ratios in the patient did not indicate deficient activity of dopamine-b-hydroxylase, a marker of Menkes syndrome."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;CEREBROSPINAL FLUID COPPER AND CATECHOLAMINE RATIOS&quot;">
      <data key="d0">"BIOCHEMICAL MARKER"</data>
      <data key="d1">"Cerebrospinal fluid copper and catecholamine ratios in the patient fell within the ranges established for classical Menkes disease."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;P1001L MUTATION&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"The P1001L mutation was confirmed in mosaicism within the proband’s genomic DNA, a finding typical of classic Menkes disease. This mutation creates a novel BsmAI restriction site."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;ATP7A EXON 7 AS CONTROL FOR BSMAI DIGESTION&quot;">
      <data key="d0">"MOLECULAR ANALYSIS"</data>
      <data key="d1">"The control for complete BsmAI digestion was confirmed using exon 7 of the ATP7A gene, indicating that the PCR results were valid and reflecting a different level of mosaicism between tissues."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;WILD TYPE ALLELE TO MUTANT ALLELE RATIO IN BLOOD DNA&quot;">
      <data key="d0">"MOLECULAR ANALYSIS"</data>
      <data key="d1">"The patient had a higher proportion of wild type alleles compared to mutant ones in blood DNA, indicating lower copper transport activity typical of Menkes disease. The ratio was 77:23."</data>
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
    </node>
    <node id="&quot;GENETIC VARIANT CONFIRMATION&quot;">
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d1">"Confirmed mosaicism for the P1001L mutation was found only in tissue samples, typical of classic Menkes disease. "]&gt;&gt;6) ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MOSAICISM IN TISSUES&quot;">
      <data key="d2">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d1">"Confirmed mosaicism for the P1001L mutation was found only in tissue samples, typical of classic Menkes disease. "]&gt;&gt;6) ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CACO-2 CELLS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"Caco-2 cells are a human colon adenocarcinoma cell line used for studying the physiology of the small intestine and colonic epithelium, including drug transport and metabolism."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;GPX4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"GPX4 (glutathione peroxidase) is an antioxidant enzyme that plays a crucial role in protecting cells against oxidative stress by reducing hydrogen peroxide and other lipid-peroxides. It is encoded by the gene of the same name, located on chromosome 1p23."&lt;SEP&gt;"GPx4 is a selenoprotein whose levels are measured in response to changes in cellular viability and oxidative stress conditions."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7&lt;SEP&gt;chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;IDI-T VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The T variant (rs7ohnology involving transfection with IDI-T coding sequences linked to the GPX4 3′UTR. This genetic variant is associated with a significant variation in enzyme expression levels."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;IDI-C VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The C variant (rs713041) also involves transfection with IDI-C coding sequences linked to the GPX4 3′UTR. Like the IDI-T, this variant is associated with a broad range of expression levels."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;3′UTR MODIFICATION&quot;">
      <data key="d0">"EPIGENETIC MODIFICATION"</data>
      <data key="d1">"The T and C variants in the GPX4 3′UTR influence transcript stability and translation by modulating the availability of sequestered proteins, such as RNA-binding proteins, which can affect enzyme expression levels."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;GPX1 ACTIVITY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"GPX1 is another selenocysteine-containing antioxidant enzyme that functions alongside GPX4 to protect cells from oxidative stress. The activity of these enzymes reflects the cellular availability of selenium, which can be influenced by dietary intake and genetic variants."&lt;SEP&gt;"GPx1 activity shows a marked difference between clones expressing similar levels of IDI transcripts under oxidative stress conditions."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7&lt;SEP&gt;chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;TR1 AND GPX4 PROTEINS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"These proteins are part of the selenoprotein family and function as antioxidants in protecting cells against oxidative damage. Their levels are sensitive to changes in selenium availability."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;SELENOPROTEIN H&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"This protein is another member of the selenoprotein family, involved in various cellular processes including antioxidant defense and possibly competing with GPX4 for selenocysteine during translation."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;ROS MEASUREMENT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Reactive Oxygen Species (ROS) are generated as a byproduct of normal cellular metabolism. Measuring ROS levels can provide insights into the oxidative stress status of cells under various conditions, such as exposure to different concentrations of tert-butylhydroperoxide."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;GPX ACTIVITY AND GPX4 LEVELS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The activities of antioxidant enzymes like GPX1 and GPX4 are indicators of the cellular availability of selenium. Variations in these enzyme levels can be influenced by genetic factors, dietary intake of selenoprotein-rich foods, and environmental conditions."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;SELENOPROTEIN EXPRESSION">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"This refers to the regulation of gene expression that results in the synthesis of specific proteins containing selenium. These proteins play critical roles in antioxidant defense systems within cells."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;IDI-T VARIANT SPECIFICITY">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The IDI-T variant exhibits a specific pattern of expression that differs from other genetic variants in the GPX4 gene. This may influence interactions with proteins involved in its regulation and function within Caco-2 cells."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;GPX1 GENE FUNCTION">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"GPX1 is another critical component of the antioxidant defense system, functioning alongside GPX4 to protect against oxidative stress. Its role in maintaining cellular balance under various physiological states is well established."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;TR1 PROTEIN ANTIOXIDANT CAPACITY">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"This protein represents a specific form of antioxidant capacity within Caco-2 cells, contributing to the overall protection against reactive oxygen species and lipid peroxidation."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;SELENOCYSTEINE INCORPORATION MECHANISM">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The incorporation of selenocysteine into proteins like GPX4 and TR1 is a complex process involving translation mechanisms that can be influenced by the genetic context as well as environmental conditions such as selenium availability."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;GPX4 LEVELS AND ANTIOXIDANT FUNCTION">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Levels of GPx4 in Caco-2 cells are indicative of the cellular antioxidant status, reflecting both internal metabolic processes and external influences like dietary intake of selenoprotein-rich foods."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;SELENOPROTEIN H PROTEIN ROLE">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"This protein plays a specific role within the cell's defense mechanisms against oxidative damage. Its expression levels can be influenced by various factors including genetic variants and environmental selenium availability."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;ROS MEASUREMENT TECHNIQUE ACCURACY">
      <data key="d0">"TECHNOLOGICAL ADVANCEMENT"</data>
      <data key="d1">"The use of techniques like real-time PCR in measuring ROS levels requires careful validation to ensure accurate interpretations, especially when dealing with variations such as the IDI-T variant which may influence gene expression dynamics."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;GPX4 AND GPX1 ANTIOXIDANT ENZYME COMPETITION">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Under conditions of selenium deficiency or competition for selenocysteine, there can be differential expressions of antioxidant enzymes like GPX4 and GPx1. This affects the balance between oxidative stress and antioxidant defense in cells."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;SELENOPROTEIN EXPRESSION VARIABILITY">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The expression of selenoproteins is subject to variability due to genetic factors, environmental influences like selenium availability, and physiological states such as exposure to different concentrations of oxidative stressors."</data>
      <data key="d2">chunk-c7872499c2a84b16c506a135d8033bb7</data>
    </node>
    <node id="&quot;IDI-T CELLS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"IDI-T is a cell line used in experiments studying the effects of selenite on cellular viability."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;IDI-C CELLS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"IDI-C is another cell line studied for its response to oxidative stress and selenium levels."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;SELENIUM&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Selenium is an essential nutrient required by both IDI-T and IDI-C cells for their growth and function."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;TR1, GPX1, GPX4 MRNAS&quot;">
      <data key="d0">"TRANSCRIPTS"</data>
      <data key="d1">"These transcripts of genes encoding antioxidant enzymes are similar between IDI-T and IDI-C cells grown under various selenium conditions."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;SELENOPROTEIN H MRNA&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The selenoprotein H mRNA is significantly lower in IDI-C cells compared to IDI-T, regardless of the medium's selenium content."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;TERT-BUTYLHYDROPEROXIDE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Tert-butylhydroperoxide is used as an oxidant to challenge the cells' viability and measure ROS levels."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;ROS LEVELS&quot;">
      <data key="d0">"REACTIVE OXYGEN SPECIES"</data>
      <data key="d1">"Mean ROS levels show a greater increase in IDI-C clones than in IDI-T clones under oxidative stress conditions."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;GPX ACTIVITY&quot;">
      <data key="d0">"PROTEIN ACTIVITY"</data>
      <data key="d1">"There is a significant difference in GPx activity between different cell lines and within single clones under varying selenite conditions."</data>
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
    </node>
    <node id="&quot;SELENOPROTEIN EXPRESSION&quot;">
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d1">"Selenium supply influences the expression of various selenoproteins, with IDI-C showing lower levels compared to IDI-T.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GPX4 IN IDI-C CELLS&quot;">
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d1">"IDI-C cells exhibit greater sensitivity to oxidative stress as evidenced by their higher ROS levels and reduced viability under depleted selenium conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SENSITIVITY TO OXIDATIVE STRESS&quot;">
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d1">"IDI-C cells exhibit greater sensitivity to oxidative stress as evidenced by their higher ROS levels and reduced viability under depleted selenium conditions.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SELENIUM CONCENTRATION IN MEDIUM&quot;">
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d1">"Changes in the Se content of the medium affect cell viability differently, with IDI-C cells showing greater viability at high concentrations compared to IDI-T.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SELENOPROTEIN EXPRESSION CHANGES&quot;">
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d1">"Changes in the Se content of the medium affect cell viability differently, with IDI-C cells showing greater viability at high concentrations compared to IDI-T.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GPX ACTIVITY DIFFERENCES&quot;">
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d1">"Different GPx activities are observed between different clones and under varying selenite conditions, indicating a complex interplay of transcript levels with antioxidant response mechanisms.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IDI TRANSCRIPTS EXPRESSION LEVELS WITHIN CLONES&quot;">
      <data key="d2">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d1">"Different GPx activities are observed between different clones and under varying selenite conditions, indicating a complex interplay of transcript levels with antioxidant response mechanisms.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHAT GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CHAT is a gene involved in acetylcholine receptor formation, with 12 missense mutations and one nonsense mutation identified."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;P.THR553ASN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The protein p.Thr553Asn is encoded by the CHAT gene and affects acetylcholine receptor formation."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;P.SER704PRO&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The protein p.Ser704Pro is also encoded by the CHAT gene, detected in this laboratory but functionally characterized elsewhere."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;P.ALA557THR&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The protein p.Ala557Thr affects acetylcholine receptor formation and was inherited from a mother with only one copy of the allele, suggesting heterozygosity."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;P.VAL136MET&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The protein p.Val136Met is observed in three patients, altering acetylcholine receptor formation."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;P.ALA557THR MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The p.Ala557Thr mutation determines the phenotype in one patient and was inherited from only the mother's side of the family, indicating heterozygosity."&lt;SEP&gt;"The p.Ala557Thr mutation in patient 10 determines the phenotype of this individual, indicating a genetic contribution to disease."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;QUANTITATIVE RT-PCR&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Quantitative RT-PCR revealed genetic variants affecting acetylcholine receptor formation at a molecular level."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;CHAT CDNA&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"CHAT contains two alternative start sites that yield different proteins, influencing acetylcholine receptor formation."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;BOSC 23 CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Mutant CHAT transcripts are expressed at significantly lower levels in Bosc 23 cells, affecting cell function and protein expression."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;E. COLI&quot;">
      <data key="d0">"ORGANISM"</data>
      <data key="d1">"CHAT cDNAs were transformed into E. coli to examine protein expression of mutant and wild-type enzymes."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;NI-NTA COLUMN&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The enzymes were purified using a Ni-NTA column followed by fast protein liquid chromatography to analyze their kinetic properties and thermal stability."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;SPINAL CORD CHAT TRANSCRIPT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"CHAT contains two alternative start sites that yield different proteins, influencing spinal cord acetylcholine receptor formation."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;P.THR553ASN MUTATION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The p.Thr553Asn mutation affects the kinetic parameters and thermal stability of CHAT enzymes."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;PATIENT 8&quot;">
      <data key="d0">"INDIVIDUAL"</data>
      <data key="d1">"Patient 8 is homozygous for the p.Ala557Thr CHAT mutation, demonstrating its dominant effect on acetylcholine receptor formation."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;P.ILE689SER MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Patient 11 carries a nonsense mutation in the form of p.Ile689Ser, affecting protein expression and interpretation in the context of disease."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;SPINAL CORD CHAT TRANSCRIPTS&quot;">
      <data key="d0">"TRANSCRIPT TYPE"</data>
      <data key="d1">"CHAT contains two alternative start sites that yield different proteins influencing spinal cord acetylcholine receptor formation."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;HOMOZYGOSITY FOR P.ALA557THR&quot;">
      <data key="d0">"PHENOTYPIC DETERMINATION"</data>
      <data key="d1">"Patient 8 is homozygous for the p.Ala557Thr CHAT mutation, demonstrating a dominant impact on acetylcholine receptor formation and phenotype."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;MOLECULAR CHARACTERIZATION OF CHAT ENZYMES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"CHAT contains two alternative start sites that yield 70 kDa and 74 kDa proteins at a constant ratio, influencing spinal cord cholinergic innervation."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;P.THR553ASN MUTATION IN CHAT GENE&quot;">
      <data key="d0">"KINETIC PARAMETERS OF CHAT ACTIVATION"</data>
      <data key="d1">"The p.Thr553Asn mutation alters one or more rate constants affecting the activation of cholinergic transmission, impacting neuronal activity."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;P.ALA557THR MUTATION IN CHAT GENE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS AND DISEASE RISK"</data>
      <data key="d1">"The p.Ala557Thr mutation influences folate metabolism and may contribute to the risk of cardiovascular disease by altering nitric oxide synthesis pathways."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;CHAT PROTEIN EXPRESSION IN E. COLI&quot;">
      <data key="d0">"ORGANISM AND CELLULAR FUNCTION"</data>
      <data key="d1">"Histidine-tagged CHAT cDNAs were genetically engineered into E. coli for protein expression analysis, providing insight into gene function at the molecular level."</data>
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
    </node>
    <node id="&quot;ACETYLCHOLINE RECEPTOR FORMATION&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"The CHAT gene encodes proteins involved in acetylcholine receptor formation, with mutations altering this process significantly."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PHENOTYPE DETERMINATION&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"The p.Ala557Thr mutation determines the phenotype of patient 10, influencing their physiological function related to acetylcholine receptor formation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EXPRESSION LEVELS&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"Mutant CHAT transcripts are expressed at significantly lower levels in Bosc 23 cells, affecting cellular function and protein expression."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MUTANT CHAT TRANSCRIPTS&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"Mutant CHAT transcripts are expressed at significantly lower levels in Bosc 23 cells, affecting cellular function and protein expression."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;KINETIC PARAMETERS OF CHAT MUTANTS&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"Ten mutations alter one or more rate constants of ChAT activation, compromising the thermal stability of the mutant proteins."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;THERMAL STABILITY&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"Ten mutations alter one or more rate constants of ChAT activation, compromising the thermal stability of the mutant proteins."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RATE CONSTANTS OF CHAT ACTIVATION&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"The p.Thr553Asn mutation affects one or more rate constants of ChAT activation, altering enzyme function."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NONSENSE MUTATION ON SECOND ALLELE&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"The p.Ala557Thr mutation also determines the phenotype in patient 10, who carries a nonsense mutation on her second allele."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;P.ALA557THR MUTATION IN PATIENT 10&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"The p.Ala557Thr mutation also determines the phenotype in patient 10, who carries a nonsense mutation on her second allele."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONSANGUINEOUS MARRIAGE&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"Patient 11 is born to consanguineous parents, indicating a genetic contribution to their condition and disease manifestation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PATIENT 11 BIRTH&quot;">
      <data key="d2">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d1">"Patient 11 is born to consanguineous parents, indicating a genetic contribution to their condition and disease manifestation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CPG SITES&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"CpG sites are markers for methylation levels in DNA and can be associated with various oxidative stress markers."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;TGSH&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"TGSH is an important marker of oxidative stress, indicative of the oxidative state of an individual."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;GSH&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Glutathione, in its reduced form, is a key antioxidant and indicator of oxidative stress levels."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;GSSG&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Gamma-glutamylcysteine (GSSG) represents the oxidized form of glutathione, used as a marker for oxidative stress."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;GLUTATHIONE METABOLISM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Glutathione metabolism is an important physiological process that reflects antioxidant capacity and oxidative stress levels."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;OXIDATIVE STRESS MARKERS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Various markers, including TGSH, GSH, GSSG and others, are associated with oxidative stress in individuals."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;HYSERINE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Hydroxy-L-proline (Hyp) is a marker of oxidative stress measured in our study."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;HYP&quot;&gt;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Hydroxy-L-proline (Hyp) reflects collagen cross-linking, an indicator of oxidative stress in the body."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;DNA METHYLATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"DNA methylation patterns are influenced by environmental factors such as exposure to oxidative stress markers."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;BLOOD SAMPLES&quot;">
      <data key="d0">"ENVIRONMENT"</data>
      <data key="d1">"The analysis was performed on blood samples from 966 individuals, representing a population-based study of elderly individuals."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;PLOIDY LEVEL&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Ploidy level represents an environmental factor that can influence DNA methylation patterns.") ("entity"</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;NADPH OXIDASE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"NADPH oxidase is an enzyme complex involved in the production of reactive oxygen species, contributing to oxidative stress."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;CYTOCHROME C&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Cytochrome c is a protein that participates in apoptosis and redox signaling related to oxidative stress."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;SUPEROXIDE DISMUTASE (SOD)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Superoxide dismutase (SOD) is an enzyme involved in the detoxification of superoxide, reducing its harmful effects on cells."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;CATALASE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Catalase is an enzyme found in cells that helps break down hydrogen peroxide, mitigating oxidative damage."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;GLUCOCORTICOIDS (GCS)&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Glucocorticoids are steroid hormones and drugs known to influence inflammatory responses associated with oxidative stress."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;SULFORAPHANE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Sulforaphane is a phytochemical found in broccoli that has antioxidant properties, helping combat oxidative stress."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;INTERLEUKIN-6 (IL-6)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Interleukin-6 is a cytokine involved in the inflammatory response and immune system regulation under conditions of oxidative stress."</data>
      <data key="d2">chunk-491fec1ffc43ca0e67c1080702f038a7</data>
    </node>
    <node id="&quot;CPG&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"CpGs are a key component of DNA methylation variation and play a critical role in gene regulation."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;GENOMIC LOCATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The genomic location of CpGs associated with oxidative markers is investigated to understand their functional roles."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;CPG ISLAND SHORES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Phenotype-associated CpGs were enriched in CpG island shores, suggesting a potential role in gene regulation."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;PROMOTER OF GENES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"More phenotype-associated CpGs are located in promoters of genes, potentially affecting transcription from adjacent genes."&lt;SEP&gt;"Promoters are where transcription initiation occurs, potentially affecting the genes they adjoin."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;REGULOMEDB SCORE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Twenty-three percent of sites showed strong evidence of being located in a functional regulatory region according to RegulomeDB score."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;CPG ISLAND&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Functional CpGs are enriched in proximity to CpG islands, which can influence gene expression and biological processes."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;E2F1 GENE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The E2F1 gene is involved in atherosclerosis and coronary heart disease, which may be associated with oxidative stress markers."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;TF BINDING SITES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Significant enrichment of TF binding sites suggests a complex regulatory network affecting the genes around them."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;FUNCTIONAL ANNOTATION CLUSTERING TOOL&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Functional annotation clustering tools help identify relevant biological processes associated with CpG markers."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;PHOSPHORYLATION PROCESSES&quot;">
      <data key="d0">"FUNCTIONAL ANNOTATION"</data>
      <data key="d1">"Genes cluster into annotations relating to functional terms such as phosphorylation and phosphate/phosphorous metabolic processes.") ("entity"</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;FDR (FALSE DISCOVERY RATE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"FDR is used to control the rate of false discoveries in genomic studies, including those involving CpGs and oxidative stress markers."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;GENOTYPE-PHENOTYPE ASSOCIATIONS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"We investigated whether genotype-phenotype associations overlap with cis-meQTL SNPs and functional regulatory regions."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;CIS-MEQTL (CIS-EQTL FOR METHYLATION)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Twenty-eight percent of phenotype CpGs showed significant cis-meQTL, suggesting a genetic influence on DNA methylation variation."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;NOMINAL ASSOCIATIONS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"There is modest suggestive evidence for nominal associations between genotypic variants and oxidative stress markers in GWAS studies."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;CHD (CORONARY HEART DISEASE)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Genetic association of SNPs with oxidative stress markers suggests a relationship with environmental factors like diet and lifestyle."</data>
      <data key="d2">chunk-b05610f4a9a1033449b92655bfb67b28</data>
    </node>
    <node id="&quot;BCL2L11&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"BCL2L11 is annotated with CpG sites associated with methylation and SNP associations."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;CEP5OHNOSINE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CEP55 is a protein linked to methylation at CpG sites."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;CPB1&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CPB1 is another protein associated with methylation at CpG sites."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;INTERGENIC SITE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An intergenic site on chromosome 4 is linked to SNPs and methylation associations."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;HISTONE CLUSTER 1 H4D&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The histone cluster 1, H4d gene has a 3'-UTR associated with methylation markers."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;DISHEVELLED-1&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"DVL1 is another protein linked to epigenetic variation and disease risk."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;OXIDATIVE MARKERS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Oxidative stress markers are associated with both CVD and T2D, indicating a potential link between environmental factors and health outcomes."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;CPGS ASSOCIATED OXIDATIVE STRESS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"66 CpGs associated with oxidative markers are tested for their relationship to disease incidence."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;CARDIOVASCULAR DISEASE (CVD)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Incident cases of cardiovascular disease were assessed, showing no significant association with methylation at phenotype-associated CpGs."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;METHYLATION LEVELS AT CG08170869&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Lower methylation levels at the histone cluster gene were associated with a higher risk of Type 2 Diabetes."&lt;SEP&gt;"Methylation levels at the histone cluster gene, specifically cg08170869, were associated with a higher risk of developing Type 2 Diabetes."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;HYPOMETHYLATION IN DVL1&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Hypomethylation in the dishevelled-1 gene was also linked to an increased risk of Type 2 Diabetes."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;METHYLATION LEVELS AT CG11842944 IN ZNF341&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Methylation levels at a CpG in the ZNF341 gene were associated with heart failure events.") ("entity"</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;ZNF341 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ZNF341 gene is involved in transcriptional regulation and was found to be associated with heart failure events."</data>
      <data key="d2">chunk-8276370dea9f12d2b305c355f74c7f6e</data>
    </node>
    <node id="&quot;GLU246LYS MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The Glu246Lys mutation occurs in the FMN binding site of complex I and could potentially be involved in NADH binding."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;FMN BINDING SITE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The Glu246Lys mutation occurs in the FMN binding site, which is important for NADH interaction with complex I."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;IRON-SULFUR CLUSTER&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Complex I contains iron–sulfur clusters that are predicted to be necessary for proper functioning of the protein."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;NADH BINDING SITES&quot;">
      <data key="d0">"PROTEIN FUNCTION"</data>
      <data key="d1">"The protein containing NADH, flavin mononucleotide (FMN) and iron–sulfur cluster binding sites is complex I in the electron transport chain."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;COMPLEX 1&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Complex 1 functions to release electrons from NADH via the electron transport chain mechanism."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;UBIQUINONE BINDING SITES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Complex I interacts with ubiquinone, allowing for proper movement of electrons through the process."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;UBIQUINONE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Ubiquinone is an essential component in complex I and plays a role in electron transfer processes."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;ELECTRON TRANSPORT CHAIN&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Complex 1 is part of the electron transport chain, which facilitates movement of electrons through cells."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;LEBER OPTIC ATROPHY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Mutations in MT-ND1 cause disorders including Leber optic atrophy and mitochondrial complex I deficiency."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;MITOCHONDRIAL COMPLEX I DEFICIENCY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Deficiencies related to mutations in the NADH dehydrogenase subunit 1, such as complex I deficiency, can impact metabolic pathways."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;NADH DEHYDROGENASE SUBUNIT 1 (MT-ND1)&quot;">
      <data key="d0">"MITOCHONDRIAL GENOME"</data>
      <data key="d1">"This variant found in MT-ND1 is part of the respiratory complex I and affects mitochondrial function."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;3754C&gt;A VARIANT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The 3754C&gt;A mutation, present in approximately 22% heteroplasmy, suggests its potential impact on cellular processes influenced by mtDNA."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;MUTATION FREQUENCY&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"150,740 nuclear and 32 mtDNA variants were found, with several identified as disease-causing mutations in genes such as COQ2."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;COQ2 GENE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Mutations in the coenzyme Q2 homolog gene (COQ2) have been reported to cause coenzyme Q10 deficiency and related disorders."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;COENZYME Q10 DEFICIENCY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The c.437G&gt;A mutation found in COQ2 is associated with coenzyme Q10 deficiency, as documented by OMIM (#609825).") ("entity"</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;FLAVIN MONONUCLEOTIDE (FMN)&quot;">
      <data key="d0">"PROTEIN FUNCTION"</data>
      <data key="d1">"FMN is an essential cofactor in complex I for the proper functioning of the protein, facilitating NADH binding and interaction with other components."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;IRON-SULFUR CLUSTERS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Iron–sulfur clusters are critical for the function of complex I, enabling electron transfer processes within cells."</data>
      <data key="d2">chunk-5d67fc9ddf960da009981b77d8d37f33</data>
    </node>
    <node id="&quot;CMH000068&quot;">
      <data key="d2">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d1">"This gene was sequenced to a nuclear exome target coverage of 88.05% and mtDNA base covered at 10× or greater, aligning with the sequencing performed on CMH000067" relationship_description</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OPRM1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">&gt;&lt;OPRM1 is a gene that plays a role in drug and alcohol addiction. It has been studied for its relationship with medication effects and subjective responses to drugs including alcohol."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;ALDH2 GENOTYPE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"ALDH2 genotype was found to be a significant covariate in alcohol consumption and self-administration."&lt;SEP&gt;&gt;&lt;ALDH2 genotype is an environmental factor that may influence the metabolism of alcohol, potentially affecting medication-induced side effects such as drowsiness."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544&lt;SEP&gt;chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;ADH1B GENOTYPE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">&gt;&lt;ADH1B genotype is related to physiological processes involved in alcohol metabolism and subjective responses to alcohol consumption."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;AUDIT SCORE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">&gt;&lt;AUDIT score is a physiological process that varies by genotype and may influence drug-induced side effects such as drowsiness or sedation."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;DRINKING DAYS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">&gt;&lt;Drinking days, past 30 days, are related to the physiological processes of alcohol metabolism and medication side effects in OPRM1 genotype groups."</data>
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;PLACEBO&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Participants taking placebo during the experiment had lower levels of drowsiness compared to those on naltrexone, indicating a potential relationship between medications and subjective responses such as drowsiness.")&lt;SEP&gt;"The placebo group received a non-active substance, serving as a control for the study."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836&lt;SEP&gt;chunk-62d8719735e6c6eaa899d9ea64143544</data>
    </node>
    <node id="&quot;NALTREXONE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Naltrexone is one of the medications used for pharmacotherapy during alcohol use disorder treatment."</data>
      <data key="d2">chunk-27037cc5f35c77d6a57fa2f0fa1dc4a6</data>
    </node>
    <node id="&quot;ADHOHNB1B GENOTYPE&quot;">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"The relationship between OPRM1 and ADH1B genes is complex; they both play a role in subjective responses to alcohol but are not directly linked according to the provided data.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DROWSINESS&quot;">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"Naltrexone, as medication taken during an experiment on drug effects, was associated with higher drowsiness levels compared to placebo participants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEDICATION&quot;">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"Naltrexone, as medication taken during an experiment on drug effects, was associated with higher drowsiness levels compared to placebo participants.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PLACEBO PARTICIPANTS&quot;">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"Participants taking placebo in a study had lower levels of drowsiness than those on naltrexone.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RINGING IN THE EARS&quot;">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"Naltrexone, as medication, was associated with increased ringing in the ears compared to participants on placebo.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OPRM1 GENOTYPE&quot;">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"Genotype differences across OPRM1 may influence AUDIT scores as well as medication-induced drowsiness or sedation.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEDICATION EFFECTS&quot;">
      <data key="d2">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d1">"The number of drinking days in the past 30 days is a demographic factor that varies by genotype and influences subjective responses to alcohol infusion sessions, including medication side effects such as drowsiness.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALDH2 RS671&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs671 is a genetic variant associated with ALDH2 enzyme activity, which affects daily alcohol consumption."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;GENES&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ALDH2 gene regulates alcohol metabolism and its variants impact alcohol consumption patterns."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;RS671 POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another genetic variant, rs671, has been identified as a risk factor for hypertension and cardiovascular disease."&lt;SEP&gt;"The rs671 polymorphism influences blood cortisol levels, as demonstrated in the study population."</data>
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;DAILY DRINKS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Higher daily drinks were observed across different ALDH2 genotypes."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;CORTISOL LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Cortisol levels varied according to the rs671 polymorphism in both sexes, with significant differences between groups."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;AGE DISTRIBUTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Significant differences were observed in age distribution across genotypes, with GA group being older than other groups."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;EDUCATION STATUS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Educational status was also a significant factor influencing blood cortisol levels."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;HYPERTENSION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Hypertension is a disease characterized by increased blood pressure, specifically in individuals carrying the rs2231142 T allele or females with polymorphisms at both loci."&lt;SEP&gt;"Hypertension is a disease condition influenced by various factors, including genotypes and lifestyle choices."</data>
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579&lt;SEP&gt;chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;DIABETES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Diabetes is another health condition identified in the study population with significant differences across ALDH2 genotypes."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;ALDH2 GENE EXPRESSION&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The expression of the ALDH2 gene, which encodes for an enzyme critical to alcohol metabolism, is a key factor influencing individual responses to alcohol."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;ALDH2 ENZYME FUNCTION&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The ALDH2 enzyme plays a crucial role in breaking down acetaldehyde, a toxic metabolite of alcohol, and thus impacts the effects of alcohol on individuals."</data>
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
    </node>
    <node id="&quot;GA GENOTYPE&quot;">
      <data key="d2">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d1">"The GA genotype group was older than other groups in both sexes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PARTICIPANT COUNT&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A total of 1026 individuals were enrolled in the study."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;GENDER DISTRIBUTION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The participants included a gender distribution of 699 males and 507 females."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;HYPERTENSION PREVALENCE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"In the study population, there was a higher prevalence of hypertension in individuals with hyperuricemia compared to controls."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;BLOOD BIOMARKERS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Individuals in the HUA group had higher levels of serum creatinine, TG, LDL, and BMI but lower levels of HDL."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;LIPID LEVELS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"There was a significant difference in lipid levels between individuals with hyperuricemia and those without it."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;DIURETICS USE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The use of diuretics was relatively low and did not reach statistical significance between the two groups."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;SNPS TESTED&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Single Nucleotide Polymorphisms (SNPs) are genetic markers that have been tested for their potential to influence treatment response within the combination-therapy treated patients."&lt;SEP&gt;"The three tested SNPs were in Hardy-Weinberg equilibrium: SLC2A9 rs3733591, ABCG2 rs2231142, and SLC22A12 rs893006."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8&lt;SEP&gt;chunk-befd5ea20007b1d02d987897c798dadd</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 13}]</data>
    </node>
    <node id="&quot;GENOTYPE FREQUENCIES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"No strong evidence for departure from Hardy-Weinberg equilibrium was found except nominally in Romania (p=0.02)."&lt;SEP&gt;"There was a significant difference in genotype frequency of SLC22A12 rs893006 between HUA cases and controls, particularly in males."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5&lt;SEP&gt;chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;RISK ALLELES ASSOCIATION&quot;">
      <data key="d0">"URIC ACID LEVELS"</data>
      <data key="d1">"Molecular Interaction"</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;SNPS ASSOCIATION BY GENDER&quot;">
      <data key="d0">"GENDER FACTORS"</data>
      <data key="d1">"The T allele of rs2231142 ABCG2 was associated with sUA level and HUA in both males and females, while the C risk allele in SLC2A9 rs3722591 was only associated with sUA level and HUA in females."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;SNPS ASSOCIATION BY GENDER DETAILED&quot;">
      <data key="d0">"GENDER FACTORS"</data>
      <data key="d1">"The SLC22A12 rs893006 G risk allele was only associated with sUA level in males. The C risk allele in SLC2A9 was only significant in females."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;UA LEVELS BY SNP GENOTYPES&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"There was a significant difference in sUA levels based on genotype of the ABCG2 polymorphism, particularly between T/T and G/G genotypes.") ("entity"</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;HYPERTENSION PREVALENCE IN HUA CASES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"There was a higher prevalence of hypertension among individuals with hyperuricemia compared to the control group."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;BLOOD PRESSURE LEVELS BY HYPERTENSIVE STATUS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Although there was no significant difference in blood pressure between HUA cases and controls, hypertensive patients were more prevalent among those with hyperuricemia."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;MEDICATION USE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The ratio of diuretics was relatively low and did not reach statistical significance between the two groups, suggesting potential differences in medication usage may have influenced the results."</data>
      <data key="d2">chunk-befd5ea20007b1d02d987897c798dadd</data>
    </node>
    <node id="&quot;SODIUM URATE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Sodium urate is a compound involved in the management of hyperuricemia."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;HYPERURICEMIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Hyperuricemia is a condition characterized by high levels of sodium urate in the bloodstream."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;UA LEVELS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"UA Levels are involved in the management of hyperuricemia and are measured for clinical relevance."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;SLC2A9 RS3733951&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The SLC2A9 rs3733951 genomic variant is associated with variations in UA levels."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;ABCG2 RS2231142&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The ABCG2 rs2231142 polymorphism is also linked to changes in sUA levels and hyperuricemia risk."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;CARDIOVASCULAR RISK FACTORS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Cardiovascular risk factors such as obesity, hypertension, and lipid levels influence UA levels and predispose to hyperuricemia."&lt;SEP&gt;"Other cardiovascular risk factors such as age, body mass index, and smoking status were not associated with sUA level in this study."</data>
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579&lt;SEP&gt;chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;TG LEVELS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Elevated triglyceride (TG) levels are indicative of LPL deficiency."&lt;SEP&gt;"High TG levels are associated with an increased risk of developing hyperuricemia according to clinical studies."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86&lt;SEP&gt;chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;HDL LEVELS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Low HDL levels can contribute to the development of high sUA and subsequent hyperuricemia.") ("entity"</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;ORPHAN DRUG&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Urate-lowering drugs are considered orphan drugs due to their specific application in treating rare cases of hyperuricemia and gout."</data>
      <data key="d2">chunk-e3ddbe8dd84aeaf2dbe30550c6c32d00</data>
    </node>
    <node id="&quot;RS2228269 POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific polymorphic variant in the rs2228269 locus is associated with increased risk of hypertension."</data>
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579</data>
    </node>
    <node id="&quot;RS2231142 POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another specific polymorphic variant in the rs2231142 locus is also associated with increased risk of hypertension, specifically among hypertensive individuals."</data>
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579</data>
    </node>
    <node id="&quot;UA (URIC ACID)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Serum uric acid levels are influenced by genetic variants and dietary factors such as purine-rich foods intake."</data>
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;DIETARY PURINES&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Purine-rich foods are high in dietary purines, which can be metabolized into uric acid, influencing serum levels of UA (Uric Acid)."</data>
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;HYPERTENSIVE INDIVIDUALS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Hypertensive individuals often have higher baseline levels of uric acid, possibly due to genetic or environmental factors."</data>
      <data key="d2">chunk-7091ed039203b69ad83d281b22c89579</data>
    </node>
    <node id="&quot;LRP2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"LRP2 (rs57989581) is a gene associated with kidney function and has been linked to increased risk of hypertension."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;NFATC1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"NFATC1 is a gene involved in the regulation of important physiological processes related to kidney health."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;CKD&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Chronic Kidney Disease (CKD) is a condition associated with reduced kidney function, leading to potential complications like ESRD."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;ESRD&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"End-Stage Renal Disease (ESRD) is the final stage of chronic kidney disease where renal replacement therapy may be required."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;DIABETIC NEPHROPATHY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Diabetic Nephropathy is a complication of diabetes that affects kidney function, impacting eGFR values."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;ESRD RISK&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Increased risk of ESRD is associated with the presence of specific alleles linked to altered metabolic pathways affecting renal health."</data>
      <data key="d2">chunk-3edc72730d68b4c7fd6ba397aa087391</data>
    </node>
    <node id="&quot;GCKR GENE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Three variants mapping to 11.7 kb at GCKR are associated with an increased risk of CKD, making GCKR a likely effector transcript for eGFR."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;NFATC1 GENE&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"NFATC1 gene transcript is influenced by renal proximal tubular epithelial cells DHSs, suggesting a role in kidney function."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;RGS14 GENE&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"RGS14 encodes a member of the regulator of G protein signaling family, modulating downstream effects of Gα subunits in kidneys."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;DROSOPHILA MELANOGASTER NFAT GENE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Loss-of-function mutations in Drosophila melanogaster NFAT gene are associated with increased salt sensitivity, indicating a role in ionic or osmotic regulation."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;NOS1 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The NOS1 protein is involved in vascular function and interacts with folate metabolism to maintain cardiovascular health."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;GCKR GENOMIC VARIANT&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Variants at GCKR are associated with an increased risk of CKD, indicating a role in renal function and potential impact on kidney disease outcomes."</data>
      <data key="d2">chunk-45a965c3c3013c70d0fa0f1680283083</data>
    </node>
    <node id="&quot;LOCO MUTANTS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">&gt;&lt;&gt;locod06164/+ and locoEY-P283/+&lt;/&gt;</data>
      <data key="d2">chunk-5ac437b050552f5db2abf19f1bf897cf</data>
    </node>
    <node id="&quot;CAMPYLOBACTER GENOME DATABASE ID&quot;">
      <data key="d0">"CGL0873"</data>
      <data key="d1">"This isolate was one of several studied for its role in quinolone resistance, highlighting a genetic variant within the NOS1 gene."&gt; "Campylobacter Genome Database ID: CGL0873"</data>
      <data key="d2">chunk-6264e17a8290bc0a9e24c68c21c1f15c</data>
    </node>
    <node id="&quot;EPIGENETIC MODIFICATION&quot;">
      <data key="d0">"EPIGENETIC MODIFICATION"</data>
      <data key="d1">"Epigenetic modifications linked to poor dietary patterns can affect nitric oxide synthesis."&lt;SEP&gt;"Epigenetic modifications linked to poor dietary patterns can alter nitric oxide synthesis."</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568&lt;SEP&gt;chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;ANTIMICROBIAL DRUGS&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Patients were treated with antimicrobial drugs for their campylobacteriosis, including fluoroquinolones and macrolides."</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;CAMPYLOBACTER ISOLATES&quot;">
      <data key="d0">"MICROORGANISM"</data>
      <data key="d1">"Campylobacter isolates are microbes that can cause infections in humans, often from contaminated food products such as chicken or turkey."]("entity"</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;BROILER CHICKENS&quot;">
      <data key="d0">"ANIMAL SOURCE"</data>
      <data key="d1">"Broiler chickens can serve as a source for Campylobacter infections, which have been reported in association with consumption of these birds' products."]("relationship"</data>
      <data key="d2">chunk-0d155c005072e55d94179ce7952bf5a9</data>
    </node>
    <node id="&quot;HTR2A&quot;">
      <data key="d0">"HTR2A GENE IS INVOLVED IN SOCIAL DISINHIBITION.")</data>
      <data key="d1">1</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS9534511&quot;">
      <data key="d0">"MUTATION"</data>
      <data key="d1">"rs9534511 on HTR2A gene is a mutation associated with increased risk of social disinhibition.")</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;HTR3B&quot;">
      <data key="d0">"HTR3B GENE IS INVOLVED IN SOCIAL DISINHIBITION.")</data>
      <data key="d1">3</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;RS4938056&quot;">
      <data key="d0">"MUTATION"</data>
      <data key="d1">"Minor allele of rs4938056 was associated with increased risk of social disinhibition, positively impacting the score."&lt;SEP&gt;"rs4938056 on HTR3B gene is a mutation associated with increased risk of social disinhibition.")</data>
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed&lt;SEP&gt;chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;TAS&quot;">
      <data key="d0">"TOOTH AGILITY SCORE (TAS)"&lt;-&gt;"TAS SCORE, WHICH MEASURES TOOTH MOBILITY IN RATS AND MICE, MAY BE ASSOCIATED WITH SOCIAL DISINHIBITION."</data>
      <data key="d1">5</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;DAS&quot;">
      <data key="d0">"DIGIT ALGESIOMETER SCORE (DAS)"&lt;-&gt;"DAS SCORE, WHICH MEASURES PAIN SENSITIVITY IN RODENTS, MAY ALSO BE RELATED TO SOCIAL DISINHIBITION."</data>
      <data key="d1">6</data>
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
    </node>
    <node id="&quot;PARAMETER ESTIMATES&quot;">
      <data key="d0">"PARAMETER ESTIMATES"</data>
      <data key="d1">"Parameter estimates ranged from 0.19 to 0.32 for positively associated SNPs, and from −0.29 to −0.64 for negatively associated SNPs."</data>
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
    </node>
    <node id="&quot;RS16870286&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"Minor allele of rs16870286 was negatively associated with an increase in social disinhibition score, providing a protective effect."</data>
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
    </node>
    <node id="&quot;PARENTAL EDUCATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Parental education was also not significantly associated with the social disinhibition score."</data>
      <data key="d2">chunk-36d70bb8409856300dd77669e7c1f9ed</data>
    </node>
    <node id="&quot;RS9保">
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d1">"rs9534511 on HTR2A gene is associated with increased risk of social disinhibition.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS4938056">
      <data key="d2">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d1">"rs4938056 on HTR3B gene is associated with increased risk of social disinhibition.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CNR1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CNR1 is a gene involved in regulating CB1 receptor levels, which are associated with drug-seeking behavior and alcohol cues. The genetic variation at rs2023239 affects this regulation."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;RS2023239&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"rs2023239 is a genomic variant associated with changes in dopamine signaling."&lt;SEP&gt;"rs2023239 is a genomic variant located upstream of exon 3 in the CNR1 gene. This variant has been described as an alternative promoter, affecting CB1 receptor levels."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e&lt;SEP&gt;chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;BROCA">
      <data key="d0">)"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Brain areas such as Brodmann areas 9 and 10 are involved in physiological processes related to drug-seeking behavior and alcohol cues."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;BRODMANN AREAS&quot;">
      <data key="d0">"NEUROLOGICAL STRUCTURE"</data>
      <data key="d1">"Brodmann areas 9 and 10 are specific regions of the brain that have been associated with drug-seeking behavior and alcohol cue processing."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;F1,69&quot;">
      <data key="d0">)"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"F1,69 refers to a statistical result from an analysis involving the measurement of reward and positive affect in individuals. This process is related to brain activity and subjective measures associated with drug-seeking behavior and alcohol cues."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;PROFILE OF MOOD STATES&quot;">
      <data key="d0">"MEASURED VARIABLE"</data>
      <data key="d1">"The Profile of Mood States is a measure used to assess reward, positive affect, and other mood states related to drug-seeking behavior and alcohol cues. This variable has been correlated with genetic variants like rs2023239."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;AUDIT&quot;">
      <data key="d0">)"MEASURED VARIABLE"</data>
      <data key="d1">"AUDIT is a tool used for measuring alcohol use disorder in individuals participating in studies on drug-seeking behavior and brain activity related to alcohol cues. This measure has been correlated with genetic variants like rs2023239."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;NACC">
      <data key="d0">)"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Brain areas such as NAcc are involved in physiological processes related to drug-seeking behavior and alcohol cues, particularly in relation to brain activation during exposure to drug or cue stimuli."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;VMPFC">
      <data key="d0">)"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Brain area such as VMPFC is involved in physiological processes associated with reward and positive affect. This area has been correlated with genetic variants like rs2023239, indicating a relationship between brain activity and subjective measures."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;VTA">
      <data key="d0">)"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Brain areas such as VTA are involved in physiological processes related to drug-seeking behavior. These areas have been associated with differential activation during exposure to alcohol cues or reward stimuli like drugs."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;OFC">
      <data key="d0">)"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Brain area such as OFC is involved in physiological processes related to reward and positive affect, particularly in relation to subjective measures of drug-seeking behavior. This area has been associated with correlations between brain activation and self-reported desire for alcohol."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;AUQ SCORE&quot;">
      <data key="d0">)"MEASURED VARIABLE"</data>
      <data key="d1">"AUQ score stands for urge to consume alcohol score. It is a measure used to assess the level of subjective desire to consume alcohol in individuals participating in studies on drug-seeking behavior and brain activity related to alcohol cues.")&gt; ("entity"</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;ALCOHOL CUES&quot;">
      <data key="d0">&gt;"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Alcohol cues are environmental stimuli that can trigger drug-seeking behavior in individuals. Exposure to these cues may lead to increased activation of areas such as NAcc, VMPFC, and OFC related to reward and positive affect."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;REWARD&quot;">
      <data key="d0">&gt;"MEASURED VARIABLE"</data>
      <data key="d1">"Reward is a subjective measure often used in studies on drug-seeking behavior and brain activity. It can be influenced by factors like genetic variants or environmental cues that may impact areas such as NAcc, VMPFC, and OFC."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;POSITIVE AFFECT&quot;">
      <data key="d0">&gt;"MEASURED VARIABLE"</data>
      <data key="d1">"Positive affect is another subjective measure often used in studies on drug-seeking behavior and brain activity. It can be influenced by factors like genetic variants or environmental cues that may impact areas such as NAcc, VMPFC, and OFC."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;ALCOHOL USE DISORDER&quot;">
      <data key="d0">&gt;"DISEASE"</data>
      <data key="d1">"Alcohol use disorder is a condition defined by alcohol use that leads to clinically significant impairment or distress. This can be measured using tools like AUDIT."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;NEUROCIRCUITRY&quot;">
      <data key="d0">&gt;"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Neurocircuitry refers to the complex neural networks involved in processes such as drug-seeking behavior and reward, including areas such as Brodmann areas 9 and 10."</data>
      <data key="d2">chunk-27c6611dceafae880176ce8a7e7fc07e</data>
    </node>
    <node id="&quot;CT GROUP&quot;">
      <data key="d0">"INDIVIDUALS"</data>
      <data key="d1">"The CT group (n=23) consists of individuals who have the CT genotype, which may influence their response to alcohol-related cues and treatment outcomes."&lt;SEP&gt;"The CT group (n=23) consists of individuals who have the CT genotype, which may influence their response to olanzapine treatment."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;TT GROUP&quot;">
      <data key="d0">"INDIVIDUALS"</data>
      <data key="d1">"The TT group (n=46) consists of individuals with the TT genotype."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;MEDICATION OLANZAPINE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Olanzapine is a medication targeting dopamine signaling that may interact with rs2023239, influencing reward and positive affect in individuals."</data>
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
    </node>
    <node id="&quot;CUE-ELICITED CRAVING&quot;">
      <data key="d2">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d1">"Genomic variant rs2023239 interacts with olanzapine to influence cue-elicited craving and drinks per drinking day.") ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LPL GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"LPL gene is associated with autosomal recessive disorder LPL deficiency, affecting lipid metabolism and hydrolysis of chylomicrons."&lt;SEP&gt;"The LPL gene is associated with severe hypertriglyceridemia in a compound heterozygote patient."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86&lt;SEP&gt;chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;LIPOPROTEIN LIPASE (LPL)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"LPL is a protein involved in multiple stages of lipid metabolism including the hydrolysis of chylomicrons."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;CHYLOMICRONS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Chylomicrons are formed from dietary fat and are later hydrolyzed by LPL."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;MEDIUM-CHAIN TRIGLYCERIDES (MCT)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Enfaport Lipil contains medium-chain triglycerides to be processed by LPL in the bloodstream."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;LONG-CHAIN FATTY ACIDS (LCFA)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The formula also includes long-chain fatty acids for essential lipid metabolism."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;ERUPTIVE XANTHOMAS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Eruptive xanthomas are a clinical feature of LPL deficiency, appearing in affected individuals as yellow papules."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;LIPEMIA RETINALIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Lipemia retinalis is a visible sign of high lipid levels and hypertriglyceridemia caused by LPL deficiency."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;HEPATO-SPLENOMEGALY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Hepato-splenomegaly can occur in individuals with LPL deficiency, associated with the disease's clinical presentation.") ("entity"</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;ADRENOLEUKODYSTROPHY (ALD)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Adrenoleukodystrophy (ALD) is a rare inherited disorder of lipid metabolism affecting the nervous system."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;MITOCHONDRIAL DISORDERS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Mitochondrial disorders encompass various genetic diseases that affect energy production in cells, leading to diverse symptoms and severity levels."</data>
      <data key="d2">chunk-bbdb97da6903bfbdae42d4c3cb9c9c63</data>
    </node>
    <node id="&quot;EXON 5&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A novel p.Q240H mutation in exon 5 of the LPL gene causes severe hypertriglyceridemia."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;HYPERTRIGLYCERIDEMIA&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Hypertriglyceridemia is a condition caused by mutations in the LPL gene and elevated TG levels."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;LIPOLYSIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The lipolytic process is regulated by the LPL gene and local domain in lipoprotein metabolism."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;MCT OIL&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"MCT oil, used as a fat supplement, can be absorbed directly into the portal vein."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;PORTAL VEIN&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Absorption of MCTs in the portal vein is direct and beneficial for patients with LPL deficiency."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;HYPERVISCOSITY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Elevated TG levels can lead to hyperviscosity, causing gastrointestinal hemorrhage and pancreatitis."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;PANCREATITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Lipolysis-related disorders like LPL deficiency are associated with frequent episodes of pancreatitis."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;DIETARY FAT RESTRICTION&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Dietary fat restriction is a cornerstone therapy for managing hypertriglyceridemia in LPL deficiency."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;GEMFIBROZIL&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Gemfibrozil may be used to lower TG levels when combined with dietary restrictions."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;OMEGA-3 FATTY ACIDS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Omega-3 fatty acids can help reduce TG levels when combined with a fat-restricted diet."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;ORLISTAT&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Orlistat is another drug that may lower TG levels but has controversial usage in LPL deficiency management."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;DGAT1 INHIBITORS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Oral diacylglycerol O-acyltransferase 1 (DGAT1) inhibitors are being investigated for their role in reducing dietary fat absorption."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;NOVEL LPL GENE MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A novel p.Q240H mutation is responsible for severe hypertriglyceridemia in the patient discussed."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;SEVERE HYPERTRIGLYCERIDEMIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The patient with LPL deficiency presents with extreme elevations of TG levels, necessitating dietary restriction and drug therapy."</data>
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
    </node>
    <node id="&quot;LPL GENE MUTATION&quot;">
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d1">"Mutations in the LPL gene are associated with severe hypertriglyceridemia in patients with lipolysis-related disorders.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TREATMENT&quot;">
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d1">"Dietary fat restriction is a cornerstone of treatment for managing complications related to LPL deficiency and hypertriglyceridemia.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CLINICAL MANIFESTATIONS&quot;">
      <data key="d2">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d1">"Hypertriglyceridemia leads to clinical manifestations such as eruptive xanthomas, lipemia retinalis, and gastrointestinal hemorrhage.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PATIENT&quot;">
      <data key="d0">"PATIENTS RECRUITED FOR THE STUDY ARE INDIVIDUALS UNDERGOING TREATMENT WITH PACLITAXEL-CARBOPLATIN COMBINATION THERAPY OR CARBOPLATIN MONO-THERAPY.")</data>
      <data key="d1">"Patients were included in the study as participants."&gt;&lt;SEP&gt;1</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836&lt;SEP&gt;chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;TOPIRAMATE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Topiramate is a medication used to treat conditions such as alcohol use disorder and epilepsy."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;RS2832407 GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Rs2832407 is a genetic variant that affects individual's response to medication and occurrence of adverse events."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;C-HOMOZYGOTE&quot;">
      <data key="d0">"GENOTYPIC GROUP"</data>
      <data key="d1">"Rs2832407*C-homozygotes are individuals carrying two copies of the C allele, which may influence drug efficacy and side effects."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;A-ALLELE CARRIER&quot;">
      <data key="d0">"GENOTYPIC GROUP"</data>
      <data key="d1">"Individuals with at least one A allele (A-allele carriers) also participated in the study, influencing their response to medication."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;ADVERSE EVENT SEVERITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The severity of adverse events was evaluated and reported as moderate or greater."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;MODERATE ADVERSE EVENTS&quot;">
      <data key="d0">"MILD"</data>
      <data key="d1">"Among topiramate patients, the mean adverse event severity was 1.3 (SD=0.4), compared with 1.1 (SD=0.5) in the placebo group, a non-significant difference."</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;SEVERE ADVERSE EVENTS&quot;">
      <data key="d0">"MILD"</data>
      <data key="d1">"Among topiramate patients and placebo patients, a small percentage reported severe or greater adverse events."&gt;) ("entity"</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;MEDICATION GROUP&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Participants were assigned to either topiramate or placebo medication groups, influencing their response to treatment."&gt;</data>
      <data key="d2">chunk-0c7ab28db433187759e760725a105836</data>
    </node>
    <node id="&quot;LACTASE GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The Lactase gene (LCT) is involved in lactose digestion and its regulation has been studied for understanding lactose persistence/non-persistence.")&gt;10</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;MCM6 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The MCM6 gene is part of a region that surrounds the lactase persistence/non-persistence SNP C/T-13910 and mediates individual differences in LCT mRNA.")&gt;12</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;VILLI ENTEROCYTES&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"Steady-state LCT mRNA levels varied significantly among individuals, differing up to 29-fold.")&gt;14</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;ENTEROCYTES&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Enterocytes are a type of intestinal epithelial cell that plays a critical role in lactose digestion.")&gt;16</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;INTESTINAL EPITHELIAL CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Villus enterocytes are a key component in the physiological process of lactose digestion.")&gt;18</data>
      <data key="d2">chunk-ec104044b3aa65560be8d81dbb3940d6</data>
    </node>
    <node id="&quot;MCM6&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"MCM6 is a gene associated with age-dependent changes in LCT expression and lactase persistence/non-persistence."&lt;SEP&gt;"MCM6 is a protein involved in regulation of LCT mRNA levels."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c&lt;SEP&gt;chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;LCT&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"LCT is the gene involved in lactose digestion, critical for milk consumption post-weaning."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;LACTASE NON-PERSISTENT INDIVIDUALS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Individuals with non-persistent lactase phenotype have increased DNA modifications associated with age and decreased LCT expression."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;LACTASE PERSISTENT (TT) INDIVIDUALS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"In TT genotypes, there is a significant increase in MCM6 promoter DNA modification densities suggesting active regulation of LCT expression at adulthood."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;C-13910&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variant C-13910 associated with increased lactase persistence and changes at intron 13 of the MCM6 gene."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;T-13910&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variant T-13910 is associated with decreased LCT expression in non-persistent lactase individuals."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;ENTEROCYTE SAMPLES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Age-related DNA modification changes were investigated in enterocyte samples stratified for C/T-13910 genotypes."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;H3K27AC AND H3K4ME1 PEAKS&quot;">
      <data key="d0">"EPIGENETIC MODIFICATION"</data>
      <data key="d1">"Enhancer element identified at LCT intron 2 using chromatin marks from an adult mouse, indicative of active regulation in lactase persistence individuals."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;LACTASE NON-PERSISTENT (CC) INDIVIDUALS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"In CC genotypes, DNA modifications consistently increased with age across LCT and MCM6 suggesting a mechanism for reduced LCT expression over time."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;LNCRNA LOC100507600&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"LOC100507600 is an lncRNA transcribed from the opposite DNA strand to LCT, potentially regulating its expression in lactase persistent individuals."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;SNP -13910&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"SNP-13910 and related variants are associated with variations in LCT expression across different populations.") ("entity"</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;MAMMALS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The evolution of lactase persistence across mammals may have been influenced by dietary patterns involving lactose as an available energy source post-weaning."</data>
      <data key="d2">chunk-ea45644d73f260cf365527dcc3af86e1</data>
    </node>
    <node id="&quot;LOC100507600&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"LOC100507600 (lncRNA) affects the expression of LCT and MCM6 mRNAs."</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;LACTASE REGULATING LNCRNA&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The CRISPR-Cas9 system was used to manipulate regulatory regions in genes affecting lactase levels.") ("entity"</data>
      <data key="d2">chunk-512b044cf65a4e519d519c6239959c6c</data>
    </node>
    <node id="&quot;RS4988235&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The minor allele for all populations is the 'T' allele at rs4988235, consistent with that in southern and eastern Europe."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;COUNTRY SPECIFIC MAF ESTIMATES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Differences were observed in the consumption patterns of milk in differing allele groups."&lt;SEP&gt;"Nutrient"</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;LACTASE NON-PERSISTENT CC GENOTYPE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"In controls, genotype was seen to be associated with milk drinking OR 2.39 [1.81, 3.15], p=6.9*10−10."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;OR&lt; (&quot;ENTITY&quot;">
      <data key="d0">"INDIVIDUALS"</data>
      <data key="d1">"Nutrient"</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;INDIVIDUALS WITHOUT GENETIC DATA&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Descriptive statistics and milk drinking profiles for all study participants are included..."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;POPULATION&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"In controls, genotype was seen to be associated with milk drinking OR 2.39 [1.81, 3.15], p=6.9*10−10."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;GENOTYPE CC&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"There was an elevated risk of RCC among those consuming milk as opposed to never consumers (OR=1.35)."</data>
      <data key="d2">chunk-7a423a439657efc1126fb6a075919ea5</data>
    </node>
    <node id="&quot;FANCONI ANEMIA CELL LINE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The Fanconi anemia cell line is associated with bilateral radial aplasia, absent thumbs, microcephaly, micrognathia, and café au lait spots.")</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;BILATERAL RADIAL APLASIA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Bilateral radial aplasia is a physical abnormality associated with Fanconi anemia.")</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;ABSENT THUMBS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The absence of thumbs is a feature of the Fanconi anemia cell line, suggesting a genetic disorder.")</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;MICROCEPHALY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Microcephaly is a condition seen in individuals with Fanconi anemia and may be related to brain development issues.")</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;CAFÉ AU LAIT SPOTS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Café au lait spots are often associated with genetic disorders like those found in the Fanconi anemia cell line, possibly indicating a common underlying condition or environmental exposure.")</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;CHROMOSOMAL BREAKAGE&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Elevated chromosomal breakage levels have been observed in peripheral blood samples of individuals with Fanconi anemia and may be related to the disease process.")</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;SOMATIC MOSAICISM&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Somatic mosaicism, a phenomenon seen in a small subset of FA patients, suggests complex cellular dynamics involving genetic variation within single cells.")</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;HYPERSENSITIVITY TO CROSSLINKING AGENTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Fibroblasts derived from the Fanconi anemia cell line are hypersensitive to crosslinking agents such as MMC and DEB, indicating a possible physiological response linked to their cellular state.")</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;FA CORE COMPLEX&lt;&quot;|&gt;&quot;PROTEIN&quot;">
      <data key="d0">"THE DEFICIENCY OF FA PATHWAY ACTIVATION IN FIBROBLASTS SUGGESTS THE INVOLVEMENT OF SPECIFIC PROTEINS LIKE THE FA CORE COMPLEX IN FANCONI ANEMIA.")</data>
      <data key="d1">9</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;FANCD2 MONOUBIQUITINATION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Deficiency of FANCD2 monoubiquitination, a process critical for DNA repair and stability, is observed in fibroblasts from the Fanconi anemia cell line.")</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;FANCA MUTATION&lt;&quot;|&gt;&quot;DISEASE&quot;">
      <data key="d0">"A SINGLE FANCA MUTATION HAS BEEN DETECTED IN INDIVIDUALS WITH FANCONI ANEMIA, SUGGESTING A GENETIC CAUSE FOR THE CELLULAR PHENOTYPE AND DISEASE SEVERITY OBSERVED IN THIS CONDITION.")</data>
      <data key="d1">11</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;NORMAL LEVELS OF FANCA&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Despite a specific FANCA mutation, normal levels of FANCA were detected by western blot in fibroblasts from Fanconi anemia cell line, indicating complex interactions between genetic and cellular factors.")</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;NONSYNONYMOUS MUTATION&lt;&quot;|&gt;&quot;MOLECULAR INTERACTION&quot;">
      <data key="d0">"A NONSYNONYMOUS MUTATION IS ASSOCIATED WITH THE DISEASE PHENOTYPE OF FANCONI ANEMIA, AFFECTING PROTEIN FUNCTION IN A CRITICAL BIOLOGICAL PATHWAY RELATED TO DNA REPAIR AND STABILITY.")</data>
      <data key="d1">13</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;NONSENSE-MEDIATED DECAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The presence of premature stop codons in UBE2T transcripts may result in nonsense-mediated decay, further contributing to the complex cellular phenotype observed in Fanconi anemia.")</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;FANCONI ANEMIA CORE COMPLEX&lt;&quot;|&gt;&quot;PROTEIN&quot;">
      <data key="d0">"THE FA CORE COMPLEX LIKELY PLAYS A SIGNIFICANT ROLE IN THE CELLULAR DEFECTS OBSERVED IN FANCONI ANEMIA CELLS.")</data>
      <data key="d1">2</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;ID2 COMPLEX&lt;&quot;|&gt;&quot;PROTEIN&quot;">
      <data key="d0">"THE ID2 COMPLEX MAY BE INVOLVED IN THE REGULATION OF SPECIFIC PHYSIOLOGICAL PROCESSES WITHIN INDIVIDUALS WITH FANCONI ANEMIA, CONTRIBUTING TO THE DISEASE PHENOTYPE.")</data>
      <data key="d1">3</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;LYMPHOBLASTOID CELL LINE (LCL)&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"RA2946 is a LCL derived from blood samples showing mosaicism in the subject with Fanconi anemia.")</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;ALUYA5 REPEATS&lt;&quot;|&gt;&quot;MOLECULAR INTERACTION&quot;">
      <data key="d0">"THE PRESENCE OF ALUYA5 REPEATS MAY HAVE FACILITATED SPECIFIC GENETIC EVENTS LIKE DELETIONS AND DUPLICATIONS WITHIN UBE2T, CONTRIBUTING TO COMPLEX CELLULAR DYNAMICS IN THE CONTEXT OF FANCONI ANEMIA.")</data>
      <data key="d1">5</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;NONSENSE-MEDIATED DECAY (NMD)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The presence of premature stop codons may lead to Nonsense-mediated decay, further impacting gene expression and protein function within cells like those in the Fanconi anemia cell line.")</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;EXTENDED EXON 6 VARIANT (DUPEX2_6)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"This variant involving extended exon 6 may have functional implications for UBE2T, contributing to the complex genetic and cellular phenotype observed in Fanconi anemia.")</data>
      <data key="d2">chunk-b3b792ab4e6f6251de68ef6e959aee1f</data>
    </node>
    <node id="&quot;UBE2T&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"UBE2T is a gene associated with the cause of Fanconi anemia-T subtype."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;RA2627 CELLULAR DEFECTS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"RA2627 cellular defects are caused by deficiency in UBE2T."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;WILD TYPE UBE2T&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Overexpression of wild type UBE2T rescued FA phenotypes, indicating its importance for normal cell function."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;MMC&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Exposure to MMC and other crosslinking agents is associated with cellular defects in RA2627 fibroblasts due to the absence of UBE2T gene expression."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;DEB&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Exposure to DEB, a mutagenic chemical agent, was part of the conditions that caused FA-T phenotype in subjects with deficient UBE2T function."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;CISPLATIN&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Cisplatin is another toxic compound known to induce cellular defects associated with deficiency of UBE2T gene expression."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;FANCONI ANEMIA-T&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Fanconi anemia T subtype is the disease condition caused by the absence or deficiency of functional UBE2T gene in affected individuals."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;MONOUBIQUITINATION OF FANCD2 AND FANCI&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Restoration of monoubiquitination of FANCD2 and FANCI by wild type UBE2T expression is a key indicator of its functional rescue in FA-T subtype."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;FANCD2 FOCI&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The formation of FANCD2 foci, restored by UBE2T overexpression, is crucial for maintaining DNA repair integrity."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;CELL CYCLE DISTRIBUTION">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"UBE2T expression in RA2627 fibroblasts resulted in an appropriate cell cycle distribution comparable to that of wild type BJ cells."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;OVEREXPRESSION OF UBE2T&quot;">
      <data key="d0">"PROTEIN EXPRESSION MODIFIER"</data>
      <data key="d1">"The process of overexpressing wild type UBE2T into RA2627 fibroblasts was a strategy used to correct the FA-T cellular phenotypes."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;MMC TREATMENT&quot;">
      <data key="d0">"CHEMICAL EXPOSURE"</data>
      <data key="d1">"MMC (Mecobalamin), a crosslinking agent, is one of several chemicals that can induce cellular defects in FA-T fibroblasts due to UBE2T gene deficiency."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;DEB TREATMENT&quot;">
      <data key="d0">"CHEMICAL EXPOSURE"</data>
      <data key="d1">"The chemical DEB (Dioleoyl-DL-biotin) is a mutagenic agent used to study its effects on cellular function in FA-T fibroblasts, which lack functional UBE2T expression."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;CISPLATIN TREATMENT&quot;">
      <data key="d0">"CHEMICAL EXPOSURE"</data>
      <data key="d1">"Cisplatin, another toxic compound known for inducing cellular defects in the absence of proper gene functions like that affecting UBE2T."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;FANCD2 MONOUBIQUITINATION AND DNA REPAIR PROCESS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS MODIFIER"</data>
      <data key="d1">"The restoration of FANCD2 monoubiquitination by UBE2T expression is a key indicator of successful DNA repair processes in FA-T fibroblasts."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;FANCI GENE EXPRESSION&quot;">
      <data key="d0">"PROTEIN INTERACTION PARTNER"</data>
      <data key="d1">"In the context of Fanconi anemia, both FANCI and FANCD2 are involved in monoubiquitination required for DNA repair pathways that can be affected by UBE2T gene expression."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;CELL CYCLE DISTRIBUTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS MODIFIER"</data>
      <data key="d1">"Analysis of cell cycle distribution following MMC treatment revealed an accumulation of cells in G2 phase in FA-T fibroblasts, which was rescued by overexpression of wild type UBE2T."</data>
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
    </node>
    <node id="&quot;ENVIRONMENTAL FACTORS&quot;">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"Exposure to mutagenic agents like MMC and DEB is known to induce FA-T cellular defects, which are rescued by restoration of functional UBE2T expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;UBE2T GENE EXPRESSION AND FUNCTION&quot;">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"Exposure to mutagenic agents like MMC and DEB is known to induce FA-T cellular defects, which are rescued by restoration of functional UBE2T expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FANCD2 MONOUBIQUITINATION AND DNA REPAIR&quot;">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"The normalization of FANCD2 monoubiquitination and foci formation upon UBE2T overexpression is indicative of its critical role in maintaining DNA repair integrity.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 13}]</data>
    </node>
    <node id="&quot;FANCONI ANEMIA T SUBTYPE CAUSE&quot;">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"The cellular defects observed in RA2627 fibroblasts are directly caused by the deficiency of functional UBE2T gene expression, as demonstrated through rescue experiments using wild type UBE2T.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RA2627 FIBROBLASTS">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"The cellular defects observed in RA2627 fibroblasts are directly caused by the deficiency of functional UBE2T gene expression, as demonstrated through rescue experiments using wild type UBE2T.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FANCD2 MONOUBIQUITINATION RESTORED BY UBE2T EXPRESSION&quot;">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"The restoration of FANCD2 monoubiquitination following the overexpression of wild type UBE2T in FA-T fibroblasts is a strong indicator that functional UBE2T gene expression has significant implications for DNA repair processes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MOLECULAR INTERACTION MODIFIER&quot;">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"The restoration of FANCD2 monoubiquitination following the overexpression of wild type UBE2T in FA-T fibroblasts is a strong indicator that functional UBE2T gene expression has significant implications for DNA repair processes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ENVIRONMENTAL FACTOR MMC INDUCES CELLULAR DEFECTS IN FIBROBLASTS LACKING FUNCTIONAL UBE2T GENE&quot;">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"Exposure to mutagenic chemicals like MMC is known to induce FA-T cellular defects, highlighting the critical role of functional UBE2T expression in preventing these genetic deficiencies.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RELATIONSHIP MODIFIER&quot;">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"Exposure to mutagenic chemicals like MMC is known to induce FA-T cellular defects, highlighting the critical role of functional UBE2T expression in preventing these genetic deficiencies.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FANCD2 FOCI FORMATION AND DNA REPAIR PROCESS CORRELATED WITH UBE2T GENE EXPRESSION&quot;">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"The restoration of FANCD2 foci formation upon overexpression of wild type UBE2T in FA-T fibroblasts is a strong indicator that functional UBE2T gene expression plays a key role in maintaining DNA repair processes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OVEREXPRESSION OF UBE2T CORRECTS CELLULAR PHENOTYPES IN FIBROBLASTS LACKING FUNCTIONAL GENE&quot;">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"The process of overexpressing wild type UBE2T into FA-T fibroblasts effectively rescues cellular phenotypes, supporting the hypothesis that functional UBE2T gene expression is critical for normal cellular function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PROTEIN EXPRESSION MODIFIER&quot;">
      <data key="d2">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d1">"The process of overexpressing wild type UBE2T into FA-T fibroblasts effectively rescues cellular phenotypes, supporting the hypothesis that functional UBE2T gene expression is critical for normal cellular function.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AFFYMETRIX GENECHIP HUMAN GENOME U133A 2.0 ARRAYS&quot;">
      <data key="d0">"PRODUCT"</data>
      <data key="d1">"The Affymetrix GeneChip Human Genome U133A 2.0 Arrays are used for gene expression profiling and screening of transcripts including genes."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;DERMAL FIBROBLASTS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Dermal fibroblasts are skin cells that were analyzed in this study to understand gene expression patterns related to disease states."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;MUTATION P.ARG62TRP AND MUTATION P.ARG101HIS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The mutations p.Arg62Trp and p.Arg101His are examples of missense mutations identified in RPS19 that affect gene function."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;MUTATION C.58DELG AND MUTATION C.1-1G&gt;A&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The mutations c.58delG and c.1-1G&gt;A are examples of genomic variants in RPS19 that affect gene function."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;MUTATION C.DEL58G">
      <data key="d0">"MUTATIONAL STATUS"</data>
      <data key="d1">"Mutation c.del58G is a frameshift mutation expected to cause exon 2 skipping and potential NMD pathway activation."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;MUTATION C.1-1G&gt;A&quot;">
      <data key="d0">"MUTATIONAL STATUS"</data>
      <data key="d1">"Mutation c.1-1G&gt;A affects an intron 1 acceptor splice site, leading to exon 2 skipping and expected reduced RPS19 expression."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;INGENUITY PATHWAYS ANALYSIS&quot;">
      <data key="d0">"PRODUCT"</data>
      <data key="d1">"Ingenuity Pathways Analysis is used for detecting biological processes and molecular functions in differentially expressed genes related to DBA patients."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;AMINOACYL-TRNA BIOSYNTHESIS, GLYCINE, SERINE, THREONINE METABOLISM, DEATH RECEPTOR SIGNALING, INTERFERON INDUCTION, ANTIVIRAL RESPONSE&quot;">
      <data key="d0">"PATHWAY"</data>
      <data key="d1">"These pathways are statistically significantly enriched in the differentially expressed genes found in DBA patients compared to controls."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;RP GENES&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"RP genes such as RPL22, RPL27A, and RPS3 play a role in protein synthesis processes."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;CELL DEATH, CELLULAR DEVELOPMENT, LIPID METABOLISM, MOLECULAR TRANSPORT&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Genes involved in these functions are identified through molecular function enrichment analysis of the differentially expressed genes.") ("entity"</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;HYPERSENSITIVITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Hypersensitivity refers to a heightened immune response that can lead to inflammation or other adverse reactions in individuals."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;HAPLOINSUFFICIENCY THEORY&quot;">
      <data key="d0">"CONCEPT"</data>
      <data key="d1">"The haploinsufficiency theory is proposed for the pathogenesis of Diamond-Blackfan anemia (DBA), where reduced function of RPS19 leads to impaired cell growth and development."</data>
      <data key="d2">chunk-34ffb077c584b98555081f882f8f8b94</data>
    </node>
    <node id="&quot;RP GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">1</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL22&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">2</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL27A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">3</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL29&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">4</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL31&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">5</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL14&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">6</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL18A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">7</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPS3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">8</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL18&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">9</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL13&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">10</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">11</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL34&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">12</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPS2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">13</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPS12&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">14</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL15&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">15</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RPL28&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">16</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;CLUSTER RELATED TO TOP BIO FUNCTIONS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">20</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 14}, {"level": 2, "cluster": 16}]</data>
    </node>
    <node id="&quot;CLUSTER RELATED TO DISEASES AND DISORDERS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">21</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 10}]</data>
    </node>
    <node id="&quot;CANCER RELATED GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">22</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;HAEMATOLOGICAL DISORDER GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">23</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;IMMUNOLOGICAL DISORDER GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">24</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;RENAL DISORDER GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">25</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;SKELETAL DISORDER GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">26</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;DEVELOPMENTAL TISSUE GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">29</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;EMBRYONIC TISSUE GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">30</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;SKELETAL TISSUE GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">31</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;CONNECTIVE TISSUE GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">32</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;SKELETAL DEVELOPMENT GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">38</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;CONNECTIVE TISSUE DEVELOPMENT GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">39</data>
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
    </node>
    <node id="&quot;CELL DEATH&quot;">
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d1">"Clusters of RP genes are related to cell death and cellular development.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LIPID METABOLISM&quot;">
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d1">"Clusters of RP genes are involved in lipid metabolism.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MOLECULAR TRANSPORT&quot;">
      <data key="d2">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d1">"Clusters of RP genes contribute to molecular transport.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ADALIMUMAB&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Adalimumab is a biological therapy used for managing autoimmune conditions such as paradoxical psoriasis.")&lt;SEP&gt;"Adalimumab is a treatment for paradoxical psoriasis regressed when it was discontinued.")</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;PARADOXICAL PSORIASIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Paradoxical psoriasis is a condition where patients develop severe HS and paradoxical psoriasiform reactions following treatment with adalimumab.")</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;HYDROCORTISONE PROGESTERONE RECEPTOR MODULATOR&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Hydrocortisone, as part of the body's response to inflammation, may play a role in paradoxical psoriasis regressed when adalimumab was discontinued.")</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;HS SEVERE HYPERHIDROSIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"HS, also known as severe hyperhidrosis, is characterized by erythematous-pustular lesions and a Hurley III condition in paradoxical psoriasiform reactions.")</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;ANTI-TNFΑ BIOTHERAPY&quot;">
      <data key="d0">"DRUG THERAPY"</data>
      <data key="d1">"Adalimumab is an anti-TNFα biological therapy used to manage autoimmune conditions like paradoxical psoriasis.")</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;SARTORIUS SCORE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The Sartorius score measures the severity of HS and provides a clinical assessment for paradoxical psoriasiform reactions treated with adalimumab.")</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;SKIN BIOPSY EXCISION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Patient 3 refused to undergo skin biopsy, precluding histological analyses for further understanding of the pathogenesis of paradoxical psoriasis regressed when adalimumab was discontinued.")</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;T-LYMPHOCYTES CD3+ NEUTROPHILS MAST CELLS MONOCYTES MACROPHAGES&quot;">
      <data key="d0">"INFLAMMATION AND PARADOXICAL PSORIASIFORM REACTIONS"</data>
      <data key="d1">"Characterization of leukocyte subpopulations, including T-lymphocytes, neutrophils, mast cells, monocytes, and macrophages in paradoxical psoriasiform reactions highlights differences compared to classical plaque-type psoriasis.")</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;IL-17A IL-22 IFN-Γ&quot;">
      <data key="d0">"T-LYMPHOCYTE CYTOKINES INFLAMMATION PARADOXICAL PSORIASIFORM REACTIONS"</data>
      <data key="d1">"The expression of cytokines like IL-17A, IL-22, and IFN-γ in paradoxical psoriasiform reactions suggests a complex interplay between immune cells contributing to this condition.")</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;BDCA2+ PLASMACYTOID DENDRITIC CELLS (PDCS)&quot;">
      <data key="d0">"LEUKOCYTE SUBPOPULATIONS PARADOXICAL PSORIASIFORM REACTIONS"</data>
      <data key="d1">"Paradoxical psoriasis exhibited a prominent infiltrate of BDCA2+ pDCs in the dermis, significantly more abundant than in classical psoriasis (~2.7‐fold increase).")</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;T-LYMPHOCYTES CD3+&quot;">
      <data key="d0">"CD8+" NEUTROPHILS MAST CELLS MONOCYTES MACROPHAGES"</data>
      <data key="d1">"Leukocyte Subpopulations Paradoxical Psoriasiform Reactions"</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;HYDROCORTISONE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Hydrocortisone may play a role in paradoxical psoriasis regressed when adalimumab was discontinued, contributing to inflammation and immune response observed in this condition.")</data>
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
    </node>
    <node id="&quot;CCHCR1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">1)("entity"</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;RS130079&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"Another SNP identified as rs130079 is associated with genetic variation in CCHCR1."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;RS746647&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"A third SNP, rs746647, has also been detected within the CCHCR1 gene region."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;IL23R&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">2)("entity"</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;RS72676067&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"Another SNP detected in IL23R is rs72676067."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;RS1004819&quot;">
      <data key="d0">"SNP"</data>
      <data key="d1">"A third SNP identified in the IL23R gene region, rs1004819."</data>
      <data key="d2">chunk-72f4505e43f67f3564607392cb178656</data>
    </node>
    <node id="&quot;NEUTROPHILS INFLAMMATORY CYTOKINE IL-36Γ&quot;">
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d1">"IL-36γ positivity was enhanced in dermis of patients with paradoxical psoriasis compared to classical plaque-type psoriasis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PARADOXICAL PSORIASIFORM REACTIONS&quot;">
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d1">"IL-36γ positivity was enhanced in dermis of patients with paradoxical psoriasis compared to classical plaque-type psoriasis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T-CELLS IFN-Γ&quot;">
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d1">"IFN-γ immunoreactivity decreased and IL-22 positivity was significantly augmented in the infiltrate of paradoxical skin reactions compared to classical psoriasis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MACROPHAGES CD15+ NEUTROPHILS&quot;">
      <data key="d2">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d1">"CD15+ neutrophils, c-kit/CD117+ mast cells, and monocytes in dermis of paradoxical skin reactions were significantly increased (~3.8-, 3.5-, and 1.8-fold increase) compared to classical psoriasis.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FANCL GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The predicted human DRWD domain is related to the FANCL gene."&gt;</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;DRWD DOMAIN&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The structure of the DRWD domain reveals insights into a key physiological process in the context of protein folding and regulation."&gt;</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;HUMAN DRWD DOMAIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The human DRWD domain is composed of residues 109–294, spanning 70 × 25 × 20 Å."&gt;</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;DMFANCL GENE VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A comparison using the DALI server reveals a genomic variant in the DmFANCL gene (PDB code 3K1L) as a structural homologue to the human DRWD domain."&gt;</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;DROSOPHILA UBE2 ENZYME&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"E2 UBC enzymes show significant RWD fold hits only for the C-terminal lobe of the human central domain, indicating a molecular interaction that is structurally conserved between E2 UBC enzymes."&gt;</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;UBE2T CATALYTIC CYSTEINE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The cysteine in the URD β-element lies in the same position as the catalytic cysteine of Ube2T, a nutrient involved in forming thioester bonds for ubiquitination."&gt;</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;HYDROPHOBIC RESIDUES&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Surface hydrophobic residues on the human FANCL domain reveal differences in surface composition that may reflect different dietary patterns or protein requirements in vertebrates and invertebrates."&gt;</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;HUMAN DRWD DOMAIN RESIDUE RANGE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The human DRWD domain is composed of residues spanning from 109 to 294, encompassing a central region within the FANCL gene."&gt;</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;FUSED BILOBAL SHAPE DIMENSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The fused bilobal shape dimension (70 × 25 × 20 Å) of the human DRWD domain represents an aspect of its physiological structure and function in protein folding processes."&gt;</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;ALPHA-HELICES AND BETA-STRANDS COUNT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The composition includes four α-helices and nine β-strands, which contribute to the functional architecture within the human FANCL central domain.")&gt;</data>
      <data key="d2">chunk-6b6599f2e169a7aa2a4822b71605cbc8</data>
    </node>
    <node id="&quot;UBE2T BINDING&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The Ube2T binding interaction between NOS1 and its substrates involves complex formation assessed by size-exclusion chromatography and ITC."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;RING DOMAIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The RING domain is a key component of the NOS1 protein, involved in regulating nitric oxide production through molecular interactions with other proteins such as Ube2T."</data>
      <data key="d2">chunk-e097891654194982dfc0ef87401d3aa9</data>
    </node>
    <node id="&quot;MUTANT L248A/F252A/L254A/I265A&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The mutant L248A/F252A/L254A/I265A disrupts FANCI protein function by affecting its binding to FANCD2."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;MUTANT W212A/L214A&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Another mutation (W212A/L214A) affects the same region of the FANCI protein, but has no impact on binding to FANCD2."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;HYDROPHOBIC PATCHES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The exposed hydrophobic patches on FANCI and other proteins are critical for their function in DNA repair."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;DNA REPAIR PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The entire process of DNA repair is a metabolic pathway that ensures cellular stability by correcting errors in DNA replication."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;DNA DAMAGE RESPONSE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"DNA damage response is a physiological process regulated by genes and proteins like FANCI, affecting cell survival and function."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;CELLULAR RESPONSES&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Cellular responses to DNA damage are influenced by the environment and lifestyle factors such as exposure to carcinogens or radiation."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;FANCD2 BINDING SITE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The binding of FANCI to FANCD2 is a molecular interaction critical for proper functioning in response to DNA damage.") ("entity"</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;FANCD2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FANCD2 is another gene involved in the same pathway of DNA repair and response as FANCI, working together to maintain genomic integrity."</data>
      <data key="d2">chunk-6135f8baf39fe26dcea3d987aa6100ac</data>
    </node>
    <node id="&quot;FGFR4 RS351855&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"FGFR4 rs351855 Gly388Arg is a functional genetic variant associated with differential colesevelam treatment effect on AC t1/2 and GC24."&lt;SEP&gt;"No significant association was found between serum C4 or total stool BA with Fgfr4 rs351855, suggesting dietary patterns are more influential in the physiological processes related to BA synthesis and excretion.")</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070&lt;SEP&gt;chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;COLESEVELAM TREATMENT EFFECT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Colesevelam treatment shows significant effects on drug metabolism in healthy control patients, as assessed by changes in CT (drug concentration time)."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;FGFR4 RS376618&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"FGFR4 rs376618 is a non-significant SNP that does not affect differential treatment effects."&lt;SEP&gt;"No significant association of serum C4 or total stool BA with Fgfr4 rs376618 tested, suggesting dietary patterns are more influential in the physiological processes related to BA synthesis and excretion.")</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070&lt;SEP&gt;chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;AC T1/2&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"AC t1/2 (area under the curve) measures drug concentration time and significance in colesevelam treatment outcomes."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;GC24&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"GC24 measures changes in drug concentration for healthy control patients, indicative of different treatments' effects."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;FGFR4 RS17618244&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"KLB rs4975017 is a functional variant associated with numerical but not statistically significant differential colesevelam treatment effects on AC t1/2 and GC24."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;ARG728GLN&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"KLB Arg728Gln is a molecular interaction related to the differential treatment effect of colesevelam in healthy control patients.") ("entity"</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;FGFR4 GG GENOTYPE GROUP&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"In FGFR4 GG genotype group, there was no significant effect of colesevelam treatment on CT or changes in drug concentration time. "</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;CA/AA KLB GENOTYPE GROUP&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"In CA/AA KLB genotype group, colesevelam compared to placebo was associated with lower GC24 value."</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;CC KLB GENOTYPE GROUP&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"No significant treatment effects were observed in the CC KLB genotype group for either CT or drug concentration time changes. "</data>
      <data key="d2">chunk-5c78814fb7c198ee95071ee5a8462070</data>
    </node>
    <node id="&quot;PARTICIPANT DEMOGRAPHICS&quot;">
      <data key="d0">"PARTICIPANT DEMOGRAPHICS"</data>
      <data key="d1">"The section discusses participant demographics including age, BMI, and estimated daily fat intake across different subgroups of IBS-D, IBS-C, and HV."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;ESTIMATED DAILY FAT INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Daily fat intake during the study period is another demographic factor used to categorize participants and investigate its impact on gastrointestinal symptoms such as IBS-D, IBS-C, and HV."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 14}, {"level": 2, "cluster": 16}]</data>
    </node>
    <node id="&quot;PREVIOUS CHOLECYSTECTOMY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A previous cholecystectomy was recorded in a portion of the study's population which is indicative of their medical history before participating in the study."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;SERUM FGF19&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Serum FGF19 levels were measured as part of assessing the participant's nutritional status and its potential relationship with gastrointestinal health."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;STOOL WEIGHT&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Stool weight was one of the measurements taken in this study to assess digestive function among participants categorized into IBS-D, IBS-C, and HV subgroups."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;FASTING SERUM FGF19 LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"No significant relationship was found between fasting serum FGF19 levels and the subgroups studied which could suggest a potential factor influencing BA synthesis in this population.")</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;STOOL FAT&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Total stool fat levels were measured to assess potential dietary patterns associated with different physiological processes and subgroups of IBS patients. These values varied significantly among the three groups studied.")</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;TOTAL STOOL BA&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"There was a strong correlation between total stool BA levels and both stool weight (rs = 0.737, P &lt; .001), indicating a relationship with dietary patterns contributing to the observed physiological processes.")</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;FGFR4 RS351855, FGFR4 RS376618&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"No significant associations were found between serum C4 or total stool BA with these genetic variants which could indicate other factors influencing the physiological processes studied in this population.")</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;FGFR4 RS1966265, KLB RS17618244&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"These candidate gene polymorphisms were assessed for their relationship with BA synthesis and excretion but showed no significant associations indicating that other factors such as diet might be more influential in this context.")</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;KLB RS17618244&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"No significant associations were found between serum C4 or total stool BA with KLB rs17618244, further emphasizing the influence of diet and other factors on physiological processes.")</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;IBS-C&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Irritable Bowel Syndrome - Constipation (IBS-C) represents another group with symptoms indicative of slow transit. This category shows different patterns in BA synthesis, excretion compared to IBS-D or HV groups."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;HV&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Healthy Volunteers (HV) serve as a control group and represent individuals without the gastrointestinal conditions studied here. Their physiological processes related to BA synthesis might be less influenced by dietary factors leading to different patterns compared to IBS subgroups.</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;FGFR4 RS1966265, FGFR4 RS376618, KLB RS17618244&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"These candidate gene polymorphisms were assessed for their relationship with BA synthesis and excretion among different IBS subgroups. No significant associations found between these genes and serum C4 or total stool BA suggest that dietary patterns are more influential in the physiological processes studied."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;FGFR4 RS1966265, FGFR4 RS376618&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"No significant association was found between serum C4 or total stool BA and FGFR4 rs1966265, FGFR4 rs376618 suggesting that dietary patterns are more influential in the physiological processes related to BA synthesis and excretion among IBS subgroups."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;KLB RS17618244, FGFR4 RS351855&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"No significant association was found between serum C4 or total stool BA and KLB rs17618244, Fgfr4 rs351855 suggesting that dietary patterns are more influential in the physiological processes related to BA synthesis and excretion among IBS subgroups."</data>
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
    </node>
    <node id="&quot;SERUM C4&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"There was a significant association between serum C4 levels and physiological processes affecting IBS subgroups. Higher values were observed in IBS-D compared to IBS-C and HV participants.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 10}]</data>
    </node>
    <node id="&quot;FGFR4 RS1966265&quot;">
      <data key="d2">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d1">"A candidate genetic variant was marginally associated with stool BA, suggesting a potential influence on physiological processes related to BA synthesis and excretion in this population.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 10}]</data>
    </node>
    <node id="&quot;FAAP20&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FAAP20 encodes a 20 kDa protein involved in DNA repair and genomic stability. It interacts with FANCA through its N-terminal region and contains a conserved UBZ domain at its C-terminal extremity.")|&gt;1&lt;SEP&gt;"FAAP20 encodes a 20 kDa protein involved in DNA repair and genomic stability. It interacts with FANCA through its N-terminal region and contains a conserved UBZ domain in its C-terminal extremity.")|&gt;1&lt;SEP&gt;"FAAP20 is a protein with molecular weight of approximately 20 kDa that plays a critical role in DNA repair and maintaining genomic stability.")|&gt;1</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;FANCA&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FAAP20 interacts with FANCA to maintain DNA repair pathways and genomic stability, suggesting their co-regulation in response to environmental factors affecting dietary patterns and nutrients like folate.")|&gt;2&lt;SEP&gt;"FANCA encodes one of the key components involved in DNA damage response pathways, particularly through its interaction with FAAP20 to maintain genome integrity.")|&gt;2&lt;SEP&gt;"FANCA is a gene that encodes for one of the components involved in DNA repair pathways, interacting with FAAP20 to maintain genomic stability.")|&gt;2</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;UBZ DOMAIN&quot;">
      <data key="d0">"PROTEIN FEATURE"</data>
      <data key="d1">"FAAP20 contains a conserved UBZ domain at its C-terminal extremity. This domain is important for protein function and interaction with other proteins involved in DNA repair.")|&gt;3</data>
      <data key="d2">chunk-cc528af98598e1adb4684c0166430cf4</data>
    </node>
    <node id="&quot;ILE44&quot;">
      <data key="d0">"PROTEIN INTERACTION SITE"</data>
      <data key="d1">"Ile44 is a protein interaction site on Ubiquitin, involved in hydrophobic interactions with side chains of Leu8, Ile44 and Val70 as well as the aliphatic portions of Thr66 and His68."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;LEU8&quot;">
      <data key="d0">"PROTEIN RESIDUE"</data>
      <data key="d1">"Leu8 is a protein residue that forms part of the hydrophobic patch on Ubiquitin involved in protein-protein interactions."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;VAL70&quot;">
      <data key="d0">"PROTEIN RESIDUE"</data>
      <data key="d1">"Val70 is another protein residue that contributes to the hydrophobic patch on Ubiquitin, along with Leu8 and Ile44."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;THR66&quot;">
      <data key="d0">"PROTEIN RESIDUE"</data>
      <data key="d1">"Thr66 is an aliphatic portion of a protein residue involved in forming the hydrophobic patch on Ubiquitin."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;HIS68&quot;">
      <data key="d0">"PROTEIN RESIDUE"</data>
      <data key="d1">"His68 is another aliphatic portion of a protein residue that contributes to the hydrophobic patch on Ubiquitin."</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;ARG72&quot;">
      <data key="d0">"LEU171 HYDROGEN BONDING"&lt;/&gt;"'ARG72 IS INVOLVED IN HYDROGEN BONDING WITH LEU171 DURING PROTEIN-PROTEIN INTERACTIONS AT THE ILE44 SITE ON UBIQUITIN.") ("ENTITY"</data>
      <data key="d1">"Gln30"</data>
      <data key="d2">chunk-fa32a208a2f004c10c1b6777c3be13f2</data>
    </node>
    <node id="&quot;NEMO-UBZ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"NEMO-UBZ is a protein that interacts with ubiquitin differently from RAD18-UBZ and WRNIP1-UBZ, involving conserved Pro21-Val22 in the β-loop being replaced by Pro398-Lys399 or Glu636-Lys637 respectively."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;POLΗ-UBZ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Polη-UBZ is another protein that interacts with ubiquitin differently from NEMO-UBZ, involving four Ub-interacting residues being conserved or replaced by equivalent residues in Polη-UBZ."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;FAAP20-UBZ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"FAAP20-UBZ is a protein whose α-helix interacts with ubiquitin, involving conserved Asp164 and Leu167 being replaced by equivalent residues in FAAP20-UBZ."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;UBIQUITIN&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Ubiquitin is a nutrient molecule that interacts with various proteins to regulate cellular processes."</data>
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
    </node>
    <node id="&quot;RAD18-UBZ&quot;">
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d1">"NEMO-UBZ and RAD18-UBZ interact with ubiquitin differently, involving a different mode of interaction compared to WRNIP1-UBZ.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;WRNIP1-UBZ&quot;">
      <data key="d2">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d1">"WRNIP1-RAD18 both proteins interact with ubiquitin differently; RAD18 has residues involved in Ub binding that are different from those in WRNIP1.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CD PATIENTS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"CD Patients" refers to a group of patients suffering from Crohn's disease, which includes symptoms such as chronic diarrhea and abdominal pain."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;HEALTHY CONTROLS&quot;">
      <data key="d0">"INDIVIDUAL"</data>
      <data key="d1">"158 healthy individuals used as a comparison group for the study."&lt;SEP&gt;"A total of 212 healthy controls were also included in the analysis."&lt;SEP&gt;"Healthy controls are individuals without any signs or symptoms of diseases like Crohn's disease."&lt;SEP&gt;"Healthy controls had higher % of predicted FEV1, FVC compared to asthmatic patients."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc&lt;SEP&gt;chunk-6f7ce1c71bd46f223756da44b0d0bb2c&lt;SEP&gt;chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;CONSANGUINEOUS PARENTS&quot;">
      <data key="d0">"FAMILY FACTOR"</data>
      <data key="d1">"Consanguineous parents, who share similar genetic backgrounds, can influence the health outcomes in their children."&lt;SEP&gt;"The three siblings were born to consanguineous parents, suggesting a closer genetic relationship between the parents which may have contributed to their shared phenotype of growth failure and health issues."|</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc&lt;SEP&gt;chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;CHRONIC DIARRHEA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Chronic diarrhea is a common symptom seen in CD patients and represents a physiological process of disturbed gastrointestinal function."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;ABDOMINAL PAIN&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Abdominal pain, another common symptom among CD patients, can be attributed to various physiological processes affected by the disease condition."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;ANOREXIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Anorexia is one of several clinical symptoms experienced by individuals with Crohn's disease and could potentially be linked to factors such as inflammation or malabsorption."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;ABDOMINAL DISTENSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Abdominal distension can occur in CD patients due to physiological processes affected by the disease, possibly including gastrointestinal gas accumulation."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;TYPE 1 DIABETES MELLITUS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Among the autoimmune manifestations seen in our patient group, Type 1 diabetes mellitus was present in 32% of participants."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;AUTOIMMUNE THYROIDITIS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"In addition to Type 1 diabetes and Crohn's disease, autoimmune thyroiditis was observed among the non-autoimmune disease manifestations in our study group."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;SYSTEMIC LUPUS ERYTHEMATOSUS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Systemic lupus erythematosus is another autoimmune condition that appeared within this patient group, affecting 3% of participants."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;OSTEOMALACIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Among the non-autoimmune disease manifestations observed in our study, osteomalacia was seen in 5% of participants."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;SEIZURE DISORDERS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A relatively small percentage (4%) of individuals within this patient group experienced seizure disorders as part of their overall health condition."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;DOWN SYNDROME&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Down syndrome is another non-autoimmune disease manifestation observed in the study, affecting 4% of participants."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;GASTROINTESTINAL TRACT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The gastrointestinal tract plays a key role in digesting food and absorbing nutrients. In Crohn's disease, this physiological process can be disrupted leading to various symptoms including diarrhea and pain."</data>
      <data key="d2">chunk-1418daebca32811d9530c70d8e9bf4cc</data>
    </node>
    <node id="&quot;PACLITAXEL-CARBOPLATIN COMBINATION THERAPY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Paclitaxel-carboplatin combination therapy is a form of chemotherapy used in the treatment of ovarian cancer, affecting physiological processes related to drug administration and response.")</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;CARBOPLATIN MONO-THERAPY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Carboplatin mono-therapy refers to the use of carboplatin alone for chemotherapy in treating ovarian cancer, involving similar physiological processes as combination therapy but without paclitaxel.")</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;HEMATOLOGICAL TOXICITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Hematological toxicity is a physiological process that occurs during chemotherapy treatment and can include anemia, thrombocytopenia, and neutropenia.")</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;NEUROTOXICITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Sensory neuropathy is a physiological process associated with the use of certain chemotherapeutic drugs like paclitaxel-carboplatin that can result in neurological symptoms such as sensory neuropathy and febrile neutropenia.")</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;BLOOD EXAMINATIONS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Weekly blood examinations were an environmental factor considered when analyzing hematological toxicity, affecting patient monitoring during chemotherapy treatment cycles.")</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;RESIDUAL DISEASE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Residual disease after debulking surgery is a molecular interaction involving the presence of cancer cells in minimal amounts following surgical treatment, which can be relevant for prognosis and response to chemotherapy.")</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;CAUCASIAN POPULATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Most of the recruited patients were Caucasian, representing a demographic characteristic that can influence study results and outcomes in cancer treatment studies.")</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;PACLITAXEL-CARBOPLATIN COMBINATION THERAPY PATIENTS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The use of paclitaxel-carboplatin combination therapy represents a dietary pattern related to the type of chemotherapy used, which can influence patients' overall health and response during cancer treatment.")</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;CARBOPLATIN MONO-THERAPY PATIENTS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The use of carboplatin mono-therapy refers to a specific dietary pattern associated with the drug carboplatin, used for treating ovarian cancer, which can influence physiological processes in patients undergoing treatment.")</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;HEMATOLOGICAL TOXICITY ELIGIBLE PATIENTS&quot;">
      <data key="d0">"BLOOD EXAMINATIONS"</data>
      <data key="d1">"Eligibility of patients for hematological toxicity analysis involved factors related to blood examinations and their availability during the study period.")</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;SENSORY NEUROPATHY PATIENTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Patients with sensory neuropathy represent a group within the overall population studied, who developed grade 2-3 sensory and none motor neuropathy following combination treatment with paclitaxel-carboplatin.")</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;NEUROTOXICITY ELIGIBLE PATIENTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Patients selected for neurotoxicity analysis represent a subset within the overall population studied, who were eligible based on their lower risk of sensory neuropathy compared to other patients undergoing chemotherapy with paclitaxel-carboplatin.")</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;SECONDARY OBJECTIVES PATIENTS&quot;">
      <data key="d0">"PATIENT CHARACTERISTICS"</data>
      <data key="d1">"Patients included in secondary objectives for PFI (progression-free interval) and OS (overall survival) represent a diverse group of individuals treated with paclitaxel-carboplatin or carboplatin mono-therapy.")</data>
      <data key="d2">chunk-561eacb5d916258d3ed4f08f53587404</data>
    </node>
    <node id="&quot;PLATINUM DRUGS&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Platinum drugs are associated with PFI, which impacts patient outcomes like OS and PFI."</data>
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
    </node>
    <node id="&quot;PFI&quot;">
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d1">"The rs1799793 genomic variant in the ERCC2 gene correlates with PFI.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS1799793 GENOMIC VARIANT&quot;">
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d1">"The rs1799793 genomic variant in the ERCC2 gene correlates with PFI.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ERCC2 PROTEIN&quot;">
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d1">"The ERCC2 protein interacts with genes like ERCC2, influencing PFI and OS.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PLATINUM-FREE INTERVAL (PFI)&quot;">
      <data key="d2">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d1">"The ERCC2 protein interacts with genes like ERCC2, influencing PFI and OS.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CHR3:121233326–127618464&quot;">
      <data key="d0">"CHROMOSOME BAND AND LOCATION IN CHR3:121233326–127618464"</data>
      <data key="d1">1</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;UMPS GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The UMPS gene is associated with the deletion on chromosome 3."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;REFSEQ GENES&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Several RefSeq genes, including UMPS, are part of a genomic region affected by the deletion."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;AGENESIS OF THE CORPUS CALLOSUM&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The deletion does not contain any known genes causing agenesis of the corpus callosum."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;AGENE OF THE CORPUS CALLOSUM GENES&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"No genes that cause agenesis are present in the deleted region, indicating no direct link to this disease."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;SNP ARRAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The SNP array test detected a 6.4 Mb deletion on chromosome 3, which affects multiple metabolic pathways including those involving UMPS and other genes."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;UMPS GENE TESTING VIA SNP ARRAY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"SNP array testing identified heterozygous alterations in the UMPS gene across different individuals."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;HETEROZYGOUS ALTERATIONS IN UMPS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Different variants in UMPS were detected, predicted to lead to premature stop or loss of function due to nonsense-mediated mRNA decay (NMD)."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;PREMATURE STOP CODON IN UMPS VARIANTS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Mutations found in UMPS are expected to truncate the protein prematurely."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;NONSENSE-MEDIATED MRNA DECAY IN UMPS VARIANTS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The c.385G&gt;T mutation is predicted to trigger NMD upon translation, affecting protein function."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;NMD AND PROTEIN FUNCTION PREDICTIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Variants found in UMPS are expected to impact protein conformation based on predictions from multiple software programs."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;PREDICTED PATHOGENIC VARIANTS IN UMPS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The detected variants, including p.Gly129*, p.Arg230*, and others, were predicted to be pathogenic by various analysis tools."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;PATHOGENIC PREDICTIONS FOR UMPS VARIANTS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Mutations affecting UMPS are likely due to dietary factors or genetic predisposition."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;VARIANT C.224C&gt;A (P.PRO75HIS)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The c.224C&gt;A variant was found in individuals from different geographic locations, suggesting environmental exposure influences its occurrence."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;VARIANTS FOUND IN DIFFERENT INDIVIDUALS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Mutations were detected across multiple family members and unrelated individuals, indicating a common genetic mechanism or shared environment."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;VARIANT C.889G&gt;T (P.GLU297*) AND C.310A&gt;G (P.ARG96GLY)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"These variants were found in individuals from different regions, potentially reflecting local dietary patterns or environmental exposures."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;C.889G&gt;T AND C.310A&gt;G VARIANTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Variants affecting the UMPS protein are likely due to environmental factors rather than genetic causes as they were not detected in all individuals tested."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;PROTEIN CONFORMATION EFFECTS OF UMPS VARIANTS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Figure 2 shows how missense mutations alter the conformation and function of the UMPS protein, affecting physiological processes related to brain development.") ("entity"</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;MUTATION TESTER FOR UMPS VARIANTS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Mutant variants found in UMPS are predicted to affect physiological processes by various software tools including MutationTaster, SIFT, and PolyPhen-2."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;COPY NUMBER VARIATIONS EXCLUDED IN UMPS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Exclusion of copy number variations in the UMPS region suggests a role for small variant effects rather than large genomic alterations in phenotypic variability."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;VARIANT C.360A&gt;G (P.LEU120LEU)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The synonymous change c.360A&gt;G was detected, possibly reflecting dietary influences on genetic expression within the UMPS gene region."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;MATERNAL AND PATERNALLY INHERITED VARIANTS IN UMPS GENE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Variants were inherited both maternally and paternally from affected individuals to their offspring, indicating a complex familial pattern of genetic transmission affecting the UMPS gene region."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;UNKNOWN MATERNAL ORIGIN VARIANT IN UMPS GENE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The undocumented variant c.857T&gt;A was detected with an unknown maternal origin, suggesting environmental or other unidentified influences on this particular mutation."</data>
      <data key="d2">chunk-b5a1267b747ee0cf908d98fa3fc26199</data>
    </node>
    <node id="&quot;TGF-Β1 GENE&quot;">
      <data key="d0">"COLORECTAL CANCER RISK"</data>
      <data key="d1">"The TGF-ß1 (rs1800469 C/T) polymorphism was assessed for its potential role in colorectal cancer risk.")</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;INTERLEUKIN-10 GENE&quot;">
      <data key="d0">"COLORECTAL CANCER RISK"</data>
      <data key="d1">"The rs1800896 A/G polymorphism in the IL-10 gene was studied to assess CRC susceptibility among patients and controls.")</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;INTERLEUKIN-27 GENE&quot;">
      <data key="d0">"COLORECTAL CANCER RISK"</data>
      <data key="d1">"The IL-27 (rs17855750 T/G) polymorphism was analyzed for its potential impact on colorectal cancer risk among patients and controls.")</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;TRANSFORMING GROWTH FACTOR-Β1 GENE&quot;">
      <data key="d0">"COLORECTAL CANCER RISK"</data>
      <data key="d1">"The TGFß1 (rs1800469 C/T) polymorphism was studied to assess its potential influence on CRC susceptibility in a Saudi population.")</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;INTERLEUKIN-8 POLYMORPHISM&quot;">
      <data key="d0">"RS4073 T/A"</data>
      <data key="d1">"The IL-8 gene polymorphism rs4073 T/A was studied to assess its association with CRC susceptibility.")</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;TRANSFORMING GROWTH FACTOR-Β1 POLYMORPHISM&quot;">
      <data key="d0">"RS1800469 C/T"</data>
      <data key="d1">"The TGFß1 (rs1800469 C/T) polymorphism was assessed for its potential role in colorectal cancer risk.")</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;INTERLEUKIN-10 POLYMORPHISM&quot;">
      <data key="d0">"RS1800896 A/G"</data>
      <data key="d1">"The rs1800896 A/G polymorphism in the IL-10 gene was studied to assess CRC susceptibility among patients and controls.")</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;INTERLEUKIN-22 POLYMORPHISMS&quot;">
      <data key="d0">"RS1179251 C/G AND RS2227485 C/T"</data>
      <data key="d1">"Two IL-22 polymorphisms rs1179251 C/G and rs2227485 C/T were studied to assess their potential association with CRC susceptibility among Saudi patients.")</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;INTERLEUKIN-27 POLYMORPHISM&quot;">
      <data key="d0">"RS17855750 T/G"</data>
      <data key="d1">"The IL-27 (rs17855750 T/G) polymorphism was analyzed for its potential impact on colorectal cancer risk among patients and controls.")</data>
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
    </node>
    <node id="&quot;T ALLELE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The T allele, present in the control group compared to CRC patients, may be linked to a higher risk or protective effect against CRC."&lt;SEP&gt;"The T allele, present in the control group compared to CRC patients, was observed but did not reach significance in this study."</data>
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27</data>
    </node>
    <node id="&quot;COLORECTAL CANCER (CRC)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Colorectal cancer is an entity associated with specific genetic variants like the CC genotype and gene-specific alleles such as T allele."</data>
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27</data>
    </node>
    <node id="&quot;CRC PATIENTS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"CRC patients may exhibit specific dietary patterns that differ from the control group, potentially influenced by genetic factors such as the presence of the T allele."</data>
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27</data>
    </node>
    <node id="&quot;P=0.009&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The significant p value (p=0.009) indicates a strong association between CC genotype and CRC occurrence, suggesting an important physiological process in cancer development."</data>
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27</data>
    </node>
    <node id="&quot;OR=0.68&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The Odds Ratio of 0.68 for the T allele suggests a protective effect against CRC that may be related to specific metabolic pathways or gene regulatory processes."</data>
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27</data>
    </node>
    <node id="&quot;GENOTYPING TESTS&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Laboratory techniques such as genotyping tests are used in medical research and personalized medicine to identify genetic variants like CC and T alleles, which can guide therapeutic decisions."</data>
      <data key="d2">chunk-5b0cc96debf110f3544685d3b227ff27</data>
    </node>
    <node id="&quot;COLORECTAL CANCER RISK&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"The IL-8 gene polymorphism rs4073 T/A was studied to assess its association with CRC susceptibility.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERLEUKIN-8 GENE&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"The IL-8 gene polymorphism rs4073 T/A was studied to assess its association with CRC susceptibility.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INTERLEUKIN-22 GENE&quot;">
      <data key="d2">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d1">"Two IL-22 polymorphisms rs1179251 C/G and rs2227485 C/T were studied to assess their potential association with CRC susceptibility among Saudi patients.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASTHMATIC PATIENTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A total of 387 asthmatic patients were included in the analysis."&lt;SEP&gt;"Adjusting for population stratification resulted in similar results to the PCA method."&lt;SEP&gt;"Asthmatic patients had a significantly higher BMI than healthy controls."&lt;SEP&gt;"Asthmatic patients had a significantly higher total IgE than healthy controls."&lt;SEP&gt;"Asthmatic patients had reduced % of predicted FEV1, FVC and FEV1/FVC compared to healthy controls."&lt;SEP&gt;"More asthmatic patients were atopic compared to healthy controls."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;ASTHMA RISK FACTOR&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The average BMI of asthmatic patients was significantly higher than that of healthy controls."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;TSLP GENE VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"No significant association was found between TSLP SNPs and asthma susceptibility in never-smokers."&lt;SEP&gt;"SNP rs1898671"Positive association between SNP rs1898671 and asthma susceptibility in ex-smokers")&lt;SEP&gt;"TSLP SNPs are associated with asthma susceptibility, influencing physiological processes like lung function and immune responses."</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;HEALTHCARE COHORT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The analysis involved a large healthcare cohort combining 6 cohorts with 1716 asthma cases and 16888 controls."&lt;SEP&gt;"The analysis involved a large healthcare cohort combining 6 cohorts with 1716 asthma cases and 16888 controls.") ("entity"</data>
      <data key="d2">chunk-6f7ce1c71bd46f223756da44b0d0bb2c</data>
    </node>
    <node id="&quot;MAP INFECTION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Detection of MAP IS900 DNA in subjects is correlated with susceptibility to MAP infection, indicating environmental factors influence disease risk.") ("entity"</data>
      <data key="d2">chunk-6cb127717713bd0ab5be9436fc0c7568</data>
    </node>
    <node id="&quot;PTPN2/22&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"PTPN2/22 is a protein involved in immune response and may be expressed at different levels depending on MAPbacteremia presence.")</data>
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;MAPBACTEREMIA&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"MAPbacteremia is an environmental factor that affects PTPN2/22 gene expression, as indicated by the correlation with genetic variants in PTPN2 and PTPN22 genes.")</data>
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;PTPN2:RS478582&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP in PTPN2:rs478582 was present in 3 out of the 5 CD subjects, associated with higher expression of IFN-γ."&lt;SEP&gt;"A specific genomic variant (TC or CC alleles) in the PTPN2 gene is associated with increased MAPbacteremia presence and higher expression of IFN-γ.")</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;PTPN22:RS2476601&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP in PTPN22:rs2476601 was present in all 5 tested CD subjects, also associated with higher expression of IFN-γ."&lt;SEP&gt;"A specific genomic variant (GA alleles in PTPN22) is linked to MAPbacteremia presence and lower expression of IFN-γ.")</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0&lt;SEP&gt;chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;HAPLOTYPE COMBINATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The combination of SNPs at PTPN2:rs478582 and PTPN22:rs2476601 affects the molecular interaction between PTPN2/22 protein expression and IFN-γ gene activity.")</data>
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;COHORT DIFFERENCES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"There is a significant cohort difference in MAPbacteremia presence, influencing PTPN2/22 and IFN-γ relative gene expressions among CD subjects compared to healthy controls.")</data>
      <data key="d2">chunk-6a657cd0a000b6df4db8f1305b795021</data>
    </node>
    <node id="&quot;CD SUBJECTS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Subjects with Crohn's disease (CD) show a higher expression of genes like IFN-γ when compared to healthy controls.")&gt; "The functional response in T-cells from CD subjects, particularly those carrying specific SNPs in PTPN2:rs478582 and PTPN22:rs2476601, indicates a potential link between genetic variants and disease susceptibility."&lt;SEP&gt;"Subjects with Crohn's disease (CD) show altered T-cell functionality compared to healthy controls.")&gt; ("relationship"</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;PHA&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"PHA (phorbol myristate acetate) is a mitogen used to stimulate T-cells and plays a crucial role in immune responses as indicated by the observed differences in proliferation response.")&gt; ("relationship"&lt;SEP&gt;"The T-cell proliferation response to PHA is higher in CD subjects when compared to healthy controls.")&gt; ("relationship"</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;MAP PPD-LIKE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The response to MAP PPD-like also differs significantly between CD subjects and healthy controls.")&gt; ("relationship"</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;HEALTHY CONTROL SUBJECTS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The absence of SNPs in healthy control subjects suggests that these genetic factors may be linked to environmental exposures or disease states."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;CD SUBJECTS WITH MAPBACTEREMIA &amp; HETEROZYGOUS (GA) OR MINOR (CC) ALLELES IN PTPN22:RS2476601&quot;">
      <data key="d0">"T-CELL PROLIFERATION RESPONSE"</data>
      <data key="d1">"The interaction between genetic variants and environmental factors such as bacteremia is further highlighted by the observed differences among CD subjects."</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;CD SUBJECTS WITHOUT MAPBACTEREMIA &amp; PTPN22:RS2476601&quot;">
      <data key="d0">"T-CELL PROLIFERATION RESPONSE"</data>
      <data key="d1">"These findings suggest that environmental and genetic factors together modulate T-cell functionality in individuals with Crohn's disease.")&gt; ("relationship"</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;HEALTHY CONTROLS WITHOUT SNPS IN PTPN2:RS478582 &amp; PTPN22:RS2476601&quot;">
      <data key="d0">"THE ABSENCE OF SPECIFIC GENETIC VARIANTS IN HEALTHY CONTROLS SUGGESTS THAT THESE FACTORS MAY BE SIGNIFICANT PREDICTORS OF DISEASE SUSCEPTIBILITY AND IMMUNE RESPONSE.")&gt; ("RELATIONSHIP"</data>
      <data key="d1">"Healthy Controls Without SNPs In PTPN2:rs478582 &amp; PTPN22:rs2476601"</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;MAPBACTEREMIA PRESENCE IN CD SUBJECTS TREATED WITH PHA&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The presence of bacteremia is an environmental factor that influences T-cell response when compared to the absence of such exposure.")&gt; ("relationship"</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;MAPBACTEREMIA PRESENCE IN CD SUBJECTS WITHOUT PHA&quot;&amp;&quot;DIETARY PATTERN&quot;">
      <data key="d0">"THE ABSENCE OF BACTEREMIA IN SOME CD SUBJECTS SUGGESTS THAT OTHER DIETARY OR ENVIRONMENTAL EXPOSURES MAY ALSO INFLUENCE T-CELL RESPONSES.") ("ENTITY"</data>
      <data key="d1">"IFN-γ"</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;MAPBACTEREMIA PRESENCE IN CD SUBJECTS TREATED WITH PHA&quot;&amp;&quot;DIETARY PATTERN&quot;">
      <data key="d0">"THE PRESENCE OF BACTEREMIA, AN ENVIRONMENTAL FACTOR, LIKELY INTERACTS WITH DIETARY PATTERNS TO INFLUENCE T-CELL RESPONSES IN INDIVIDUALS WITH CROHN’S DISEASE.")&gt; ("RELATIONSHIP"</data>
      <data key="d1">"T-Cell Proliferation Response To PHA &amp; MAP PPD-like In CD Subjects Treated With PHA"&amp;"Physical Activity"</data>
      <data key="d2">chunk-883c371ea1f500a1ba8af8366328e8b0</data>
    </node>
    <node id="&quot;C-G AND C-A HAPLOTYPES&quot;|">
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d1">"These haplotypes were found more significantly in CD compared to healthy controls, suggesting an influence of genetic factors on PTPN2/22 expression within the disease context."|&gt;8) ("relationship"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HAPLOTYPE COMBINATIONS&quot;">
      <data key="d2">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d1">"These haplotypes were found more significantly in CD compared to healthy controls, suggesting an influence of genetic factors on PTPN2/22 expression within the disease context."|&gt;8) ("relationship"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PTPN22&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"PTPN22 is a gene that has been studied for its role in modulating T cell function and signaling pathways.")&gt;1</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;LYP-620R&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Expression of LYP-620R influences T cell proliferation and cytokine production.")&lt;SEP&gt;"The non-risk allele of PTPN22 encodes for the LYP-620R variant, which is associated with a reduced risk for Type 1 Diabetes in certain human populations.")&gt;3</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7&lt;SEP&gt;chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;CD4+ T CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"CD4+ T cells are a subset of white blood cells that play a critical role in the immune response and have been studied extensively for their genetic variations related to disease risk.")&gt;4&lt;SEP&gt;"CD4+ T cells are a type of T cell found in the immune system, involved in regulating inflammatory responses and other aspects of immunity."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca&lt;SEP&gt;chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;T1D NON-RISK ALLELE&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"The non-risk allele of PTPN22 is associated with reduced Type 1 Diabetes risk, as it encodes a variant that might influence signaling pathways in a way that reduces disease susceptibility.")&gt;5</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;CD4+ T CELLS SORTING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The sorting and isolation of CD4+ T cells into specific subsets allows for the study of gene expression variation within these distinct cellular populations, aiding in understanding genetic influences on immune cell function.")&gt;6&lt;SEP&gt;"The sorting of CD4+ T cells into subsets such as naïve, memory, and regulatory cells allows for a deeper analysis of gene expression patterns under different physiological conditions.")&gt;2. ("entity"</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;NAÏVE VS. MEMORY TCONV EXPRESSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Naïve T cells express less PTPN22 than memory T cells and T regulatory cells (Tregs), indicating a baseline difference in gene expression profiles that can be influenced by various cellular states.")&gt;7</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;PTPN22 EXPRESSION POLYCLONAL ACTIVATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Upon polyclonal activation, all three subsets of CD4+ T cells (naïve, memory, and regulatory) rapidly increase PTPN22 expression, suggesting a response to cellular stimuli that affects gene expression patterns.")&gt;8</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;PTPN22 OVEREXPRESSION&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The study involved the overexpression of the non-risk LYP-620R variant of PTPN22 in T cells, which altered signaling pathways related to calcium flux and MAPK/ERK activation.")&gt;9</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;CA2+ FLUX MODULATION BY PTPN22&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Overexpression of the non-risk LYP-620R variant in T cells resulted in decreased Ca2+ flux, indicating an alteration in cellular signaling pathways influenced by the genetic variation within this gene.")&gt;10</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;MAPK/ERK PATHWAY MODULATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The study also examined the impact of PTPN22 variants on the MAPK/ERK pathway, showing a similar effect where overexpression of LYP-620R led to decreased signaling compared to mock transfected cells.")&gt;11</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;TCR SIGNALING PATHWAYS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The study investigated the functional impact of PTPN22 variants on T cell activation and signaling pathways, including proximal events following TCR ligation such as assembly of LAT signalosome and divergent downstream signaling.")&gt;12</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;SURFACE MARKER EXPRESSION MODULATION BY PTPN22 VARIANTS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The study also explored the impact of LYP variants on surface marker expression, including dynamic changes in activation markers such as CD69, ICOS, and PD-1 over time post TCR ligation.")&gt;13</data>
      <data key="d2">chunk-daf8d8b6d90cc3f92b645357f7c1294b</data>
    </node>
    <node id="&quot;CD69&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CD69 is a protein dynamically expressed following Tconv activation.")</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;ICOS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"ICOS is a protein dynamically expressed following Tconv activation.")</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;CD25&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"CD25 is a protein dynamically expressed following Tconv activation.")</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;PD-1&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"PD-1 is a protein dynamically expressed following Tconv activation.")</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;TREGS&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of the Tregs, including CD69, ICOS, CD226, and CTLA-4, shows activation-induced expression kinetics.")</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;CA2+&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Calcium ions are involved in TCR signaling and modulate cell activation responses.")</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;PERK&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"pERK is a metabolic pathway that influences T cell activation markers like CD69, ICOS, and CD25.")</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;APCS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"APCs are involved in modulating T cell proliferation and cytokine production through antigen presentation and signaling interactions.")</data>
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
    </node>
    <node id="&quot;LYP VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The study discusses two variants of the LY6 family member (LYP) gene, specifically LYP variant and LYP-620W."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;IFNΓ&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Involved in immune response and inflammation, IFNγ secretion was not altered by overexpression of either LYP variant."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;TREG SUPPRESSIVE CAPACITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The study assessed the effect of PTPN22 gene on Treg-mediated suppression, suggesting alterations in suppressive capacity when comparing transduced vs. mock-transduced internal control Tconv cells."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;PTPN22 RS2476601 RISK VARIANT&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The PTPN22 risk variant is implicated in several autoimmune disorders and may influence disease risk by altering suppressive capacity of Treg."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;IRRADIATED AUTOLOGOUS APCS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Irradiated autologous antigen presenting cells (APCs) are used in co-cultures with sorted transduced eGFP+ Tregs for assessing suppressive capacity and impact of LYP variants on Treg:Tconv interactions."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;SUPPRESSIVE CAPACITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Suppression refers to the ability of regulatory T cells (Tregs) to inhibit activation, proliferation, and effector mechanisms in other immune cells such as conventional T cells (Tconv)."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;EGFP REPORTER CONTROL CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Internal control cells used for comparison with transduced eGFP+ Tregs in suppression assays; these are mock-transduced internal controls without any gene overexpression."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;SUPPRESSIVE ASSAY CO-CULTURE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Suppression assay co-culture involves irradiated autologous APCs and titered amounts of Tregs being assessed for their suppressive capacity against untransduced (internal control) Tconv cells."</data>
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
    </node>
    <node id="&quot;CD226&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"The dynamics of CD226 surface expression on Tregs wanes before increasing to a level higher than baseline.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 14}, {"level": 2, "cluster": 16}]</data>
    </node>
    <node id="&quot;LYP-620W&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"The impact of the LYP-620W variant on Treg but not Tconv proliferation is less pronounced than that observed with the LYP-620R variant.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 14}, {"level": 2, "cluster": 16}]</data>
    </node>
    <node id="&quot;CALCIUM IONS&quot;">
      <data key="d2">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d1">"The role of calcium ions in pERK signaling is critical for modulating TCR-induced activation responses, including expression of surface activation markers like CD69, ICOS, and CD25.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TREG&quot;">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">"Our data suggests that overexpressed PTPN22 gene influences disease risk by altering Treg-mediated suppression of Tconv cells, affecting their suppressive capacity and susceptibility to activation and proliferation.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 10}]</data>
    </node>
    <node id="&quot;TCONV CELLS&quot;">
      <data key="d2">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d1">"The study demonstrates that the PTPN22 risk variant influences disease risk by altering Treg-mediated suppression of untransduced (internal control) Tconv cells, suggesting intrinsic impacts on activation, proliferation mechanisms in Tconv.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;OAS3&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"OAS3 is a genomic variant that expresses TAG72 at a lower level compared to OAS4 and OAS7 after 72 h in culture."&lt;SEP&gt;"The expression of TAG72 in OAS3 changes over time, decreasing after 72 h in cell culture conditions."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;OAS4&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"CAR T cells specifically interact with and kill OAS4 cells due to the presence of specific receptors."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;TAG72-BBΖ CAR T CELLS&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"TAG72-BBζ CAR T cells are designed for their cytolytic activity against TAG72-positive cancer cells like OAS4 and OAS7."&lt;SEP&gt;"TAG72-BBζ CAR T cells are designed for their cytolytic activity against TAG72-positive cancer cells, like those expressed by OAS4 and OAS7."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;OVCAR3&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"OVCAR3 is a tumor model used in experiments to study the effects of regional vs. systemic delivery of CAR T cells."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;REGIONAL INTRAPERITONEAL DELIVERY&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Regional intraperitoneal delivery of CAR T cells showed potent anti-tumor activity and extended survival in mice, demonstrating its potential as a therapeutic approach."</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;IN VIVO&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The study evaluated the cytolytic activity of CAR T cells after 72 h of co-culture with patient primary ovarian cancer ascites, highlighting their role in anti-tumor responses.") ("entity"</data>
      <data key="d2">chunk-183db5c908df609bb5289896b4ba09d0</data>
    </node>
    <node id="&quot;TAG72-CAR T CELLS&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"TAG72-CAR T cells are proteins involved in anti-tumor responses against ovarian cancer."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;REPEAT DOSING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Repeat dosing of CAR T cells improves therapeutic responses over single dose treatment."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;OVARIAN CANCER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Ovarian cancer is a disease with multiple resistance mechanisms against CAR T cell therapy, including antigen escape."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;TUMOR ANTIGEN HETEROGENEITY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Tumor antigen heterogeneity in solid tumors promotes eventual antigen loss or escape from CAR T cell therapy."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;CAR T CELLS&quot;">
      <data key="d0">"MOLECULE INTERACTION"</data>
      <data key="d1">"CAR T cells interact with tumor antigens and other immune system components to target cancer cells."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;TUMOR RECURRENCES&quot;">
      <data key="d0">"DISEASE PROGRESSION"</data>
      <data key="d1">"Antigen escape contributes to tumor recurrences following CAR T cell therapy in solid tumors."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;OVCAR8, OVCAR3, AND OV90 CELLS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These cells represent genomic variants identified as potential targets in ovarian cancer research."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;MUC1&quot;, &quot;MUC16&quot;, AND TAG72&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Expression of these cell surface antigens on different tumor cells suggests a complex interaction with various nutrients or dietary factors relevant to ovarian cancer treatment."</data>
      <data key="d2">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
    </node>
    <node id="&quot;HUTTERITES&quot;">
      <data key="d0">"POPULATION"</data>
      <data key="d1">1</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;FEMALE PARTICIPANTS&quot;">
      <data key="d0">"GENDER SUBSET"</data>
      <data key="d1">3</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;FEV1/FVC&quot;">
      <data key="d0">"PHENOTYPE OF INTEREST"</data>
      <data key="d1">5</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;HERITABILITY ESTIMATES&quot;">
      <data key="d0">"LUNG FUNCTION MEASURE CONTRIBUTIONS TO PHENOTYPIC VARIANCE IN HUTTERITES"</data>
      <data key="d1">6</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;CHROMOSOME 15Q23">
      <data key="d0">"GENOMIC VARIANT OR GENE LOCATION"</data>
      <data key="d1">7</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;SNPS AT THSD4-UACA-TLE3 LOCUS&quot;">
      <data key="d0">"GENETIC VARIANT THAT IS ASSOCIATED WITH LUNG FUNCTION MEASURES IN HUTTERITES AND REPLICATED FROM PREVIOUS STUDIES"</data>
      <data key="d1">9</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;RS12441227&quot;">
      <data key="d0">"SNP IDENTIFIED WITH HIGHEST ASSOCIATION TO FEV1/FVC IN HUTTERITES AND ITS EFFECT ON LUNG FUNCTION MEASURES EXPRESSED AS PERCENTAGE OF VARIANCE EXPLAINED BY THIS SNP"</data>
      <data key="d1">11</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;SNPS AT C10ORF11 LOCUS&quot;">
      <data key="d0">"ADDITIONAL SIGNIFICANT GENETIC VARIANTS ASSOCIATED WITH FEV1 MEASURED EXCLUSIVELY IN NON-ASTHMATICS WITHIN THE POPULATION"</data>
      <data key="d1">13</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;SNPS AT CCL23-CCL18, PITPNC1, CHAF1B LOCI">
      <data key="d0">"ADDITIONAL SIGNIFICANT GENETIC VARIANTS IDENTIFIED WITH STRONG EVIDENCE OF ASSOCIATION BEYOND ASTHMATICS AND STRATIFICATION BY AGE IN SUBSETS ANALYSES ON OTHER PHENOTYPES WITHIN HUTTERITES POPULATION"</data>
      <data key="d1">15</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;SNPS AT C10ORF11, CCL23-CCL18, PITPNC1, CHAF1B LOCI">
      <data key="d0">"ADDITIONAL GENETIC VARIANTS ASSOCIATED WITH LUNG FUNCTION MEASURES IN SUBSETS ANALYSES EXCLUDING ASTHMATICS AND STRATIFIED BY AGE WITHIN THE HUTTERITES POPULATION"</data>
      <data key="d1">16</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;PREDICTIVE SNPS SELECTED FROM LASSO REGRESSION">
      <data key="d0">"80 SNP SET YIELDING BEST PREDICTIVE VALUE IN RESIDUAL FEV1/FCV FOR HUTTERITES AND USED FOR FURTHER STUDY"</data>
      <data key="d1">18</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;MEAN RESIDUAL FEV1/FVC FOR EACH BIN OF LOW FEV1/FVC ALLELES IDENTIFIED USING GRAIL ALGORITHM TO ANALYZE FUNCTIONAL CONNECTIONS BETWEEN GENES NEAR PREDICTIVE SNPS&quot;">
      <data key="d0">20) ("ENTITY"</data>
      <data key="d1">"GWAS Phenotypes of Interest for Research within Hutterites Population"</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;SPIROMETRY PHENOTYPES">
      <data key="d0">"USED IN DETERMINING LUNG FUNCTION MEASURES INCLUDED IN GENETIC ASSOCIATION STUDIES WITH GENOME-WIDE GENOTYPING DATA FOR HUTTERITES FROM AGE 6 TO 89 YEARS"</data>
      <data key="d1">3</data>
      <data key="d2">chunk-7cf8f1ee14e4f57553bbe5b4ab0c664a</data>
    </node>
    <node id="&quot;PBMCS&quot;">
      <data key="d0">"SAMPLE TYPE"</data>
      <data key="d1">"Peripheral blood mononuclear cells (PBMCs) represent a diverse group of white blood cells that play crucial roles in immunity, including antigen presentation and cytokine production."&lt;SEP&gt;"Peripheral blood mononuclear cells are used for analyzing T cell responses to neoantigens."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803&lt;SEP&gt;chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;GENOME-WIDE GENE EXPRESSION ANALYSIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Genome-wide gene expression analysis involves measuring the activity levels of all genes within specific cell types to understand their biological functions."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;1000 GENOMES REFERENCE PANEL&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The 1000 Genomes reference panel is a collection of DNA samples used as genetic markers for imputing genomic information across different populations."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;DNA METHYLATION OF CPG SITES&quot;">
      <data key="d0">"EPIGENETIC MODIFICATION"</data>
      <data key="d1">"DNA methylation involves the addition of a methyl group to the carbon 5 position of cytosine, affecting gene expression without changing the DNA sequence."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;TISSUE-BY-TISSUE ANALYSIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A tissue-by-tissue analysis is used to determine how physiological processes vary across different types of tissues and cell populations."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;BAYESIAN MODEL AVERAGING&quot;">
      <data key="d0">"METHODOLOGY"</data>
      <data key="d1">"Bayesian model averaging combines information from various sources, such as gene expression data and genetic variants, to infer relationships between genes and their regulators more accurately."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;HIERARCHICAL MODELLING&quot;">
      <data key="d0">"METHODOLOGY"</data>
      <data key="d1">"Hierarchical modeling is a statistical technique that uses multiple levels of classification for complex datasets, allowing researchers to account for the inter-relations among variables."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;CHI-SQUARE TEST P-VALUE&quot;">
      <data key="d0">"METHODOLOGY"</data>
      <data key="d1">"The chi-square test is used in statistics to compare observed data with expected data: it's a way of testing whether there are deviations from those expected if two criteria were true."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;ANTIGEN PRESENTATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Involves presenting fragments of foreign substances to T-cells during an immune response, aiding in the identification and subsequent destruction of potential threats."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;CYTOKINE PRODUCTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Cytokines are small proteins that play key roles in cell signaling involved in immune responses and host defense against pathogens."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;FIGHTING INFECTIONS AND TUMORS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"CD8+ T cells have a critical role in fighting infections by recognizing and eliminating virus-infected or cancerous cells."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;REGULATORY IMMUNE RESPONSES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"CD4+ T cells are pivotal for regulating immune responses, helping to maintain tolerance towards self-antigens and orchestrate the right balance of inflammatory activity in response to infections."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;T1D (TYPE 1 DIABETES)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"T1D is an autoimmune disease where the body's immune system attacks and destroys the insulin-producing cells in the pancreas, leading to increased blood sugar levels."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;ENDOCRINE AUTOIMMUNE DISEASES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Refers to diseases like T1D that result from dysfunction of the endocrine system wherein the immune system targets its own body’s organs such as the pancreas.</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;REGULATORY T CELLS (TREGS)&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Tregs are a subset of regulatory lymphocytes, known for their role in suppressing potentially harmful or excessive immune responses."</data>
      <data key="d2">chunk-bec60ce5d500ee78c6792a2d92b048ca</data>
    </node>
    <node id="&quot;CTLA4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CTLA4 is a gene that potentially influences expression levels of CD4+ and CD8+ T cells.")</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;VITAMIN METABOLISM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Vitamin metabolism is a physiological process that likely affects the CTLA4 gene and its regulatory functions.")</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;STAT1&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"STAT1 is another protein that plays a role in the cellular response mechanisms of T cells, including those influenced by gene expression variants like CTLA4.")</data>
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
    </node>
    <node id="&quot;EBI3&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"EBIO is a protein co-expressed and used alongside IL-27 to form heterodimers with IL-27RA in response to interferon signaling."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;IL27RA&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"IL27RA is the receptor for IL-27 cytokines and acts on T cells through its downstream STAT1/STAT3 pathway."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;HUMAN PBMCS&quot;">
      <data key="d0">"SPECIMEN TYPE"</data>
      <data key="d1">"Healthy human PBMC samples were used to study the effects of IL-27 variants on IRF1 and STAT1 expression."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;HEK293 CELLS&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"HEK293 cells were used to study the effects of IL-27 variants on IRF1 and STAT1 expression in vitro."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;REAL-TIME PCR&quot;">
      <data key="d0">"METHODOLOGY USED"</data>
      <data key="d1">"Real-time PCR was used to quantify the effects of IL-27 variants on IRF1 and STAT1 transcript levels."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;LEU119&quot;[G]">
      <data key="d0">"PROTEIN VARIANT"</data>
      <data key="d1">"A missense SNP in Leu119 results in a protein variant implicated in decreased expression of IRF1 and STAT1 transcripts."</data>
      <data key="d2">chunk-1b40d071abac0ba432a9fb0096796f45</data>
    </node>
    <node id="&quot;CTLA4 GENE&quot;">
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d1">"A genomic variant in the CTLA4 gene correlates with variations in T cell expression levels.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 7}]</data>
    </node>
    <node id="&quot;NUTRIENT METABOLISM&quot;">
      <data key="d2">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d1">"Differential dietary patterns may influence the expression levels of nutrients crucial for gene function, such as folate in this case.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 4}, {"level": 1, "cluster": 14}, {"level": 2, "cluster": 16}]</data>
    </node>
    <node id="&quot;IL-8 PROTEIN&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"IL-8 protein levels were significantly higher in the patient group compared to controls, indicating a potential link between IL-8 and asthma severity."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;ASTHMA PATIENTS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Asthma patients show elevated IL-8 serum concentrations and mRNA expression levels compared to healthy controls."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;HEALTH CONTROL GROUP&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Healthy control group has significantly lower IL-8 serum concentrations, suggesting a protective effect against asthma development."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;MILD ASTHMA PATIENTS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Patients with mild asthma have lower IL-8 serum levels compared to those with moderate and severe disease."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;MODERATE ASTHMA PATIENTS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Patients with moderate asthma show higher IL-8 serum concentrations than those with milder forms of the disease, suggesting a potential link between metabolic pathway and asthma severity."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;SERUM IL-8 LEVELS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"IL-8 serum levels are significantly influenced by environmental factors such as asthma diagnosis category (mild vs. moderate/severe)."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;PBMC COMPOSITION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"No significant difference in PBMC composition between patients with asthma and healthy controls was found."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;GENOTYPE ANALYSIS OF IL-8 GENE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Significant differences were observed in the genotype and allele distributions of rs4073 and rs2227306 polymorphisms, suggesting an association with asthma susceptibility."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;IL-8 POLYMORPHISMS&quot;">
      <data key="d0">"EPIGENETIC MODIFICATION"</data>
      <data key="d1">"No significant difference was found in IL-8 mRNA expression levels based on different IL-8 genotypes for both polymorphisms between asthmatic and healthy children."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;ASTHMA RISK&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Homozygous TT genotype of rs4073 is more frequent in asthmatics, suggesting an increased risk of asthma development among those with this genetic variant."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;ALLELE FREQUENCY OF IL-8 POLYMORPHISMS&quot;">
      <data key="d0">"ALLELE"</data>
      <data key="d1">"The presence of the rs2227306 CC genotype and alleles is associated with a higher risk for developing asthma, suggesting further investigation into its role in disease susceptibility."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;ATOPY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The frequency of rs4073 TT and rs2227306 CC genotypes differed significantly between children with atopic asthma and healthy controls."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;ASTHMA SEVERITY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Elevated IL-8 mRNA levels in patients with moderate to severe asthma suggest a potential link between metabolic pathway and disease severity."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;IL-8 HAPLOTYPE FREQUENCIES&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"LD test showed significant association of the rare diplotype AT with low risk for developing asthma among children, indicating further complexity in genetic influences on asthma susceptibility.") ("entity"</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;IL-8 MRNA LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Elevated IL-8 mRNA levels are associated with increased risk of developing asthma in children, indicating a complex interplay between physiological processes and disease susceptibility."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;PBMC COMPOSITION ANALYSIS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A significant difference was observed in PBMC composition between patients with asthma and healthy controls, suggesting potential molecular interactions contributing to asthma pathogenesis."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;GENOTYPING OF IL-8 POLYMORPHISMS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Analysis of genotype frequencies for polymorphisms related to the IL-8 gene suggests a complex relationship between genetic variations and metabolic pathway regulation in relation to asthma risk."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;ATOPY RISK FACTORS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The presence of specific alleles associated with atopy is linked to increased risk of developing both atopic and non-atopic forms of asthma, suggesting a multifactorial etiology for the disease."</data>
      <data key="d2">chunk-3c66ee37333cba1e51a2bdc729038b68</data>
    </node>
    <node id="&quot;ISHAK B SELIM HASAN&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ASAH1 is an important gene related to lipid metabolism and atherosclerosis development."</data>
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
    </node>
    <node id="&quot;IBS KERNEL&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The IBS kernel incorporates the information on the importance of rare variants, which can impact lipid metabolism and atherosclerosis risk."</data>
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
    </node>
    <node id="&quot;LINEAR KERNEL&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The linear kernel was mis-specified in this context as it did not accurately model the relationship between genetic variants and disease risk for ASAH1 gene."</data>
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
    </node>
    <node id="&quot;MIN TEST&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The min test also suffered from power loss when used to study the effect of ASAH1 gene, possibly due to its mis-specification in this context as well."</data>
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
    </node>
    <node id="&quot;ATHEROSCLEROSIS DEVELOPMENT&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Atherosclerosis development is a condition directly related to the function of genes like ASAH1, which impact lipid metabolism."</data>
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
    </node>
    <node id="&quot;ASAH1 GENE&quot;">
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d1">"The IBS kernel is important for studying the relationship between genetic variants and disease risk for ASAH1 gene, incorporating rare variant information improves test power.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ASAHOHNAU C SELIM HASAN GENE&quot;">
      <data key="d2">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d1">"ASAH1 gene plays a critical role in regulating lipid metabolism and atherosclerosis risk by influencing lipoprotein pathways.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COMBINATION-THERAPY TREATED PATIENTS&quot;">
      <data key="d0">"PATIENTS"</data>
      <data key="d1">"Combination-therapy treated patients are the cohort in this study, consisting of 43 individuals."&lt;SEP&gt;"These individuals make up the control and case groups in this study, designated by N responders or non-responders respectively."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;N RESPONDERS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"In the combination-therapy treated patients, N responders represent the control group."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;NON-RESPONDERS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Among the non-responders in the combination-therapy cohort, there were 10 cases of disease."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;COMBINATION-THERAPY COHORT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The combination-therapy treated patients are part of a larger physiological process involving drug treatments and their effects on response rates."</data>
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
    </node>
    <node id="&quot;RS17388568&quot;">
      <data key="d2">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d1">"Carriers of at least one minor allele (GA or AA) in rs17388568 SNP are 74% less likely to respond to anti-PD-1 treatment compared to those with GG genotype.")|&gt;3) ("entity"</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 6}]</data>
    </node>
    <node id="&quot;N RESPONDERS/CASES&quot;">
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d1">"These individuals make up the control or case groups in this study, designated by N responders or non-responders respectively.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STATISTICAL SIGNIFICANCE&quot;">
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d1">"None of the Associations"&lt;SEP&gt;"None of the associations"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;COMBINATION-THERAPY COHORT SAMPLE SIZE&quot;">
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d1">"Due to small sample size in the combination-therapy cohort, confidence intervals are wide suggesting reduced power to detect significant effects.")&lt;SEP&gt;"This suggests a reduction in power to detect significant effects due to the small sample size of combination-therapy treated patients, leading to wider confidence intervals indicating reduced statistical certainty.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;WIDE CONFIDENCE INTERVALS&quot;">
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d1">"Due to small sample size in the combination-therapy cohort, confidence intervals are wide suggesting reduced power to detect significant effects.")&lt;SEP&gt;"This suggests a reduction in power to detect significant effects due to the small sample size of combination-therapy treated patients, leading to wider confidence intervals indicating reduced statistical certainty.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NO SIGNIFICANT ASSOCIATION&quot;">
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d1">"Despite adjusting for age, sex and treatment drugs, no significant association with treatment response was observed amongst patients grouped by anti-CTLA-4, anti-PD-1 or combination-therapy treatments indicating limited impact of these drug types on overall patient response.")&lt;SEP&gt;"Despite adjusting for age, sex and treatment drugs, no significant association with treatment response was observed amongst patients grouped by anti-CTLA-4, anti-PD-1 or combination-therapy treatments.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TREATMENT RESPONSE&quot;">
      <data key="d2">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d1">"Despite adjusting for age, sex and treatment drugs, no significant association with treatment response was observed amongst patients grouped by anti-CTLA-4, anti-PD-1 or combination-therapy treatments indicating limited impact of these drug types on overall patient response.")&lt;SEP&gt;"Despite adjusting for age, sex and treatment drugs, no significant association with treatment response was observed amongst patients grouped by anti-CTLA-4, anti-PD-1 or combination-therapy treatments.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EBNA2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"EBNA2 is a gene involved in targeting specific MS risk genes through genetic variation at their risk alleles."&lt;SEP&gt;1</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6&lt;SEP&gt;chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;TNFRSF1A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"EBNA2 targets TNFRSF1A through binding to its risk allele, influencing the expression of this gene which is associated with MS."&lt;SEP&gt;5</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6&lt;SEP&gt;chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;TBX6&quot;">
      <data key="d0">"TARGET GENE"</data>
      <data key="d1">"EBNA2 inhibits the expression of TBX6."&lt;SEP&gt;6</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6&lt;SEP&gt;chunk-bb351b97d99fce93d17df522db92dda7</data>
    </node>
    <node id="&quot;TRAFL">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"TRAFL is a gene that may be related to MS risk loci.")</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;CD40&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">3</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;TNFAIP8&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">4</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;RCOR1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">7</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;CLECL1&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">8</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;EBV LATENCY III PROGRAM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">18</data>
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
    </node>
    <node id="&quot;TRAFL&quot;">
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d1">"EBNA2 binds preferentially to the risk allele for TRAFL, altering its expression.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MS RISK LOCI&quot;">
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d1">"Risk alleles for MS are associated with altered physiological processes, including immune evasion during EBV latency III infection.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 10}]</data>
    </node>
    <node id="&quot;LATENCY III PROGRAM&quot;">
      <data key="d2">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d1">"The modulation of risk gene expression by EBNA2 is part of the Latency III program in EBV-infected cells.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS3842787&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Rs3842787 is a genomic variant associated with aspirin insensitivity in the COX-2 gene."&lt;SEP&gt;"Rs3842787, linked to the COX-2 gene, also exhibits a strong connection with aspirin insensitivity."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;RS20417&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Rs20417 is a gene associated with aspirin insensitivity in the COX-1 gene."&lt;SEP&gt;"Rs20417, when associated with COX-1 gene, shows significant association with aspirin insensitivity among cases and controls."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;RS20118426&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Rs20118426 is a genomic variant associated with aspirin insensitivity in the ITGA2 gene."&lt;SEP&gt;"The genomic variant associated with ITGA2B is also linked to its transcript and thus influences the occurrence of aspirin insensitivity."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;RS1126643&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Rs1126643 associated with ITGA2B gene is strongly predictive of aspirin insensitivity in both cases and controls."&lt;SEP&gt;"Rs1126643 is a genomic variant associated with aspirin insensitivity in the ITGA2B gene."&lt;SEP&gt;"Rs1126643 is linked with aspirin resistance and its corresponding risk allele contributes significantly to the condition among case subjects.") ("entity"</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;ITGA2B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ITGA2B, which hosts rs20118426, is a gene that correlates with aspirin insensitivity among case subjects."&lt;SEP&gt;"Itga2b protein is linked with the ITGA2 gene via rs1126643. This protein plays a vital role in cell adhesion and migration, crucial for various physiological processes including inflammation responses."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;COX-2&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The COX-2 gene, which carries rs3842787, plays a role in regulating nitric oxide production related to cardiovascular health."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;COX-1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Cox-1, also known as ALOX5 or ACP, encodes for proteins that are significant contributors to the inflammatory response and vascular function."</data>
      <data key="d2">chunk-54c4fede216a6c4183b95ee1a2edcb17</data>
    </node>
    <node id="&quot;P1&quot;">
      <data key="d0">"PATIENT"</data>
      <data key="d1">"Infant P1 had normal proportions of CD8+ TEMRA cells by the specified time point, suggesting a potential developmental variation or stability."&lt;SEP&gt;"The oldest sibling, patient 1 (P1), was conceived by in-vitro fertilization and born premature at 25 weeks but appropriate for gestational age with a birth weight of 650-g and birth length of 30 cm."|</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589&lt;SEP&gt;chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;P2&quot;">
      <data key="d0">"PATIENT"</data>
      <data key="d1">"Born AGA at 37 weeks, weighing 2040-g. At the time of presentation, he was 2 years old with severe short stature and height SDS of −5.06, displaying a GHI phenotype similar to P1."|</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;P3&quot;">
      <data key="d0">"PATIENT"</data>
      <data key="d1">"Presented at 7 months of age and born AGA at 35 weeks, weighing 1900-g. She had failure to thrive and severe short stature with height SDS −4.7."|</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;GHI PHENOTYPE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The clinical phenotype of the siblings, including severe short stature and recurrent infections, suggests a GHI (Growth Hormone Insensitivity) phenotype consistent with their below-normal IGF-1 concentrations."|</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;WES ANALYSIS&quot;">
      <data key="d0">"PROCEDURE"</data>
      <data key="d1">"At presentation at age 3.9, P1 underwent trio clinical whole exome sequencing which revealed a homozygous nonsense mutation in STAT5B associated with growth and immune impairments."|</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;RHIGF-1 THERAPY&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Upon evaluation at CCHMC, the siblings were placed on recombinant human insulin-like growth factor 1 (rhIGF-1) to improve growth as recommended for GHI patients."|) ("entity"</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;IGF-1 CONCENTRATIONS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The siblings showed below-normal IGF-1 concentrations, suggesting an impairment in the production or action of this critical growth factor."|</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;ALSACID LABILE SUBUNIT&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Below-normal acid labile subunit (ALS) levels were also noted alongside their low IGF-1, pointing to broader issues affecting protein regulation and function in these individuals."|</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;SUPPLEMENTAL OXYGEN&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Antibiotic treatments were used as part of the medical management for recurrent infections suffered by all three siblings during infancy and early childhood."|</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;CORTICOSTEROIDS&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"At times, corticosteroids were required to manage conditions such as bronchopulmonary dysplasia and atopic eczema in P1 and P3 respectively."|</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;LEVOTHYROXINE TREATMENT&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Autoimmune thyroiditis was diagnosed in both P2 and P3, leading to the prescription of levothyroxine for their treatment."|</data>
      <data key="d2">chunk-825b9a3dd613f4c55dbf49fa3998d0d5</data>
    </node>
    <node id="&quot;T CELL LYMPHOPENIA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"STAT5B deficient patients typically have reductions in the number of NK cells along with impaired function, and normal to elevated levels of B cells with increased immunoglobulin production."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;NK CELLS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Reduced expression of STAT5B may be associated with reduced numbers of NK cells."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;IMMUNE PROFILES&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Evaluation of immune profiles in our patients revealed reductions and alterations typical for STAT5B deficient individuals, including elevated B cell levels and changes in memory T cells."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;B CELLS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Increased immunoglobulin production is associated with the presence of a LOF STAT5B variant. This suggests an interaction between reduced STAT5B function and increased B cell activity."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;IGE LEVELS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Sustained elevations in IgE levels were noted, indicating an atopic phenotype consistent with prior studies on STAT5B deficiency."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;ATOPIC PHENOTYPE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The development of chronic eczema and reactive airway disease aligns with the presentation often associated with a deficient STAT5B status."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;AUTOIMMUNITY&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Anti-thyroglobulin and anti-thyroid peroxidase antibodies, indicative of autoimmune thyroiditis, were present in our siblings. This suggests an interaction between reduced T regulator function due to STAT5B deficiency and the development of autoimmunity."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;T REG CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Roles of STAT5B include FOXP3 induction for Tregs (T regulatory cells), which are responsible for self-tolerance, were assessed in our younger patients but showed normal maintenance despite reduced numbers."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;CD4+CD25+ CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Reductions in Treg function have been noted in prior reports on STAT5B deficiency. However, the data from these young patients did not show a consistent decline suggesting that the impairment may be limited to long-term maintenance."</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;MEMORY CD8+ T CELLS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Dysregulation of memory CD8+ T cells was observed in our siblings. This suggests an interaction between impaired immune regulation and alterations in memory/naïve subsets typical for STAT5B deficient patients.") ("entity"</data>
      <data key="d2">chunk-e323b0d4f82733a78f687e51f47b500a</data>
    </node>
    <node id="&quot;TCM CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"TCM cells are normal cells that remained within the normal ranges."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;FIGURE S4C&quot;">
      <data key="d0">"DOCUMENT ELEMENT"</data>
      <data key="d1">"Figure S4C is a part of document related to TCM cells and their proportions."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;FIGURE 3C&quot;">
      <data key="d0">"DOCUMENT ELEMENT"</data>
      <data key="d1">"Figure 3C is another document element that likely refers to the same data as Figure S4C, possibly indicating continued normalcy in other cell types or measurements."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;CD4+ TEM CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"No alterations in the proportion of CD4+ TEM cells were identified."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;CD8+ TEM CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Increases in CD8+ TEM cell proportions became significant with age in each sibling, suggesting a possible trend or clinical significance."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;SIBLING RELATIONSHIP&quot;">
      <data key="d0">"RELATIONSHIP TYPE"</data>
      <data key="d1">"Each sibling represents a separate individual, likely related through family lineage."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;P2 AND P3&quot;">
      <data key="d0">"INDIVIDUALS"</data>
      <data key="d1">"Infant P2 and P3 showed elevations in CD8+ TEMRA cells during infancy which normalized around age 4."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;STAT5B DEFICIENCY&quot;">
      <data key="d0">"DISEASE OR SYNDROME"</data>
      <data key="d1">"The patients carried an LOF STAT5B variant associated with critical roles in CD8+ T cell activation and homeostasis."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;CD8+ MEMORY T CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"Patients had elevated proportions of CD8+ memory T cells, which may be a key feature indicative of the disease state or genetic condition being studied."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;STAT5B LOF VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The focus on an STAT5B LOF variant suggests that this genetic factor may be central to understanding the physiological or pathological processes observed in T cells and potentially other cell types as well."&lt;SEP&gt;"The study focuses on an LOF STAT5B variant that is critical for understanding the dysregulation observed in CD8+ T cells."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;CD8+ TEMRA CELLS&quot;">
      <data key="d0">"AGE AND DEVELOPMENTAL CHANGE"</data>
      <data key="d1">"Infant P2 and P3 showed elevations in CD8+ TEMRA cells which normalized around age 4, suggesting a developmental trajectory or normalization process."</data>
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
    </node>
    <node id="&quot;AGE WITH CLINICAL SIGNIFICANCE&quot;">
      <data key="d2">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d1">"Increases in CD8+ TEM cell proportions became clinically significant with age, indicating a potential clinical relevance or trend.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS4713586 TT AND RS7775228 TC OR CC GENOTYPES&quot;">
      <data key="d0">"HLA‐DRB1*07:01–DQA1*02:01–DQB1*02:02 HAPLOTYPE"</data>
      <data key="d1">14&lt;SEP&gt;17</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;RS28383172 AG OR GG GENOTYPES&quot;">
      <data key="d0">"HLA‐DRB1*07:01–DQA1*02:01–DQB1*02:02 HAPLOTYPE"</data>
      <data key="d1">19</data>
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
    </node>
    <node id="&quot;EUR SUPER POPULATION&quot;">
      <data key="d0">"POPULATION"</data>
      <data key="d1">"The EUR super population shows higher sensitivity and negative predictive value in algorithm V for SNP tagging."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;1000 GENOMES DATASET&quot;">
      <data key="d0">"DATASET"</data>
      <data key="d1">"In the different comparisons on the 1000 Genomes dataset, algorithm V generally outperforms algorithms II, III, and IV across various parameters, indicating improved accuracy in genotyping SNPs compared to other methodologies."&lt;SEP&gt;"In the different comparisons on the 1000 Genomes dataset, algorithm V generally outperforms algorithms II, III, and IV across various parameters."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;HLA-DRB1*07:01–DQA1*02:01–DQB1*02:02">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This is a specific HLA haplotype that was evaluated for its association with E. coli ASP hypersensitivity, as part of the screening tests designed to identify affected patients in the SNP-genotyped subpopulation."&lt;SEP&gt;"This is a specific HLA haplotype that was evaluated for its association with E. coli ASP hypersensitivity."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;E. COLI ASP HYPERSENSITIVITY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The test aimed to identify patients with E. coli ASP hypersensitivity among the SNP-genotyped subpopulation, identified a small proportion of affected individuals.") ("entity"</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;SENSITIVITY VALUE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"In the evaluation using the HLA-DRB1*07:01–DQA1*02:01–DQB1*02:02 haplotype, a sensitivity value of 23.4% was observed, indicating that this marker could identify a small proportion of affected patients."</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;SPECIFICITY VALUE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The test conducted on the SNP-genotyped subpopulation exhibited good specificity with an 88.5% rate, suggesting it correctly identified most individuals without E. coli ASP hypersensitivity."]</data>
      <data key="d2">chunk-1f50436a36721971a0a256131d7fca62</data>
    </node>
    <node id="&quot;HLA‐DRB1*07:01 ALLELE&quot;">
      <data key="d2">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d1">"Carries HLA‐DRB1*07:01 allele"</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HIV-INFECTED INDIVIDUALS&quot;">
      <data key="d0">"INDIVIDUAL"</data>
      <data key="d1">"150 individuals infected with HIV who participated in the study."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;MEAN AGE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The mean age (years ± SD) of participants were 36 yrs ± 3.2 in HIV-infected individuals and 33 yrs ± 6.47 in healthy controls, indicating differences in demographic profile."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;TOBACCO&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Tobacco consumption was analyzed among a subset of the study population, but no significant association with TLR7 polymorphism was observed."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;ALCOHOL&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Alcohol use was also examined in relation to TLR7 polymorphisms and again found no significant associations."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;RS179009 POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The rs179009 AG genotype is less common in advanced stages of HIV disease, suggesting a possible protective effect against severe infection."</data>
      <data key="d2">chunk-05d583f893b703816ad8de9561aa5292</data>
    </node>
    <node id="&quot;HIV DISEASE PROGRESSION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">1</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
    </node>
    <node id="&quot;HIV&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">3</data>
      <data key="d2">chunk-2c91cdebb36ef064eb01a7021a961302</data>
    </node>
    <node id="&quot;ALK R1275Q NEOEPITOPE&quot;">
      <data key="d0">"NEOEPITOPE"</data>
      <data key="d1">"ALK R1275Q is a mutation in the ALK gene that results in specific neoepitopes, which are potential targets for immunotherapy."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;TARGETED THERAPY&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"The identification of ALK R1275Q-derived neoepitopes may lead to targeted therapies specifically designed to elicit an immune response against these targets in NBL patients."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;HLA-B*15:01&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A genomic variant of HLA-B*15:01 has been linked to altered peptide binding properties."&lt;SEP&gt;"High resolution X-ray structures for HLA-B*15:01 are used as templates for comparative modeling calculations."&lt;SEP&gt;"The two ALK-derived neoantigens bind to HLA-B*15:01 with distinct affinities, indicating specific immune responses that could be exploited for therapeutic purposes."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2&lt;SEP&gt;chunk-d3a9c93928447522ce3df4209f8ac803&lt;SEP&gt;chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;TARGET-30-PARHAM&quot;">
      <data key="d0">"SAMPLE"</data>
      <data key="d1">"Sample from NBL tumor identified through ProTECT analysis as harboring ALK R1275Q neoepitopes."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;TARGET-30-PANWRR&quot;">
      <data key="d0">"SAMPLE"</data>
      <data key="d1">"Additional sample from the TARGET cohort identified with ALK R1275Q mutation, not associated with HLA-B*15:01 expression."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;TARGET-30-PANXJL&quot;">
      <data key="d0">"SAMPLE"</data>
      <data key="d1">"Another sample in the TARGET cohort expressing a close relative of HLA-B*15:01, HLA-B*15:03."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;TARGET-30-PAPTFZ&quot;">
      <data key="d0">"SAMPLE"</data>
      <data key="d1">"Additional sample showing ALK R1275Q mutation and expression of non-HLA restricted epitope (HLA-A*02:01) via ARDIYRASY antigen."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;TARGET-30-PAPTLV&quot;">
      <data key="d0">"SAMPLE"</data>
      <data key="d1">"Final sample in the TARGET cohort expressing ALK R1275Q mutation and another non-synonymous neoepitope (ZNF717), not linked to HLA expression."</data>
      <data key="d2">chunk-52a8c1d4352526a90e26deb6f06682d2</data>
    </node>
    <node id="&quot;NEOEPITOPE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Tumor neoepitopes are proteins that bind to MHC molecules.")&gt;1</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;DECAMER PEPTIDE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The decamer peptide is a protein involved in binding to the HLA-B*15:01 molecule through its anchor residues within the A/B, F-pockets of the MHC groove."&gt;)&gt;3&lt;SEP&gt;"The decamer peptide is a specific sequence bound to the MHC molecule for structural characterization."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803&lt;SEP&gt;chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;HLA-B*15:01 MOLECULE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The HLA-B*15:01 protein is involved in binding tumor neoepitopes."&gt;)&gt;5</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;IN VITRO REFOLDING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"In vitro refolding processes are used to study the binding interactions between proteins like tumors neoepitopes and MHC molecules."&gt;)&gt;7</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;DIFFERENTIAL SCANNING FLUORIMETRY (DSF)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"DSF is a method for assessing kinetic stability in proteins like p/MHC complexes."&gt;)&gt;9) ("entity"</data>
      <data key="d2">chunk-830d8819004960d1d149ac70149c72a0</data>
    </node>
    <node id="&quot;ILE4&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Ile4 is a residue in the decamer peptide sequence."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;TYR5&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Tyr5 is another amino acid residue in the decamer peptide sequence."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;SER8&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Ser8 is present in the decamer peptide sequence."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;YOR9&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Yor9 is a residue in the neoepitope sequence for HLA-B*15:01."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;ARG151&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Arg151 in MHC α2 helix changes orientation with peptide binding, suggesting interaction dynamics."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;HLA ALPHA 2 HELIX&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The HLA alpha 2 helix undergoes a significant widening upon complex formation with the neoepitope and nonamer peptides."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;ARG6&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Arg6 is positioned deeper in the MHC groove with the addition of the C-terminal Tyr in the peptide sequence."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;ARG1275Q&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Arg1275Q is a mutation that affects the neoepitope for HLA-B*15:01 binding potential."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;ALK R1275Q NEOPEPTIDE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The ALK R1275Q mutation influences peptide/HLA interaction affinity."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;TRYPTOPHAN 9&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Tyrosine at position 9 in the neoepitope sequence is part of hydrophobic interactions with MHC residues."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;HYDROGEN BONDS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Intra-peptide hydrogen bonds form as a result of compacted peptide conformation, contributing to stability."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;SALT BRIDGES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Salt bridges are observed in the decamer complex, enhancing binding affinity."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;ELECTROSTATIC INTERACTIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Electrostatic interactions involve MHC residues and contribute to p/MHC stability."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;HYDROPHOBIC INTERACTIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Hydrophobic interactions pack peptides against the MHC, contributing to complex stabilization."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;MHC RESIDUES&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Changes in MHC residues orientated towards solvent suggest altered interaction dynamics with TCRs."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;ARG67&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Arg67 on the α1 helix is involved in steric hindrance with the self-peptide Arg2 side chain rotation."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;ALA 24 MET 45&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Ala24 and Met45 residues are part of the MHC floor, potentially causing clashes with the self-peptide in structure modeling."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;ASP3 ARG6&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Asp3 and Arg6 extend further into the groove for additional peptide interactions."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;ARG24 MET 45&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Conservation of anchor residues in MHC-binding pockets influences complex formation with self-peptide."</data>
      <data key="d2">chunk-de413ae6100407d8dadd5bdee87c1074</data>
    </node>
    <node id="&quot;HLAR1275Q&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"HLAR1275Q is a genomic variant associated with determining outcomes in targeted cancer immunotherapies."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;ALK R1275Q&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"ALK R1275Q represents the protein involved in targeted cancer immunotherapies."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;T CELL RESPONSE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Targeting of T cell response is critical for determining outcomes in cancer immunotherapy."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;HLAB*15:84&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The HLARB*15:84 allele shows the lowest binding energy for a decamer peptide in our study."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;HLAB*15:107&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The HLAB*15:107 allele exhibits the lowest binding energy for a nonamer peptide, according to our findings."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;SURFACE FEATURES OF PEPTIDES&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Surface features of peptides poised for interactions with TCRs are predicted using computational methods."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;TCR INTERACTIONS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Predicting peptide/HLA and TCR interactions is crucial for expanding the range of individuals that can mount a T cell response to ALK R1275Q neoepitopes."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;X-RAY STRUCTURES&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"High-resolution X-ray structures are used as templates in predicting peptide/HLA interactions and surface features for potential TCR targets."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;ENERGY MINIMIZATION OF PEPTIDE AND HLA RESIDUES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Energy minimization is employed to predict highly reproducible binding energies between peptides, HLA alleles, and interacting residues."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;REFOLDING OF ALK-DERIVED NONAMER AND DECAMER PEPTIDES WITH HLA-A*01:01&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"In vitro refolding of peptides shows the formation of stable p/MHC complexes for structural characterization, supporting our simulations."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;PURITY OF PURIFIED COMPLEX&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The purity of purified complex is evaluated to understand thermal stability and other characteristics."</data>
      <data key="d2">chunk-614333487e4b92705503909d34155179</data>
    </node>
    <node id="&quot;HLA-A*01:01&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"HLA-A*01:01 is an allele associated with the presentation of peptides bound to MHC class I molecules."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;NONAMER PEPTIDE&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The nonamer peptide is another sequence bound to the same MHC molecule for structural characterization."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;TETRAMER STAINING ASSAY&quot;">
      <data key="d0">"METHODOLOGY"</data>
      <data key="d1">"The tetramer staining assay uses MHC-peptide complexes to identify CD8+ T cells recognizing neoantigens."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;FLOW CYTOMETRY ANALYSIS&quot;">
      <data key="d0">"METHODOLOGY"</data>
      <data key="d1">"Multichannel flow cytometry is employed for analyzing the reactivity of CD8+ T cells against neoepitopes presented by MHC molecules.") ("entity"</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;MUTATED PROTEINS&quot;">
      <data key="d0">"PROTEIN VARIANT"</data>
      <data key="d1">"HLA-B*15:01 is a gene variant associated with altered peptide binding properties in response to mutated proteins like the ALK neoepitopes."</data>
      <data key="d2">chunk-d3a9c93928447522ce3df4209f8ac803</data>
    </node>
    <node id="&quot;IGM ANTI-PC GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IgM Anti-PC gene is associated with levels of immunoglobulin M (IgM), and its variants are linked to cardiovascular disease.")</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;RS74420772 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Rs74420772 is a single nucleotide polymorphism in the IgG Anti-PC gene that achieved genome-wide significance in TwinGene, suggesting a strong genetic link to cardiovascular disease.")&lt;SEP&gt;"Rs74420772 is a single nucleotide polymorphism in the IgM Anti-PC gene that achieved genome-wide significance in TwinGene, suggesting a strong genetic link to cardiovascular disease.")</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;RS1P31.3 SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Rs1p31.3 is another single nucleotide polymorphism associated with IgG levels and cardiovascular risk factors, although it did not achieve genome-wide significance in this study.")&lt;SEP&gt;"Rs1p31.3 is another single nucleotide polymorphism associated with IgM levels and cardiovascular risk factors, although it did not achieve genome-wide significance in this study.")</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;RS11Q24.1 SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Rs11q24.1 is a set of six single nucleotide polymorphisms associated with IgG levels that achieved genome-wide significance and were successfully replicated in further validation.")&lt;SEP&gt;"Rs11q24.1 is a set of six single nucleotide polymorphisms associated with IgM levels that achieved genome-wide significance and were successfully replicated in further validation.")</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;TWINGENE STUDY&quot;">
      <data key="d0">"JOURNAL"</data>
      <data key="d1">"The SNP rs74420772 was significant in the TwinGene study, indicating a strong genetic link to cardiovascular disease as determined by the study’s findings.")</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;PHENOTYPE MATCHING COHORT&quot;">
      <data key="d0">"SAMPLE POPULATION"</data>
      <data key="d1">"Individuals with both IgG anti-PC measurements and genotypes available were used in this study, forming the basis for analysis of genetic factors influencing cardiovascular risk.")&lt;SEP&gt;"Individuals with both IgM anti-PC measurements and genotypes available were used in this study, forming the basis for analysis of genetic factors influencing cardiovascular risk.")</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;META-ANALYSIS OF GWAS RESULTS&quot;">
      <data key="d0">"STUDY DESIGN"</data>
      <data key="d1">"A meta-analysis of three individual discovery GWAS results was conducted to identify significant genomic associations with IgG levels, using a total of 3002 individuals for analysis.")&lt;SEP&gt;"A meta-analysis of three individual discovery GWAS results was conducted to identify significant genomic associations with IgM anti-PC levels, using a total of 3002 individuals for analysis.")</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;LINKAGE DISEQUILIBRIUM BLOCK&quot;">
      <data key="d0">"GENOMIC FEATURE"</data>
      <data key="d1">"The two SNPs in 1p31.3 and the six SNPs in 11q24.1 are part of a strong linkage disequilibrium block, suggesting that they may influence IgG levels through interactions with nearby genes.")&lt;SEP&gt;"The two SNPs in 1p31.3 and the six SNPs in 11q24.1 are part of a strong linkage disequilibrium block, suggesting that they may influence IgM levels through interactions with nearby genes.")</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;GRAMD1B GENE&quot;">
      <data key="d0">"GENE INTERACTION"</data>
      <data key="d1">"The genomic region containing the leading SNP rs35923643 is near the GRAMD1B gene, hinting at a potential functional relationship between these genetic elements and IgG levels.")&lt;SEP&gt;"The genomic region containing the leading SNP rs35923643 is near the GRAMD1B gene, hinting at a potential functional relationship between these genetic elements and IgM levels.")</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;CLL SUSCEPTIBILITY ALLELES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The allele rs35923643-G was identified as the top risk allele for chronic lymphocytic leukemia (CLL), suggesting a strong genetic link to this disease.")</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;PRS FOR GENERAL IGM LEVELS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Polygenic risk score analyses indicated that PRSs on the basis of general IgM increasing alleles were positively associated with IgM anti-PC levels, supporting a genetic influence on these biomarkers.")</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;JONSSON ET AL. STUDY SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"In addition to our discovery meta-analysis, Jonsson et al.'s study also identified nine genome-wide significant SNPs for general IgG levels, including rs2476601 and rs735665.")&lt;SEP&gt;"In addition to our discovery meta-analysis, Jonsson et al.'s study also identified nine genome-wide significant SNPs for general IgM levels, including rs2476601 and rs735665.")</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;INTERLYMPH CONSORTIUM STUDY CLL SUSCEPTIBILITY ALLELES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The InterLymph consortium study also identified genome-wide significant SNPs for chronic lymphocytic leukemia (CLL), supporting the genetic basis of disease susceptibility.")</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;PRS FOR IGM ANTI-PC LEVELS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"PRSs on the basis of IgM anti-PC increasing alleles were associated with higher risk of CLL, indicating a complex relationship between genetic variation in IgM levels and disease susceptibility.")</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;ODDS RATIO FOR CLL RISK ALLELES&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The 33 independent genome-wide significant SNPs identified for CLL risk explained a small but statistically significant portion of the variance in disease risk, suggesting a complex genetic architecture.")</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;DNASEI HYPERSENSITIVITY PEAK&quot;">
      <data key="d0">"METABOLIC PATHWAY FEATURE"</data>
      <data key="d1">"Peaks of DNaseI hypersensitivity within the LD block suggest that these genomic regions may be involved in gene regulation processes related to IgG levels and cardiovascular risk factors.")&lt;SEP&gt;"Peaks of DNaseI hypersensitivity within the LD block suggest that these genomic regions may be involved in gene regulation processes related to IgM levels and cardiovascular risk factors.")</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;HISTONE MARK MONOMETHYLATED HISTONE H3 LYSINE 4 PEAK&quot;">
      <data key="d0">"EPIGENETIC MODIFICATION FEATURE"</data>
      <data key="d1">"Peaks of histone mark monomethylated histone H3 lysine 4 within the LD block indicate potential epigenetic modifications that may influence gene expression and IgG levels.")&lt;SEP&gt;"Peaks of histone mark monomethylated histone H3 lysine 4 within the LD block indicate potential epigenetic modifications that may influence gene expression and IgM levels.")</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;PRS ANALYSIS SUMMARY&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"PRSs on the basis of IgG anti-PC increasing alleles were positively associated with IgG, supporting a genetic contribution to these biomarkers. These findings highlight the complex interplay between genetic factors and disease risk in populations.")&lt;SEP&gt;"PRSs on the basis of general IgM increasing alleles were positively associated with IgM anti-PC, supporting a genetic contribution to these biomarkers. These findings highlight the complex interplay between genetic factors and disease risk in populations.")</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;IGG ANTI-PC GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IgG Anti-PC gene is associated with levels of immunoglobulin G (IgG), and its variants are linked to cardiovascular disease.")</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;PRS FOR GENERAL IGG LEVELS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Polygenic risk score analyses indicated that PRSs on the basis of general IgG increasing alleles were positively associated with IgG anti-PC levels, supporting a genetic influence on these biomarkers.")</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;PRS FOR IGG ANTI-PC LEVELS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"PRSs on the basis of IgG anti-PC increasing alleles were associated with higher risk of CLL, indicating a complex relationship between genetic variation in IgG levels and disease susceptibility.")</data>
      <data key="d2">chunk-0dc1ddaa86432d222da7fc75090f700a</data>
    </node>
    <node id="&quot;LOCUS 11Q24.1&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The locus 11q24.1 is a genomic variant shared between IgM anti-PC and CLL."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;RS35923643&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"RS35923643 is located in the LD block, associated with chromatin immunoprecipitation-sequencing (ChIP-seq) experiments and regulatory marks."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;HISTONE MARK MONOMETHYLATED HISTONE H3 LYSINE 4 (H3K4ME1)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Regulatory marks such as H3K4Me1 are involved in chromatin immunoprecipitation-sequencing experiments and transcription factor binding."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;DEOXYRIBONUCLEASE I (DNASEI) HYPERSENSITIVITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"DeoxyribonucleaseI hypersensitivity is another regulatory mark associated with the chromatin immunoprecipitation-sequencing experiments and transcription factor binding."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;TRANSCRIPTION FACTOR (TF)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"22 different transcription factors were suggested to bind within ~700bp region around rs35923643 according to the Encyclopedia of DNA Elements (ENCODE)."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;RUNX3 BINDING MOTIFS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The strongest signals for RUNX3 binding were observed in the ChIP-seq experiments, with motifs including SNP rs35923643 at position 391 bp."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;SPI1 (SPLEEN TYROSINE KINASE 1)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"In the same ChIP-seq experiment for RUNX3, signals were also observed for SPI1, another transcription factor involved in leukocyte differentiation and proliferation."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <node id="&quot;REGULOMEDB&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Support from RegulomeDB suggests rs35923643 may affect TF binding, potentially impacting CLL risk and disease development."</data>
      <data key="d2">chunk-83ee45fa1acb6546ff72e454c7880f7b</data>
    </node>
    <edge source="&quot;AGE&quot;" target="&quot;ENVIRONMENTAL FACTOR&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"No evidence of interaction between age and the association of TCF7L2 variants with type 2 diabetes risk was found.")</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE&quot;" target="&quot;PHYSIOLOGICAL PROCESS&quot;">
      <data key="d4">27.0</data>
      <data key="d5">"Aging is a physiological process that can affect various health markers such as HbA1c levels and diabetes risk in the subcohort.")&lt;SEP&gt;"Both cohorts were adjusted for age range which indicates the relevance of physiological processes that occur within different ages, impacting both phenotypes.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4&lt;SEP&gt;chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE&quot;" target="&quot;BMI&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"There was an association between age and BMI, with higher BMIs corresponding to older participants, as indicated by significant differences across subgroups (overall P = .036).")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSICAL ACTIVITY&quot;" target="&quot;CORTISOL LEVELS&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Physical activity is a lifestyle factor influencing blood cortisol levels in the study population.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PRS (POLYMORPHISM RS1799982)&quot;" target="&quot;BMI&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"Polymorphism rs1799982 is associated with higher BMI in participants with early menarche age.")</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PRS (POLYMORPHISM RS1799982)&quot;" target="&quot;MENOPAUSE AGE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Nutrient Intake"&lt;&gt;"No significant interaction between PRS and menopausal age affects nutrient intake for obesity risk.")</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PRS (POLYMORPHISM RS1799982)&quot;" target="&quot;FRIED FOOD INTAKE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Fried food intake exhibits an interaction with the PRS to affect BMI and offset genetic influence on obesity risk.")</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MENARCHE AGE&quot;" target="&quot;NUTRIENT INTAKE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Early menarche age influences the nutrient intake of individuals, which may affect obesity risk.")</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;SMOKER V. NON-SMOKER&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Smoking status is an environmental factor that was part of the dietary pattern examined for its impact on metabolic pathways.")</data>
      <data key="d6">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;INTERACTIONS OF GENOTYPE AND DIET INTERVENTION&quot;">
      <data key="d4">84.0</data>
      <data key="d5">"The Healthy Eating group's dietary pattern is likely to influence gene expression in a way that may reduce cardiovascular disease risk.")&lt;SEP&gt;"The Mediterranean group's dietary pattern is associated with reduced cardiovascular disease risk, indicating a strong diet-gene interaction.")&lt;SEP&gt;"The significant change in the nutrient 20:4 n-6 (AA) was found to be related to a specific dietary pattern, suggesting its influence on gene expression.")&lt;SEP&gt;"The significant genotype-by-diet interaction found in the study relates to a dietary pattern, suggesting its role in gene-diet interactions.")&lt;SEP&gt;"The study highlights a specific dietary pattern (Healthy Eating), which influenced gene-diet interactions as indicated by the significant interaction.")&lt;SEP&gt;"This study shows a significant diet-gene interaction in the context of the Healthy Eating dietary pattern, indicating that it may influence gene expression.")</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;SEX&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Gender-specific dietary patterns were evident among participants, which might influence metabolic pathways differently.")</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;STUDY CENTER&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The geographic location of each participant's study center could influence dietary patterns which, in turn, may impact their overall health outcomes.")</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;LEAFY GREENS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">&gt;(</data>
      <data key="d6">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;P.T935M&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Variant p.T935M presented a uniform state with only one kind of haplogroup on WD chromosomes, reflecting a distinct dietary pattern." )</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;CLUSTER RELATED TO TOP BIO FUNCTIONS&quot;">
      <data key="d4">27.0</data>
      <data key="d5">"Clusters of genes related to top bio functions are associated with dietary patterns and molecular transport.")</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;ESTIMATED DAILY FAT INTAKE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The estimated daily fat intake during the study was a demographic factor that varied among different subgroups of IBS patients.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;BMI&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"There was a correlation between BMI and estimated daily fat intake which might influence dietary patterns that could affect physiological processes related to BA synthesis, excretion within different disease states such as IBS-D.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;CD226&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The dynamics of CD226 surface expression on Tregs wanes before increasing to a level higher than baseline.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;LYP-620W&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The impact of the LYP-620W variant on Treg but not Tconv proliferation is less pronounced than that observed with the LYP-620R variant.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;NUTRIENT METABOLISM&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Differential dietary patterns may influence the expression levels of nutrients crucial for gene function, such as folate in this case.")</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;SEC16B_RS543874&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"SEC16B is a Gene involved in endoplasmic reticulum export factor, regulating physiological processes related to energy intake.")</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;DNAJC27_RS713586&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"DNAJC27 is a Gene that functions as part of the heat shock protein family involved in cellular stress responses and energy regulation.")</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;MC4R_RS6567160&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"MC4R (Melanocortin-4 Receptor) is a Gene involved in the regulation of appetite and body weight through its protein product, which interacts with other genes to control energy balance.")</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;GIPR_RS1444988703&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"GIPR (Glucose-Dependent Insulinotropic Peptide Receptor) is a Gene that plays a key role in glucose homeostasis and energy expenditure, influencing obesity risk.")</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;TCF7L2_RS1345860&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"TCF7L2 is a Gene associated with type 2 diabetes and impaired glucose regulation, impacting overall metabolic health and the risk of obesity related to these conditions.")</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;TUFM GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Transcription Factor Binding Sites"</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;BMP4&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The top SNP for the BMP4 gene was rs17563, which showed association with both 'age at first tooth' and 'number of teeth' phenotypes.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;CDON&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The CDON gene's top SNP, rs4937076, is linked with 'number of teeth' in both studies analyzed.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;ADK&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"The ADK gene's top SNP, rs997154, was found in the context of 'age at first tooth'.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;MSRB3&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"The MSRB3 gene was confirmed to have an association with the number of teeth phenotype.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;RAD51C&quot;">
      <data key="d4">19.0</data>
      <data key="d5">"The SNP at RAD51C, rs412000, is linked to both physiological processes related to tooth development and was identified as a nutrient-related gene.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;CMH000068&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"This gene was sequenced to a nuclear exome target coverage of 88.05% and mtDNA base covered at 10× or greater, aligning with the sequencing performed on CMH000067" relationship_description</data>
      <data key="d6">chunk-b930cdd3706af881cfa771b341af097d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE&quot;" target="&quot;CCHCR1&quot;">
      <data key="d4">1.0</data>
      <data key="d5">1)("relationship"</data>
      <data key="d6">chunk-72f4505e43f67f3564607392cb178656</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BDNF_RS6265&quot;" target="&quot;PROTEIN&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"BDNF (Brain-Derived Neurotrophic Factor) is a Protein associated with neuronal survival and synaptic plasticity, influencing cognitive functions and energy expenditure.")</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTEIN&quot;" target="&quot;OLFM4_RS9568856&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"OLFM4 is a Protein involved in various cellular processes including cell adhesion and growth regulation, crucial for physiological functions related to body weight management.")</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTEIN&quot;" target="&quot;CDKAL1_RS9356744&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"CDKAL1 is a Protein involved in the regulation of insulin secretion and glucose metabolism, which affects energy intake and body weight management.")</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTEIN&quot;" target="&quot;APOA2_RS7018394&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"APOA2 is a Protein associated with lipid metabolism and atherosclerosis prevention, affecting energy intake and body weight management through its regulation of cholesterol transport in the bloodstream.")</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTEIN&quot;" target="&quot;TGFBR2_RS1859123&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"TGFBR2 (Transforming Growth Factor-Beta Receptor Type 2) is a Protein involved in signaling pathways related to cellular processes, which influences physiological responses that impact obesity risk.")</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTEIN&quot;" target="&quot;CACNB2&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"A SNP in CACNB2 protein, rs10740993, was found to be associated with the number of teeth at one year old.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTEIN&quot;" target="&quot;CALU/OPN1SW&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"SNPs in the CALU/OPN1SW protein region were associated with 'age at first tooth', as indicated by rs1799922 and related variants.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTEIN&quot;" target="&quot;AJUBA/C14ORF93&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"SNPs in the AJUBA/C14orf93 protein region were linked to 'number of teeth', according to rs7924176 and other associated variants.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROTEIN&quot;" target="&quot;IGF2BP1&quot;">
      <data key="d4">15.0</data>
      <data key="d5">"SNPs in the IGF2BP1 protein region were linked to 'number of teeth' and also appeared at genome-wide significant levels for these associations.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO_RS1421085&quot;" target="&quot;NUTRIENT&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"FTO (Fat Mass and Obesity Associated Gene) is a Nutrient associated gene that modulates energy homeostasis, influencing obesity risk through its impact on appetite regulation.")</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NUTRIENT&quot;" target="&quot;METFORMIN&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Metformin is an intervention that significantly decreased fasting proinsulin levels compared with placebo and other treatments.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NUTRIENT&quot;" target="&quot;INTERACTIONS OF GENOTYPE AND DIET INTERVENTION&quot;">
      <data key="d4">67.0</data>
      <data key="d5">"The increase in long chain n-3 PUFA is associated with reduced cardiovascular disease risk, indicating a strong diet-gene interaction.")&lt;SEP&gt;"The significant increase in long chain n-3 PUFA was observed in the Mediterranean group, indicating a nutrient influence on gene expression.")&lt;SEP&gt;"The significant increase in long chain n-3 PUFA was observed primarily in the Mediterranean group, suggesting a relationship with reduced cardiovascular disease risk.")</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NUTRIENT&quot;" target="&quot;THERAPY&quot;">
      <data key="d4">142.0</data>
      <data key="d5">"Disease"</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NUTRIENT&quot;" target="&quot;EDA&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"SNPs in the EDA region were associated with both 'number of teeth' and 'age at first tooth', as reported by rs412000, a nutrient-related SNP.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NUTRIENT&quot;" target="&quot;FOLATE&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Dietary Pattern"&lt;SEP&gt;"Dietary Pattern"&lt;"|&gt;"Folate, a nutrient found in leafy greens such as spinach or lettuce, is positively associated with β2M gene variants linked to hypertension risk.")&lt;SEP&gt;"Folate, as found in leafy greens, may influence the gene's expression indirectly through dietary pathways.")</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9&lt;SEP&gt;chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NUTRIENT&quot;" target="&quot;NUTRIENT&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The intake of nutrients such as those found in leafy greens may be influenced by dietary patterns associated with increased migraine risk due to gene-related genetic polymorphisms.")</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;SECTANB1_RS2089641&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"SECTANB1 (Selectin B1) is a Gene involved in molecular interactions related to immune responses, inflammation, and cardiovascular health. This gene plays a role in the overall physiological processes that impact obesity risk.")</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;SEX&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"No significant interaction found between sex and the genetic variant rs7903146 and its relation to diabetes risk.")</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;INTERACTIONS OF GENOTYPE AND DIET INTERVENTION&quot;">
      <data key="d4">32.0</data>
      <data key="d5">"The FADS1/2 gene cluster likely influences molecular processes related to cardiovascular disease risk, as indicated by the significant genotype-diet interaction.")&lt;SEP&gt;"The increase in long chain n-3 PUFA was linked to a genomic variant, suggesting molecular interactions at play.")</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;THERAPY&quot;">
      <data key="d4">68.0</data>
      <data key="d5">"Disease"</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;KCNJ2 KCNJ160&quot;">
      <data key="d4">17.0</data>
      <data key="d5">"The SNP rs17563 in the KCNJ2 gene, interacting with another gene KCNJ160, was associated with both 'age at first tooth' and 'number of teeth'.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;NF-ΚB P65/RELA&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"NF-κB p65/RelA activation is regulated by NEMO SUMOylation."</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;FANCD2 MONOUBIQUITINATION AND DNA REPAIR&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The normalization of FANCD2 monoubiquitination and foci formation upon UBE2T overexpression is indicative of its critical role in maintaining DNA repair integrity.")</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;MOLECULAR INTERACTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genomic variants in the BDNF gene can influence molecular interactions related to migraine risk.")</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION&quot;" target="&quot;SNPS TESTED&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Despite testing for multiple SNPs, no significant associations were found suggesting a potential molecular interaction affecting response rates remains unclear.")&lt;SEP&gt;"The associations with 23 SNPs tested did not reach statistical significance, suggesting a potential molecular interaction affecting response rates is unclear.")</data>
      <data key="d6">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;PLANT-BASED DIET INTAKE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"High plant-based diet intake shows an interaction with PRS to influence BMI scores, protecting against obesity in adults with high PRS.")</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;ENVIRONMENTAL FACTOR&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"No evidence of interaction between BMI and TCF7L2 variants associated with type 2 diabetes risk was found.")</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;RS671 POLYMORPHISM&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Body Mass Index varied significantly according to the RS671 polymorphism, indicating its influence on BMI.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;ALDH2 RS671&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Genetic variants like ALDH2 rs671 influence BMI, as indicated by significant differences across genotypes.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;PHYSIOLOGICAL PROCESS&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"There was a significant correlation between BMI and total stool BA suggesting that dietary patterns might influence both aspects of gastrointestinal health in this population. This supports further investigation into how these factors interact to affect IBS symptoms.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO GENE&quot;" target="&quot;OBESITY RISK&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The FTO gene is associated with obesity risk, particularly significant in AA subjects but not university students.")</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNP&quot;" target="&quot;EDUCATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"There is a statistically significant interaction between the FTO SNP and education regarding obesity risk in certain populations.")</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EDUCATION&quot;" target="&quot;OBESITY RISK&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"There is a significant interaction between education level and genetic factors such as the FTO gene, affecting obesity risk in certain populations.")</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EDUCATION&quot;" target="&quot;HCR SUBJECTS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"In HCR subjects, education level does not significantly interact with genetic factors such as the FTO gene regarding obesity risk.")</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GP&quot;" target="&quot;OHP&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The joint analysis of GP (presumably referring to Genotype Population or Genetic Population) and OHP shows an interaction term between education and the FTO SNP influencing obesity risk.")</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OHP&quot;" target="&quot;METABOLIC PATHWAY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"OHP refers to physiological processes that are influenced by both educational attainment and genetic variants like the FTO SNP.")</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIFESTYLE FACTOR&quot;" target="&quot;PHYSICAL ACTIVITY (PA)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"In HCR subjects particularly, physical activity level was found to interact with the FTO SNP to influence BMI, suggesting that individual's lifestyle habits can modify genetic susceptibility to overweight and obesity.") ("entity"</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIFESTYLE FACTOR&quot;" target="&quot;INTERACTIONS OF GENOTYPE AND DIET INTERVENTION&quot;">
      <data key="d4">240.0</data>
      <data key="d5">"Although not explicitly mentioned, physical activity is likely an environmental factor that influences dietary intake which in turn affects gene expression.")&lt;SEP&gt;"Although not explicitly mentioned, physical activity is likely an environmental factor that influences dietary patterns which could impact gene expression.")&lt;SEP&gt;"Similar to the Mediterranean group, physical activity may be an environmental factor influencing dietary intake which impacts gene expression.")&lt;SEP&gt;"Similarly, the Healthy Eating group's physical activity likely influences dietary patterns which could impact gene expression.")&lt;SEP&gt;"The study does not mention lifestyle factors like physical activity but it's likely an environmental influence on dietary intake which in turn affects gene expression.")</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIFESTYLE FACTOR&quot;" target="&quot;ENVIRONMENTAL FACTOR&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Environmental factors such as lifestyle choices and diet can influence the risk of developing migraines, influenced by gene-related genetic polymorphisms.")</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;METABOLIC PATHWAY&quot;" target="&quot;GENOTYPING PLATFORM&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The use of specific genotyping platforms like the Illumina Human Quad 660 chip can influence how genetic data is interpreted and potentially linked to metabolic pathway functioning.")</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;METABOLIC PATHWAY&quot;" target="&quot;LATENCY III PROGRAM&quot;">
      <data key="d4">17.0</data>
      <data key="d5">"The modulation of risk gene expression by EBNA2 is part of the Latency III program in EBV-infected cells.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;G × D INTERACTION&quot;" target="&quot;TCF7L2 GENE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Potential G × D interactions for genetic variants in the TCF7L2 gene were most frequently investigated among cohort studies and some other publications, while findings of other genetic variants were often limited to one publication only.")</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2 GENE&quot;" target="&quot;RS7903146&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The rs7903146 variant is located within the TCF7L2 gene, affecting risk for type 2 diabetes.")</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY FACTORS&quot;" target="&quot;FIBER AND WHOLE GRAIN&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Interaction between fiber or whole grain intake and genetic variants showed significant associations with incident Type 2 Diabetes (T2D).")</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NUTRIENT ZINC INTAKE&quot;" target="&quot;RS855791 GG-GENOTYPE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The TT genotype for rs855791 showed no interaction with dietary patterns or T2D incidence in exposure strata."|&lt;&gt;0.5) ("relationship"</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TABLE 1&quot;" target="&quot;T2D-ESRD GROUP VS CONTROL GROUP&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The case group had a higher mean age at enrollment compared to the nondiabetic control subjects."</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TABLE 1&quot;" target="&quot;WOMEN IN CASE AND CONTROL GROUPS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The case group included more women than the control group, indicating potential differences in risk factors.")</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEX&quot;" target="&quot;ENVIRONMENTAL FACTOR&quot;">
      <data key="d4">23.0</data>
      <data key="d5">"Sex was also included as a covariate in the analysis, affecting both cohorts under study and therefore influencing results related to 'age at first tooth' and 'number of teeth'.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AFRICAN ANCESTRY DEGREE&quot;" target="&quot;ENVIRONMENTAL FACTOR&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"There was no significant interaction observed between the degree of African ancestry and TCF7L2 gene variants related to diabetes risk.")</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR&quot;" target="&quot;DPP COHORT&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Fasting proinsulin levels were associated with the genotype at the SLC30A8 locus in the DPP cohort, before and after interventions.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR&quot;" target="&quot;AGE, SEX, ETHNICITY&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Adjustments for age, sex, and ethnicity did not significantly affect the association between genotype at SLC30A8 locus and fasting proinsulin levels after DPP interventions.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR&quot;" target="&quot;INTERACTIONS OF GENOTYPE AND DIET INTERVENTION&quot;">
      <data key="d4">48.0</data>
      <data key="d5">"Dietary intake of the nutrient 20:4 n-6 (AA) was found to interact with genotypes, suggesting an environmental factor at play.")&lt;SEP&gt;"The FADS1/2 gene cluster influences molecular interactions related to dietary intake, as indicated by the significant interaction.")&lt;SEP&gt;"The Mediterranean group's diet likely influences physiological processes related to fatty acid concentrations in the colon.")&lt;SEP&gt;"The study's findings suggest a relationship between the FADS1/2 gene cluster, dietary patterns (Healthy Eating), and cardiovascular disease risk.")</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR&quot;" target="&quot;DIET&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Dietary habits, including intake of nutrients such as calcium and dietary fiber, were associated with colorectal cancer risk in cases compared to controls, according to the WHI Observational Study results.") ("entity"</data>
      <data key="d6">chunk-d311ac0182b37003c75c0005b4337fa6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR&quot;" target="&quot;MATERNAL FOLATE INTAKE&quot;">
      <data key="d4">29.0</data>
      <data key="d5">"Low maternal folate intake has been linked to an increased risk of NTD-affected pregnancies.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR&quot;" target="&quot;MATERNAL EDUCATION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Less education was associated with a decreased risk of an NTD-affected pregnancy among both non-Hispanic White and Hispanic mothers, possibly due to factors such as higher folic acid supplement use or increased awareness about prenatal health.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR&quot;" target="&quot;TYMS GENE INTERACTION WITH FOLATE INTAKE&quot;">
      <data key="d4">27.0</data>
      <data key="d5">"The interaction between the TYMS gene and folate intake was associated with reduced risk of NTD-affected pregnancies for mothers in the low folate intake group, suggesting that both genetic predisposition and environmental factors such as diet play a role in determining this risk.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR&quot;" target="&quot;INFANT GENDER">
      <data key="d4">23.0</data>
      <data key="d5">"Case infants were more likely to be female than control infants, suggesting that factors such as gender may also play a role in determining risk of NTD-affected pregnancies in their infants.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR&quot;" target="&quot;INFANT FORMAL EDUCATION OF MOTHERS">
      <data key="d4">17.0</data>
      <data key="d5">"Lower levels of formal education were associated with decreased risk for an NTD-affected pregnancy. This may indicate differences in access to or use of prenatal health resources among different socioeconomic groups.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR&quot;" target="&quot;LOW FOLATE INTAKE CATEGORY&quot;">
      <data key="d4">30.0</data>
      <data key="d5">"Individuals with low intake of folates were at an increased risk for NTD-affected pregnancies according to the study's findings. This suggests that dietary factors may play a significant role in determining this risk.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY FACTORS" target="&quot;IMPACT ON GLYCEMIC STATUS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Factors such as fasting plasma glucose (FPG) and two-hour plasma glucose (2hPG), which are dietary factors, were positively associated with participants' baseline BMI levels.") ("entity"</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ETHNICITY" target="&quot;GLYCEMIC STATUS ANCESTRY ASSOCIATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Participants from different ethnic backgrounds like East Asian (22.7% of T2D), African (18.0%), South Asian (16.1%) had a higher prevalence and percentage decrease in IFG/IGT status compared to the NGT group."])(("relationship"</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;DRUG&quot;">
      <data key="d4">18.0</data>
      <data key="d5">"The study does not provide a direct relationship between statins and personalized therapy for cardiovascular disease. However, it may indirectly suggest that medications like statins could be part of an individualized approach to diet-gene interactions.")</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;THERAPY&quot;">
      <data key="d4">66.0</data>
      <data key="d5">"The concept of statins as therapy for cardiovascular disease implies a relationship with genetic factors that may influence drug response and risk of disease.")</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISEASE&quot;" target="&quot;SHMT1 GENE&quot;">
      <data key="d4">28.0</data>
      <data key="d5">"A reduction in risk for an NTD-affected pregnancy was observed among mothers with the SHMT1 gene SNP rs669340 CG compared to those with the CC genotype. This indicates that there may be a protective effect associated with this specific gene variant.")</data>
      <data key="d6">chunk-9a35876dc1aaf7342f023cab4f5b9914</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENDER BALANCE IN STUDY POPULATION&quot;" target="&quot;M:F RATIO&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"The study population had a male predominance with an M:F ratio of 2:1, which is slightly higher than expected but representative of the overall ALL population at Texas Children's Hospital.")</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FASTING PROINSULIN LEVELS&quot;" target="&quot;SLC30A8 RISK ALLELE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"This association was statistically significant, indicating a potential genetic contribution to increased fasting proinsulin levels.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FASTING PROINSULIN LEVELS&quot;" target="&quot;DPP INTERVENTION&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Despite being adjusted for multiple physiological variables and demographic factors, fasting proinsulin levels showed significant decreases indicating that the DPP intervention had a broad impact on metabolic pathways related to diabetes risk.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC30A8 RISK ALLELE&quot;" target="&quot;DPP INTERVENTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Fasting proinsulin levels decreased significantly in all active intervention groups compared with placebo, including lifestyle and medication-based interventions.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIPID ACCUMULATION&quot;" target="&quot;PNPLA3&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"PNPLA3 regulates lipid accumulation in cells, as demonstrated by high glucose and the presence of certain fatty acids like oleic acid (OA).")</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIPID ACCUMULATION&quot;" target="&quot;2-DEOXY-D-GLUCOSE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"2-deoxy-D-glucose led to a reduction in lipid content, suggesting its impact on reducing cholesterol levels.")</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PNPLA3&quot;" target="&quot;FAS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Expression Patterns of FAS and ACC-1 are similar to those of PNPLA3, indicating they may be regulated by the same factors.")</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EXERCISE SUPPRESSED PNPLA3 EXPRESSION&quot;" target="&quot;GLUCAGON SECRETION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Our in vivo data showed that exercise suppressed PNPLA3 expression and suggested the involvement of glucagon stimulation.")</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPT&quot;" target="&quot;G.28854194C/G VARIANT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Physiological Process"</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPT&quot;" target="&quot;SENP1&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Insulin Production"</data>
      <data key="d6">chunk-fc33d6399ec56e65d007269407f1953d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TRANSCRIPT&quot;" target="&quot;NOS1 GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Paradoxical psoriasis regressed when adalimumab was discontinued, indicating that the NOS1 gene may be involved in this condition's pathogenesis.")</data>
      <data key="d6">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1&quot;" target="&quot;CORTICOTROPIN-RELEASING HORMONE (CRH)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Stress Effects"</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ISOC1&quot;" target="&quot;LDLRAP1&quot;">
      <data key="d4">3.5</data>
      <data key="d5">"Isochorismatase Domain Containing 1 (ISOC1) interacts with Low Density Lipoprotein Receptor Adapter Protein 1 (LDLRAP1), crucial for lipid metabolism and clearance of low-density lipoprotein from the bloodstream.")</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE&quot;" target="&quot;TAG LEVELS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Differential TAG levels were observed among different genotypes, regardless of smoking status or diet patterns.")</data>
      <data key="d6">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE&quot;" target="&quot;INTERACTIONS OF GENOTYPE AND DIET INTERVENTION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The significant interaction found for 20:4, n-6 (AA) concentrations in the colon suggests a relationship between FADS1/2 genotype and diet intervention.")</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SMOKING STATUS&quot;" target="&quot;CORTISOL LEVELS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Smoking is a physiological process affecting blood cortisol levels in both sexes.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG LEVELS&quot;" target="&quot;GENE TYPE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Differential TAG levels were observed among different genotypes, regardless of smoking status or diet patterns.")</data>
      <data key="d6">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APOC1&quot;" target="&quot;PPP1R3B&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"PPP1R3B is located near APOC1 on chromosome 2. The proximity suggests that PPP1R3B may interact with or be influenced by genes like APOC1 involved in lipid metabolism.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GCKR&quot;" target="&quot;PABPC&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"GCKR is involved in glucose metabolism which may impact the regulation of PABPC and gene expression related to insulin secretion.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GCKR&quot;" target="&quot;CRP&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"GCKR is a gene that plays a crucial role in insulin secretion and may influence CRP levels through its impact on metabolism and inflammation pathways.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PPP1R3B&quot;" target="&quot;HNF4A&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"HNF4A, a gene critical for metabolic function, likely influences PPI1R3B by regulating pathways involved in cellular processes including cell signaling.")&lt;SEP&gt;"PPP1R3B is likely influenced by HNF4A, which regulates genes associated with lipid and glucose metabolism, suggesting a relationship in the context of cellular processes such as cell signaling pathways.")&lt;SEP&gt;"PPP1R3B may be regulated by HNF4A through shared targets or processes involving metabolic regulation, which can impact lipid and glucose metabolism including inflammatory pathways that influence CRP levels.)</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PPP1R3B&quot;" target="&quot;IL1F10&quot;">
      <data key="d4">19.0</data>
      <data key="d5">"IL1F10 is part of the interleukin-1 family and may interact with PPP1R3B through its involvement in inflammatory responses or cellular processes linked to metabolic pathways.")&lt;SEP&gt;"PPP1R3B may be regulated by IL1F10 due to shared pathways or targets involved in inflammatory responses, metabolic regulation, or cellular processes critical for cardiometabolic phenotypes.")&lt;SEP&gt;"PPP1R3B may be regulated by IL1F10 through cellular processes or metabolic regulation, affecting both inflammation and cardiometabolic phenotypes.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PPP1R3B&quot;" target="&quot;CRP&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"PPP1R3B, influencing cellular processes such as cell signaling pathways that are likely involved in inflammatory responses leading to changes in CRP levels.)</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PPP1R3B&quot;" target="&quot;MODY SIGNALING&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"PPP1R3B is located near MODY signaling pathways, which suggests a possible relationship between PPP1R3B and pathways related to metabolic disorders like diabetes.)</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HNF4A&quot;" target="&quot;CRP&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"HNF4A, known to regulate genes associated with lipid and glucose metabolism, likely influences CRP levels as part of the metabolic regulation pathway for inflammatory responses.)</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL1F10&quot;" target="&quot;CRP&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"IL1F10 is involved in interleukin-1 family signaling which may influence CRP levels through pathways related to inflammation and metabolic regulation.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRP&quot;" target="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"No significant association detected with CRP and its impact on ovarian cancer risk.")</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ARHGAP11A&quot;" target="&quot;SLEEP DURATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"An intronic variant in ARHGAP11A is associated with increased sleep duration."]</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SULT1A1&quot;" target="&quot;CODING REGION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The common deletion rs3833080 affects the coding region of SULT1A1, impacting its function and presence confirmed by resequencing analysis due to high similarity with flanking sequences.")</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SULT1A1&quot;" target="&quot;TRANSCRIPTION FACTOR BINDING SITES&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The non-synonymous alleles at these variants may change transcription factor binding sites and splicing enhancer/silencer binding sites, impacting SULT1A1 function.")</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;RS61737565&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Physiological Process"</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;RS8061877&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Molecular Interaction"</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;INTERACTIONS OF GENOTYPE AND DIET INTERVENTION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"A significant increase in the genomic variant associated with long chain n-3 PUFA was observed, indicating a genetic factor influencing fatty acid concentrations.")</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;SNPS&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"Each SNP that reached genome-wide significance is a genomic variant associated with 'age at first tooth' and 'number of teeth'.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;HMGA2&quot;">
      <data key="d4">18.0</data>
      <data key="d5">"A genomic variant in the HMGA2 region reached genome-wide significance for 'number of teeth', as indicated by rs17101923.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;TMEM9&quot;">
      <data key="d4">21.0</data>
      <data key="d5">"A variant in the TMEM9 region previously reported as genome-wide significant for 'secondary dentition' showed no genome-wide significance but still provided suggestive evidence of association with both phenotypes.")</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;NOS1&quot;">
      <data key="d4">3.0</data>
      <data key="d5">&gt;(</data>
      <data key="d6">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;RS3184504&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Hypertension"</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;CYP2C9*11&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"rs1057910 is a CYP2C9 genomic variant associated with increased risk of cardiovascular disease.")</data>
      <data key="d6">chunk-f433e179cd5e32035a0303b9a14da3f1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;GENOMIC VARIANT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"BDNF rs6265 (G/A) polymorphism in BDNF gene has been linked to an increased risk of migraine.")</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;PHYSIOLOGICAL PROCESS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Genetic polymorphisms in the BDNF gene are linked to physiological processes that influence migraine risk.")</data>
      <data key="d6">chunk-814fe155e9cb953da61f6a79d1d25784</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;CTLA4 GENE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"A genomic variant in the CTLA4 gene correlates with variations in T cell expression levels.")</data>
      <data key="d6">chunk-5b68770e1b446d6cba0d4e1ecabf497b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSIOLOGICAL PROCESS&quot;" target="&quot;INTERACTIONS OF GENOTYPE AND DIET INTERVENTION&quot;">
      <data key="d4">43.0</data>
      <data key="d5">"A significant interaction was found in the analysis, suggesting a relationship between physiological processes like gene-diet interactions.")&lt;SEP&gt;"The increase in long chain n-3 PUFA is likely related to a reduced risk of cardiovascular disease, suggesting an influence on this health outcome.")&lt;SEP&gt;"The increase in long chain n-3 PUFA was observed, indicating a process related to colon fatty acid concentrations.")&lt;SEP&gt;"The study found that in the Mediterranean group, colon fatty acid concentrations remained fairly constant, indicating a process specific to this dietary pattern.")</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSIOLOGICAL PROCESS&quot;" target="&quot;NITRIC OXIDE SYNTHESIS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Increased nitric oxide synthesis, as influenced by the NOS1 and Nos2 genes, is associated with hypertension risk due to its role in vascular tone regulation.")</data>
      <data key="d6">chunk-c29d575e156569afaa1ca3d6418a71b9</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSIOLOGICAL PROCESS&quot;" target="&quot;CLUSTER RELATED TO DISEASES AND DISORDERS&quot;">
      <data key="d4">28.0</data>
      <data key="d5">"Clusters of genes related to diseases and disorders interact with physiological processes such as haematological, immunological, renal, and skeletal functions.")</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSIOLOGICAL PROCESS&quot;" target="&quot;SERUM C4&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"There was a significant association between serum C4 levels and physiological processes affecting IBS subgroups. Higher values were observed in IBS-D compared to IBS-C and HV participants.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSIOLOGICAL PROCESS&quot;" target="&quot;FGFR4 RS1966265&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"A candidate genetic variant was marginally associated with stool BA, suggesting a potential influence on physiological processes related to BA synthesis and excretion in this population.")</data>
      <data key="d6">chunk-7aea4201f8f5f090ffa8d3bfe2fcdff6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSIOLOGICAL PROCESS&quot;" target="&quot;TREG&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Our data suggests that overexpressed PTPN22 gene influences disease risk by altering Treg-mediated suppression of Tconv cells, affecting their suppressive capacity and susceptibility to activation and proliferation.")</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSIOLOGICAL PROCESS&quot;" target="&quot;MS RISK LOCI&quot;">
      <data key="d4">15.0</data>
      <data key="d5">"Risk alleles for MS are associated with altered physiological processes, including immune evasion during EBV latency III infection.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS IN ALOX15&quot;" target="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"No association was found between SNPs in ALOX15 and ovarian cancer risk according to the combined analyses at various SNPs, including IL1B rs7596684 and PTGS1 rs2282169.")</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CCL2&quot;" target="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"No association was observed between SNPs in CCL2 and CRP for ovarian cancer risk according to the study results.")</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL18&quot;" target="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"No evidence of an IL18 SNPs link to ovarian cancer risk was observed in the study.")</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL6&quot;" target="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"No significant relationship detected between IL6 SNPs and their impact on ovarian cancer risk.")</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER RISK&quot;" target="&quot;CDX-2&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The Cdx-2 gene may be associated with an increased risk of ovarian cancer, as suggested by various studies reviewed here.")</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER RISK&quot;" target="&quot;TAQI&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Variant TaqI appears to have no significant impact on the risk of ovarian cancer according to the meta-analysis conducted.")</data>
      <data key="d6">chunk-dc5e8cc04a1b16b1e00f3a4120e004c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1 (PTGS1)&quot;" target="&quot;RS2282169&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"rs2282169 of PTGS1 is a genomic variant associated with increased ovarian cancer risk according to the study results.")</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;RS17388568&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Carriers of at least one minor allele (GA or AA) in rs17388568 SNP are 74% less likely to respond to anti-PD-1 treatment compared to those with GG genotype.")|&gt;3) ("entity"</data>
      <data key="d6">chunk-2b5346dfc62015294aa57aeab3960cd1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PARTICIPANTS&quot;" target="&quot;STUDY CENTER&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Participants at different study centers had varying lifestyles and dietary habits that could affect their health outcomes.")</data>
      <data key="d6">chunk-770a24a1a31cf671a7681e7c98a7ee91</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTERACTIONS OF GENOTYPE AND DIET INTERVENTION&quot;" target="&quot;THERAPY&quot;">
      <data key="d4">43.0</data>
      <data key="d5">"Although not directly mentioned, the concept of statins as therapy for cardiovascular disease implies a relationship with gene-diet interactions.")&lt;SEP&gt;"The concept of personalized therapy is mentioned in the context of managing cardiovascular disease risk, which could be influenced by dietary patterns and genetic factors.")</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;THERAPY&quot;" target="&quot;PERSONALIZED THERAPY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Personalized therapies based on genetic and nutritional profiles are being explored to manage cardiovascular health."/&gt;&gt;13) ("entity"</data>
      <data key="d6">chunk-1d2a8d3ce4f9baae7e1c9c14410045d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONDITION&quot;" target="&quot;SC RESPONSES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Participants had more non-specific skin conductance responses during the stress condition compared to no-stress condition, reflecting heightened physiological reactivity.") ("entity"</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOS1 GENE&quot;" target="&quot;ADALIMUMAB&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Paradoxical psoriasis regressed when adalimumab was discontinued, indicating that the NOS1 gene may be involved in the pathogenesis of this condition.")</data>
      <data key="d6">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLITIS&quot;" target="&quot;CARD9-/- MICE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Impaired Recovery"</data>
      <data key="d6">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLITIS&quot;" target="&quot;HISTOPATHOLOGIC ALTERATIONS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">2) ("entity"</data>
      <data key="d6">chunk-4d5e7ab61a7357d5106f4a8a355f40d0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10 RESPONSE&quot;" target="&quot;PRO-IL-1Β PRODUCTION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"IL-10 inhibits pro-IL-1β production, which is crucial for attenuating disease severity and modulating the Th17 response in inflammatory bowel diseases."])(Supplementary Fig. 6a) ("entity"</data>
      <data key="d6">chunk-f2c864ef2d87119a8129e011b1c42e3c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MICROBIOTA&quot;" target="&quot;MICROBIOTA&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The gut microbiota of Card9−/− mice shows pro-inflammatory effects and affects the susceptibility to colitis.")</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MICROBIOTA TRANSFER PHENOCOPY&quot;" target="&quot;PHENOTYPE RECAPITULATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The phenotype observed in Card9−/− mice was recapitulated by colonizing WT GF mice with the Card9−/− microbiota, indicating that gut microbiota plays a key role in colitis susceptibility.")</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MICROBIOTA TRANSFER PHENOCOPY&quot;" target="&quot;FUNGAL COMPONENT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The involvement of fungal components in colitis susceptibility was assessed through antifungal treatment during microbiota transfer experiments.")</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MICROBIOTA TRANSFER PHENOCOPY&quot;" target="&quot;IL-22 AXIS DEFECT&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"A deficiency in the IL-22 axis was observed in Card9−/−→GF mice, which may underlie impaired recovery from DSS-induced injury and colitis susceptibility.")</data>
      <data key="d6">chunk-e025ebd5580ff5f1a76bedbcaed2a0b6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PERSONALIZED THERAPIES IN CARDIOVASCULAR HEALTH&quot;" target="&quot;STATINS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">&gt;(</data>
      <data key="d6">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DENDRITIC CELLS &amp; MACROPHAGES&quot;" target="&gt;(">
      <data key="d4">10.0</data>
      <data key="d5">&lt;&gt;)"Involved in stimulating IL-22 producing cells, yet no significant differences observed between specific genotypes like Card9−/−→GF and WT→GF mice.")</data>
      <data key="d6">chunk-29025895ac187b8e88dec5cea9478842</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CC GENOTYPE&quot;" target="&quot;T ALLELE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The occurrence of colorectal cancer (CRC) showed a significant association between the CC genotype and presence of the T allele, indicating a potential genetic link in CRC development.")</data>
      <data key="d6">chunk-5b0cc96debf110f3544685d3b227ff27</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NEMO&quot;" target="&quot;NF-ΚB SIGNALLING PATHWAY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Enhanced NEMO SUMoylation enhances NF-κB signalling pathway activation in adipocytes."</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INCREASED IKBKAPPA PHOSPHORYLATION AND NEMO SUMOYLATION ENHANCE NF-ΚB P65/RELA ACTIVATION IN ADIPOCYTES.&quot;" target="&quot;NF-ΚB P65/RELA ACTIVATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">6) ("entity"</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-6&quot;" target="&gt;&quot;CYTOKINES&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"IL-6 is an inflammatory cytokine produced by macrophages and other immune cells, which was found to be significantly higher in SENP1 knockdown adipocytes."</data>
      <data key="d6">chunk-f290cff8dac7b522b4f56d03e8df48ce</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.P992L&quot;" target="&quot;HAPLOGROUP E&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Variant p.P992L presented a complex haplotype spectrum including six haplogroups (D, E, F, G, H, I), with Haplogroup E being more common on WD chromosomes." )</data>
      <data key="d6">chunk-fa2d834930246b534181c3d6d2c049e1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC VARIANT CONFIRMATION&quot;" target="&quot;MOSAICISM IN TISSUES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Confirmed mosaicism for the P1001L mutation was found only in tissue samples, typical of classic Menkes disease. "]&gt;&gt;6) ("entity"</data>
      <data key="d6">chunk-c5f88943265b25ad302b08fd04a602d7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IDI-T VARIANT&quot;" target="&quot;GPX1 ACTIVITY&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The IDI-T variant associated with higher gene expression levels may influence GPX1 activity through yet unknown mechanisms. This could affect oxidative stress responses in Caco-2 cells under different conditions.")&gt; ("entity"</data>
      <data key="d6">chunk-c7872499c2a84b16c506a135d8033bb7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IDI-C CELLS&quot;" target="&quot;SELENOPROTEIN EXPRESSION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Selenium supply influences the expression of various selenoproteins, with IDI-C showing lower levels compared to IDI-T.")</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GPX4 IN IDI-C CELLS&quot;" target="&quot;SENSITIVITY TO OXIDATIVE STRESS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"IDI-C cells exhibit greater sensitivity to oxidative stress as evidenced by their higher ROS levels and reduced viability under depleted selenium conditions.")</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SELENIUM CONCENTRATION IN MEDIUM&quot;" target="&quot;SELENOPROTEIN EXPRESSION CHANGES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Changes in the Se content of the medium affect cell viability differently, with IDI-C cells showing greater viability at high concentrations compared to IDI-T.")</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GPX ACTIVITY DIFFERENCES&quot;" target="&quot;IDI TRANSCRIPTS EXPRESSION LEVELS WITHIN CLONES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Different GPx activities are observed between different clones and under varying selenite conditions, indicating a complex interplay of transcript levels with antioxidant response mechanisms.")</data>
      <data key="d6">chunk-a908a3115a9120ca2623513fe4a5e13a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHAT GENE&quot;" target="&quot;ACETYLCHOLINE RECEPTOR FORMATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The CHAT gene encodes proteins involved in acetylcholine receptor formation, with mutations altering this process significantly."</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.ALA557THR MUTATION&quot;" target="&quot;PHENOTYPE DETERMINATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The p.Ala557Thr mutation determines the phenotype of patient 10, influencing their physiological function related to acetylcholine receptor formation."</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;P.THR553ASN MUTATION&quot;" target="&quot;RATE CONSTANTS OF CHAT ACTIVATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The p.Thr553Asn mutation affects one or more rate constants of ChAT activation, altering enzyme function."</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EXPRESSION LEVELS&quot;" target="&quot;MUTANT CHAT TRANSCRIPTS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Mutant CHAT transcripts are expressed at significantly lower levels in Bosc 23 cells, affecting cellular function and protein expression."</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KINETIC PARAMETERS OF CHAT MUTANTS&quot;" target="&quot;THERMAL STABILITY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Ten mutations alter one or more rate constants of ChAT activation, compromising the thermal stability of the mutant proteins."</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NONSENSE MUTATION ON SECOND ALLELE&quot;" target="&quot;P.ALA557THR MUTATION IN PATIENT 10&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The p.Ala557Thr mutation also determines the phenotype in patient 10, who carries a nonsense mutation on her second allele."</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONSANGUINEOUS MARRIAGE&quot;" target="&quot;PATIENT 11 BIRTH&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Patient 11 is born to consanguineous parents, indicating a genetic contribution to their condition and disease manifestation."</data>
      <data key="d6">chunk-2266e03ff38ff200390d9e9e50efbd74</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OPRM1 GENE&quot;" target="&quot;ALDH2 GENOTYPE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The OPRM1 gene interacts with ALDH2 genotype, which may influence the effects of alcohol on drug-induced side effects such as drowsiness.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OPRM1 GENE&quot;" target="&quot;ADHOHNB1B GENOTYPE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The relationship between OPRM1 and ADH1B genes is complex; they both play a role in subjective responses to alcohol but are not directly linked according to the provided data.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AUDIT SCORE&quot;" target="&quot;OPRM1 GENOTYPE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Genotype differences across OPRM1 may influence AUDIT scores as well as medication-induced drowsiness or sedation.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DRINKING DAYS&quot;" target="&quot;MEDICATION EFFECTS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The number of drinking days in the past 30 days is a demographic factor that varies by genotype and influences subjective responses to alcohol infusion sessions, including medication side effects such as drowsiness.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NALTREXONE&quot;" target="&quot;RINGING IN THE EARS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Naltrexone, as medication, was associated with increased ringing in the ears compared to participants on placebo.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DROWSINESS&quot;" target="&quot;MEDICATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Naltrexone, as medication taken during an experiment on drug effects, was associated with higher drowsiness levels compared to placebo participants.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DROWSINESS&quot;" target="&quot;PLACEBO PARTICIPANTS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Participants taking placebo in a study had lower levels of drowsiness than those on naltrexone.")</data>
      <data key="d6">chunk-62d8719735e6c6eaa899d9ea64143544</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALDH2 RS671&quot;" target="&quot;DAILY DRINKS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Higher daily alcohol consumption was observed across various ALDH2 genotypes.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS671 POLYMORPHISM&quot;" target="&quot;CORTISOL LEVELS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"This polymorphism affects blood cortisol levels significantly among different genotypes.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS671 POLYMORPHISM&quot;" target="&quot;HYPERTENSION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Significant differences were observed between hypertension risk and the rs671 polymorphism, indicating its impact on cardiovascular health.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS671 POLYMORPHISM&quot;" target="&quot;UA (URIC ACID)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The rs671 polymorphic variant is linked to increased uric acid levels that may contribute to the risk of hypertension among hypertensive individuals.")</data>
      <data key="d6">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CORTISOL LEVELS&quot;" target="&quot;EDUCATION STATUS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Educational status influences blood cortisol levels, as shown by the study population's characteristics.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE DISTRIBUTION&quot;" target="&quot;GA GENOTYPE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The GA genotype group was older than other groups in both sexes.")</data>
      <data key="d6">chunk-9e14f9bdee02839e4a6b12cff2020a5a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTENSION&quot;" target="&quot;UA (URIC ACID)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Higher levels of serum uric acid are associated with higher risks of both hypertension and disease progression in hypertensive individuals carrying these polymorphic variants.")</data>
      <data key="d6">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTENSION&quot;" target="&quot;DIETARY PURINES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Increased intake of purine-rich foods can lead to higher serum uric acid levels, which are associated with an increased risk of developing hypertension and cardiovascular disease.")</data>
      <data key="d6">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TG LEVELS&quot;" target="&quot;CLINICAL MANIFESTATIONS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Hypertriglyceridemia leads to clinical manifestations such as eruptive xanthomas, lipemia retinalis, and gastrointestinal hemorrhage.")</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2228269 POLYMORPHISM&quot;" target="&quot;RS2231142 POLYMORPHISM&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The two specific genetic variants, rs2228269 and rs2231142, appear to independently contribute to increased risk of hypertension.")</data>
      <data key="d6">chunk-7091ed039203b69ad83d281b22c89579</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HTR2A&quot;" target="&quot;RS9保">
      <data key="d4">1.0</data>
      <data key="d5">"rs9534511 on HTR2A gene is associated with increased risk of social disinhibition.")</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HTR2A&quot;" target="&quot;TAS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The HTR2A gene is involved in tooth ageness and might influence TAS scores, which could affect social disinhibition."</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HTR3B&quot;" target="&quot;RS4938056">
      <data key="d4">2.0</data>
      <data key="d5">"rs4938056 on HTR3B gene is associated with increased risk of social disinhibition.")</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HTR3B&quot;" target="&quot;DAS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Similarly, the HTR3B gene may be associated with pain sensitivity (as measured by DAS score), which can impact overall well-being and potentially lead to social disinhibition."</data>
      <data key="d6">chunk-d4e04dd6cd6ea28f04fd72d964574ec1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2023239&quot;" target="&quot;CUE-ELICITED CRAVING&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Genomic variant rs2023239 interacts with olanzapine to influence cue-elicited craving and drinks per drinking day.") ("entity"</data>
      <data key="d6">chunk-7542fe4e6d1c727325a6be02a71f8e59</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTRIGLYCERIDEMIA&quot;" target="&quot;LPL GENE MUTATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Mutations in the LPL gene are associated with severe hypertriglyceridemia in patients with lipolysis-related disorders.")</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY FAT RESTRICTION&quot;" target="&quot;TREATMENT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Dietary fat restriction is a cornerstone of treatment for managing complications related to LPL deficiency and hypertriglyceridemia.")</data>
      <data key="d6">chunk-1e1db26cd046378fc4ac9fd4c4d35c86</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RA2627 CELLULAR DEFECTS&quot;" target="&quot;FANCONI ANEMIA-T&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The deficiency in UBE2T gene function is the cause of Fanconi anemia T subtype, as demonstrated by rescue experiments involving overexpression of the wild type UBE2T gene.")</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTORS&quot;" target="&quot;UBE2T GENE EXPRESSION AND FUNCTION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Exposure to mutagenic agents like MMC and DEB is known to induce FA-T cellular defects, which are rescued by restoration of functional UBE2T expression.")</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FANCONI ANEMIA T SUBTYPE CAUSE&quot;" target="&quot;RA2627 FIBROBLASTS">
      <data key="d4">1.0</data>
      <data key="d5">"The cellular defects observed in RA2627 fibroblasts are directly caused by the deficiency of functional UBE2T gene expression, as demonstrated through rescue experiments using wild type UBE2T.")</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FANCD2 MONOUBIQUITINATION RESTORED BY UBE2T EXPRESSION&quot;" target="&quot;MOLECULAR INTERACTION MODIFIER&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The restoration of FANCD2 monoubiquitination following the overexpression of wild type UBE2T in FA-T fibroblasts is a strong indicator that functional UBE2T gene expression has significant implications for DNA repair processes.")</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MOLECULAR INTERACTION MODIFIER&quot;" target="&quot;FANCD2 FOCI FORMATION AND DNA REPAIR PROCESS CORRELATED WITH UBE2T GENE EXPRESSION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The restoration of FANCD2 foci formation upon overexpression of wild type UBE2T in FA-T fibroblasts is a strong indicator that functional UBE2T gene expression plays a key role in maintaining DNA repair processes.")</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENVIRONMENTAL FACTOR MMC INDUCES CELLULAR DEFECTS IN FIBROBLASTS LACKING FUNCTIONAL UBE2T GENE&quot;" target="&quot;RELATIONSHIP MODIFIER&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Exposure to mutagenic chemicals like MMC is known to induce FA-T cellular defects, highlighting the critical role of functional UBE2T expression in preventing these genetic deficiencies.")</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVEREXPRESSION OF UBE2T CORRECTS CELLULAR PHENOTYPES IN FIBROBLASTS LACKING FUNCTIONAL GENE&quot;" target="&quot;PROTEIN EXPRESSION MODIFIER&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The process of overexpressing wild type UBE2T into FA-T fibroblasts effectively rescues cellular phenotypes, supporting the hypothesis that functional UBE2T gene expression is critical for normal cellular function.")</data>
      <data key="d6">chunk-ffd1276c89bcac745a7e58082e97236f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RP GENE&quot;" target="&quot;CELL DEATH&quot;">
      <data key="d4">17.0</data>
      <data key="d5">"Clusters of RP genes are related to cell death and cellular development.")</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RP GENE&quot;" target="&quot;LIPID METABOLISM&quot;">
      <data key="d4">18.0</data>
      <data key="d5">"Clusters of RP genes are involved in lipid metabolism.")</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RP GENE&quot;" target="&quot;MOLECULAR TRANSPORT&quot;">
      <data key="d4">19.0</data>
      <data key="d5">"Clusters of RP genes contribute to molecular transport.")</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EMBRYONIC TISSUE GENE&quot;" target="&quot;CELL DEATH&quot;">
      <data key="d4">34.0</data>
      <data key="d5">"Embryonic tissue genes contribute to cell death and developmental processes.")</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SKELETAL TISSUE GENE&quot;" target="&quot;LIPID METABOLISM&quot;">
      <data key="d4">35.0</data>
      <data key="d5">"Skeletal tissue genes are involved in lipid metabolism and cellular development.")</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONNECTIVE TISSUE GENE&quot;" target="&quot;MOLECULAR TRANSPORT&quot;">
      <data key="d4">36.0</data>
      <data key="d5">"Connective tissue genes contribute to molecular transport and cellular development.")</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SKELETAL DEVELOPMENT GENE&quot;" target="&quot;CELL DEATH&quot;">
      <data key="d4">41.0</data>
      <data key="d5">"Skeletal development genes contribute to cell death and developmental processes.")</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONNECTIVE TISSUE DEVELOPMENT GENE&quot;" target="&quot;LIPID METABOLISM&quot;">
      <data key="d4">42.0</data>
      <data key="d5">"Connective tissue development genes are involved in lipid metabolism and cellular development.")</data>
      <data key="d6">chunk-dcbd547f8218e7097805720fd6ea43ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIPID METABOLISM&quot;" target="&quot;ASAHOHNAU C SELIM HASAN GENE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"ASAH1 gene plays a critical role in regulating lipid metabolism and atherosclerosis risk by influencing lipoprotein pathways.")</data>
      <data key="d6">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NEUTROPHILS INFLAMMATORY CYTOKINE IL-36Γ&quot;" target="&quot;PARADOXICAL PSORIASIFORM REACTIONS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"IL-36γ positivity was enhanced in dermis of patients with paradoxical psoriasis compared to classical plaque-type psoriasis.")</data>
      <data key="d6">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PARADOXICAL PSORIASIFORM REACTIONS&quot;" target="&quot;T-CELLS IFN-Γ&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"IFN-γ immunoreactivity decreased and IL-22 positivity was significantly augmented in the infiltrate of paradoxical skin reactions compared to classical psoriasis.")</data>
      <data key="d6">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PARADOXICAL PSORIASIFORM REACTIONS&quot;" target="&quot;MACROPHAGES CD15+ NEUTROPHILS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"CD15+ neutrophils, c-kit/CD117+ mast cells, and monocytes in dermis of paradoxical skin reactions were significantly increased (~3.8-, 3.5-, and 1.8-fold increase) compared to classical psoriasis.")</data>
      <data key="d6">chunk-0380fd029b3eda680c87c1b8bcbe7f4c</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NEMO-UBZ&quot;" target="&quot;RAD18-UBZ&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"NEMO-UBZ and RAD18-UBZ interact with ubiquitin differently, involving a different mode of interaction compared to WRNIP1-UBZ.")</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;POLΗ-UBZ&quot;" target="&quot;FAAP20-UBZ&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Both Polη-UBZ and FAAP20-UBZ interact with ubiquitin similarly, involving conserved or equivalent residues involved in Ub binding between these two proteins.")</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RAD18-UBZ&quot;" target="&quot;WRNIP1-UBZ&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"WRNIP1-RAD18 both proteins interact with ubiquitin differently; RAD18 has residues involved in Ub binding that are different from those in WRNIP1.")</data>
      <data key="d6">chunk-5bfe051a79e5e215dd3fc65296825591</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PFI&quot;" target="&quot;RS1799793 GENOMIC VARIANT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The rs1799793 genomic variant in the ERCC2 gene correlates with PFI.")</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ERCC2 PROTEIN&quot;" target="&quot;PLATINUM-FREE INTERVAL (PFI)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The ERCC2 protein interacts with genes like ERCC2, influencing PFI and OS.")</data>
      <data key="d6">chunk-e8f81fdd25a22582c6ce3d1e15f74af3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLORECTAL CANCER RISK&quot;" target="&quot;INTERLEUKIN-8 GENE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The IL-8 gene polymorphism rs4073 T/A was studied to assess its association with CRC susceptibility.")</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLORECTAL CANCER RISK&quot;" target="&quot;INTERLEUKIN-22 GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Two IL-22 polymorphisms rs1179251 C/G and rs2227485 C/T were studied to assess their potential association with CRC susceptibility among Saudi patients.")</data>
      <data key="d6">chunk-bd81c38d10d8773bc4076cbb20bc289f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C-G AND C-A HAPLOTYPES&quot;|" target="&quot;HAPLOTYPE COMBINATIONS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"These haplotypes were found more significantly in CD compared to healthy controls, suggesting an influence of genetic factors on PTPN2/22 expression within the disease context."|&gt;8) ("relationship"</data>
      <data key="d6">chunk-84ec948f22126cef7d93b1d7465b79db</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTPN22&quot;" target="&quot;TCONV CELLS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The study demonstrates that the PTPN22 risk variant influences disease risk by altering Treg-mediated suppression of untransduced (internal control) Tconv cells, suggesting intrinsic impacts on activation, proliferation mechanisms in Tconv.")</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CA2+&quot;" target="&quot;CALCIUM IONS&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The role of calcium ions in pERK signaling is critical for modulating TCR-induced activation responses, including expression of surface activation markers like CD69, ICOS, and CD25.")</data>
      <data key="d6">chunk-d53a9f0fba772a7b52b906f476f0aef7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LYP VARIANT&quot;" target="&quot;IFNΓ&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Overexpression of the LYP variants did not alter IFNγ secretion, indicating a consistent response among cells regardless of gene variant.")</data>
      <data key="d6">chunk-dee0a8a550579bff19f48d41446e842d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG72-CAR T CELLS&quot;" target="&quot;REPEAT DOSING&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Repeat dosing promotes more extensive tumor regression and better control over tumors compared to single dose treatments.")</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER&quot;" target="&quot;TUMOR ANTIGEN HETEROGENEITY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Antigen escape contributes to tumor recurrences in ovarian cancer, where tumor antigen heterogeneity plays a key role.")</data>
      <data key="d6">chunk-7fe5e7a40fe11afeb152e614de7ef1cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IBS KERNEL&quot;" target="&quot;ASAH1 GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The IBS kernel is important for studying the relationship between genetic variants and disease risk for ASAH1 gene, incorporating rare variant information improves test power.")</data>
      <data key="d6">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LINEAR KERNEL&quot;" target="&quot;ASAH1 GENE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The linear kernel was mis-specified in this context as it did not accurately model the relationship between genes like ASAH1 and atherosclerosis risk for a case study involving epistasis.")</data>
      <data key="d6">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MIN TEST&quot;" target="&quot;ASAH1 GENE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"For studies of the effect of ASAH1 gene, both the min test suffered from substantial power loss due to mis-specification when modeling its relationship with lipid metabolism and atherosclerosis risk.")</data>
      <data key="d6">chunk-076f6aeeb369546413bc63c9f305553a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COMBINATION-THERAPY TREATED PATIENTS&quot;" target="&quot;N RESPONDERS/CASES&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"These individuals make up the control or case groups in this study, designated by N responders or non-responders respectively.")</data>
      <data key="d6">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COMBINATION-THERAPY TREATED PATIENTS&quot;" target="&quot;STATISTICAL SIGNIFICANCE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"None of the Associations"&lt;SEP&gt;"None of the associations"</data>
      <data key="d6">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COMBINATION-THERAPY COHORT SAMPLE SIZE&quot;" target="&quot;WIDE CONFIDENCE INTERVALS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Due to small sample size in the combination-therapy cohort, confidence intervals are wide suggesting reduced power to detect significant effects.")&lt;SEP&gt;"This suggests a reduction in power to detect significant effects due to the small sample size of combination-therapy treated patients, leading to wider confidence intervals indicating reduced statistical certainty.")</data>
      <data key="d6">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NO SIGNIFICANT ASSOCIATION&quot;" target="&quot;TREATMENT RESPONSE&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Despite adjusting for age, sex and treatment drugs, no significant association with treatment response was observed amongst patients grouped by anti-CTLA-4, anti-PD-1 or combination-therapy treatments indicating limited impact of these drug types on overall patient response.")&lt;SEP&gt;"Despite adjusting for age, sex and treatment drugs, no significant association with treatment response was observed amongst patients grouped by anti-CTLA-4, anti-PD-1 or combination-therapy treatments.")</data>
      <data key="d6">chunk-0d49552280a277a8a26456d06f8f26a8</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2&quot;" target="&quot;TRAFL&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"EBNA2 binds preferentially to the risk allele for TRAFL, altering its expression.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2&quot;" target="&quot;CD40&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"EBNA2 binds prefrerentially to the protective allele of CD40, reducing its expression in lymphoblastoid cell lines compared to uninfected B cells.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2&quot;" target="&quot;TNFAIP8&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"EBNA2 binds preferentially to the risk allele of TNFAIP8, decreasing its expression.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2&quot;" target="&quot;TNFRSF1A&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"EBNA2 binds prefrerentially to the protective allele of TNFRSF1A, reducing its expression.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2&quot;" target="&quot;TBX6&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"No significant relationship between EBNA2 and TBX6 was observed in this study.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EBNA2&quot;" target="&quot;RCOR1&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"There is no evidence of a direct interaction between EBNA2 and RCOR1.")</data>
      <data key="d6">chunk-03962ffc6066ee5da582bdc89310b1d6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CD8+ TEM CELLS&quot;" target="&quot;AGE WITH CLINICAL SIGNIFICANCE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Increases in CD8+ TEM cell proportions became clinically significant with age, indicating a potential clinical relevance or trend.")</data>
      <data key="d6">chunk-4389e37ac64d551cdf89e7f4230a3589</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS28383172 AG OR GG GENOTYPES&quot;" target="&quot;HLA‐DRB1*07:01 ALLELE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Carries HLA‐DRB1*07:01 allele"</data>
      <data key="d6">chunk-0dd0781947ec4a92007eb1736b1888c2</data>
      <data key="d7">1</data>
    </edge>
  </graph>
</graphml>
